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Abstract
The construction of complex molecular architectures in a facile and efficient manner remains
an overarching goal for the chemical sciences. The development of synthetic linchpins, simple
compounds that are used to join complex molecular fragments together, represents a powerful
method for improving synthetic efficiency. A major challenge associated with linchpin-based
synthetic strategies is the development of chemoselective and atom economic reactions that
enable late-stage introduction of the linchpin compound.
Chiral propargylic alcohols are versatile synthetic intermediates and their preparation
enables entry into a variety of alkyne-based linchpin strategies. Continued optimization of
Zn-ProPhenol-catalyzed alkyne addition has led to the development of practical and general
conditions for the asymmetric alkynylation of aldehydes. This methodology operates with
relatively low catalyst loading and can avoid the use of excess alkyne and dialkylzinc reagents.
The total synthesis of asteriscunolide D was completed in just nine steps using a Zn-
ProPhenol-catalyzed asymmetric alkynylation and Ru-catalyzed alkene-alkyne coupling. Other
highlights of this protecting-group-free synthesis include the use of a thionium-induced
cyclization to form the challenging 11-membered humulene ring. At the core of this succinct
and selective synthetic strategy is the use of methyl propiolate as a strategic linchpin. In just
two steps, three new bonds were formed to atoms derived from methyl propiolate and this
ultimately enabled the construction of this structurally challenging natural product.
An enantioselective formal total synthesis of aspergillide B has been accomplished using
sequential Zn-catalyzed alkyne additions to a masked butane dialdehyde linchpin. This
synthesis has led to the development of new conditions for Zn-ProPhenol-catalyzed alkynylation
that provide excellent yield and enantioselectivity using just a single equivalent of alkyne.
Ru-catalyzed trans-hydrosilylation provides the desired E alkene geometry and also allows
chemoselective differentiation of the two double bonds in a subsequent hydrogenation step.
This synthetic route provides access to aspergillide B in just 15 steps, using six highly efficient
transition metal-catalyzed reactions.
Labillarides E-H are a group of diastereomeric oxylipin natural products with very
interesting structural features and spectroscopic properties. The development of a Pd-
catalyzed allylic alkylation cascade has enabled the rapid construction of the furanopyrone
core and alkenyl side chain of these compounds. The use of density functional calculations,
in conjunction with spectroscopic data obtained from the truncated labillaride E-H structure,
has provided good evidence that labillarides E and G have a 3,6-syn configuration, whereas
labillarides F and H have a 3,6-anti configuration. Subsequent development of the Pd-AA
cascade methodology has led to the discovery of a highly regioselective Pd-AA cascade with
non-symmetric dihydropyran substrates. The combination of allylic carbonate and anomeric
siloxy leaving groups in the dihydropyran substrate enables control of the many regiochemical
possibilities in this reaction. Ultimately, annulation proceeds stereoconvergently to give a cis-
fused furopyran from either cis- or trans-substituted starting material. During the course of this
iv
research, the assignment of the remote relative stereochemistry of a number of 3,6-dihydro-2H -
pyran starting materials and side products was achieved through a novel NMR-based analysis
of axial shielding magnitudes.
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Introduction
1
1.1. PREAMBLE 2
1.1 Preamble
The purpose of this introduction is to provide background and context to the research that
follows, while also conveying a sense of why I have chosen to address specific research questions
and why synthetic problems were approached in a certain way. Specifically, it is designed to
address three main questions that underpin the field of synthetic organic chemistry:
Target – What compounds should be synthesized and why?
Methodology – What reactions should be used to construct bonds in a molecule?
Strategy – In what order should these reactions be performed to maximize efficiency?
Each of these relatively simple questions has enormous implications for the way in which one
performs research in synthetic organic chemistry and spans topics such as pharmacodynamics,
atom economy, chemoselectivity, stereoselectivity, and retrosynthetic analysis. The following
three sections aim to provide an awareness of the implications that the research contained
within this thesis has in regard to target, methodology and strategy.
1.2 Total Synthesis and Natural Product Analogues
in the Drug Discovery Process
Natural products have inspired the development of many life saving medical treatments.1
Ailments such as bacterial infection, inflammatory diseases and cancer can be treated with
natural products or natural product derivatives. Pharmacophores found in nature represent an
unparalleled source of lead structures in the discovery of new therapeutic drugs. For example,
the natural products Taxol R© (paclitaxel, 1) and erythromycin (2) are currently used to treat
cancer and bacterial infection, respectively (Scheme 1.1).2 In addition to their direct use, the
structures of Taxol R© and erythromycin have inspired the development of the superior semi-
synthetic drugs, docetaxel (Taxotere R©, 3) and azithromycin (Zithromax R©, 4).3,4 Scheme 1.1
highlights the structural modifications made to these natural products to provide improved
medicinal properties. Docetaxel has a better aqueous solubility than Taxol R© and this results
in an improved pharmacokinetic profile. The structural modifications present in azithromycin
result in improved bioavailability and potency against gram-negative bacteria compared to
erythromycin. These examples highlight the power of chemical synthesis in discovering novel
medicinal compounds.
The total synthesis of a natural product is a process that often provides a wealth of
knowledge and scientific bounty along the way. The essence of total synthesis has been
linked to a quotation from Nobel Laureate Richard Feynman, “What I cannot create, I do not
understand”.5 Among other things, total synthesis provides a means to prepare substantial
quantities of scarce, biologically active natural products. These compounds are present in the
host organism in minute quantities, making biological evaluation and medical application very
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Scheme 1.1 Therapeutic Drugs Inspired by Natural Products
difficult when relying solely on natural sources. The synthetic preparation of a natural product
allows further research into its therapeutic properties and is also a useful tool for confirming
the structure and absolute configuration of the molecule. A number of structural revisions
have been reported in the literature as a result of new insights gained from total synthesis.6
Total synthesis provides an excellent platform to investigate the medicinal properties of
natural product analogues. Advanced synthetic intermediates provide exciting opportunities
to explore derivatives that aren’t accessible from the natural product itself. These structural
modifications provide valuable insight into structure–activity relationships and the binding
interactions that elicit a specific biological response.7 The epothilones are an excellent example
of the synergistic application of total synthesis and rational drug design. Epothilone A
(5, R=H) and B (5, R=CH3) were first isolated by Hölfe from Sorangium cellulosum, a
myxobacteria (Figure 1.1).8 Danishefsky and coworkers reported the first total synthesis of
epothilone A in 1996.9 Despite the exciting in vitro anticancer activity of the epothilones,
their clinical use is precluded by significant toxicity, even at subtherapeutic doses.10 Using
diverted total synthesis, a number of advanced synthetic intermediates were converted into
natural product analogues.11 This ultimately led to the development of a number of superior
therapeutic drugs, two of which have progressed into clinical trials (Figure 1.1).
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Figure 1.1 The Synthetic Evolution of Epothilones as Therapeutic Agents.
1.3 The Pursuit of Atom Economy in Total Synthesis
1.3.1 Introduction
Improving the efficiency of chemical synthesis has long been a fundamental goal for the chemical
sciences. This goal has been pursued primarily through the development of new chemical
transformations that generate molecular complexity in a facile and selective manner.12 The
efficiency of a chemical reaction can be measured using a variety of metrics, one of the most
prominent being atom economy.13 A number of landmark achievements in atom economic
synthesis have been a direct result of the development of transition metal-catalyzed reactions,
such as the Pd-catalyzed asymmetric allylic alkylation, ruthenium-catalyzed alkene-alkyne
coupling, and zinc-catalyzed direct asymmetric aldol reactions (vide infra). The application
of these methodologies in the synthesis of complex natural products provides a paradigm for
further advancements in atom economic synthesis.
The goal of atom economy is to maximize the mass efficiency of a reaction; ideally, all
the atoms of the starting materials are incorporated into the final product, using all other
reagents in a catalytic manner. On a fundamental level, atom economy is enabled by the
efficient activation of reagents, where control over the selectivity of bond-forming processes is
paramount. In some instances the adjacent functional groups make bond forming inherently
efficient, as is the case for the highly atom economic Diels-Alder reaction. This reaction can
often occur in a stereoselective manner by simply heating the appropriate diene and dienophile,
such as 6 and 7 (Scheme 1.2).14 However, the majority of cases are not that simple, and
additional atoms are required to activate the reacting centers and control selectivity. The
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conjugate addition shown in Scheme 1.2 highlights the necessity of additional atoms to activate
the starting materials and direct the reaction to occur in a stereoselective manner.15 In this
case, a nucleophilic carbon atom is created by the presence of an adjacent magnesium atom.
Nucleophilic addition is then directed via the magnesium alkoxide ‘ate’ complex 8, which is
formed by prior deprotonation of the hydroxyl group using lithium diisopropylamide (LDA) and
manipulation of the Schlenk equilibrium using a crown ether. Intramolecular delivery of the
nucleophile ultimately results in a stereoselective conjugate addition, albeit with considerable
lithium and magnesium byproducts.
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80 oC, 30 h
91% yield
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OTBSR
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O
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LDA, THF, -78 oC
then 15-crown-5
then
MgBr
-78 oC to rt
63% yield(R = CO2Me)
Thermal Diels-Alder Reaction: Excellent Atom Economy
Conjugate Addition using Magnesium: Poor Atom Economy
Mg, Li Salts
2 eq.
MgBr2, HN(iPr)2 Li
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Scheme 1.2 Considering Atom Economy in Bond Construction.
Maximizing atom economy while maintaining high levels of selectivity remains challenging.
The conjugate reduction of the α,β-unsaturated aldehyde, citral (9) serves to highlight the
extensive efforts that are required to evolve an atom-economic solution (Scheme 1.3). This
transformation poses three major challenges: avoidance of 1,2-reduction of the aldehyde,
selectivity for the enone double bond in the presence of an electron-rich trisubstituted alkene
and avoiding the generation of a reactive enolate capable of participating in an unwanted aldol
reaction. A variety of conditions have been used to overcome these challenges and perform this
selective transformation in high yield (Scheme 1.3). However, the efficiency of these reactions,
in terms of atom economy, varies considerably and in a number of cases the mass of the
reaction byproducts is greater than that of the desired product 10. For example, the use
of Stryker’s reagent, [(Ph3P)CuH]6, provides a very mild and selective hydride source for 1,4-
reduction.16 The resulting copper enolate is trapped as a silyl enol ether, which is subsequently
hydrolyzed to produce the desired aldehyde 10. However, this method does not use mass
economically, producing the stoichiometric reaction byproducts [(Ph3P)CuCl]4 and TBS-OH
with a combined molecular weight of 1577 g/mol.17 The remaining methods in Scheme 1.3
contain increasing levels of atom economy, and include: Pd-catalyzed conjugate reduction using
Bu3SnH and hydrolysis of the resulting tin enolate,18 organocatalytic transfer hydrogenation
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Scheme 1.3 Atom Economy in the Conjugate Reduction of Citral.
using the Hantzsch ester (11),19 Pd-catalyzed transfer hydrogenation using formic acid and
triethylamine,20 and lastly, an enantioselective rhodium-catalyzed hydrogenation.21 While an
excellent yield of the desired aldehyde 10 is obtained in each case, the mass efficiency of
most of these reactions is poor and therefore limits the broader application of this chemistry.
Consequently, the highly atom-economic rhodium-catalyzed hydrogenation is part of a patented
process used by BASF for the industrial preparation of (–)-menthol. The rhodium catalyst
used to facilitate this asymmetric transformation can be recovered after the reaction and reused
multiple times.
1.3.2 Pd-Catalyzed Asymmetric Allylic Alkylation
Palladium-catalyzed allylic alkylation, often referred to as the Tsuji-Trost reaction, has become
a powerful synthetic tool and is capable of high levels of chemo-, regio-, and stereoselectivity.22
The first report of this reaction was limited to the addition of enamine or malonate-based
nucleophiles to stoichiometric pi-allyl palladium chloride dimer.23 Soon after this initial report,
Trost and coworkers discovered that the addition of phosphine ligands dramatically enhanced
the electrophilicity of pi-allyl palladium complexes (Scheme 1.4).24 This discovery greatly
expanded the substrate scope of these reactions and ultimately led to the development of chiral
phosphine ligands for Pd-catalyzed asymmetric allylic alkylation (Pd-AAA).25 Scheme 1.4
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Scheme 1.4 The Evolution of Pd-Catalyzed Allylic Alkylation.
highlights the development of this methodology from the original stoichiometric racemic
reaction to the modern catalytic enantioselective variants. Interestingly, some of the earliest
research in the Trost group on the alkylation of stoichiometric pi-allyl palladium complexes
was performed by Terry Fullerton, a New Zealand Fulbright Scholar conducting post-doctoral
research at the University of Wisconsin – Madison.26 Some of the most elegant applications of
Pd-AAA reactions have been in the generation of chiral quaternary centers, a formidable task
that often warrants special consideration in the planning of a synthesis.27
The synthetic strategy for the total synthesis of hamigeran B (12) was based on the use
of a Pd-AAA reaction to form a challenging chiral quaternary center.28 Hamigeran B is a
secondary metabolite originally isolated from the poecilosclerid sponge Hamigera tarangaensis
collected from the Hen and Chicken Islands in New Zealand by Bergquist and Fromont (family
Anchinoidae, syn. Phorbasidae).29 This compound displays potent anti-viral activity against
both polio and herpes viruses, with only slight cytotoxicity to host cells. Moderate anti-
cancer activity against P-388 leukemia cells was also observed (IC50 = 13.5 µM). The principal
disconnections in the retrosynthesis of hamigeran B are shown in Scheme 1.5. The carbocyclic
core of 12 was envisioned to arise from the intramolecular Heck reaction of aryl triflate 13.
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This intermediate can be traced back to the aryl lithium reagent 14 and the aldehyde produced
from ozonolysis of the terminal alkene 15. Alkene 15 could be generated using a Pd-AAA
with a ketone enolate derived from 16. This class of nucleophiles has proven to be much more
challenging to employ in AAA reactions than stabilized enolates derived from β-dicarbonyl
compounds.30
The synthesis began with the formation of racemic ketone 16 from 2-methylcyclopentanone
using a tandem formylation/vinylogous etherification sequence (Scheme 1.6). The prochiral
tin enolate derived from 16 provided excellent yield and enantiomeric excess in the Pd-AAA
reaction with only 1 mol % of the active palladium catalyst. It was discovered that when
fresh nBuLi was used to generate LDA for this reaction the ee of the product, 15, dropped
dramatically. It was hypothesized that the presence of lithium alkoxides in older nBuLi sources
aids the stereoselectivity of this process. It was ultimately discovered that the addition of seven
equivalents of tBuOH provides a reliable and scalable transformation. Lithium dimethylcuprate
was then used to convert the tert-butyl enol ether into an isopropyl group. This was followed
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Scheme 1.6 Total Synthesis of Hamigeran B.
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by formation of an enol triflate and a one-pot dihydroxylation–periodate cleavage to produce
aldehyde 17. In five additional steps aldehyde 17 was converted to the aryl ketone 13 required
for the intramolecular Heck reaction. The intramolecular Heck reaction provided the desired
product 18 in an optimized yield of 58%, along with two isomeric alkene side products in a
combined yield of 29%. The use of a carbonate base rather than a tertiary amine base proved
essential to avoid hydrogenolysis of the aryl triflate. Compound 18 was then deprotected using
BBr3, and the trisubstituted double bond reduced using an iridium-catalyzed hydrogenation
to give the kinetically favoured product with the isopropyl group on the concave face of the
molecule. The corresponding palladium-catalyzed hydrogenation gave the thermodynamically
favoured C6-epimer, which is presumably due to the equilibration of a semi-hydrogenated
intermediate. Lastly, oxidation using selenium dioxide and careful monobromination provided
the natural product 12. Ultimately, hamigeran B (12) was prepared using a 16-step longest
linear sequence.
The decarboxylative Pd-AAA reaction has recently emerged as an attractive alternative to
the traditional Pd-AAA with preformed metal enolates.31 Allyl enol carbonates, such as 19,
can be used to prepare α-chiral ketones in excellent yield and enantiomeric excess, while also
avoiding the use of stoichiometric additives, such as Me3SnCl (Scheme 1.7).32 Ionization of
the allyl carbonate and extrusion of carbon dioxide forms a cationic pi-allyl palladium complex
and an enolate anion. This variant of the Pd-AAA reaction enables the use of milder reaction
conditions and a wider variety of substrates. Stoltz and coworkers have recently applied this
strategy in a formal total synthesis of hamigeran B, as shown in Scheme 1.7.32 In this case,
the trifluoromethyl substituted phosphinooxazole (PHOX) ligand, L3, was used to facilitate a
Pd-catalyzed decarboxylative AAA reaction and provide the desired product 20 in excellent
yield and enantioselectivity.
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Scheme 1.7 Decarboxylative Pd-AAA Reaction in the Synthesis of Hamigeran B.
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1.3.3 Ruthenium-Catalyzed Alkene-Alkyne Coupling
The formation of carbon-carbon bonds is fundamental to chemical synthesis, and yet many
syntheses still remain dependent on the use of activating groups or the presence of adjacent
polarizing functionality to selectively construct these bonds. The ruthenium-catalyzed alkene-
alkyne coupling provides a tool by which simple unsaturated carbons can be coupled in a
highly atom-economic fashion (Scheme 1.8).33 Using this reaction, the coupling of 1-octyne
(21) and 1-octene (22) produces a ca. 5:1 mixture of branched (23) and linear (24)
products.34 Additionally, no homocoupling products of either alkyne or alkene were observed.
Ru
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Scheme 1.8 Ruthenium-Catalyzed Alkene-Alkyne Coupling.
Two major mechanistic pathways have been proposed: one operates under thermodynamic
control and produces the branched product; the other is under kinetic control and leads to the
linear product. In reactions where β-hydride elimination is slower than ruthenacyclopentane
formation (i.e. coupling of 21 and 22; R, R’= alkyl), the steric interaction between the alkynyl
substituent and the [CpRu]+ moiety becomes differential and the thermodynamic product is
formed on the basis of INT1 being favoured over INT2. Conversely, formation of the kinetic
product is often observed with hindered alkynes, such as TMS-acetylene (see Scheme 1.10). In
this case, regioselectivity is governed by the minimization of steric interactions in the transition
state, and therefore TS2, where the alkynyl substituent points away from the alkene terminus,
is favoured over TS1. With these mechanistic considerations in mind, the use of certain alkyne
substitution patterns and reaction conditions can lead to regioselective alkene-alkyne coupling,
providing a powerful tool for chemical synthesis.
The Ru-catalyzed alkene-alkyne coupling was used to great effect in the synthesis of
mycalamide A (25),35 a highly potent antitumor agent originally isolated from the New Zealand
1.3. THE PURSUIT OF ATOM ECONOMY IN TOTAL SYNTHESIS 11
marine sponge Mycale sp.36 Mycalamide A has been shown to inhibit protein synthesis and
induce apoptosis in cancerous cells.37 Retrosynthetic disconnection of the central amide bond
provides (–)-7-benzoylpederic acid 26 and azide 27, two fragments that have been utilized in
a previous synthesis reported by Nakata and co-workers (Scheme 1.9).38 Compound 26 was
envisioned to arise from the 1,4-diene 28, which in turn comes from the ruthenium-catalyzed
alkene-alkyne coupling of 29 and the commercially available alkene 30.
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Scheme 1.9 Retrosynthetic Analysis of Mycalamide A.
The homopropargylic alcohol 29 was prepared in a single step by the addition of TMS-
acetylene to (2S,3S)-2,3-epoxybutane (31, Scheme 1.10). The steric bulk of the trimethylsilyl
group serves to direct the subsequent Ru-catalyzed alkene-alkyne coupling, producing the
branched product 28 regioselectively. TBS-protection, dihydroxylation and selective mono-
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Scheme 1.10 Synthesis of (–)-7-Benzoylpederic Acid.
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esterification provided 32 as a 1:1 mixture of syn diastereomers. The poor diastereoselectivity
in this transformation proves to be inconsequential, as the oxidative cyclization of alcohol
32 produces a mixture of diastereomeric hemiketals that ultimately equilibrate to the desired
compound 33 on silica gel. Methylation of 33 was followed by a two-step removal of the silyl
group and a dealkylative saponification to provide (–)-7-benzoylpederic acid 26. Azide 27
was prepared in 18 steps and together the two fragments constitute a formal total synthesis of
mycalamide A.
1.3.4 Zn-Catalyzed Direct Asymmetric Aldol Reaction
The aldol reaction has proven to be an incredibly powerful synthetic tool in the preparation
of complex molecular targets.39 The development of this reaction has enabled highly efficient
transformations that produce β-hydroxy carbonyl compounds with excellent control of chemo-,
regio-, and stereoselectivity. The traditional aldol reaction involves the step-wise formation
of an enolate by addition of a stoichiometric amount of base to a carbonyl donor, followed
by addition of an aldehyde (Scheme 1.11). Control of enantioselectivity in this process has
typically been achieved through the use of a chiral auxiliary on the donor, such as Evans’
chiral oxazolidinone.40 The direct aldol reaction provides an atom-economic variant of the
traditional aldol reaction, avoiding the production of stoichiometric byproducts and the use of
chiral auxiliaries.41 The major challenge of the catalytic direct aldol reaction with transition
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Scheme 1.11 Differentiating Traditional Enolate Aldol and Direct Aldol Reactions.
metal complexes is creating reaction conditions that enable catalyst turnover. The metal
alkoxide that results from addition of an enolate to an aldehyde is often less basic than the
starting enolate, which prevents catalyst dissociation and turnover. Chemoselectivity can also
be a significant problem as the acceptor, an aldehyde, is often more acidic than the ketone
or an ester equivalent used as the donor. Failure to address these issues often results in
low reactivity or the generation of a number of different aldehyde self-aldol side products.
The dinuclear zinc ProPhenol catalyst 34 provides an elegant solution to these problems
(Scheme 1.12).42 This bifunctional Lewis acid/Brönsted base system serves to activate both
reactants, create a chiral pocket for enantioselective addition, and act as a proton shuttle to
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release the product from the catalyst. The acetophenone-based donors shown in Scheme 1.13
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afford β-hydroxy ketone products 35 and 36 with excellent levels of enantioselectivity and
good yields. Triphenylphosphine sulfide was used as an additive to improve catalyst turnover;
however, it was later discovered that the beneficial effects of this additive were limited to
certain substrates.43 A variety of α-hydroxy ketones have been shown to provide excellent yield,
diastereoselectivity and enantiomeric excess with this methodology, creating two stereocenters
in a single reaction. Interestingly, the aldehyde-derived stereocenter of 36 has the opposite
absolute configuration to that in the product, 35, obtained when acetophenone is used as
the donor . This phenomenon is rationalized by a proposed bidentate coordination of the α-
hydroxy ketone donor, bridging the two zinc atoms and altering the approach of the aldehyde
to favour the opposite facial selectivity.
The excellent atom economy and stereoselectivity of the Zn-ProPhenol aldol reaction
was used to great effect in the total synthesis of the complex macrocyclic natural product,
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Scheme 1.13 Direct Asymmetric Aldol Reaction with the Zn-ProPhenol Catalyst.
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laulimalide (37).44 Laulimalide displays microtubule stabilizing activity similar to that of
peloruside A and, as a result, is highly cytotoxic towards a number of cancer cell lines.45 The
major retrosynthetic disconnections of this synthesis include macrocyclization via a ruthenium-
catalyzed alkene-alkyne coupling and a Z -selective Still-Gennari olefination to tether the two
major fragments 38 and 39 (Scheme 1.14). The northern fragment 38 was envisioned to
arise from Julia olefination to connect dihydropyran 40 and the protected polyol 41, which
in turn arises from the direct asymmetric aldol reaction of hydroxy 2-ethylacylpyrrole (42)
and aldehyde 43. The forward synthesis commenced with the preparation of the donor and
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Scheme 1.14 Retrosynthetic Analysis of Laulimalide.
acceptor for the direct asymmetric aldol reaction. Aldehyde 43 was prepared in four steps
from (S)-glycidyl tosylate via functional group interconversion and epoxide opening with a
vinyl cuprate. The zinc ProPhenol catalyst ent-34 facilitated the direct asymmetric aldol
reaction of 42 and 43, providing the desired product 44 in 53% yield and 10:1 diastereomeric
ratio (Scheme 1.15). Formation of a p-methoxyphenyl (PMP) acetal followed by reduction of
the N -acylpyrrole with NaBH4 leads to alcohol 45. Oxidation with Dess-Martin periodinane
(DMP) and Julia-Kocienski olefination with phenyltetrazole sulfone 40 provided the desired
E-alkene 46 selectively. The cyclic PMP-acetal was then selectively opened with DIBAL-H and
the resulting alcohol was esterified with phosphonoacetic acid 47 under Yamaguchi conditions
to complete the northern fragment 38.
The Southern fragment, 39, was prepared in 15 steps from d-aspartic acid and coupled
to 38 using a Still-Gennari olefination to produce a 62% yield of the desired product as a 5:1
mixture of Z/E-geometric isomers (Scheme 1.16). Macrocyclization was then achieved using
an intramolecular ruthenium-catalyzed alkene-alkyne coupling. Under highly dilute reaction
conditions this reaction provided near quantitative yield of the desired macrocycle 48. MOM-
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Scheme 1.16 Total Synthesis of Laulimalide.
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deprotection under acidic conditions was then followed by allylic transposition using a highly
active perrhenate catalyst, O3ReOSiPh. The desired rearranged product 49 was formed in 78%
yield with complete retention of stereochemistry. The stereochemistry of the allylic alcohol
was then inverted by oxidation with Dess-Martin periodinane (DMP) followed by Corey-
Bakshi-Shibata (CBS) reduction. Subsequent Sharpless asymmetric epoxidation and PMB-
deprotection furnished the natural product, laulimalide (37). The final step was performed in
the presence of a pH 7 buffer to prevent the known acid-catalyzed rearrangement of laulimalide
to isolaulimalide.46
1.3.5 Concluding Remarks
The palladium-catalyzed asymmetric allylic alkylation, Ru-catalyzed alkene-alkyne coupling
and the Zn-ProPhenol-catalyzed asymmetric aldol reaction all form carbon-carbon bonds in
a highly atom economic manner. The total syntheses of hamigeran B, mycalamide A and
laulimalide clearly highlight the power and utility of these transition metal-catalyzed reactions.
Although all of these syntheses rely on transformations with poor atom economy at some stage,
the merit of each approach lies in the pursuit of atom-economic synthesis and the development
of tools and synthetic strategies for this goal. Striving to adhere to the principles of atom
economy necessitates an innovative and invention-based approach to synthesis and aids in
expanding the frontiers of chemical synthesis.
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1.4 Linchpin-Based Strategies in Total Synthesis
1.4.1 Introduction
The development of linchpin-based methods represents a powerful strategy for efficient
synthesis. A linchpin is literally described as “One that serves to hold together parts or elements
that exist or function as a unit,”47 however, to define this term within the context of chemical
synthesis, the following definition is proposed;
A relatively simple compound that serves to join and hold together molecular
fragments that ultimately exist together in a target molecule.†
The Bestmann ylide (50) is an excellent example of a linchpin and in many instances the dual
reactivity of this compound can be used in a single multicomponent reaction (Scheme 1.17).48
In this case, nucleophilic addition of the amine, 51, to the ketene is followed by a Wittig
reaction between the resulting phosphorous ylide and piperonal, ultimately producing the α,β-
unsaturated amide 52.
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Scheme 1.17 A Linchpin Strategy Using the Bestmann Ylide.
1.4.2 The Strategic Application of Synthetic Linchpins
The ultimate aim of a linchpin-based strategy is to achieve improved synthetic efficiency
through the use of convergent synthesis. This approach involves the union of multiple
compound fragments, and therefore aids in the design of a route with a high degree of
convergence. However, the efficiency imparted by this tactic is dependent on the methodology
and disconnections used to implement it. Ideally, the key linchpin sequence would introduce
a high level of structural complexity (i.e. chiral centers, cyclic connectivity, functional group
content, etc.) and occur at a late stage in the synthesis to maximize convergence. Scheme 1.18
illustrates a formylation–alkyne addition linchpin strategy used in the total synthesis of
petrocortyne A (53).49 In this synthesis, dimethylformamide (54) was used as a highly effective
linchpin; reacting with a lithium acetylide to provide, after acidic workup, an ynal which was
subsequently reacted with a second lithium acetylide to furnish the desired propargylic alcohol
as a mixture of diastereoisomers that could be separated by chiral HPLC. This late stage
linchpin sequence creates a highly convergent, and therefore efficient, synthesis. Using the
†The words ‘relatively simple’ provide a qualitative means of distinguishing a linchpin-based strategy from a
standard fragment coupling, whereby three or more large fragments are joined together at the end of a synthesis.
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Scheme 1.18 Convergence and Strategic Linchpin Sequences.
same disconnections, a hypothetical ‘early stage’ linchpin sequence would ultimately produce
petrocortyne A in a longer, four step, linear sequence.50 Comparison of these two routes
illustrates an important distinction between linchpin-based strategies: the implementation of
a linchpin sequence late in a synthetic route, with advanced intermediates, provides a highly
convergent and more efficient approach to a target molecule. Additionally, a late stage linchpin
sequence typically contains more functional groups and molecular complexity and therefore
demands higher levels of chemoselectivity and efficiency (i.e. reagent stoichiometry and yield).
Consequently, the term strategic linchpin has been coined to highlight the importance of this
distinction when evaluating similar linchpin-based strategies. Inherent to this definition is also
the requirement that a linchpin be a simple compound relative to the fragments being coupled
– this serves to differentiate a linchpin sequence from simple chain elongation or three-fragment
coupling in a synthesis.
The utility of linchpin-based strategies in total synthesis is a direct result of two inherent
characteristics: firstly, the retrosynthetic disconnections that accompany this strategy result
in multiple fragments and therefore impart convergence to a proposed route; secondly, the
isolated preparation of a linchpin molecule often enables the introduction of potentially
sensitive functional groups without a reliance on protecting group manipulations and redox
operations to achieve chemoselectively. The application of linchpin sequences can be classified
into three subgroups: linear, cyclic, and multi-tether linchpin strategies (Figure 1.2). A linear
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Figure 1.2 Classification of Linchpin Strategies.
linchpin strategy serves to couple two discrete molecular fragments via a series of intermolecular
reactions. An example of this can be seen in the use of the Bestmann ylide (50) in the synthesis
of 6-aminopenicillanates (i.e. 55).48 Alternatively, a cyclic linchpin strategy consists of an
initial intermolecular reaction, followed by a subsequent intramolecular reaction to ultimately
form a ring system. Phorboxazole A (57) has been prepared using this strategy; first coupling
the carboxylic acid 56 and then using a Horner-Wadsworth-Emmons olefination to form the
macrocyclic ring.51 Lastly, a multi-tether linchpin strategy forms three or more inter- or
intramolecular bonds and, as a result, the linchpin often becomes embedded in the target
molecule. A highly efficient six-step synthesis of strychnine (59) was enabled by the use of
a multi-tether linchpin strategy.52 In this total synthesis, the pyridinium salt 58 was used to
form a tryptamine-derived Zincke aldehyde, which subsequently underwent an intramolecular
Diels-Alder reaction, conjugate addition and intramolecular hemiacetal formation. Ultimately,
four C–C bonds and one C–O bond were formed to the original five carbons derived from the
pyridine ring in 58.
A number of structural motifs have found frequent use as linchpins in total synthesis.
Some of these privileged linchpin structures are shown in Figure 1.3. The key to the utility
of these reagents lies in the high levels of chemoselectivity that can be obtained despite the
dual reactivity contained within the linchpin moiety. Epoxy halide or alcohol derivatives
(class I) provide a very useful three-carbon linchpin with two differentiated electrophilic sites.
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Figure 1.3 Privileged Linchpins and their Application in Total Synthesis.
Epichlorohydrin (I: X = Cl) was used to couple two advanced fragments in a total synthesis of
muconin reported by Jacobsen and coworkers.53 α,β-Unsaturated carbonyls (class II) display
a wide range of reactivity and, under certain conditions, can function as either a nucleophile or
electrophile.54 Prostaglandin E2-1,15-lactone was synthesized by Fürstner and coworkers using
a cyclopentenone linchpin (II: R = alkyl, R’ = alkyl).55 In this case, conjugate addition of a
vinylzinc nucleophile was followed by trapping of the resulting enolate with an electrophile,
allowing functionalization of both the α and β positions in a single pot. The macrocyclic
structure of littoralisone has also been constructed using this class of privileged linchpins –
a cinnamic acid derivative (II: R = OH, R’ = Ar) was first coupled via ester formation and
then underwent a [2+2] cycloaddition to form the desired macrocyclic ring system.56 α-Halo
carbonyls and their derivatives (class III) provide a versatile two-carbon linchpin that have
been used in the synthesis of both goniodiol and platensimycin.57 In the synthesis of goniodiol,
an alkoxide nucleophile is added to the α position of α-bromo N -methyl-N -methoxy acetamide
(III: R = N(OMe)Me, X = Br) and the product was subsequently reacted with PhMgBr to give
an α-alkoxy acetophenone. Conversely, the α-position of ethyl 2-(diethoxyphosphoryl)acetate
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(III: R = CO2Et, X = P(O)(OEt)2) acts as a nucleophile in a Horner-Wadsworth-Emmons
olefination used to tether the aliphatic portion of platensimycin. Subsequent saponification
and amide bond formation were used to introduce the aryl fragment of platensimycin. Indole
and oxindole-based heterocycles (class IV) are often inherently nucleophilic at the 3-position
and electrophilic at the 2-position. This bifunctional reactivity makes these heterocycles
excellent linchpins in the synthesis of indole alkaloid natural products.58 Baran and coworkers
recently utilized a tryptamine derivative (IV: Boc-Trp-Phe-OMe) as a linchpin in a direct
indole-aniline coupling en route to the natural product kapakahine F.59 In this case, N -
iodosuccinimide was used to facilitate an oxidative indole coupling with o-iodoaniline along
with spontaneous intramolecular addition of an amine to C2. The resulting indole-fused
pyrrolidine was isomerized to give the six-membered lactam present in kapakahine F. Lastly,
dithianes (class V) serve as a powerful one-carbon nucleophilic linchpin and, through the use of
a Brook rearrangement (V: R = TBS), can often add to two different electrophiles in a single
pot.60 Nucleophilic additions to epoxides and carbonyls have enabled the rapid and convergent
assembly of various polyketide natural products and analogues thereof. Such a strategy was
utilized by Smith and coworkers in an attempted synthesis of peloruside A, which instead led to
the C2-epimer.61 Additionally, the conversion of a dithiane into a ketone means that dithianes
serve as acyl anion equivalents in an umpolung-based approach. Thus, the dithiane-derived
carbon atom can ultimately serve as an electrophile and can be utilized in the formation of
cyclic ketals and hemiketals, as in the 2-epi-peloruside synthesis.
Overall, the privileged linchpin structures shown in Figure 1.3 and their application in
synthesis provides an instructive model for the further development and improvement of
linchpin-based synthetic strategies.
1.4.3 Catalytic Applications of Linchpins in Total Synthesis
The pursuit of convergent synthetic routes has led to the discovery of a variety of highly efficient
linchpin-based total syntheses. However, the design elements of such strategies are often
understated, despite the efficiency they impart to a synthesis. To illustrate the efficiency and
application of strategic linchpin couplings, the following section highlights recent applications
of late stage linchpin sequences in the synthesis of complex natural products. An emphasis
has been placed on natural product syntheses that use catalytic methodology to couple the
linchpin.
Transition metal catalysis has provided some of the highest impact chemical research of
recent times, and as a result three Nobel prizes have been recently awarded for discoveries in
transition metal catalysis.62 The mild reaction conditions and high levels of chemoselectivity
afforded by many transition metal-catalyzed reactions make them well suited to the coupling of
a linchpin with an advanced synthetic fragment. Additionally, high catalyst turnover numbers
and possible regio- and enantioselectivity has the potential to enable linchpin sequences that
not only unite major synthetic fragments, but do so in a way that simultaneously introduces
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a high level of structural complexity.
Conjugated polyene systems are versatile synthetic intermediates and common in a range of
biologically active natural products.63 Coleman and coworkers recently utilized diene 64 as a
linchpin for the synthesis of E,E polyene systems and to ultimately achieve the total synthesis
of lucilactaene (Scheme 1.19).64 The bis-metallated 1,3-butadiene 64 enabled an orchestrated
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Scheme 1.19 A Pd-Catalyzed Cross Coupling Linchpin Strategy
sequence of C–C bond forming events, namely a chemoselective Stille cross coupling followed
by Suzuki-Miyuara cross coupling. Both reactions are high yielding and butadiene 64 can be
prepared in just three steps by stannyl-cupration of propargaldehyde diethyl acetal, followed
by acetal hydrolysis and Takai olefination with dichloromethylborinate.65 The orthogonal
reactivity of the Stille cross coupling arises from the need for basic reaction conditions to
effect transmetallation of palladium with boron, therefore base-free conditions and the use of
triphenylarsine as an ancillary ligand enable selective Pd-cross coupling with vinyl iodide 66.
In certain cases, a one-pot sequential cross coupling can be achieved, functionalizing both ends
of the diene in a single process.
Halogen-selective Suzuki-Miyaura cross couplings have been used very effectively to
enable aromatic rings to function as synthetic linchpins (Scheme 1.20). 5-Bromo-2-iodo-3-
methoxypyrazine (67) was used as a highly effective linchpin in the total synthesis of the
bis-indole natural product, dragmacidin D (68).66 In this case, chemoselective coupling of
heteroaryl iodide 67 and boronic acid 69 was achieved using precise temperature control.
Performing the first Suzuki-Miyaura cross coupling at 23 ◦C provided bromopyrazine 70. The
second cross coupling was performed with a more reactive boronate ester 71 and a reaction
temperature of 50 ◦C. Interestingly, the aryl bromide present in 70 is unaffected during these
reactions, as oxidative insertion into C–X bonds on the pyrazine ring is much faster than
an ordinary phenyl halide. With both indoles in place, installation of the aminoimidazolium
ring and deprotection were all that was required to synthesize the natural product. This
was ultimately achieved through silyl deprotection, oxidation, nitromethane addition, and a
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Scheme 1.20 Halogen Selective Suzuki Linchpin in the Synthesis of Dragmacidin D
second oxidation to provide nitromethylketone 73. The two indole nitrogen protecting groups
were subsequently removed, and the use of stannous chloride provided mild conditions for
the reduction of the nitro group. Removal of the benzyl and methyl ethers was effected
by iodotrimethylsilane (TMSI) and the aminoimidazolium unit was installed by addition of
cyanamide followed by treatment with trifluoroacetic acid (TFA). Interestingly, the order of
this step-intensive sequence was crucial and the use of hydrogenative conditions was precluded
by the heteroaryl bromide functionality.
Sonogashira cross coupling with silylated acetylenes, such as TMS-acetylene, can also
be utilized to achieve linchpin-based synthetic strategies through the use of sequential cross
coupling with each end of the ethylene motif. This approach was used to great effect in the total
synthesis of the polycyclic natural product kibdelone C (74).67 The linchpin sequence began
with the coupling of isoquinoline 75 with TIPS-acetylene (Scheme 1.21). Fluoride-mediated
silyl deprotection was then used to reveal a second terminal acetylene 76 which was used in
a copper-free Sonogashira cross coupling with xanthone 77, to provide 78, which contains all
the carbons of the natural product. Interestingly, the Cu-free conditions and slow addition of
the alkyne were necessary to prevent oxidative dimerization.68 The aryl alkyne 78 was then
subjected to hydrogenation, copper-catalyzed iodination and Boc protection to provide iodide
79. Compound 79 was then subjected to highly optimized palladium-catalyzed C–H arylation
conditions to generate the hexacyclic ring system of the kibdelones. Lastly, chlorination and
careful removal of the various protecting groups provided the natural product kibdelone C
(74).
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Scheme 1.21 Alkyne Cross Coupling Linchpin Strategy
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The mild and selective nature of ruthenium-catalyzed alkene metathesis is also well suited
to a variety of linchpin-based synthetic strategies. The well established methodology of ring-
closing metathesis means that the use of a late-stage allylation or vinylation, followed by
intramolecular alkene metathesis constitutes a relatively straightforward linchpin strategy
for the synthesis of macrocyclic targets.69 Alkene cross metathesis represents a much more
challenging task, as a number of substrates are prone to statistical homo-coupling. A partial
solution to this problem can be found in the use of a substantial excess of a readily available
alkene. However, the use of a strategic linchpin sequence late in a synthesis typically involves
advanced fragments that are too valuable to be used in excess. A recent total synthesis
of the potent anticancer natural product FR901464 utilized a late-stage strategic linchpin
based around the use of Ru-catalyzed alkene cross metathesis (Scheme 1.22).70 In this case,
methacrolein served as a linchpin for the coupling of two advanced tetrahydropyran-based
fragments. The linchpin sequence began with a ruthenium-catalyzed alkene cross metathesis
between methacrolein and 80. To maximize the efficiency of this reaction and avoid undesired
O
N
H
OAcO O
O
HO
OH
H
FR901464: from methacrolein
O
O
HO
OH
H
H
O
O
N
H
OAcO O
H
O
N
H
OAcO
O
N
H
OAcORu-1, CH2Cl2
40% yield
Ph3PCH3Br,
KOtBu, THF
86% yield
57% yield
Ru-1, CH2Cl2
Ru
NMesMesN
O NO2
Cl
Cl
Ru-1
80
81
82
83
Scheme 1.22 Alkene Cross Metathesis Linchpin Strategy
homocoupling products, 20 equivalents of methacrolein were used along with the nitro-
substituted variant of the Hoveyda-Grubbs catalyst (Ru-1). This catalyst has increased
activity relative to the traditional catalysts for alkene metathesis and facilitates alkene cross
metathesis with electron-deficient alkenes (i.e. methacrolein) particularly well.71 Subsequent
Wittig olefination provided the 1,3-diene 81 needed for the key fragment coupling reaction.
Alkene cross metathesis of 82 and 81, catalyzed by Ru-1, provided the natural product
FR901464 (83), albeit in modest yield. However, this final transformation is particularly
challenging as FR901464 is highly sensitive to pH – decomposition has been reported on silica
gel and also in slightly basic aqueous buffer solutions.
Catalytic C–H bond functionalization represents one of the most exciting areas in organic
synthesis, and has been the focus of many research efforts.72 C–H bonds are often ubiquitous
in intermediates used for synthetic organic chemistry, and this presents both a daunting
challenge, in terms of selectivity, and an outstanding opportunity for synthetic efficiency.
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Palladium-catalyzed C–H arylation was recently applied by Baran and Gutekunst to achieve a
linchpin-based synthesis of two piperarborenine natural products (Scheme 1.23).73 In this case
a simple disubstituted cyclobutane serves as a highly efficient linchpin for the construction of
the bis-arylated tetrasubstituted cyclobutane 84. A key to this strategy was the use of a 2-
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Scheme 1.23 Cyclobutane C–H Arylation Linchpin Strategy
aminothioanisole directing group (Ar) to promote C–H bond cleavage and enable stereoselective
arylation. The coupling of aryl iodide 86 to cyclobutane 85 required extensive optimization
and it was ultimately found that hexafluoroisopropanol (HFIP) and pivalic acid were critical
to the success of the reaction. Ultimately, the desired product 87 was obtained in 52% yield
with only traces of bis-arylated side products. Selective epimerization of the C1 stereocenter
provided 88 in good yield with less than 10% undesired epimerization. The second palladium-
catalyzed C–H arylation proceeded in good yield, and again installed the aryl group cis to
the amide-based directing group. Piperarborenine B (84) was prepared from 89 in three
additional steps: the directing group was carbamoylated and both the amide and ester bonds
were cleaved using lithium hydroperoxide. This was followed by conversion of the bis-carboxylic
acid to the bis-acid chloride and nucleophilic addition of 5,6-dihydropyridinone. Ultimately,
piperarborenine B was prepared in just seven steps using this succinct linchpin-based strategy.
Annulative linchpin coupling represents a highly efficient method of connecting advanced
synthetic intermediates and can be used to achieve multi-tether linchpin strategies (see
Figure 1.2). The Pd-catalyzed trimethylenemethane (TMM) [3+2] cycloaddition is a powerful
catalytic method by which this can be achieved and is the focal point of a recent synthesis of
marcfortine B.74 In this case, the TMM donor 90 is used in a carboxylative TMM cycloaddition
with 91.75 The proposed mechanism of this reaction proceeds via formation of a pi-allyl Pd
complex and ionization of the vinyl silane to generate Pd-TMM complex I which traps the
carbon dioxide generated during pi-allyl-Pd formation. The resulting intermediate (II), bearing
a single silyl group, undergoes a rearrangement to generate a second Pd-TMM complex, III,
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which participates in a cycloaddition with the electron deficient alkene 91. This transformation
introduces high levels of structural complexity, creating two C–C bonds in the formation
of a spirocyclic five-membered ring. Additionally, the exocyclic alkene and carboxylic acid
generated in this reaction serve as handles for further synthetic manipulation. Ultimately,
five bonds were formed to carbons derived from the linchpin compound 90, enabling a highly
convergent total synthesis of marcfortine B.
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Scheme 1.24 TMM [3+2] Cycloaddition in the Synthesis of Marcfortine B.
The development of hydrogen-mediated C–C bond formation represents a significant
breakthrough in redox economic synthesis and a departure from the use of stoichiometric
metallated nucleophiles.76 Pioneering work from the Krische group has established a wide range
of hydrogen-mediated C–C bond forming variants,77 while also developing this methodology
within the context of total synthesis.78 Utilizing this methodology as part of a linchpin-based
synthetic strategy has led to the most concise synthesis of a bryostatin natural product to
date (Scheme 1.25).79 Bryostatin 7 (97) was prepared in just 20 linear steps. The synthesis
is comprised of five separate hydrogen-mediated C–C bond forming events, two of which are
shown in Scheme 1.25. In both cases, Ir-catalyzed dehydrogenation of an alcohol provides the
hydrogen source. Allyl acetate and 1,1-dimethylallene (98) react with the respective aldehydes
to ultimately provide chiral allylic alcohols. The key linchpin sequence is shown in Scheme 1.26
and begins with the iridium-catalyzed allylation of aldehyde 99. The enantioselectivity of this
allylation is irrelevant as the following steps, selective mono-desilylation and oxidation, result
in the conversion of the alcohol into ketone 101. Acid-catalyzed trans-esterification and ketal
formation stereoselectively generate the desired tetrahydropyran. The allyl group introduced
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Scheme 1.25 Reaction and Strategy Development in the Synthesis of Bryostatin 7.
in the first step of the linchpin sequence could be ozonized to provide aldehyde 102, now
primed for coupling with the other major bryostatin fragment. Compounds 102 and 103
were coupled using a stereoselective Prins-type annulation developed by Keck and Yu.80 The
desired methylene tetrahydropyran 104 was obtained in good yield along with 22% of the
side product that results from elimination of methanol. However, both the desired product
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and side product participate in acidic methanolysis to yield the same desired product with
the TBS-ether and acetonide protecting groups removed. Bryostatin 7 was prepared from
compound 104 in 8 additional steps. The application of merged redox and C–C bond forming
events central to this synthesis represents a new and highly efficient paradigm for synthetic
strategy.77 Additionally, it could be argued that a number of reaction sequences throughout
this synthesis contain linchpins, and perhaps this is part of the reason why this strategy leads
to such an efficient synthesis.
1.4.4 Summary
The development of linchpin-based synthetic strategies represents an exciting and powerful
approach to natural product synthesis. The merit of this tactic stems from the highly
convergent nature of a late-stage linchpin coupling and the use of a linchpin molecule to
introduce reactive functional groups that would be incompatible with conditions used earlier
in the route. However, the efficiency imparted by a linchpin sequence is dependent on the
methodology and disconnections used to implement it. Thus, the major challenge of this
chemistry is the development and use of chemoselective reactions that introduce high levels of
structural complexity when coupling the linchpin compound.
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2.1 Introduction to Alkyne Addition
2.1.1 Metal Alkynylides
The unique properties of terminal alkynes make them versatile and highly efficient scaffolds
for the construction of C–C bonds in organic synthesis.1 The high s character of the alkynyl
carbon enables the stabilization of negative charge, making terminal alkynes much more acidic
than their alkenyl or alkyl counterparts (Figure 2.1).2 Deprotonation with an alkali metal base
(i.e. nBuLi, NaNH2 etc.) gives rise to various alkali metal alkynylides (M = Li, Na, K).
These nucleophiles have been used extensively in organic synthesis, and have been shown to
react efficiently with a wide variety of electrophiles, including epoxides, ketones, amides, imines
and alkyl halides. Additionally, alkynes can function as pi-acids and coordinate to transition
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Figure 2.1 Acidity, Bonding and Reactivity of Terminal Alkynes.
metals, which increases the acidity of the terminal proton further and enables deprotonation
under particularly mild conditions. Since the use of strong bases is often incompatible with
highly functionalized compounds, this property makes alkynes extremely useful in the synthesis
of complex molecules. A range of transition metals have been used in this capacity, with the
most well known examples being the use of Cu(I) in Castro-Stephens and Sonogashira cross
coupling reactions.3 Scheme 2.1 highlights the use of these mild reaction conditions in the
synthesis of epothilone B.4 In general, the broad synthetic utility of alkynes lies in their
bifunctional reactivity. A terminal alkyne can act as a nucleophile via deprotonation and
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subsequent alkylation or metal-catalyzed cross coupling (vide supra). Conversely, the latent
electrophilicity of alkynes can be chemoselectively activated by complexation with a transition
metal. Furthermore, the reactivity of propargyl alcohols toward SN2 displacement extends the
activation to the propargylic position as well. This synthetic versatility makes the catalytic
enantioselective preparation of propargylic alcohols especially valuable.
2.1.2 Propargylic Alcohols
Propargylic alcohols serve as robust and versatile intermediates in the synthesis of fine
chemicals, natural products and therapeutic agents (Scheme 2.2).5 Three general approaches
have been utilized for the synthesis of secondary propargyl alcohols: enantioselective ynone
reduction (A),6 asymmetric alkyne addition to aldehydes (B),7 and enantioselective ynal
alkylation (C).8 Although a number of catalysts have been developed to facilitate both ynone
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Scheme 2.2 Formation and Reactivity of Propargylic Alcohols.
reduction and ynal alkylation, the application of these methods is limited by the propensity of
the alkynyl substrates to decompose, isomerize, and act as Michael acceptors. The addition of
a terminal acetylene to an aldehyde avoids these problems and provides a convergent approach
to the desired propargylic alcohol.
The mild reactivity of organozinc reagents has enabled the enantioselective addition of
alkyl, vinyl, and alkynyl groups to a variety of carbonyl compounds with excellent functional
group tolerance.9 The asymmetric addition of alkynylzinc nucleophiles to aldehydes has
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recently generated a large amount of interest in the chemical community.10 Early reports
by Carreira demonstrated that stoichiometric (+)-N -methylephedrine (L5), Zn(OTf)2, and
triethylamine could be used to achieve alkyne metalation and addition to aliphatic aldehydes
under particularly mild conditions.11 High enantioselectivity and yield were obtained with a
variety of alkynes, although aryl and α,β-unsaturated aldehydes typically gave lower yields.
The initial conditions requiring stoichiometric zinc and N -methylephedrine were ultimately
rendered catalytic by increasing the reaction temperature to 60 ◦C.11f Independent work by
Pu and Chan demonstrated the utility of (S)-BINOL (L6) in conjunction with Ti(OiPr)4 and
either Et2Zn or Me2Zn to facilitate nucleophilic addition of alkynes to aldehydes.12,13 These
conditions require an excess of alkyne and dialkylzinc but ultimately provide good yield and
enantioselectivity with a range of substrates. A number of other chiral zinc catalysts have
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Scheme 2.3 Selected Alkynylation Examples.
also been reported to enable the enantioselective addition of alkynes to aldehydes.14 Efficient
asymmetric alkyne addition often requires the use of relatively high catalyst loadings and an
excess of alkyne and dialkylzinc reagents.15 An ongoing goal in this field is the development
of an efficient chiral catalyst system capable of adding functionalized alkynes to a wide range
of aldehydes while minimizing the use of excess reagents and stoichiometric additives. The
development of such a catalyst system would ultimately enable facile access to chiral propargyl
alcohols and entry into alkyne-based strategies in the synthesis of natural products.
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2.2 Zinc-ProPhenol Catalyzed Alkynylation
of Aldehydes
2.2.1 Introduction and Prior Work
The design and development of the ProPhenol ligand, L4,16 as an enantioselective catalyst
for base-mediated nucleophilic addition has led to the discovery of a number of highly efficient
transformations.17 The combination of the ProPhenol ligand and a dialkylzinc reagent has been
shown to catalyze the asymmetric Mannich and Henry reactions,18,19 the desymmetrization of
meso 1,3-diols,20 and the direct aldol reaction (see Section 1.3.4).21 The success of this catalyst
system with stabilized nucleophiles, such as enolates and nitronates, prompted the investigation
of zinc alkynylides and their addition to aldehydes (Scheme 2.4). The ultimate goal of
these investigations was to develop a practical and general methodology for zinc-catalyzed
enantioselective alkynylation of aldehydes using the commercially available ProPhenol ligand,
L4.
R1
O
H
R1
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R2
OH N
Ph
PhHO
N
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Ph OH
(S,S)-L4
Me2Zn
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Scheme 2.4 Zn-ProPhenol Catalyzed Alkyne Addition.
Initial optimization
Optimization of the enantioselective addition of phenyl- and TMS-acetylene to p-anisaldehyde
commenced with the screening of several C2 symmetric ligands, (S,S)-L4, L7 and L8, designed
in the Trost group (Table 2.1)†.22,23 Stoichiometric zinc alkynylide was required for adequate
enantioselectivity, and all optimization was initially carried out using nearly three equivalents of
dialkylzinc and alkyne. Further experiments to improve the atom economy of this alkynylation
methodology will be discussed in Section 2.2.3. Ligand screening revealed that the ProPhenol
ligand, (S,S)-L4, provided the best results in terms of both yield and enantioselectivity, with
the desired propargyl alcohol being isolated in 78% yield and 80% ee (entry 1). Ligands
L7 and L8, resembling a Salen ligand and the backbone of the Trost phosphine ligands for
Pd-catalyzed asymmetric allylic alkylation, also provided the desired product, albeit with a
lower enantioselectivity of 35% and –66% ee, respectively (entries 2–3). These results are in
contrast to Cozzi’s asymmetric alkyne addition to ketones, which utilizes a similar Salen ligand
to obtain excellent results.25 Enantiomeric induction by (S,S)-L4 was found to be a robust
process and provided excellent selectivity for the (R)-propargylic alcohol 106a, across a range of
†The results in Table 2.1 were obtained by Andrew Weiss and Axel von Wangelin.
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Table 2.1 Initial Optimization.
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temperatures and catalyst loadings (entries 4–7).26 Consequently, the majority of optimization
experiments were focused primarily on improving reactivity and catalyst turnover. Reducing
the catalyst loading to 10 mol % and increasing the reaction time to 48 h produced the desired
product in 77% yield and 83% ee (entry 5). These results are similar to those obtained in
entry 1 with 20 mol % (S,S)-L4. In an attempt to obtain even better enantioselectivity the
alkyne addition was performed at –20 ◦C with both 5 and 10 mol % (S,S)-L4 (entries 6–
7). These reactions provided similar levels of enantioselectivity but resulted in a substantial
decrease in conversion over ca. two days. TMS-acetylene was found to be less reactive than
phenyl acetylene in ProPhenol-catalyzed alkyne additions. However, by increasing the reaction
concentration, improved reactivity could be obtained with TMS-acetylene to ultimately provide
the desired product in 74% yield and 85% ee (entry 10). The optimal alkyne concentration was
found to be 0.38 M and a further increase in concentration, to 0.69 M, resulted in decreased
enantioselectivity (entry 11). At higher reaction concentrations (ca. 2 M) the ligand-free
background reaction proceeds readily, and is presumably the cause of the slight decrease
in enantioselectivity.27 Unfortunately, decreasing the catalyst loading further (< 10 mol %)
provided lower yield and significantly lower ee (entries 13–14). The optimization of reaction
temperature, time, concentration and catalyst loading has enabled the addition of either TMS-
acetylene or phenylacetylene to p-anisaldehyde in high yield (>70%) and ee (>70%) with a
catalyst loading of just 10 mol %. Interestingly, similar results were generally observed for
dimethyl- and diethylzinc; however, others have noted that alkyl transfer from dimethylzinc
is significantly slower than from diethylzinc, and therefore dimethylzinc was chosen to avoid
potential alkyl addition side products.28
Alkynylation of Unsaturated Aldehydes
A variety of aryl and α,β-unsaturated aldehydes underwent efficient alkyne addition using
the previously optimized conditions (Scheme 2.5).22,23 High yields and enantioselectivies
were obtained in additions to benzaldehydes containing both electron-donating and electron-
withdrawing substituents. Substitution on each aromatic carbon was tolerated and particularly
O
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H
(2.8 equiv)
10 mol % (S,S)-Prophenol,
2.95 equiv Me2Zn, 
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+
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up to 99% ee
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Scheme 2.5 Alkynylation of Unsaturated Aldehydes.
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good results were obtained with ortho-substituted benzaldehydes. Good results were also
obtained with a variety of alkynes and only small variations in yield and enantioselectivity
were observed. Alkyne addition to α,β-unsaturated aldehydes provides a particularly valuable
extension of substrate scope. The resulting alkenyl alkynyl carbinols contain three orthogonal
functional groups primed for further synthetic manipulation.
Methyl propiolate represents a particularly attractive class of nucleophile for alkyne
addition to aldehydes.29 The resulting γ-hydroxy-α,β-acetylenic esters are extremely versatile
synthetic intermediates and have been used in a number of total syntheses.30 Propiolate donors
have traditionally been difficult substrates for asymmetric alkynylation due to their propensity
to decompose in the presence of Lewis acids and nucleophiles.31 However, methyl propiolate
ultimately proved to be one of the most effective alkynes under Zn-ProPhenol alkynylation
conditions (Table 2.2)§. Excellent results were obtained with a range of α,β-unsaturated
aldehydes, including (E)-non-2-enal, which provided 97% ee with methyl propiolate (entry
2), a major improvement from the 36% ee obtained with TMS-acetylene. The superior results
are presumed to be a consequence of the inductive stabilization of the alkynylide along with
potential coordination of the propiolate ester with the bimetallic catalyst.
Table 2.2 Addition of Methyl Propiolate to α-β-Unsaturated Aldehydes.
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§The results in Table 2.2 were obtained by Andrew Weiss, Mark Bartlett and Vincent Chan.
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7
[e]
  
 
95% 82% 
8 
  
97% 72% 
[a] Isolated yield. [b] Enantiomeric excess determined by chiral HPLC. [c] Reaction 
performed using 3 equiv alkyne and 3 equiv Me2Zn.
 [d] Reaction performed using 
(R,R)-L4. [e] Reaction performed using ethyl propiolate.  
CHO
OMe OMe
OH
CO2Et
OH
CO2Me
CHO
2.2.2 Alkyne Addition to Aliphatic Aldehydes
n-Alkylcarboxaldehydes are particularly challenging substrates for alkynylation due to their
propensity to enolize and undergo cross-aldol side reactions.32 Thus, initial research on
ProPhenol-catalyzed alkyne additions only investigated the use of unsaturated aldehydes
(Scheme 2.5). However, it was subsequently discovered that a variety of aliphatic aldehydes
are also suitable electrophiles for asymmetric alkynylation (Table 2.3). The addition of
methyl propiolate to n-Alkylcarboxaldehydes, such as octanal and dihydrocinnamaldehyde,
typically provided moderate yields (50–70%) but excellent enantioselectivity (>90% ee). α-
and β-substituted aliphatic aldehydes, with a decrease propensity for enolization, proceeded
in good yield and enantioselectivity. For example, the addition of methyl propiolate to
cyclopropanecarboxaldehyde gave the desired propargylic alcohol in 88% yield and 94%
ee. On the other hand, aliphatic aldehydes with an increased propensity to enolize,
such as cyclopentane carboxaldehyde and 3-methylbut-3-enal, did not produce the desired
products. Furthermore, the increased steric hindrance of 2,2-dimethyl-substituted aldehydes
often resulted in decreased enantioselectivity, although addition of methyl propiolate to
pivaldehyde provided the desired product in 88% ee. However, the analogous 3-chloro-
and 3-methoxycarbonyl substrates provided significantly lower enantioselectivity, generating
the corresponding propargylic alcohols in 72% and 75% ee respectively. Unfortunately, 2,2-
diethoxypent-4-enal provided the desired propargyl alcohol as a racemic mixture, even at the
lower reaction temperature of –40 ◦C. Presumably, the inductive effects of the gem-diethoxy
group increase the reactivity of the aldehyde to the point where the uncatalyzed background
reaction is facile. Extension of this methodology to aliphatic aldehydes further demonstrates
the generality of the ProPhenol-catalyzed alkynylation with respect to both nucleophile and
electrophile.
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Table 2.3 Enantioselective Alkynylation of Aliphatic Aldehydes.
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2.2.3 Mechanistic Inferences and Reoptimization
Proposed Mechanism
The proposed mechanism for ProPhenol-catalyzed alkyne addition involves the formation of
a dinuclear zinc species, A (Scheme 2.6). This complex contains both Brønsted basic and
Lewis acidic sites, and can therefore act as a bifunctional catalyst, activating two reagents
simultaneously. The relative acidity of a terminal alkyne (e.g. pKa (DMSO) PhCCH = 28.7)33
enables the formation of an alkynylzinc nucleophile, which undergoes nucleophilic addition to
the si face of an aldehyde. Product dissociation via metal exchange liberates a propargylic zinc
alkoxide and regenerates the active catalyst. Turnover of the catalyst in this way necessitates
the use of a stoichiometric amount of organozinc reagent. In contrast, the ProPhenol-catalyzed
direct aldol reaction requires only a catalytic amount of dialkylzinc reagent and dissociation
of the product alkoxide is postulated to occur via proton exchange.21
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Scheme 2.6 Proposed Mechanism for ProPhenol-Catalyzed Alkynylation of Aldehydes.
Additive Effects and TPPO
During parallel research into the ProPhenol-catalyzed addition of diynes, Vincent Chan
discovered that the presence of acetate groups in the substrate, far from the reacting alkyne
terminus, resulted in significantly higher enantioselectivity.34 It was then hypothesized that
this Lewis basic group interacts with the dinuclear zinc catalyst and reinforces the chiral
pocket created by the ProPhenol ligand. The proposed coordination is supported by the X-ray
crystal structure of the ProPhenol dinuclear zinc complex reported by Ding and coworkers
(Figure 2.2).35 The crystal structure contains a molecule of THF (blue circle) coordinated to
each of the zinc atoms, analogous to the postulated interaction with a Lewis base. Screening
a variety of substoichiometric Lewis basic additives revealed that the addition of 20 mol %
triphenylphosphine oxide (TPPO) provided optimal results. The largest improvements were
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Figure 2.2 Zn-ProPhenol Crystal Structure and Proposed Interaction with Lewis Basic
Additives.
observed in cases where the substrates lacked potential Lewis basic sites (Table 2.4).† Greatly
increased enantioselectivity was observed for the addition of TMS-acetylene to (E)-nonenal
upon addition of TPPO (entry 2).
Table 2.4 Enantioselective Alkynylation with TPPO.
Reagent Stoichiometry and Reoptimization
To maximize the practicality and synthetic efficiency of this methodology we sought to reduce
reagent stoichiometry to a minimum. Ideally, the alkyne addition could be catalytic in metal
with the resultant zinc alkoxide serving as a base for subsequent alkyne deprotonations.
Carreira and coworkers were able to achieve alkynylation that was catalytic with respect to
zinc triflate by increasing the reaction temperature to 60 ◦C.11f Previous work in the Trost
group by Andrew Weiss had revealed that the use a catalytic amount of dimethylzinc and
elevated reaction temperatures in the ProPhenol-catalyzed alkynylation resulted in recovered
starting material.36. Additionally, it was shown that the use of just a slight excess of alkyne and
dimethylzinc, either 1.2 or 1.5 equivalents of each, caused a significant drop in enantioselectivity
†The experiments in Table 2.4 were performed by Vincent Chan.
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Table 2.5 Alkynylation with Reduced Stoichiometry.
(Table 2.5,∗∗ entries 2 and 5).36 Zinc alkoxides are known to form aggregates,37 and it was
hypothesized that the aggregation state of the reactive zinc species plays an important role
in enantioselectivity. Since the aggregation state is likely to be concentration dependent, a
number of experiments were performed with the concentration of alkyne and dimethylzinc
held constant, while reducing the stoichiometry of each (as opposed to a ca. 2-fold dilution).
Consequently, the ProPhenol-catalyzed addition of 1-octyne was found to give the same high
enantioselectivity with half the amount of alkyne, although a drop in yield was observed (entry
2). The lower yield is presumably a consequence of decreased reactivity and to counter this, the
reaction concentration was increased to 0.48 M. When this adjustment was made in conjunction
with the use of 20 mol % TPPO, the desired product was obtained in 80% yield and 93% ee
using just 1.2 equivalents of alkyne (entry 3). TMS-acetylene also required higher reaction
concentration and 20 mol % TPPO to provide high yield and enantioselectivity (entry 6).
The concentration dependence of this reaction led to the possibility of a dimeric active
catalyst.38 A number of dimeric zinc amino alcohol catalysts have been reported that display
characteristic non-linear asymmetric induction in alkyl addition to aldehydes.39 In the case
of the ProPhenol ligand, the enantiomeric excess of the product displayed a linear correlation
with the enantiopurity of the ProPhenol ligand used to catalyze the reaction.§, 36 Therefore, it
is likely that a single ProPhenol ligand is present in the enantiodetermining step.
∗∗Entries 1, 2, 4 and 5 were performed by Andrew Weiss
§These experiments were performed by Andrew Weiss
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Alkynylzinc Formation and Analysis of the Alkyne Premix
Reducing the equivalents of alkyne used in additions to enolizable aldehydes represents a much
more challenging prospect. These reactions produce undesired cross aldol side products and
reducing the equivalents of alkyne exacerbates the problem (see Table 2.6, entries 1–3). It was
hypothesized that this side reaction occurs as a result of incomplete alkynylzinc formation and
the presence of unreacted dimethyl zinc in the reaction mixture. Formation of the alkynylzinc
species is driven, in part, by the entropically favored release of methane gas. However, a number
of additional factors also contribute to the overall composition of the alkyne premix. Non-polar
solvents have been shown to disfavor formation of the alkynylzinc species. For example, in the
case of phenylacetylene in heptane, no formation of the methylalkynylzinc species is observed.40
A number of other Zn-alkyne addition methodologies rely on the use of additives to aid in
the formation of the alkynylzinc nucleophile.41 A stepwise 1H NMR analysis of the methyl
propiolate/Me2Zn/(S,S)-L4 premix in toluene-d8 was used to evaluate alkyne deprotonation.
Using a 1.2/1.5/0.1 ratio of methyl propiolate/Me2Zn/(S,S)-L4, integration of the peaks at
0.17 (s, 3H, CH3ZnCC) and –0.69 (s, 6H, (CH3)2Zn) ppm revealed that approximately 30% of
the desired alkynylzinc species was being formed during the standard 1 hour premix at room
temperature (Figure 2.3).42 Deprotonation of the terminal alkyne was not observed in the
Figure 2.3 1H NMR Analysis of the Alkyne Premix.
absence of the ProPhenol ligand. Analysis of the alkyne premix by volumetric gas titration
of methane revealed that the initial rate of deprotonation is rapid but tapers off after about
15 minutes. The volume of methane obtained over the standard premix time was in good
agreement with the 1H NMR results. In contrast to enolizable aldehydes, the presence of
significant amounts of dimethylzinc has little effect on the outcome of alkyne additions to
aryl and α,β-unsaturated aldehydes.43 Minor amounts of methyl addition side products, such
as compound 108, have been isolated in only a small number of cases (for example, see:
Scheme 2.7). ProPhenol-catalyzed methyl addition is a relatively slow process and, in the case
of 2-naphthaldehyde, required 3 days to react with approximately half of the starting material
(Scheme 2.8).
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Scheme 2.7 Competing Reaction Pathways: A Methyl Addition Side Product.
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Scheme 2.8 Evaluating ProPhenol-Catalyzed Asymmetric Alkylation.
These observations prompted the investigation of methods to facilitate the formation of the
alkynylzinc nucleophile and, therefore, reduce the amount of dimethylzinc present (Table 2.6).
The addition of aliphatic alkyne 111 to the enolizable aldehyde 112 provided the desired
propargylic alcohol 113 in low yield under the original super-stoichiometric conditions (entry
1). The low yield is a consequence of competing aldol side reactions, which provide a complex
mixture of oligomers including compound 114, which was isolated as a mixture of diastereomers
(19% yield). The use of Lewis basic additives such as N -methylimidazole (NMI), DMSO and
DMF to aid the formation of the desired alkynylzinc nucleophile provided a low yield of the
desired product 113 (entries 4–6).41 However, extending the alkyne premix time from 1 hour
to 24 hours provided 58% yield of propargylic alcohol 116 (entry 7). Combining this discovery
with a higher catalyst loading (20 mol %) led to an optimized result of 69% yield and 67% ee for
this challenging alkyne-aldehyde pairing (entry 8). Applying our mechanistic understanding
led to a modest improvement in the addition of a non-stabilized alkyne nucleophile (111) to an
enolizable aliphatic aldehyde (115), the most challenging combination for this methodology.
In contrast to the previous set of results, enolizable aliphatic aldehydes were shown
to be excellent electrophiles in the ProPhenol-catalyzed alkynylation when more stabilized
nucleophilic alkynes were employed. For example, the higher acidity of methyl propiolate
provides improved results with enolizable aldehydes relative to other alkynes (Table 2.7).
Addition of methyl propiolate to octanal under the initial conditions provides propargylic
alcohol 117 in 62% yield. Lowering the reaction stoichiometry from 2.8 to 1.2 equivalents
of alkyne results in a significantly decreased yield (entry 4). Longer alkyne premix time
results in visible decomposition of methyl propiolate (entry 5). Therefore the use of higher
catalyst loading was used to aid the consumption of dimethylzinc through alkynylzinc formation
(Entries 6–7). Ultimately, 57% yield and 90% ee of the desired propargyl alcohol were obtained
using 1.2 equivalents of alkyne.
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Table 2.6 Optimization of Alkyne Addition with an Enolizable Substrate.
OBz
O
OBz
HO
10 mol% (S,S)-L4,
X equiv       2,
Y equiv Me2Zn, Toluene
4 oC, 48 hours
OR
OR
23a - R = TBS
23b - R = PMBt
24a - R = TBS
24b - R = PMBt
H 111
111 112
115
113
116
 CHO X/Y conditions yield
[a]
 ee
[b]
 
1 112 2.8/2.95 - 35%
[c]
 45% 
2 112 2.8/2.95 20 mol % TPPO 39% 62% 
3 112 1.2/1.5 20 mol % TPPO 22% 54% 
4 112 1.2/1.3 30 mol % NMI 11% 72% 
5 112 1.2/1.4 4 equiv DMSO 4% 14% 
6 112 1.2/1.4 4 equiv DMF 10% 17% 
7 115 2.8/2.95 
20 mol % TPPO, 24 
hour alkyne premix 
58% 50%
[d]
 
8 115 2.8/2.95 
20 mol % (S,S)-L4 
40 mol % TPPO, 24 
hour alkyne premix 
69% 67%
[d]
 
[a] Isolated yield. All reactions were run on a 0.1625 mmol scale. [b] Enantiomeric 
excess determined by chiral HPLC analysis. [c] Isolated along with 19% yield of the 
cross aldol side product 111 [d] Enantiomeric excess determined by 1H-NMR 
analysis of the corresponding (S)-methyl mandelate. 116
OBz
HO
HO
OTBS
OTBS
114
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Table 2.7 Optimization of Methyl Propiolate Addition to Octanal.
CO2Me
OH
10 mol% (S,S)-L4,
Y equiv Me2Zn, 
Toluene
4 oC, 48 hours
O
CO2Me6 6H
(X equiv)
e
e107
entry X/Y conditions yield
[a]
 ee
[b]
 
1 2.8/2.95 - 62% 92% 
2 1.5/1.5 - 37% 86% 
3 1.5/1.5 
20 mol % 
TPPO 
35% 90% 
4 1.2/1.5 - 42% 91% 
5 2.8/2.95 
(Et2Zn) 
4 h alkyne 
premix 
60% 70% 
6 1.2/1.5 
20 mol % 
(S,S)-L4 
57% 90% 
7 2.8/2.95 
20 mol % 
(S,S)-L4 
72% 87% 
[a] All reactions were run on a 0.325 mmol scale. Isolated yield. [b] Enantiomeric 
excess determined by chiral HPLC analysis. 107
Alkynylation with Reduced Alkynylide Stoichiometry.
The use of a stoichiometric amount of alkyne would facilitate the use of complex alkynes to
access important synthetic targets, such as aspergillide B (see Chapter 4), in a highly efficient
manner. Thus, we were pleased to observe that the newly developed reaction conditions allowed
for the use of only 1.2 equivalents of alkyne with a variety of aldehydes (Scheme 2.9). In line
with our previous results, the nature of the alkyne affected the results of the alkynylation.
Methyl propiolate provided good enantioselectivity and yield with each class of aldehydes:
aliphatic, α,β-unsaturated and aryl. Higher catalyst loadings were used with enolizable
aldehydes to disfavour aldol side reactions. More specifically, using 20 mol % of the ProPhenol
ligand enabled the addition of methyl propiolate to 3-phenylpropionaldehyde in 76% yield and
93% ee. Alkynylation with only 1.2 equivalents of a non-stabilized aliphatic alkyne proved
much more challenging. However, increased reaction concentrations and the use of TPPO as
an additive enabled these alkyne additions to proceed in good yield and enantioselectivity.
Notably, the addition of an aliphatic alkyne to fumaraldehyde dimethyl acetal provided the
desired product 118 in 88% yield and 90% ee using just a single equivalent of alkyne. The
addition of aliphatic alkynes to enolizable aldehydes is particularly challenging and, in the
example shown in Scheme 2.9, only moderate yield and enantioselectivity was obtained even
when an excess of alkyne was used in conjunction with TPPO, increased catalyst loading and
a 24 hour alkyne premix.
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[a] 10 mol % (S,S)-L4 used in reaction. [b] 20 mol % (S,S)-L4, 40 mol % TPPO used in 
conjunction with a 24 h premix. [c] 20 mol % (S,S)-L4 used in reaction. [d] 20 mol % 
TPPO used in this reaction. [e] Reaction performed with 10 mol % (R,R)-L4. [f] 10 mol 
% (S,S)-L4, 20 mol % TPPO and 1 equiv of alkyne were used in this reaction.
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Scheme 2.9 Scope and Evaluation of Alkynylation with Reduced Stoichiometry.
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2.2.4 Synthetic Applications
The development of the Zn-ProPhenol-catalyzed alkyne addition methodology has enabled
the total synthesis of a wide range of complex natural products (vide infra). The synthetic
utility of this transformation is a direct consequence of the mild reaction conditions and
broad substrate scope that has become a focal point of this methodology. Propargylic alcohol
moieties are present in a number of biologically and structurally interesting polyacetylenic
natural products. The ProPhenol ligand enables the direct and convergent installation of
this functionality, as shown in the total synthesis of adociacetylene B, 123 (Scheme 2.10).44
The key intermediate, bis-enal 124, was prepared from the symmetric propargylic alcohol 125
using a Ru-catalyzed redox-isomerization.45 This atom-economic transformation avoids the use
of protecting groups and multiple redox operations often used with conventional olefination
chemistry. Bis-alkynylation of 124 with TMS-acetylene provided the desired product 126 in
excellent enantioselectivity and 9:1 mixture of dl and meso diastereomers. Alkynylation with
the conditions from the original optimization (3 equiv Me2Zn, 3 equiv alkyne and 10 mol
% (S,S)-L4) resulted in significant amounts of the mono-alkynylation product and starting
material, even when extending the reaction time to 3 days. The superior performance of the
methyl propiolate-derived alkynylzinc nucleophile was once again illustrated by the increased
yield and dr obtained relative to TMS-acetylene. The resulting γ-hydroxy-α,β-acetylenic ester
O
OH OH
5 5
R R
 -TMS
OO 5 5 O
yield ee dr (dl:meso)
71% >99% 17:1
61% >99% 9:1
R
(S,S)-L4 (20 mol%)
 Me2Zn (6 equiv)
toluene, 4 ºC, 3 d
R (6 equiv)
prod
-CO2CH3
R = H (–)-adociacetylene B
O5 5
HO OH
In(OTf)3, CSA, 
IndenylRu(PPh3)2Cl(10 mol% each)
71% yield
123
124
125
126
127
Scheme 2.10 Total Synthesis of Adociacetylene B.
2.2. ZINC-PROPHENOL CATALYZED ALKYNYLATION
OF ALDEHYDES 53
127 was saponified and decarboxylated to provide (–)-adociacetylene B (123) in a highly
efficient manner. (R,R)-L4 was also used to facilitate this reaction, providing access to both
enantiomers of the natural product.
The orthogonal reactivity of alkynes was utilized to great effect in the total synthesis
of (+)-spirolaxine methyl ether, 128 (Scheme 2.11).46 ProPhenol-catalyzed addition of the
aliphatic alkyne 129 to 3,5-dimethoxybenzaldehyde provided propargylic alcohol 130 in high
ee and yield. In 5 steps this intermediate was transformed into α,β-unsaturated aldehyde
131, the substrate required for the second key alkyne addition–hydrogenation sequence. The
Zn-ProPhenol-catalyzed addition of a 4,4-diethoxybut-1-yne (132) was used to introduce a 4-
carbon linchpin that enabled the union of the phthalide fragment with the spiroketal fragment.
This alkyne-based strategy ultimately led to the total synthesis of spirolaxine methyl ether
in 13 linear steps and provided a first glimpse at the efficiency of alkyne-based linchpin
strategies. This work also highlights the utility of asymmetric alkyne addition as a surrogate
for a saturated alkyl group addition in the preparation of chiral alcohols.
82% yield,
 90% ee
OMe O
O
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OMe
MeO
O
OMe
MeO
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OMe
MeO
O
O
O
O
OMe
MeO
O
O
(+)-spirolaxine methyl ether
52% yield, 
5:1 dr
10 mol % (R,R)-L4,
 Me2Zn, Toluene,
4 oC, 2 d
10 mol % (S,S)-L4,
 Me2Zn, Toluene,
4 oC, 2 d
MeO
OEt
EtO
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OEt
OEt
OTBS OTBS
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OMe O
O
OTBS
MeO
1) TBSCl, imidazole
2) Pt2O, H2, EtOAc
3) PPTS, acetone,
           H2O
4) Ohira-Bestmann
     reagent, K2CO3,
nBuLi, BF3 OEt2
2) HCl/H2O
3) [PdCl2(PhCN)2]
O1)
128
129 130
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Scheme 2.11 Alkyne Additions in the Total Synthesis of Spirolaxine Methyl Ether.
The Zn-ProPhenol-catalyzed addition of methyl propiolate to 3-methylbutanal (133), ini-
tially shown in Table 2.3, was recently used to construct an enantioenriched propargyl mesylate
used in the total synthesis of ushikulide A, 134 (Scheme 2.12).47 In this synthesis, the γ-
hydroxy-α,β-acetylenic ester 135 was subjected to a saponification/decarboxylation/mesylation
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sequence to provide propargyl mesylate 136. This intermediate was then used in a
palladium-catalyzed Marshall-Tamaru propargylation.48 The terminal alkyne functionality was
subsequently converted to an (E)-vinyl iodide and used in a B-alkyl Suzuki cross coupling to
tether the two major fragments of ushikulide A. Ultimately, this alkyne-based linchpin strategy
enabled the first total synthesis of (–)-ushikulide A in just 21 linear steps.47
 (S,S)-L4, Me2Zn, 
Toluene, 
4 ºC, 2 d
88% yield
95% ee
O
Me
O
OBz
Me
PMBO
O
O
Me
O
OBz
Me
PMBO
HO
H
OMs
Pd(OAc)2, PPh3
Et2Zn, THF
 
90% yield, 4:1 dr
(–)-ushikulide A
O
Me
O
O
Me
OH
O
O
OH
OH
Me OH
Me
HO
Me
1) LiOH, H2O, 
THF; CH3CN, 
CuCl, 75% yield
2) MsCl, 
Et3N, CH2Cl2 
95% yield OMsOH
CO2Me
O
CO2MeH
134
133 135 136
Scheme 2.12 Asymmetric Alkyne Addition in the Total Synthesis of Ushikulide A.
2.2.5 Summary
Continued optimization of Zn-ProPhenol-catalyzed alkyne addition has led to the development
of practical and general conditions for the asymmetric alkynylation of aldehydes.23 This
synthetically efficient methodology operates with relatively low catalyst loading and can avoid
the use of excess alkyne and dialkylzinc reagents. The chiral propargylic alcohols produced
in this reaction are versatile synthetic intermediates and have enabled the synthesis of various
complex natural products.49 Further research into the asymmetric alkynylation of enolizable
aldehydes is currently underway in the Trost group.
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2.3 Experimental Data for Chapter 2
2.3.1 General Experimental Methods
All reactions were performed under a nitrogen or argon atmosphere in flame- or oven-dried
glassware unless reported otherwise. Solvents were purified on an alumina column solvent
purification system. All reagents were purchased commercially and used without further
purification unless stated otherwise. When possible, commercial aldehydes were distilled
under nitrogen immediately prior to use. TLC was preformed with glass-backed plates coated
with 0.2 mm silica (Merck, DC-Platten, Kieselgel, 60 F254). Visualization was performed by
fluorescence quenching or staining with aqueous ceric ammonium molybdate, p-anisaldehyde or
potassium permanganate. Organic solutions were concentrated on a rotary evaporator below
35 ◦C. Flash column chromatography was preformed using silica gel (CM Science, Kieselgel 60,
230-400 mesh, ASTM). All isolated and characterized compounds were >95% pure as judged
by 1H-NMR spectroscopic analysis. 1H and 13C nuclear magnetic resonance (NMR) data were
acquired on a Varian Inova 300 (300 MHz), Varian Mecrury 400 (400 MHz), Varian Direct
Drive 400 (400 MHz) and Varian Unity 500 (500 MHz) spectrometers as indicated. Data are
listed as follows: chemical shift in ppm using chloroform as internal standard (7.26 ppm),
multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, quint = quintet, m = multiplet
or overlap of non-equivalent resonances, br = broad, app. = apparent, obs. = (partially)
obscured), integration, peak assignment. Optical rotation was measured on a Jasco DIP-100
polarimeter in 5 cm cells with a sodium 589 nm filter. The reported specific rotations are an
average of 10 measurements and are reported as [α]D25, concentration (g/100 mL), and solvent.
Infrared (IR) absorption data were acquired a a thin film on sodium chloride plates using a
PerkinElmer Paragon 500 FT-IR spectrometer. High–resolution mass spectrometry (HRMS)
was performed on a Waters Micromass Q-TOF API-US mass spectrometer. Chiral HPLC
analysis was performed on a Thermo Separation Products Spectra Series P-100 and Agilent
Technologies 1200 Series HPLC using the indicated Chiralcel R© and Chiralpak R© columns. The
absolute stereochemistry of each alkyne addition product is proposed on the basis of analogy
to previous results obtained with the ProPhenol ligand (L4). The use of (S,S)-L4 has been
shown to provide the (R)-propargylic alcohol and vice versa. Additionally, the HPLC retention
times, for a number of known propargylic alcohols, match those reported in the literature and
support this assignment of absolute stereochemistry. The absolute configuration of 120 was
also confirmed by the X-ray crystal structure of a subsequent synthetic intermediate, 137.
Representative Alkynylation Procedures
Alkynylation Procedure A: Super-Stoichiometric Conditions
Methyl 4-cyclopropyl-4-hydroxybut-2-ynoate, 107j.
OH
CO2Me
To a solution of (S,S)-ProPhenol ligand (21 mg, 0.033 mmol, 10 mol %) and methyl
propiolate (82 µL, 0.92 mmol, 2.8 equiv) in anhydrous toluene (2 mL) was added dimethyl zinc
(800 µL, 1.2 M solution in toluene, 0.96 mmol, 2.95 equiv) at 0 ◦C (2.73 mL total toluene,
0.34 M alkyne concentration). The reaction mixture was warmed to room temperature and
stirred for 60 minutes before addition of the cyclopropane carboxaldehyde (24 µL, 0.325 mmol,
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1 equiv) at 0 ◦C. The reaction was stirred for 48 hours at 4 ◦C before quenching with
saturated, aqueous NH4Cl. The organic phase was extracted three times with Et2O and the
combined organics were concentrated in vacuo. The crude product was purified by flash column
chromatography. The title compound was isolated as a clear yellow oil (44 mg, 88% yield).
Rf = 0.22 (2:1, PE:Et2O). 1H-NMR (500 MHz, CDCl3): δ 4.26 (t, J = 6.6 Hz, 1H), 3.81
(s, 3H), 1.99 (d, J = 6.1 Hz, 1H), 1.32 (m, 1H), 0.65 (m, 2H), 0.52 (m, 2H). 13C-NMR (126
MHz, CDCl3): δ 154.1, 86.7, 76.3, 65.6, 53.1, 17.0, 3.7, 2.2. IR (film): 3411 (br, OH), 3088,
3011, 2957, 2886, 2237, 1715, 1436, 1256, 1034, 752 cm−1. HRMS - EI (m/z): calculated
for C8H10O3: 154.0630, found: 154.0626, 2.6 ppm. Chiral HPLC: Chiralcel R© OD column,
heptane/iPrOH = 90:10, 0.5 mL/min, λ = 220 nm: 15.8/17.3 min (94% ee). [α]D25 = –51.9 ◦
(c = 0.98, CHCl3).
Alkynylation Procedure B: TPPO and Reduced Reagent Stoichiometry
1-Phenyl-5-trimethylsilanyl-pent-1-en-4-yn-3-ol, 138.
OH
TMSPh
To a solution of (S,S)-ProPhenol ligand (20.8 mg, 0.0325 mmol, 10 mol %), triphenylphos-
phine oxide (18 mg, 0.065 mmol, 20 mol %) and TMS-acetylene (56 µL, 0.39 mmol, 1.2 equiv)
in anhydrous toluene (0.44 mL) was added dimethyl zinc (406 µL, 1.2 M solution in toluene,
0.488 mmol, 1.5 equiv) at 0 ◦C (0.813 mL total toluene, 0.48 M alkyne concentration). The
reaction was warmed to room temperature and stirred for 60 minutes before addition of the E-
cinammaldehyde (43 mg, 0.325 mmol, 1 equiv) at 0 ◦C. The reaction was stirred for 48 hours
at 4 ◦C before quenching with saturated, aqueous NH4Cl. The organic phase was extracted
three times with Et2O and the combined organics were concentrated in vacuo. The crude
product was purified by flash column chromatography. The title compound was isolated as a
white solid (67 mg, 83% yield). 1H-NMR (400 MHz, CDCl3): δ 7.40-7.43 (m, 2H), 7.32-7.36
(m, 2H), 7.25-7.29 (m,1H), 6.77 (dd, J = 16, 1.2 Hz, 1H), 6.29 (dd, J = 16, 6 Hz, 1H), 5.05
(dt, J = 6, 1.2 Hz, 1H), 1.96 (t, J = 6 Hz, 1H), 0.21 (s, 9H). 13C-NMR (101 MHz, CDCl3):
δ 136.0, 132.0, 128.6, 128.1, 127.8, 126.8, 104.1, 91.3, 66.3, -0.2. Chiral HPLC: Chiralcel R©
AD column, heptane/iPrOH = 90/10, 1.0 mL/min, λ = 254 nm: 6.97/8.79 min (88% ee).
Characterization data matches literature.50
2.3.2 Experimental Details and Characterization Data
Alkyne Additions to Aliphatic Aldehydes
Methyl 4-hydroxy-5-methylhex-2-ynoate, 107a.
OH
CO2Me
This reaction was run according to alkynylation procedure A with isobutyraldehyde (30
µL, 23 mg, 0.325 mmol) and methyl propiolate (82 µL, 0.92 mmol, 2.8 equiv) in toluene (2 mL)
at 4 ◦C for 48 h. The title compound was isolated as a clear colorless oil (31 mg, 60% yield).
Rf = 0.29 (2:1, PE:Et2O). 1H-NMR (500 MHz, CDCl3): δ 4.31 (d, J = 6 Hz, 1H), 3.81 (s,
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3H), 1.95 (sextet, J = 6 Hz, 1H), 1.06 (dd, J = 6.5 Hz, 6H). 13C-NMR (126 MHz, CDCl3):
δ 154.0, 87.5, 67.8, 53.1, 34.4, 18.2, 17.7. IR (film): 3418, 2965, 2236, 1722, 1470, 1436, 1386,
1371, 1253, 1037, 953, 752 cm−1. Chiral HPLC: Chiralcel R© AS column, heptane/iPrOH
= 98:2, 0.8ml/min, 220nm) 24.29/27.99 min, 90% ee. [α]D25 = +6.85 ◦ (c = 0.216, CHCl3).
Characterization data matches literature.51
Methyl 4-hydroxyhex-2-ynoate, 107b.
OH
CO2Me
This reaction was run according to alkynylation procedure A with propionaldehyde (23 µL,
19 mg, 0.325 mmol) and methyl propiolate (82 µL, 0.92 mmol, 2.8 equiv) in toluene (2 mL) at
4 ◦C for 48 h. The title compound was isolated as a clear colorless oil (20.3 mg, 44% yield).
Rf = 0.26 (2:1, PE:Et2O). 1H-NMR (400 MHz, CDCl3): δ 4.44 (t, J = 6.4 Hz, 1H), 3.78 (s,
3H), 1.80 (quintet, J = 7.2 Hz, H), 1.04 (t, J = 7.6 Hz, 2H). 13C-NMR (101 MHz, CDCl3):
δ 154.1, 88.3, 76.5, 63.5, 53.1, 30.3, 9.5. IR (film): 3415, 2971, 2939, 2881, 2237, 1719, 1437,
1252, 1117, 1062, 1035, 1012, 972, 940, 878, 752 cm−1. Chiral HPLC: Chiralcel R© OB-H
column, heptane/iPrOH = 95:5, 0.8 ml/min, λ = 220 nm) 18.68/19.83 min, 91% ee. [α]D25
= +5.5 ◦ (c = 0.77, CHCl3). Characterization data matches literature.51
Methyl 4-hydroxy-5,5-dimethylhex-2-ynoate, 107c.
OH
CO2Me
This reaction was run according to alkynylation procedure A with pivaldehyde (36 µL, 28
mg, 0.325 mmol) and methyl propiolate (82 µL, 0.92 mmol, 2.8 equiv) in toluene (2 mL) at
4 ◦C for 48 h. The title compound was isolated as a clear colorless oil (51.1 mg, 92% yield).
Rf = 0.13 (5:1, PE:Et2O). 1H-NMR (300 MHz, CDCl3): δ 4.16 (d, J = 6.1 Hz, 1H), 3.81 (s,
3H), 2.04 (d, J = 4.4 Hz, 1H), 1.05 (s, 9H). 13C-NMR (76 MHz, CDCl3): δ 154.0, 87.4, 76.9,
71.3, 53.1, 36.4, 25.5. IR (film): 3444, 2960, 2908, 2872, 2236, 1715, 1480, 1483, 1436, 1395,
1367, 1258, 1083, 1043, 1013, 954, 884, 828, 753, 655 cm−1. HRMS – EI (m/z): calculated
for C9H14O3: 170.0943, found: 170.0939, 2.2 ppm. Chiral HPLC: Chiralcel R© AD column,
heptane/ iPrOH = 95:5, 1.0 mL/min, λ = 220 nm: 10.35, 11.4 min, 88% ee. [α]D25 = +2.27 ◦
(c = 0.89, CHCl3). Characterization data matches literature.29d
Methyl 5-ethyl-4-hydroxyhept-2-ynoate, 107d.
OH
CO2Me
This reaction was run according to alkynylation procedure A with 2-ethyl butyraldehyde
(40 µL, 33 mg, 0.325 mmol) and methyl propiolate (82 µL, 0.92 mmol, 2.8 equiv) in toluene
(2 mL) at 4 ◦C for 48 h. The title compound was isolated as a clear colorless oil (36 mg,
60% yield). Rf = 0.43 (2:1, PE:Et2O). 1H-NMR (300 MHz, CDCl3): δ 4.56 (t, J = 5.5 Hz,
1H), 3.81 (s, 3H), 1.94 (d, J =6 Hz, 1H), 1.65-1.39 (m, 5H), 0.97 (m, 6H). 13C-NMR (126
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MHz, CDCl3): δ 154.0, 87.96, 77.03, 64.7, 53.1, 47.2, 22.0, 11.7. IR (film): 3420, 2965, 2937,
2879, 2235, 1716, 1461, 1436, 1383, 1254, 1133, 1054, 1026, 968, 908, 830, 753 cm−1. Chiral
HPLC: Chiralcel R© AD column, heptane/iPrOH = 97:3, 0.8ml/min, λ = 220 nm: 12.74/15.67
min, 88% ee. [α]D25 = –1.83 ◦ (c = 0.78, CHCl3). Characterization data matches literature.52
Methyl 4-hydroxyhex-2-ynoate, 107e.
OH
CO2Me
This reaction was run according to alkynylation procedure A with octanal (51 µL, 41 mg,
0.325 mmol) and methyl propiolate (82 µL, 0.92 mmol, 2.8 equiv) in toluene (2 mL) at 4 ◦C
for 48 h. The title compound was isolated as a slight yellow oil (41 mg, 62% yield). Rf =
0.17 (5:1, PE:Et2O). 1H-NMR (500 MHz, CDCl3): δ 4.5 (q, J = 6.5 Hz 1H), 3.8 (s, 3H),
2.36 (br s, 1H), 1.78 (m, 2H), 1.48 (m, 2H), 1.33 (m, 11H). 13C-NMR (126 MHz, CDCl3): δ
154.1, 88.6, 76.4, 62.3, 53.1, 37.1, 32.0, 29.4, 25.2, 22.9, 22.6, 14.3. IR (film): 3418, 2955, 2857,
2237, 1715, 1460, 1435, 1379, 1253, 1125, 1066, 987, 964, 752, 736 cm−1. Chiral HPLC:
Chiralcel R© OD column, heptane/iPrOH = 99:1, 0.8 ml/min, λ = 220 nm: 36.5/41.08 min,
92% ee. Characterization data matches literature.12f
Methyl 6-chloro-4-hydroxy-5,5-dimethylhex-2-ynoate, 107f.
OH
CO2Me
Cl
This reaction was run according to alkynylation procedure A with 3-chloro-2,2-dimethyl-
propanal (37 mg, 0.325 mmol) and methyl propiolate (82 µL, 0.92 mmol, 2.8 equiv) in toluene
(2 mL) at 4 ◦C for 48 h. The title compound was isolated as a slight yellow oil (48 mg, 72%
yield). Rf = 0.2 (5:1, PE:Et2O). 1H-NMR (400 MHz, CDCl3): δ 4.54 (s, 1H), 3.79 (s, 3H),
3.65 (d, J = 10.8 Hz, 1H), 3.42 (d, J = 10.8 Hz, 1H), 1.11 (s, 6H) 13C-NMR (101 MHz,
CDCl3): δ 153.8, 86.1, 78.1, 53.1, 52.1, 40.8, 21.9, 20.7. IR (film): 3444, 2971, 2878, 2237,
1714, 1470, 1436, 1389, 1370, 1253, 1080, 1039, 1012, 953, 910, 867, 830, 775, 752, 726, 659
cm−1. Chiral HPLC: Chiralcel R© AD column, heptane/iPrOH = 90:10, 1.0 ml/min, λ = 220
nm: 7.35/8.19 min (77% ee).
Methyl 4-hydroxy-6-methylhept-2-ynoate, 107g.
OH
CO2Me
This reaction was run according to alkynylation procedure A with 3-methylbutanal (36 µL,
28 mg, 0.325 mmol) and methyl propiolate (82 µL, 0.92 mmol, 2.8 equiv) in toluene (2 mL)
at 4 ◦C for 48 h. The title compound was isolated as a slight yellow oil (35 mg, 62% yield).
Rf = 0.29 (2:1, PE:Et2O). 1H-NMR (400 MHz, CDCl3): δ 4.5 (q, J = 6.9 Hz, 1H), 3.76 (s,
3H), 2.7 (d, J = 5.2 Hz, 1H), 1.84 (sept, J = 6.7 Hz, 1H), 1.64 (m, J = 7.4 Hz, 2H), 0.92
(dd, J = 6.6, 3.4 Hz, 6H). 13C-NMR (101 MHz, CDCl3): δ 154.2, 89.0, 76.3, 60.7, 53.1, 45.9,
24.7, 22.7, 22.4. IR (film): 3415, 2958, 2936, 2872, 2237, 1721, 1469, 1436, 1388, 1370, 1254,
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1138, 1071, 1041, 997, 935, 752 cm−1. HRMS - EI (m/z): [MC9H14O3 – (CH3)2CHCH2]+
calculated for C5H6O3: 114.0317, found 114.0320, -2.8 ppm. Chiral HPLC: Chiralcel R© OD
column, heptane/iPrOH = 98:2, 0.8 mL/min, λ = 220 nm: 21.57/23.67 min (93% ee). [α]D25
= +13.8 ◦ (c = 0.93, CHCl3). Characterization data matches literature.12f
Methyl 4-hydroxy-6-phenylhex-2-ynoate, 107h.
OH
CO2Me
Ph
This reaction was run according to alkynylation procedure A with hydrocinnamaldehyde
(43 µL, 44 mg, 0.325 mmol) and methyl propiolate (82 µL, 0.92 mmol, 2.8 equiv) in toluene (2
mL) at 4 ◦C for 48 h. The title compound was isolated as a slight yellow oil (46 mg, 65% yield).
Rf = 0.17 (2:1, PE:Et2O). 1H-NMR (500 MHz, CDCl3): δ 7.3 (m, 2H), 7.2 (m, 3H), 4.47 (s,
1H), 3.79 (s, 3H), 2.95 (s, 1H), 2.81 (t, 2H), 2.1 (m, 2H). 13C-NMR (126 MHz, CDCl3): δ
154.2, 140.8, 128.8, 128.75, 126.4, 88.5, 76.6, 61.4, 53.1, 38.4, 31.3. IR (film): 3415, 3028, 2954,
2929, 2863, 2236, 1716, 1603, 1496, 1455, 1436, 1257, 1059, 1030, 947, 913, 751, 701 cm−1.
HRMS – EI (m/z): calculated for C13H14O3: 218.0943, found: 218.0934, 4.0 ppm. Chiral
HPLC: Chiralcel R© OD column, heptane/iPrOH = 95:5, 1.0 ml/min, λ = 220 nm: 26.6/28.0
min, 95% ee. [α]D25 = –40.4 ◦ (c = 1.06, CHCl3). Characterization data matches literature.29d
Methyl 4-hydroxy-5,5-dimethyloct-7-en-2-ynoate, 107i.
OH
CO2Me
This reaction was run according to alkynylation procedure A with 2,2-dimethylpent-4-enal
(37 mg, 0.325 mmol) and methyl propiolate (82 µL, 0.92 mmol, 2.8 equiv) in toluene (2 mL)
at 4 ◦C for 48 h. The title compound was isolated as a clear colorless oil (30 mg, 48% yield).
Rf = 0.14 (5:1, PE:Et2O). 1H-NMR (300 MHz, CDCl3): δ 5.92-5.78 (m, 1H), 5.16 (d, J =
5.4 Hz, 1H), 5.10 (d, 1H), 4.22 (d, J = 6.3 Hz, 1H), 3.81 (s, 3H), 2.26-2.08 (m, 2H), 1.03 (s, 6H).
13C-NMR (101 MHz, CDCl3): δ 154.1, 134.5, 118.6, 87.3, 77.9, 70.0, 53.1, 42.9, 39.2, 23.0.
IR (film): 3420, 3077, 2966, 2933, 2876, 2235, 1716, 1640, 1471, 1436, 1387, 1368, 1252, 1191,
1073, 1038, 1011, 918, 753 cm−1. Chiral HPLC: Chiralcel R© OB-H column, hept/iPrOH
= 97:3, 1.0 mL/min, λ = 220 nm, 9.41/10.33 min (70% ee). Characterization data matches
literature.53
Methyl 4-hydroxy-8-(triisopropylsilyloxy)oct-2-ynoate, 107k.
OH
CO2Me
TIPSO
This reaction was run according to alkynylation procedure A with 5-(triisopropyl-
silanyloxy)-pentanal (84 mg, 0.325 mmol) and methyl propiolate (82 µL, 0.92 mmol, 2.8 equiv)
in toluene (2 mL) at 4 ◦C for 48 h. The title compound was isolated as a slight yellow oil
(60 mg, 52% yield). Rf = 0.15 (5:1, PE:Et2O). 1H-NMR (400 MHz, CDCl3): δ 4.50 (t, J =
6.8 Hz, 1H), 3.77 (s, 3H), 3.72 (t, J = 6 Hz, 2H), 1.80 (m, 2H), 1.57 (m, 4H), 1.05 (m, 21H)
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13C-NMR (101 MHz, CDCl3): δ 154.1, 88.5, 76.4, 63.3, 62.3, 53.0, 36.8, 32.5, 21.6, 18.2,
12.2. IR (film): 3418, 2944, 2867, 2237, 1722, 1463, 1436, 1384, 1251, 1107, 1070, 1040, 1014,
996, 919, 883, 797, 752, 721, 681, 658, 639 cm−1. Chiral HPLC: Chiralcel R© OD column,
heptane/iPrOH = 98:2, 0.8 ml/min, λ = 220 nm: 17.64/20.75 min, 95% ee. [α]D25 = –0.92 ◦
(c = 1.13, CHCl3).
Dimethyl 4-hydroxy-5,5-dimethylhex-2-ynedioate, 107l.
OH
CO2Me
MeO
O
This reaction was run according to alkynylation procedure A with methyl 2,2-dimethyl-3-
oxopropanoate (42 mg, 0.325 mmol) and methyl propiolate (82 µL, 0.92 mmol, 2.8 equiv) in
toluene (2 mL) at 4 ◦C for 48 h. The title compound was isolated as a clear colorless oil (52
mg, 75% yield). Rf = 0.26 (2:1, PE:Et2O) 1H-NMR (400 MHz, CDCl3): δ 4.55 (s, 1H), 3.76
(s, 3H), 3.73 (s, 3H), 1.314 (s, 3H), 1.29 (s, 3H). 13C-NMR (101 MHz, CDCl3): δ 176.7, 153.8,
94.7, 85.5, 68.4, 53.1, 52.7, 47.7, 22.9, 20.2. IR (film): 3474, 2955, 2238, 1716, 1436, 1390,
1250, 1136, 1082, 1041, 1014, 953, 916, 752 cm−1. Chiral HPLC: Chiralcel R© AD column,
heptane/iPrOH = 90:10, 0.8 mL/min, λ = 220 nm, 11.2/12.9 min (21% ee).
1-Cyclopropyl-non-2-yn-1-ol, 107m.
OH
C6H13
This reaction was run according to alkynylation procedure A with cyclopropane carbox-
aldehyde (24 µL, 0.325 mmol) and 1-octyne (0.92 mmol, 2.8 equiv) in toluene (2 mL) at 4 ◦C
for 48 h. The title compound was isolated as a clear colorless oil (54.8 mg, 94% yield). Rf =
0.185 (11:1, PE:Et2O). 1H-NMR (500 MHz, CDCl3): δ 4.25 (tt, J = 6.5, 1.5 Hz, 1H), 2.21
(td, J = 7, 2 Hz, 2H), 1.52 (quintet, J = 7 Hz, 2H), 1.42-1.23 (m, 6H), 0.915 (t, J = 7 Hz,
3H), 0.59-0.41 (m, 5H). 13C-NMR (126 MHz, CDCl3): δ 86.2, 78.9, 66.2, 31.6, 28.9, 28.8,
22.8, 18.9, 17.5, 14.3, 3.4, 1.6. IR (film): 3356 (br, OH), 3084, 3007, 2931, 2859, 2254, 1465,
1432, 1328, 1310, 1272, 1151, 1131, 1026, 1009, 917.8, 832, 723 cm−1. Enantiomeric excess
determined from the corresponding p-nitrobenzoyl ester. To a solution of 1-cyclopropyl-non-
2-yn-1-ol from the previous reaction with DMAP (1.34 mg, 0.011 mmol, 0.05 equiv) in 1 mL
of pyridine was added p-nitrobenzoyl chloride (0.061 g, 0.33 mmol, 3 equiv). The reaction
was stirred at room temperature for 3 hours before being quenched with water, washed with
saturated aqueous CuSO4 and brine. The combined organics were dried over MgSO4 and the
solvent was removed in vacuo. The product was purified using flash column chromatography
to give a clear, colorless oil (7.3 mg, 20% yield). Rf = 0.43 (11:1, PE:Et2O). 1H-NMR (300
MHz, CDCl3): δ 8.30 (m, 4H), 5.58 (dt, J = 6.6, 1.8 Hz, 1H), 2.23 (td, J = 6.9, 2.1 Hz, 3H),
1.53 (quintet, J = 6.9 Hz, 2H), 1.43-1.3 (m, 6H), 0.70-0.55 (m, 5H).Chiral HPLC: Chiralcel R©
AD column, heptane/iPrOH = 99:1, 1.0 mL/min, λ = 254 nm: 8.56/7.43 min (69% ee).
Methyl 4-hydroxy-5,5-dimethyloct-7-en-2-ynoate, 107n.
This reaction was run according to alkynylation procedure A with methyl 5,5-diethoxy-4-
hydroxyoct-7-en-2-ynoate (56.0 mg, 0.325 mmol, 1 equiv) and methyl propiolate (82 µL, 0.92
mmol, 2.8 equiv) in toluene (2 mL) at 4 ◦C for 48 h. The title compound was isolated as a
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OH
CO2MeEtO OEt
clear yellow oil (67.7 mg, 87% yield). Rf = 0.16 (5:1, PE:Et2O). 1H-NMR (400MHz, CDCl3):
δ 5.92-5.81 (m, 1H), 5.25-5.19 (m, 1H), 5.17-5.13 (m, 1H), 4.56 (d, J = 6.4 Hz, 1H), 3.78 (s,
3H), 3.7-3.6 (m, 4H), 2.61 (d, 1H), 2.7-2.55 (m, 2H), 1.2 (dt, J = 2.4, 6.8 Hz, 6H). 13C-NMR
(101 MHz, CDCl3): δ 153.9, 132.9, 119.4, 100.9, 85.5, 77.8, 66.1, 57.6, 53.0, 38.9, 15.6. IR
(film): 3484, 2979, 2932, 2898, 2239, 1719, 1437, 1252, 1086, 1053 cm−1. Chiral HPLC:
Chiralcel R© AD (heptane/iPrOH = 90:10, 1.0 mL/min, λ = 220 nm) 5.63/6.41 min, 0% ee.
Methyl 4-cyclohexyl-4-hydroxybut-2-ynoate, 107o.
OH
CO2Me
This reaction was run according to alkynylation procedure A with cyclohexane carboxalde-
hyde (39 µL, 37 mg, 0.325 mmol) and methyl propiolate (82 µL, 0.92 mmol, 2.8 equiv) in
toluene (2 mL) at 4 ◦C for 48 h. The title compound was isolated as a slight yellow oil (45 mg,
71% yield). Rf = 0.13 (5:1, PE:Et2O). 1H-NMR (500 MHz, CDCl3): δ 4.29 (d, 1H), 3.795 (s,
3H), 2.448 (br s, 1H), 1.87 (m, 2H),1.805 (m, 2H), 1.66 (m, 2H), 1.25 (m, 2H), 1.13 (m, 2H).
13C-NMR (126 MHz, CDCl3): δ 154.2, 88.0, 67.1, 53.1, 43.8, 28.6, 28.3, 26.4, 25.9. IR (film):
3417, 2928, 2855, 2236, 1722, 1451, 1435, 1258, 1085, 1068, 1050, 1017, 965, 914, 894,845, 821,
752, 734 cm−1. Chiral HPLC: Chiralcel R© AD column, heptane/iPrOH = 99:1, 1.0 ml/min,
λ = 220 nm: 48.7/52.01 min (90% ee). [α]D25 = +3.6 ◦ (c = 0.89, CHCl3). Characterization
data matches literature.12f
See Chapter 3 for experimental details and characterization data on:
•(R,E)-methyl 4-hydroxy-5,5-dimethyl-8-oxodec-6-en-2-ynoate, 120.
See Chapter 4 for experimental details and characterization data on:
•(2S/R,8R)-11-((tert-Butyldimethylsilyl)oxy)-8-hydroxyundec-6-yn-2-yl benzoate, 113.
•(2S/R,8R)-8-Hydroxy-11-((4-methoxybenzyl)oxy)undec-6-yn-2-yl benzoate, 116.
Alkyne Additions with Unsaturated Aldehydes
1-Phenyl-undec-1-en-4-yn-3-ol, 139.
OH
C6H13Ph
This reaction was run according to alkynylation procedure A with (E)-cinammaldehyde
(43 mg, 0.325 mmol) and 1-octyne (101 mg, 0.92 mmol, 2.8 equiv) in toluene (2 mL) at 4 ◦C
for 48 h. The title compound was isolated as a clear yellow oil (79 mg, 100% yield). 1H-NMR
(500 MHz, CDCl3): δ 7.38-7.41 (m, 2H), 7.29-7.34 (m, 2H), 7.23-7.28 (m, 1H), 6.75 (d, J =
16 Hz, 1H), 6.30 (dd, J = 16, 6 Hz, 1H), 5.04 (s, 1H), 2.26(td, J = 7, 2Hz, 2H), 2.04 (s, 1H),
1.50-1.57 (m, 2H), 1.37-1.44 (m, 2H), 1.24-1.35 (m, 4H), 0.89 (t, J = 7 Hz, 3H). 13C-NMR
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(126 MHz, CDCl3): δ 136.2, 131.4, 128.8, 128.5, 127.9, 126.7, 87.5, 79.1, 63.2, 31.3, 28.55,
28.52, 22.5, 18.8, 14.0. Chiral HPLC: Chiralcel R© AD column, heptane/iPrOH = 90/10, 1
mL/min, λ = 254 nm: 9.4(major)/8.26(minor) min (77% ee). Characterization data matches
literature.22
(E)-Methyl 7-((tert-butyldimethylsilyl)oxy)-4-hydroxyhept-5-en-2-ynoate, 122.
OH
CO2Me
TBSO
This reaction was run according to alkynylation procedure A with (E)-4-((tert-butyl-
dimethylsilyl)oxy)but-2-enal (33 mg, 0.163 mmol, 1.0 equiv), methyl propiolate (41 µL, 0.46
mmol, 2.8 equiv), (R,R)-ProPhenol (11 mg, 0.0163 mmol, 10 mol %) and Me2Zn (399 µL, 1.2
M solution in toluene, 0.48 mmol, 2.95 equiv) in toluene (1 mL) at 4 ◦C for 48 h. The title
compound was isolated as a clear colorless oil (40 mg, 86% yield). Rf = 0.39 (15% EtOAc/
pet. ether). 1H-NMR (500 MHz, CDCl3): δ 6.06 (dtd, J = 15.3, 4.1, 1.3 Hz, 1H), 5.88
(ddt, J = 15.3, 5.7, 1.9 Hz, 1H), 5.07-5.04 (m, 1H), 4.24 (dt, J = 3.9, 1.8 Hz, 2H), 3.82 (s,
3H), 2.12 (d, J = 6.6 Hz, 1H), 0.94 (s, 9H), 0.10 (s, 6H). 13C-NMR (126 MHz, CDCl3): δ
153.95, 134.02, 126.21, 86.18, 62.62, 62.42, 53.15, 26.17, 18.65, 0.26, -5.06. IR (film): 3406,
2955, 2857, 2238, 1721, 1471, 1436, 1255, 1128, 1004, 837 cm−1. Chiral HPLC: Chiralpak R©
IB column, heptane:iPrOH = 95:5, 0.4 mL/min, λ = 220 nm, tR = 18.1 (minor), 18.9 (major)
minutes (95% ee). [α]D25 = +11.81 ◦ (c = 1.13, CHCl3).
Methyl 4-hydroxy-4-phenylbut-2-ynoate, 119.
OH
CO2Me
This reaction was run according to alkynylation procedure A with benzaldehyde (34 mg,
0.325 mmol) and methyl propiolate (82 µL, 0.92 mmol, 2.8 equiv) in toluene (2 mL) at 4 ◦C for
48 h. The title compound was isolated as as a clear colorless oil (0.060 g, 97% yield). Rf = 0.23
(15% EtOAc/PE). 1H-NMR (500 MHz, CDCl3): δ 7.55-7.53 (m, 2H), 7.45-7.38 (m, 3H), 5.60
(d, J = 5.8 Hz, 1H), 3.82 (s, 3H), 2.62 (d, J = 6.2 Hz, 1H). 13C-NMR (126 MHz, CDCl3): δ
153.98, 138.70, 129.25, 129.14, 126.92, 86.70, 77.90, 64.57, 53.20. Chiral HPLC: Chiralcel R©
OD column, 95:5 heptane/ isopropanol, 0.8 mL/min, 220 nm: 72% ee. Characterization data
matches literature.29d
See Chapter 4 for experimental details and characterization data on:
•(2S/R,8R,E)-11-((tert-Butyldimethylsilyl)oxy)-8-hydroxyundec-9-en-6-yn-2-yl benzoate, 121.
•(2S,8R,E)-8-Hydroxy-11,11-dimethoxyundec-9-en-6-yn-2-yl benzoate, 118.
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Miscellaneous Experiments
Procedure for the Stepwise 1H-NMR Analysis of the Alkynylation Premix
To an oven dried NMR tube was added toluene-d8 (0.486 mL) and dimethylzinc (0.124
mL of a 1.2 M solution in PhMe, 0.149 mmol, 15 equiv). A 1H-NMR spectrum (500 MHz)
was recorded, solvent suppression was not necessary. To the NMR tube was added methyl
propiolate (0.011 mL, 0.12 mmol, 12 equiv). 1H-NMR spectrum recorded. Under a stream
of nitrogen, (S,S)-ProPhenol ligand (0.0069 g, 0.01 mmol, 1 equiv) was added and 1H-NMR
spectra were recorded at 10, 30 and 50 minutes. Integration of the peaks at 0.17 (s, 3H,
CH3ZnCC) and –0.69 (s, 6H, (CH3)2Zn) ppm was used to quantify alkynylzinc formation.
Inherent to this calculation is the assumption that the deprotonation is clean and no side
reactions occur. Extending the reaction time further resulted in visible decomposition.
Entry Time Conversion
1 10 min 24%
2 30 min 26%
3 50 min 27%
1-Naphthalen-2-yl-ethanol, 110.
OH
To a solution of (S,S)-Prophenol ligand (0.038 g) in toluene (2.5 mL) was added
dimethylzinc (0.4). 2-Naphthaldehyde (0.183 g, 1.172 mmol, 1 equiv) was subsequently added
and the reaction stirred for 3 days at 4 ◦C. The title compound was isolated as a white solid
(0.92 g, 46% yield). Rf = 0.31 (2:1, PE:Et2O). 1H-NMR (300 MHz, CDCl3): δ 7.87 (m, 4H),
7.5 (m, 3H), 5.11 (m, 1H), 1.9 (d, J = 3.3 Hz, 1H), 1.62 (d, J = 6.3 Hz, 3H). Chiral HPLC:
Chiralcel R© OB-H column, hept/iPrOH 90:10, 1.0 mL/min, λ = 254 nm: 9.49/10.79 min (37%
ee). Characterization data matches literature.54
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Substrate Synthesis
Methyl 2,2-dimethyl-3-oxopropanoate
O
O H
O
To a solution of 3.08 mL of dimethylsulfoxide (DMSO, 36.3 mmol, 2.82 g, 2.4 equiv) in
120 mL of CH2Cl2 was added 1.43 mL of oxalyl chloride (16.6 mmol, 2.12 g, 1.1 equiv) at
–78 ◦C. The reaction mixture was stirred at –78 ◦C for 10 minutes before addition of methyl
3-hydroxy-2,2-dimethylpropanoate (2.0 g, 15.1 mmol, 1 equiv). The reaction was stirred for 30
minutes before addition of 10.58 mL of triethylamine (75.7 mmol, 7.68 g, 5 equiv) via syringe.
The reaction mixture was then slowly warmed to room temperature, quenched with water and
the resulting mixture extracted with CH2Cl2. The combined organic layers were washed with
brine, dried over MgSO4, filtered and concentrated in vacuo. The title compound was isolated
as a clear, colorless oil (1.048 g, 53% yield). Rf = 0.28 (5:1, PE:Et2O). 1H-NMR (400MHz,
CDCl3): δ 9.66 (s, 1H), 3.75 (s, 3H), 1.35 (s, 6H). Characterization data matches literature.55
3-Chloro-2,2-dimethyl-propionaldehyde
Cl H
O
To a solution of 3.32 mL of dimethylsulfoxide (DMSO, 39.1 mmol, 3.04 g, 2.4 equiv) in
128 mL of CH2Cl2 was added 1.54 mL of oxalyl chloride (17.9 mmol, 2.27 g, 1.1 equiv) at –78
◦C. The reaction mixture was stirred at –78 ◦C for 10 minutes before addition of 3-chloro-2,2-
dimethyl-propanol (2.0 g, 16.3 mmol, 1equiv). The reaction was stirred for 30 minutes before
addition of 11.4 mL of triethylamine (81.6 mmol, 8.28 g, 5 equiv) via syringe. The reaction
mixture was then slowly warmed to room temperature, quenched with water and the resulting
mixture extracted with CH2Cl2. The combined organic layers were washed with brine, dried
over MgSO4, filtered and concentrated in vacuo. The title compound was isolated as a clear,
colorless oil (1.948g, 99% yield). Rf = 0.69 (2:1, PE:Et2O). 1H-NMR (400MHz, CDCl3): δ
9.50 (s, 1H), 3.58 (s, 2H), 1.17ppm (s, 6H). 13C-NMR (100MHz, CDCl3): δ 203.3, 49.7, 47.7,
20.3. IR (film): 2976, 2875, 2811, 2714, 1730, 1470, 1397, 1368, 1285, 918, 875, 864, 776, 732
cm−1. Characterization data matches literature.56
5-(Triisopropyl-silanyloxy)-pentanal
TIPSO H
O
To a solution of 1.67 g of imidizole (49mmol, 2 equiv) and 1.13 mL of 5-hydroxypentanal
(1.19 g, 24.5 mmol) in 25 mL of CH2Cl2 was added triisopropylsilyl chloride (3.5 mL, 29.35
mmol, 1.2 equiv). The reaction mixture was stirred for 4 hours before being quenched
with saturated, aqueous NH4Cl. The reaction mixture was extracted with CH2Cl2, and
the combined organics washed with brine, dried over MgSO4, filtered, and concentrated in
vacuo. The crude product was purified by flash column chromatography (3% EtOAc/hexanes)
to provide the title compound as a clear, colorless oil (0.95g, 15% yield). Rf = 0.70 (2:1,
PE:Et2O). 1H-NMR (400MHz, CDCl3): δ 9.78 (s, 1H), 3.72 (t, J = 6 Hz, 2H), 2.47 (td, J
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= 6.8, 2 Hz, 2H), 1.76 (quintet, J = 6 Hz, 2H), 1.60 (m, 2H), 1.07 (m, 21H). Characterization
data matches literature.57
See Chapter 3 for experimental details and characterization data on:
•(E)-2,2-dimethyl-5-oxohept-3-enal, 140
See Chapter 4 for experimental details and characterization data on:
•(E)-4,4-Dimethoxybut-2-enal, 141
•4-((tert-Butyldimethylsilyl)oxy)butanal, 112
•4-((4-Methoxybenzyl)oxy)butanal, 115
•(E)-4-((tert-Butyldimethylsilyl)oxy)but-2-enal, 142
•(±)-Hept-6-yn-2-yl benzoate, 111
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2.3.3 Spectra
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OH
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1H-NMR (500 MHz, CDCl3)
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1H-NMR (400 MHz, CDCl3)
13C-NMR (101 MHz, CDCl3)
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OH
CO2Me
Cl
1H-NMR (400 MHz, CDCl3)
methyl 6-chloro-4-hydroxy-5,5-dimethylhex-2-ynoate
OH
CO2Me
Cl
13C-NMR (101 MHz, CDCl3)
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13C-NMR (126 MHz, CDCl3)
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3.1 Introduction
The asteriscunolides are a family of four humulene natural products originally isolated from
the Mediterranean plants Asteriscus aquaticus and Asteriscus graveolens.1 These sesquiterpene
natural products contain an inherently strained 11-membered ring with an embedded
butenolide heterocycle and two alkenes (Figure 3.1). Asteriscunolides A, B, C, and D
represent all possible alkene isomers of this cyclic framework: (Z,Z ), (Z,E), (E,Z ), and (E,E),
respectively. All four asteriscunolides display cytotoxicity towards a range of cancerous cells,
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Figure 3.1 The Asteriscunolide Family of Natural Products.
with asteriscunolide D being particularly cytotoxic towards MEL-28 (human melanoma), A-549
(human lung carcinoma), and HT-29 (human colon carcinoma) cell lines.2 Recent studies into
the mode of action of these compounds has revealed that asteriscunolide C causes apoptosis
associated with activation of mitogen-activated protein kinases.3
The unique macrocyclic structure of the asteriscunolides gives rise to a number of distorted
bond angles and atypical conformations. As a result, the initial structures of asteriscunolide
A and B were misassigned due to an unusually high 14 Hz 3JHH coupling across the cis-
disubstituted alkene. The unfunctionalized humulene framework (147) has four macrocyclic
conformations, which interconvert readily at room temperature (Figure 3.2).4 With these
properties of humulene in mind, the initial report of the structures for the asteriscunolides
proposed that asteriscunolide A and B were atropisomers of asteriscunolide C and D,
respectively. The true structure of these natural products was ultimately revealed by X-
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Figure 3.2 Cyclic Conformers of Humulene.
ray crystallography,5 which also provided detailed information on their atypical structure
(Figure 3.3). The dihedral angles of the alkenes present in these natural products provide
a good indication of the strained nature of each of the asteriscunolide macrocycles. In
this case, ring strain leads to a distortion of the typical planar geometry of an alkene in a
butenolide ring. Examination of the H2-C2-C3-C4 dihedral angle shows that asteriscunolide
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A B C D
Dihedral A B C D
H2-C2-C3-C4 0.1 ◦ -14.0 ◦ -9.0 ◦ -10.3 ◦
C13-C7-C8-O8 -131.6 ◦ 14.5 ◦ -71.9 ◦ -39.6 ◦
O8-C8-C9-H9 132.9 ◦ 80.9 ◦ -7.8 ◦ -35.8 ◦
Figure 3.3 X-Ray Crystal Structures of Asteriscunolides A, B, C, and D.
B experiences the greatest distortion (-14 ◦), followed by asteriscunolide D (-10.3 ◦), C (-9.0 ◦),
and A (0.1 ◦), respectively. Asteriscunolide A displays a much smaller deviation from the ideal
planar geometry than the other asteriscunolides, which suggests that the (Z,Z )-macrocycle
is less strained than the isomers that contain an E-alkene. Additionally, the dihedral angles
C13-C7-C8-O8 and O8-C8-C9-H9 show that neither the C6 nor the C9 alkene resides in the
same plane as the neigbouring ketone and, therefore, overlap of these adjacent pi-systems is
minimal.
The strained 11-membered ring of humulene and humulene-derived natural products
represents a formidable challenge for synthetic chemists.6 The construction of this macrocycle
has been described as a major impediment to synthesis and typically requires harsh reactions
conditions to provide only modest yields (Scheme 3.1).7 The methods used previously
to construct this ring system include: dibromide coupling,8 McMurry coupling,9 Suzuki-
Miyaura coupling,10 and a Horner-Wadsworth-Emmons (HWE) olefination.11 The use of super-
stoichiometric amounts of either Ni(CO)4 or TiCl3 at elevated temperatures is likely to tolerate
only the most robust functional groups, whereas the use of milder Suzuki-Miyaura and HWE
conditions provide low yields of the desired macrocycle. Interestingly, the intramolecular HWE
olefination shown in Scheme 3.1 provides 55% yield of a dimeric 22-membered macrocyclic
product, despite the highly dilute reaction conditions. Overall, this presents a daunting
challenge for the synthesis of a functionalized humulene natural product such as asteriscunolide
D (146), which contains potentially sensitive butenolide and carbonyl motifs in addition to
the humulene ring.
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Scheme 3.1 Previous Syntheses of Humulene Macrocycles.
3.2 Total Synthesis of Asteriscunolide D
3.2.1 Synthetic Strategy and Retrosynthetic Analysis
Our interest in asteriscunolide D originated from the potential use of Zn-ProPhenol-catalyzed
asymmetric alkyne addition and Ru-catalyzed alkene-alkyne coupling to form chiral butenolides
in a highly efficient manner (i.e. Scheme 3.2).12 The appeal of this target was augmented by
the realization that a thionium-induced cyclization could be utilized to provide a mild and
efficient method of forming the challenging 11-membered ring system (i.e. Scheme 3.3).13
O
O OHOH
CO2Et
OH
83% yield
10 mol%
CpRu(CH3CN)3PF6,
DMF, rt
+
Scheme 3.2 Ru-Catalyzed Alkene-Alkyne Coupling with γ-Hydroxy-α,β-Acetylenic Esters.
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Scheme 3.3 DMTSF-mediated Cyclization and Thioether Elimination.
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This approach represents a formal aldol disconnection, however, the desired product would be
formed irreversibly, and thus avoids problematic retro-aldol reactions that often prevent the use
of aldol reactions in the formation of macrocyclic ring systems.14 Research in both the Trost
and Overman groups has shown that thionium ions behave as ‘super carbonyl’ equivalents and
react effectively with nucleophilic alkenes.15 This reactivity led to the hypothesis that this
methodology would be an excellent candidate for the challenging task of forming the strained
humulene-based macrocycle.
Retrosynthetic disconnection of asteriscunolide D (146) began with the aforementioned
thionium-induced macrocyclization and stereospecific thioether elimination (Scheme 3.4). The
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Scheme 3.4 Retrosynthetic Analysis of Asteriscunolide D.
thioacetal and silyl enol ether functional groups required for this transformation would be
generated from the corresponding aldehyde and ketone, respectively. This sequence constitutes
a formal aldol disconnection and leads back to keto aldehyde 148. This compound would in
turn be prepared using a Ru-catalyzed addition of allyl alcohol to the γ-hydroxy-α,β-acetylenic
ester 120. The alkene-alkyne coupling reaction ultimately forms the required butenolide and
occurs with alkene migration to produce an enol, which would tautomerize to form the desired
aldehyde functionality. One potential problem was the racemization of the enantioenriched
butenolide upon exposure to basic reaction conditions. However, the adjacent gem-dimethyl
group and the macrocyclic ring strain are likely to help prevent the racemization of late-stage
intermediates. The propargylic alcohol 120 was envisioned to arise from the Zn-ProPhenol
catalyzed addition of methyl propiolate (149) to the aliphatic aldehyde 140. The efficiency of
this sequence is derived from the use of methyl propiolate as linchpin – three key bonds of the
natural product are formed with atoms derived from methyl propiolate, ultimately forming the
chiral butenolide and introducing all the carbons present in the natural product. Lastly, keto-
aldehyde 140 would be prepared via Horner-Wadsworth-Emmons olefination of the β-hydroxy
aldehyde 150.
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3.2.2 Linchpin-Based Butenolide Construction
The forward synthesis of asteriscunolide D commenced with the aldol reaction of isobutyralde-
hyde and formalin to provide the β-hydroxy aldehyde 150 in the dimeric 1,3-dioxane form
151 (Scheme 3.5). This highly efficient aldol reaction requires only a catalytic amount of
O
HH
O
H
10 mol% NEt3(neat)
91% yield
H
OOH O
O OH
OHoctane, cold
CH3CN, heat
150 151
Scheme 3.5 Aldol Reaction of Isobutyraldehyde and Formalin.
triethylamine and provides the desired product 151 in 91% yield. The higher electrophilicity
of formaldehyde relative to isobutyraldehyde and the product aldehyde, 150, means that homo
aldol and other unwanted aldol reactions are kept to a minimum. In a non-polar solvent at
4 ◦C, the product β-hydroxy aldehyde readily dimerizes to give the stable, crystalline 1,3-
dioxan-4-ol 151 as an inconsequential mixture of diastereomers. The dimer, 151, can be
converted back into the monomeric β-hydroxy aldehyde 150 by heating in a polar solvent
such as acetonitrile or THF. This cracking procedure was performed in situ with a Horner-
Wadsworth-Emmons olefination of the resulting aldehyde 150 (Scheme 3.6).† The use of
mild Masamune-Roush conditions (LiCl, DBU) with diethyl (2-oxobutyl)phosphonate in THF
provided the desired α,β-unsaturated ketone 152 in 35% yield.17 In contrast, the use of a strong
base, KOtBu, provided only the undesired Tishchenko esterification side product, 153.18 The
O
O OH
OH
O
OH
O
PRO
O
RO
solvent, 60 oC, 3h
then base, solvent,
(0.5 equiv)
(1.2 equiv)
O
ODMSO, (COCl)2,Et3N, CH2Cl2
H
83% yield
(99% on 2.6 g scale)
151
152 140
Entry Solvent Base (equiv)[a] R Yield
1 THF LiCl, DBU (1.2) Et 35%
2 THF KOtBu (1.0) Et 0%[b]
3 MeCN LiCl, DBU (1.2) Et 45%
4 MeCN LiCl, DIPEA (1.2) Et 57%
5 MeCN LiCl, DIPEA (1.2) Me 73%
6[c] MeCN LiCl, DIPEA (1.8) Me 94%
[a] equimolar amounts of LiCl and amine base were used in all cases. [b] The Tishchenko side product 153 was
the major product of this reaction. [c] 1.8 equivalents of phosphonate was used, reaction performed on a 9.8
mmol scale (1 g of 151).
Scheme 3.6 Horner-Wadsworth-Emmons Olefination and Oxidation to Prepare 140.
†Entries 5 and 6, and the large scale oxidation were performed by Aaron Burns and Thomas Tautz.
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proposed mechanism of this side reaction is shown in Scheme 3.7 and involves an intramolecular
hydride shift to provide the ester 153.19 This side reaction requires only a catalytic amount
of metal alkoxide, and therefore the use of weakly basic reaction conditions became the focus
of optimization experiments. Performing the reaction in acetonitrile under Masamune-Roush
O
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OH O
O OH
OHH
M
HO
O OH
OH Base
151 153
Scheme 3.7 Tishchenko Disproportionation: An Unwanted Side Reaction.
conditions gave a slight improvement in yield, as did the use of iPr2NEt instead of DBU (Entries
3 and 4). Surprisingly, the use of dimethyl (2-oxobutyl)phosphonate gave higher yields than
the corresponding diethyl phosphonate. Increasing the reagent stoichiometry to 1.8 equivalents
of LiCl, DIPEA, and phosphonate provided the desired α,β-unsaturated ketone 152 in an
excellent 94% yield. Subsequent Moffatt-Swern oxidation of 152 provided the aldehyde, 140,
required for the key asymmetric alkynylation step.
The original super-stoichiometric reaction conditions with 10 mol % of the ProPhenol ligand
provided the desired propargylic alcohol in 31% yield and 73% ee (Scheme 3.8, Entry 1).20
The presence of an enolizable ketone, capable of producing aldol side products,21 demands
a particularly chemoselective alkyne addition. Thus, we were delighted to discover that
increasing the catalyst loading to 20 mol % produced a marked increase in yield, providing
propargylic alcohol 120 in 72% yield and 86% ee (Entry 3). As reported in the literature,
moderate and large scale reactions required freeze-pump-thaw solvent degassing to ensure
consistent results.22‡ Using just 1.2 equivalents of methyl propiolate in conjunction with
O
H
O
MeO2C
O
OH
MeO2C
X mol % (S,S)-L4,
 2.95 equiv Me2Zn, 
Toluene, -4 oC
(2.8 equiv)
140 120
Entry X Conditions Yield ee[a]
1 10 – 31% 73%
2[b] 20 Freeze-Pump-Thaw Degassing 72% 86%
3[c] 20 Freeze-Pump-Thaw Degassing 83% 84%
4 20 1.2/1.5 equiv alkyne/Me2Zn 62% 78%
5 20 1.2/3.0 equiv alkyne/Me2Zn 61% 60%
[a] Enantiomeric excess determined by chiral HPLC analysis. Absolute stereochemistry was assigned by
analogy to previous results with (S,S)-L4 but confirmed by the X-ray crystal structure of a subsequent
synthetic intermediate, 137. [b] Reaction performed on a 6.16 mmol scale (0.95 g of 140) [c] Reaction
performed on a 16.9 mmol scale (2.6 g of 140).
Scheme 3.8 Asymmetric Alkyne Addition in the Synthesis of Asteriscunolide D.
‡Entry 3 was performed by Aaron Burns and Thomas Tautz.
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increased reaction concentration (0.48 M) gave a respectable 62% yield and 78% ee (Entry 4).
This result is particularly notable, as many of the alternative catalyst systems used for the
enantioselective addition of methyl propiolate require a large excess of alkyne.
The γ-hydroxy-α,β-acetylenic ester 120 was subsequently used in a ruthenium-catalyzed
alkene-alkyne coupling with allyl alcohol (Scheme 3.9).23 Using just 5 mol % of the cationic
ruthenium catalyst CpRu(MeCN)3PF6, the desired chiral butenolide, 148, was obtained in
51% yield. This reaction provides regioselective C–C bond formation at the α-position of
O
OH
MeO2C
HO O
OHOO O
O
O
O
H
5 mol% 
CpRu(MeCN)3PF6,
20 mol % CSA,
THF/Acetone, 
50 oC, 4h
OH
tautomerization,
lactonization
51% yield
120 148
Scheme 3.9 Ru-Catalyzed Alkene-Alkyne Coupling with Allyl Alcohol.
the propiolate via a formal syn-addition process to give the desired Z -alkene geometry, which
leads to spontaneous butenolide formation. The regioselectivity of alkene-alkyne coupling was
confirmed by 1H NMR – specifically, the presence of a distinct doublet (J = 1.5 Hz) at 7.06 ppm
corresponding to the alkenyl proton β to the carbonyl of the butenolide ring. The proposed
mechanism for this reaction is shown in Scheme 3.10 and the selectivity for attack at the
α-position is attributed to a preference for TS2 over TS1, due to reduced steric interactions
between the alkyne substituents and the incoming alkene. Additionally, the regioselectivity
of this reaction is complimentary to that observed in Michael additions to ynoates, which are
driven by electronic factors.
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R RuR
H
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+
O
O
O
O
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Scheme 3.10 Alkene-Alkyne Coupling Mechanism and Selectivity.
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3.2.3 End Game
With the carbons of the natural product in place, all that remained was the formation of the
challenging 11-membered humulene ring.§ Keto-aldehyde 148 was chemoselectively converted
into dithiophenyl acetal 155 in 79% yield using BF3·Et2O and thiophenol (Scheme 3.11).24
Subsequent silyl enol ether formation was achieved using TMSOTf and Hünig’s base to
provide compound 156. These soft enolization conditions generate the Z -TMS-enol ether 156
selectively, providing the substrate needed to perform the key thionium-induced cyclization.25
O
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O
O
H
O
O
O
PhS
PhS
OTMS
O
O
PhS
PhS
PhSH
BF3 OEt2,
CH2Cl2, rt
79% yield
TMSOTf,
DIPEA, 
CH2Cl2
90% yield
148 155 156
Scheme 3.11 Installation of the Cyclization Functionality.
Addition of 1.2 equivalents of dimethyl(methylthio)sulfonium tetrafluoroborate (DMTSF)
to compound 156 at –30 ◦C afforded the desired macrocyclic product, 137, in 41% yield
(Scheme 3.12). The restricted geometry required for cyclization provided the product as a
single diastereomer, which was recrystallized to improve the ee to >98% and provide an X-ray
crystal structure to confirm the structure and absolute stereochemistry.
O
O
O
SPh
O
O
TMSO
SPh
SPh
(DMTSF), 
4A MS,
CH2Cl2
41% yield
S
S F
B
F
FF
-+
O
O
O
SPh
H
TMS
+
156 137
Scheme 3.12 Thionium-Induced Macrocyclization.
The final alkylative thioether elimination was performed using Meerwein’s salt (Me3OBF4)
and Hünig’s base, and generated the desired E-alkene stereospecifically, providing asteriscuno-
lide D (146) in 83% yield.26 This Hoffmann-type elimination requires an antiperiplanar
orientation, and therefore produces the E-alkene geometry despite the potential formation
§The last four steps of the asteriscunolide D synthesis were completed by Aaron Burns and Thomas Tautz
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137 146
Scheme 3.13 Stereospecific Thioether Elimination to Complete the Total Synthesis.
of other alkenes. Racemization during the synthesis was excluded by performing chiral HPLC
analysis on each intermediate and comparing the results with the corresponding racemate.
Asteriscunolide D could also be used to access the other members of the asteriscunolide
family. Thus, isomerization using PhSeSePh and UV light provided a ca. 3:3:1:1 mixture of
asteriscunolides A, B, C, and D, respectively. This result suggests that all four natural products
have similar thermodynamic stabilities and highlights the importance of strict stereochemical
control during the synthesis.
3.3 Summary
In summary, the first total synthesis of asteriscunolide D was achieved in nine steps without
the use of protecting groups, and is outlined in Scheme 3.14.27 The chiral butenolide motif
was prepared enantioselectively through the sequential application of Zn-ProPhenol-catalyzed
asymmetric alkynylation and Ru-catalyzed alkene-alkyne coupling. The challenging 11-
membered humulene ring was forged using a thionium-induced cyclization. This reaction serves
as a highly efficient aldol surrogate, and avoids problems associated with competing retro-aldol
processes. At the core of this succinct and selective synthetic strategy is the use of methyl
propiolate as a strategic linchpin. In just two steps, three new bonds were formed to atoms
derived from methyl propiolate and this ultimately enabled the construction of a synthetically
challenging natural product almost 20 years after the orginal disclosure of its structure.
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Scheme 3.14 Enantioselective Total Synthesis of Asteriscunolide D.
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3.4 Experimental Data for Chapter 3
3.4.1 General Experimental Methods
Unless otherwise noted, the following conditions apply. All reactions were performed in
flame-dried septum sealed glassware with magnetic stirring under an atmosphere of argon
or nitrogen. Moisture- and oxygen-sensitive liquids and solutions were transferred using an
oven-dried stainless steel syringe or cannula. Toluene, tetrahydrofuran, acetonitrile, diethyl
ether, dimethylsulfoxide (DMSO), and dichloromethane were purified with a Solv-Tek solvent
purification system by passing through a column of activated alumina. Isobutyraldehyde
was distilled immediately before use. N,N -Diisopropylethylamine were distilled from calcium
hydride. Lithium chloride was dried at 120 ◦C for 24 hours before use. All other commercially
available chemicals were used as received, without further purification. Organic solutions were
concentrated by rotary evaporation below 40 ◦C. All isolated compounds were >90% pure
as judged by 1H-NMR. Analytical thin layer chromatography (TLC) was performed on EMD
silica gel 60 F254 plates (0.25 mm). Visualization was achieved by UV irradiation (254 nm)
or by heating after treatment with a potassium permanganate or ceric ammonium molybdate
dip. Purification of products by flash column chromatography (FCC) was conducted using
Silicycle silica gel (particle size 0.040-0.063 mm) with the solvent systems indicated. 1HNMR
spectra were recorded on either: a Varian Unity Inova 500 spectrometer at 500 MHz, a
Varian Mercury NMR spectrometer at 400 MHz, Varian Direct Drive 400 spectrometer at
400 MHz or a Varian Inova 300 at 300 MHz. Data are listed as follows: chemical shift
in ppm using chloroform as internal standard (7.26 ppm), multiplicity (s = singlet, d =
doublet, t = triplet, q = quartet, quint = quintet, m = multiplet or overlap of non-equivalent
resonances, br = broad, app. = apparent, obs. = (partially) obscured), integration. 13C-
NMR spectra were recorded on a Varian Unity Inova 500 spectrometer at 126 MHz or a
Varian Mercury NMR spectrometer at 101 MHz and the data are listed as chemical shift
in ppm using chloroform as internal standard (77 ppm). All 13C-NMR spectra were proton
decoupled. Infrared spectroscopic data was recorded as a thin film on a sodium chloride
plate using a Thermo Scientific Nicolet IR100 FT-IR spectrometer. High resolution mass
spectra were acquired by the Vincent Coates Foundation Mass Spectrometry Laboratory,
Stanford University (http://massspec.stanford.edu) on a Micromass Q-TOF API-US mass
spectrometer (Waters Corporation, Milford, MA). Chiral HPLC analysis was performed on a
Thermo Separation Products Spectra Series P-100 and Agilent Technologies 1200 Series HPLC
using the indicated Chiralcel R© and Chiralpak R© columns. Optical rotations were measured
using a Jasco DIP-1000 digital polarimeter using 5 cm glass cells with a Na 589 nm filter.
Specific rotations are reported as [α]D25, concentration (g/100 mL), and solvent.
Note: The experimental data reported below reflects the initial work on this project carried
out by the author. For details of larger scale experiments and the full synthesis, see: Trost,
B. M.; Burns, A. C.; Bartlett, M. J.; Tautz, T.; Weiss, A. H. J. Am. Chem. Soc. 2012, 134,
1474.
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3.4.2 Experimental Details and Characterization Data
Preparation of 2-(2-Hydroxy-1,1-dimethyl-ethyl)-5,5-dimethyl-[1,3]dioxan-4-ol, 151.
O
O OH
OH
To a mixture of neat isobutyraldehyde (1.28 mL, 14 mmol, 1 equiv) and triethylamine
(0.195 mL, 1.4 mmol, 0.1 equiv) was added 37 wt% formaldehyde in H2O (formalin, 1.216 g,
14.98 mmol, 1.07 equiv). The reaction mixture was heated to 60 ◦C and stirred for 1 hour, then
cooled to room temperature and octane (3.5 mL) was added. The resulting suspension was
stored at 4 ◦C overnight and the resulting precipitate was isolated by filteration and washed
with cold octane. The title compound was isolated as a white crystalline solid (1.304 g, 91%
yield, mixture of diastereomers). Rf = 0.44 and 0.39 (2:1, Et2O:PE). 1H-NMR (400MHz,
CDCl3): δ 4.90 (s, 1H), 4.82 (s, 1H), 4.59 (s, 1H), 4.41 (s, 1H), 3.86 (d, J = 11.2 Hz, 1H), 3.62
(d, J = 11.2 Hz, 1H), 3.49 (s, 2H), 3.46 (s, 2H), 3.41 (dd, J = 10.8, 1.6 Hz, 1H), 3.35 (dd, J
= 11.6, 0.8 Hz, 1H), 1.17 (s, 3H), 1.06 (s, 3H), 0.96 (s, 3H), 0.96 (s, 3H), 0.94 (s, 3H), 0.92 (s,
3H), 0.83 (s, 3H), 0.82 (s, 3H). Characterization data matches those found in the literature.16
Preparation of (E)-7-Hydroxy-6,6-dimethylhept-4-en-3-one, 152.
O
OH
A solution of 2-(2-hydroxy-1,1-dimethyl-ethyl)-5,5-dimethyl-[1,3]dioxan-4-ol, 151 (0.1 g,
0.49 mmol, 1 equiv) in acetonitrile (5 mL) was heated to 65 ◦C and stirred for 3 hours. This
solution was then cooled to room temperature and transferred via cannula to a preformed
solution of lithium chloride (0.025 g, 0.587 mmol, 1.2 equiv), N,N -diisopropylethylamine (0.101
mL, 0.98 mmol, 1.2 equiv.) and diethyl 2-oxobutanephosphonate (0.114 mL, 0.587 mmol, 1.2
equiv.) in acetonitrile (5 mL). The reaction mixture was stirred for 1 hour at room temperature
before being quenched with a 1M solution of aqueous HCl and subsequently extracted with
Et2O. The combined organics were dried over MgSO4, filtered, and concentrated in vacuo.
The crude product was purified by silica gel chromatography (2:1, Et2O:PE) and the title
compound was isolated as a clear colorless oil (0.088 g, 57% yield). Rf = 0.35 (2:1, Et2O:PE).
IR (film): 3439 (br), 2966, 2938, 1668, 1625, 1362 cm−1. 1H-NMR (500 MHz, CDCl3): δ
6.82 (d, J = 16.0 Hz, 1H), 6.12 (d, J = 16.5 Hz, 1H), 3.46 (br. s, 2H), 2.60 (q, J = 7.0 Hz,
2H), 1.10 (t, J = 7.5 Hz, 3H), 1.09 (s, 6H). 13C-NMR (125 MHz, CDCl3): δ 201.7, 153.0,
128.0, 71.2, 39.4, 33.9, 23.4, 8.3. HRMS-ESI (m/z): calculated for C9H16O2Na+, [M+Na]+,
179.1043, found 179.1053.
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Preparation of (E)-2,2-Dimethyl-5-oxohept-3-enal, 140.
O
O
H
150
To a stirred solution of oxalyl chloride (0.798 mL, 9.29 mmol, 1.1 equiv) in CH2Cl2 (30
mL) at – 78 ◦C was added a solution of dimethylsulfoxide (1.72 mL, 20.28 mmol, 2.4 equiv),
dropwise, in CH2Cl2 (30 mL). (E)-7-hydroxy-6,6-dimethylhept-4-en-3-one , 152. (1.32 g, 8.45
mmol, 1.0 equiv) was then added dropwise to the reaction mixture followed by continued
stirring for 1 h. Triethylamine (5.91 mL, 42.25 mmol, 5.0 equiv) was added dropwise and
the temperature was maintained at –78 ◦C for an additional 75 min before quenching with
saturated aqueous NH4Cl and allowing the mixture to warm to room temperature. The
reaction mixture was then diluted with water and extracted with CH2Cl2. The combined
organic extracts were washed with brine, dried over MgSO4, filtered, and concentrated in
vacuo. The crude product was purified by silica gel chromatography (1:1 PE/Et2O) affording
the title compound as a pale yellow oil. (1.079 g, 83% yield). Rf = 0.65 (1:2, PE/Et2O). 1H
NMR (400 MHz, CDCl3): δ 9.46 (s, 1H), 6.82 (d, J = 16.5 Hz, 1H), 6.15 (d, J = 16.5 Hz,
1H), 2.61 (q, J = 7.0 Hz, 2H), 1.28 (s, 6H), 1.11 (t, J = 7.0 Hz, 3H). 13C NMR (100 MHz,
CDCl3): δ 201.2, 200.6, 146.4, 129.8, 49.3, 34.1, 21.5, 8.1. IR (film): 2976, 2939, 2878, 1728,
1702, 1677, 1626, 1461, 1377, 1364, 1320, 1289, 1202, 1123, 1046, 983, 894, 779 cm−1.
Preparation of (R,E)-Methyl 4-hydroxy-5,5-dimethyl-8-oxodec-6-en-2-ynoate,
120.
O
OH
MeO2C157
To a solution of (S,S) Prophenol ligand (0.789 g, 1.23 mmol, 20 mol%) in 37.9 mL of freshly
degassed toluene (freeze-pump-thaw) was added 1.54 mL of methyl propiolate (17.25 mmol, 2.8
equiv) and 15.16 mL of dimethylzinc (1.2 M in toluene, 18.17 mmol, 2.95 equiv) at 0 ◦C. The
reaction mixture was subsequently stirred at room temperature for 60 minutes before addition
of 2,2-dimethyl-5-oxo-hept-3-enal , 140. (0.95 g, 6.16 mmol, 1 equiv) at 0 ◦C. The reaction
was moved to a 4 ◦C cold room and stirred for 48 hours. After this time the reaction was
quenched with saturated, aqueous NH4Cl (40 mL) and stirred vigorously for 5 minutes. The
reaction mixture was extracted with Et2O. The combined organics were concentrated in vacuo
and purified by flash column chromatography to provide the title compound as a yellow oil
(1.057 g, 72% yield). Rf = 0.11 (2:1, PE:Et2O). 1H-NMR (400 MHz, CDCl3): δ 6.89 (d, J
= 16.4 Hz, 1H), 6.16 (d, J = 16.4 Hz, 1H), 4.29 (s, 1H), 3.78 (s, 3H), 2.60 (q, J = 7.2 Hz,
2H), 1.42 (s, 1H), 1.21 (s, 3H), 1.20 (s, 3H), 1.1 (t, J = 7.6 Hz, 3H). 13C-NMR (CDCl3, 101
MHz): δ 201.4, 153.7, 150.0, 129.3, 85.7, 78.2, 69.6, 53.1, 42.3, 33.9, 23.2, 22.5, 8.2. IR (film):
3418, 2975, 2879, 2237, 1715, 1668, 1627, 1462, 1436, 1412, 1380, 1366, 1254, 1204, 1126, 1081,
1044, 988, 951, 895, 872, 829, 774, 752 cm−1. HPLC: Chiralcel AD (hept/iPrOH = 90:10, 0.8
ml/min, 220 nm) 12.86/16.69 min, 86% ee. [α]D = +30.98 ◦ (c = 1.13, CHCl3). HRMS-ESI
(m/z) calculated for C13H18O4Na+ [M+Na]+ 261.1097, found 261.1102.
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Preparation of (S,E)-3-(5-(2-methyl-5-oxohept-3-en-2-yl)-2-oxo-2,5-
dihydrofuran-3-yl)propanal, 148.
O
O
O
O
H148
To a solution of 8.6 µL of freshly distilled allyl alcohol (0.126 mmol, 0.0073 g, 1.5 equiv),
0.020 g of 4-hydroxy-5,5- dimethyl-8-oxo-dec-6-en-2-ynoic acid methyl ester 157 (0.084 mmol, 1
eq.) and 0.049 g of camphor sulfonic acid (0.021 mmol, 25 mol %, dried under high vacuum prior
to use) in THF/actetone (2:1 v/v ratio) was added 1.8 mg of CpRu(MeCN)3PF6 (0.0042 mmol,
5 mol %). The reaction was stirred at 50 ◦C for 2 hours. The solvent was subsequently removed
in vacuo and the crude product purified by flash column chromatography (1:5, PE:Et2O). The
title compound was isolated as a clear, colorless oil (0.0114g, 51% yield). Rf = 0.18 (1:5,
PE:Et2O). 1H-NMR (500MHz, CDCl3): δ 9.79 (t, J = 1 Hz, 1H), 7.06 (d, J = 1.5 Hz, 1H),
4.29 (s, 1H), 6.70 (d, J = 16.5 Hz, 1H), 6.14 (d, J = 16.5 Hz, 1H), 4.73 (d, J = 1.5 Hz, 1H),
2.8 (t, J = 7 Hz, 2H), 2.64 (dt, J = 1.5, 7 Hz, 2H), 2.58 (q, J = 7 Hz, 2H), 1.16 (s, 3H), 1.14
(s, 3H), 1.1 (t, J = 7 Hz, 3H). 13C-NMR (CDCl3, 125 MHz): δ 200.9, 200.5, 173.1, 148.8,
146.9, 134.6, 129.0, 86.8, 41.4, 40.8, 34.3, 23.2, 22.5, 18.4, 8.2. IR (film): 2974, 2937, 1755,
1673, 1629, 1462, 1412, 1368, 1315, 1200, 1123, 1093, 1065, 988, 911 cm−1.
For experimental details on the last four steps in the synthesis of asteriscunolide D, X-Ray
diffraction data for 137, and details on the isomerization of asteriscunolide D to asteriscunolides
A, B, and C, see: Trost, B. M.; Burns, A. C.; Bartlett, M. J.; Tautz, T.; Weiss, A. H. J. Am.
Chem. Soc. 2012, 134, 1474.
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3.4.3 Spectra
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4.1 Introduction
4.1.1 Isolation and Bioactivity
The aspergillides are a family of bioactive natural products originally derived from the marine
fungus aspergillus ostianus by Kusumi and coworkers in 2008.1 Aspergillides A, B and C,
shown in Figure 4.1, share common macrolactone and pyran motifs but differ with respect
to the stereochemistry at C3 and the unsaturation present in the pyran ring. Despite
extensive NMR data and synthetic derivatization, the original report of these natural products
incorrectly assigned the stereochemistry of aspergillide A (158) and B (159) at C3 and C13,
respectively. The synthetic efforts of Hande and Uenishi identified structural discrepancies
between the synthetic and natural material,2 prompting Kusumi and coworkers to re-examine
these compounds and ultimately revise the previous structural assignments on the basis
of X-ray crystal data from the corresponding m-bromobenzoates of aspergillides A and B
(Figure 4.2).3
3
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O
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HO
O
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HO
aspergillide A aspergillide B aspergillide C
158 159 160
Figure 4.1 The Aspergillide Family of Natural Products.
Figure 4.2 X-Ray Crystal Structures of the m-Bromobenzoates of Aspergillides A and B.
The aspergillides exhibit cytotoxicity towards a number of different cancer cell lines,
including HL-60 (human promyelocytic leukemia), MDA-MB-231 (human breast carcinoma)
and HT1080 (human fibrosarcoma) cell lines.4 Additionally, Marco and coworkers have
prepared a number of aspergillide A and B analogues, including (Z )-aspergillide A (161)
and the reduced form of aspergillide B (162). Compound 161 displayed increased cytotoxicity
towards all the cancer cell lines tested, with potency comparable to that of the clinical drug
fludarabine.5
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Table 4.1 Biological Activity of the Aspergillides and Related Analogues.
Aspergillide IC50 (µg/mL)HL-60 MDA-MB-231 HT-1080
A (158) 81.2 ± 17.5 99.0 ± 7.9 84.3 ± 13.7
B (159) 32.8 ± 7.6 68.2 ± 6.5 64.3 ± 1.5
161 1.8 ± 0.2 2.9 ± 0.2 6.5 ± 0.4
162 62.8 ± 10.9 71.2 ± 10.2 92.3 ± 13.3
O
OO
HO
O
OO
HO
(Z)-aspA* (2H)-aspB*
161 162
4.1.2 Previous Syntheses
The exciting biological activity of the aspergillides, along with the challenging structural
features present, have motivated a number of groups to pursue the synthesis of aspergillides
A–C.6,7 The majority of synthetic approaches to the aspergillides rely on the Yamaguchi
lactonization to form the 12-membered macrocyclic ring (Scheme 4.1). However, this approach
provides very different results for the different macrocyclic ring isomers of aspergillides A, B
and C. Formation of the aspergillide A macrocycle proceeded in poor yield under standard
O
OO
RO
O
OH
ROO
HO
Cl3C6H2COCl, 
NEt3, THF, 
then DMAP
[c = 0.8 mM]
30% yield
O
O
RO
O
O
OR O
O(19%)
R = TBS
O
OO
RO
O
OH
ROO
HO
Cl3C6H2COCl, 
NEt3, THF, 
then DMAP
[c = 1 mM]
73% yield
R = MOM
O
OO
RO
O
OH
ROO
HO
Cl3C6H2COCl, 
NEt3, THF, 
then DMAP
76% yield
R = MOM
Aspergillide A
Aspergillide B
Aspergillide C
163
Scheme 4.1 Yamaguchi Macrolactonization of Aspergillides A, B, and C.
Yamaguchi conditions – only 30% yield of the desired macrolactone and 19% of the undesired
dimer 163 were obtained. In contrast, aspergillides B and C cyclize much more effectively,
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providing the desired macrocyclic products in 73% and 76%, respectively. These results
suggest that the macrolactone of aspergillide A (158) is much more strained and, therefore,
harder to cyclize than the macrocycle of either aspergillide B (159) or C (160). Inspection
of the X-ray crystal structures in Figure 4.2 also suggests a high degree of ring strain in
the aspergillide A macrocycle. Alternative methods, such as Ru-catalyzed alkene metathesis,
also struggle with this challenging macrocyclization. Attempts at ring-closing metathesis to
form the aspergillide A macrocycle resulted in selective formation of the undesired Z -alkene
(see Scheme 4.5).8 Ultimately, a novel macrocyclization strategy was designed by Shishido
and coworkers to overcome the aforementioned challenges through formation of a larger 14-
membered ring followed by a transannular addition reaction to form the desired pyran and
macrocycle (Scheme 4.2).9 An intramolecular Horner-Wadsworth-Emmons olefination was
R'O
OO
RO
OR
R'O
OO
P
O
EtO
EtO
O
LiCl, DBU,
CH3CN
78% yield
1) PPTS, MeOH/THF
2) DBU, LiCl, CH3CN
82% yield
over two steps
O
OO
TBSO
R = TBS, R' = TES
O
OO
TBSO
1) PPTS, MeOH/THF
2) KH, 18-crown-6, THF
79% yield
over two steps
164
165
Scheme 4.2 Transannular Michael Addition in the Synthesis of Aspergillide A and B.
used to form the larger, 14-membered macrocycle in good yield. The desired 12-membered
macrocycle of either aspergillide A or B could be formed selectively via a transannular oxy-
Michael reaction. Transannular addition under kinetic control (DBU, LiCl) provides the
aspergillide A ring system, whereas addition under thermodynamic control (KH, 18-crown-
6) produces the aspergillide B ring system. It was also shown that aspergillide A (166) can
be readily converted into aspergillide B (159) via a retro-Michael/Michael addition process
shown in Scheme 4.3. This observation prompted the investigation of whether the isolation
conditions (SiO2 in MeOH/CHCl3) could have led to the formation of aspergillide B. However,
no reaction was observed, indicating that aspergillide B is, in fact, a natural product and not
an artifact of the isolation process.
The first total synthesis of aspergillide B (then thought to be aspergillide A) was completed
O
OO
HO
O
OO
HO
KH, 18-crown-6,
THF
94% yield
Scheme 4.3 Direct Conversion of Aspergillide A to Aspergillide B.
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by Hande and Uenishi in 2008 (Scheme 4.4).2 A Sharpless asymmetric dihydroxylation was
used to install the two adjacent stereocenters of C3 and C4 (aspergillide numbering) and
ultimately form the β-hydroxy-γ-lactone 167. Protection and functional group manipulations
then gave rise to the terminal alkene 168 which was subjected to an alkene cross metathesis
using the chiral allylic alcohol 169 and Grubbs’ second generation Ru-catalyst (Grubbs II).
This reaction produces compound 170, which was subsequently deprotected and treated
with PdCl2(CH3CN)2 to facilitate an intramolecular Pd-catalyzed allylic alkylation to form
the desired pyran ring stereospecifically. Opening of the γ-lactone with sodium methoxide
and protection of the resulting alcohol as a silyl ether provided compound 171. A second
Ru-catalyzed alkene cross metathesis was used to form compound 172 and append the
functionalized alkyl chain needed to form the macrocycle. Double saponification of 172
produced the seco acid 173 which was cyclized using a Yamaguchi macrolactonization and
deprotected to produce aspergillide B with a longest linear sequence (LLS) of 18 steps.
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89% yield O
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protection, deprotection,
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10 mol%
Grubbs II,
CH2Cl2
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O
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HO
1) TBAF, THF
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PdCl2(CH3CN)2,
THF
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over 2 stepsO
O
OH H
1) MeONa, MeOH
2) TBSOTf, CH3CN
2,6-lutidineO H
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MeO2C
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over 2 steps
BzO
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73% yield
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O H
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HO2C
HONaOH,MeOH/H2O
91% yield
1a) 2,4,6-trichlorobenzoyl
chloride, Et3N, THF
1b) DMAP, toluene
2) TBAF, THF O
OO
HO83% yield
 over 2 steps
4 steps from
tetrahydrofurfuryl alcohol
18 steps LLS
22 total steps
4 steps
167 168
169
170
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172 173
159
Scheme 4.4 The First Total Synthesis of Aspergillide B.
Murga, Marco and coworkers have also used alkene metathesis as a key step in the
synthesis of aspergillides A and B (Scheme 4.5).8,10 In this case, asymmetric allylation, alkene
isomerization, and oxidation provide access to compound 174, a common intermediate in
the synthesis of both aspergillide A and B. At this point, nucleophilic addition of an ester
enolate followed by reduction with triethylsilane provides compound 175. Saponification
and esterification yields compound 176 and sets the stage for ring closing alkene metathesis.
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Grubbs first generation Ru-catalyst provided the initially undesired Z -alkene 177 in excellent
yield. After deprotection, photoisomerization provides aspergillide A in a total of 16 linear
steps. Alternatively, reduction of lactone 174 followed by acylation and a Mukaiyama-type
nucleophilic addition provided a tert-butyl thioester which was saponified to produce carboxylic
acid 178. Alkene cross metathesis was then used to install the functionalized alkyl chain
needed for macrocyclization, producing the desired seco acid as a 7:3 mixture of E- and Z -
alkene isomers, respectively. Lastly, macrolactonization and deprotection produced the natural
product, aspergillide B.
1) O3, CH2Cl2
then PPh3
2) Ipc2Ballyl, Et2O
3) TESOTf, NEt3
60% yield 
over 3 steps
BnO
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N-trityl allylamine
2) TBAF, THF
94% over 2 steps
9:1, E:Z
PhI(OAc)2,
cat. TEMPO
84% yield
O
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O
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2a) ArCOCl, NEt3
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O
BnO
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 brsm
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Scheme 4.5 A Divergent Synthesis of Aspergillide A and B.
Fuwa and coworkers reported a highly efficient transition metal catalyzed synthesis of both
aspergillide A and B in 2010 (Scheme 4.6).11 This synthesis contains consistently high yields
throughout and was the first to recognize the utility and efficiency of an intramolecular oxy-
Michael addition to stereoselectively form either a 2,6-cis or 2,6-trans tetrahydropyran ring.
To begin the synthesis, the chiral allylic alcohol 180 was silyl-protected and subjected to a
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hydroboration/oxidation sequence. The resulting primary alcohol was then oxidized, reacted in
a Wittig olefination, and reduced, providing allylic alcohol 181 in excellent yield. A Sharpless
asymmetric epoxidation was followed by formation of a primary alkyl iodide and reductive
elimination to ultimately provide allylic alchol 182. The slow rate at which methyl acrylate
undergoes homodimerization in the presence of Grubbs II enables selective cross metathesis
with compound 182.12 MOM-protection and silyl-deprotection were subsequently used to set
the stage for the key intramolecular oxy-Michael addition. Using KOtBu at –78 ◦C provided
the 2,6-trans substituted tetrahydropyran 183 in excellent yield and diastereoselectivity. In
contrast to these kinetically controlled conditions, the thermodynamic 2,6-cis substituted
product can be obtained selectively using an excess of DBU in toluene at 135 ◦C for 36 hours.
Next, ozonolysis of the styrenyl group and a Takai olefination provide the E-vinyl iodide 184.
This compound was then used in a highly efficient B-alkyl Suzuki-Miyaura cross coupling.
These reaction conditions form the alkylboron species in situ and use triphenylarsine, a
weakly coordinating ancillary ligand that gives rise to coordinatively unsaturated Pd-complexes
with high reactivity. In contrast to the use of alkene cross metathesis to install the vinyl
side chain, this reaction provides the desired E-alkene 185 with complete selectivity. The
endgame consists of bis-saponification, Yamaguchi macrolactonization and MOM-deprotection,
providing aspergillide B (159) in an 18 step longest linear sequence.
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Scheme 4.6 Fuwa’s Transition Metal Catalyzed Synthesis of Aspergillide B.
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Galactose pentaacetate (186) was recently used as a chiral pool starting material in a
concise total synthesis of ent-aspergillide B reported by She and coworkers (Scheme 4.7).13
The protected sugar 186 was converted to the known tetrahydropyran 187 in 3 steps and
was then subjected to a 4-step protection/orthoformate elimination sequence to provide the
dihydropyran 188. Silyl deprotection, alkene hydrogenation, and oxidation gave rise to
aldehyde 189, which was subjected to a Julia-Kocienski olefination to install all the carbons
present in the natural product. Lastly, silyl deprotection and saponification provided the seco
acid required for macrocyclization, which was achieved using Mitsunobu conditions. Removal
of the MOM-protecting group produced the natural product antipode, (+)-aspergillide B, in
a longest linear sequence of 15 steps.
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OAc
OAcAcO O
HO
OH
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OTBDPS O
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OTBDPS
CO2Me
O
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O
OO
HO
ent-aspergillide B
15 steps LLS
20 total steps
1) HC(OMe)3, CSA
2) MOMCl, NaI
3) O3, NaOH, 
MeOH/CH2Cl2
4) Ac2O, 120 oC
3 steps
72% yield
1) 3HF NEt3
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4) LiBF4, CH3CN/H2O
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48% yield 
over 4 steps
ent-
186 187
188
189159
Scheme 4.7 Synthesis of ent-Aspergillide B from Chiral Pool Starting Materials.
The previous total syntheses of aspergillide A, B and C provide a number of highly valuable
pieces of information that must be taken into consideration when attempting to design an
improved synthesis of the aspergillides. This is especially true in regard to formation of the
macrocyclic ring and the minimization of protecting group and redox manipulations, two areas
that have limited the efficiency by which these bioactive natural products can be accessed.
4.2 Formal Total Synthesis of Aspergillide B
4.2.1 Synthetic Strategy and Retrosynthetic Analysis
Our interest in the aspergillides originated from the potential application of the zinc-catalyzed
asymmetric alkynylation and ruthenium-catalyzed hydrosilylation methodologies (Scheme 4.8).
The sequential application of these reactions would provide access to two chiral allylic alcohol
moieties that could ultimately lead to a highly efficient synthesis of aspergillide B. Additionally,
these disconnections would give rise to a convergent synthetic route based around alkyne
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Scheme 4.8 Sequential Application of Asymmetric Alkynylation and Ru-Catalyzed
Hydrosilylation.
additions to each end of a butane dialdehyde linchpin. This alkyne-based strategy envisioned
for the synthesis of aspergillide B is outlined in Scheme 4.9.
Retrosynthetic disconnection of the macrolactone leads back to diester 190, a late-stage
intermediate used in a previous synthesis.11 Diastereoselective formation of the pyran ring
was expected to arise from intramolecular oxy-Michael addition of the C7 hydroxyl group
and the pendant α,β-unsaturated ester in 191. It was anticipated that the two chiral
allylic alcohol moieties could be prepared by ruthenium-catalyzed hydrosilylation of the
corresponding propargylic alcohols. Lastly, asymmetric alkyne addition would be used to access
the aforementioned propargylic alcohols via separate addition of (S)-hept-6-yn-2-yl benzoate
((–)-111) and methyl propiolate (192) to each end of a butane dialdehyde equivalent 193 that
serves as a linchpin.
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Scheme 4.9 Retrosynthetic Analysis of Aspergillide B.
The development of Zn-ProPhenol catalyzed alkyne addition has enabled the enan-
tioselective synthesis of a wide range of propargylic alcohols (see Chapter 2). At the
outset of this work the ProPhenol alkylation reaction required the use of 2.8 equivalents
of alkyne and 2.95 equivalents of Me2Zn to obtain high levels of enantioselectivity and we
quickly recognized that the use of a super-stoichiometric amount of alkyne (–)-111 would be
particularly inefficient, given that this chiral intermediate would be prepared using a multistep
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synthesis. Consequently, the use of a stoichiometric quantity of alkyne in ProPhenol-catalyzed
alkynylations was investigated.
4.2.2 Alkynylation Optimization
Alkyne 111 was prepared in racemic form from 3-methyl cyclohexenone (194) using an
Eschenmoser fragmentation (Scheme 4.10).14 This sequence provided rapid access to alkyne
(±)-111, the pronucleophile needed to evaluate and optimize the reaction conditions and
aldehyde substrate used in the first key alkyne addition.
O O
O
O OH OBz
H2O2, MeOH,
5N NaOH,
10 oC, 2.5 h
88% yield
pTsNHNH2,
CH2Cl2/AcOH,
-20 oC - rt
BzCl, DMAP,
NEt3, CH2Cl2
58% yield 82% yield
LiAlH4,
Et2O
87% yield
194 195 196 197 111
Scheme 4.10 Synthesis of Alkyne (±)-111.
Using 1.2 equivalents of alkyne (±)-111, alkynylation of aliphatic aldehyde 112 resulted
in only 22% yield of the desired product 113 in 54% ee (Entry 1, Table 4.2). The low
isolated yield was a consequence of competing cross aldol side reactions, which ultimately
produce a complex mixture of oligomers (Scheme 4.11). The aldol side product 114 was
isolated in 19% yield as a mixture of diastereomers from Entry 1. The traditional super-
stoichiometric conditions provided only modest improvements in yield and enantioselectivity
(Entries 2–3). Low yields of the desired product 113 were primarily a consequence of
competing aldol reactions. The predominance of this side reaction led to the hypothesis that
incomplete formation of the alkynylzinc nucleophile may be leaving significant amounts of
basic dimethylzinc in the reaction mixture. Consequently, we examined a number of additives
and methods that have been shown to facilitate the formation of alkynylzinc nucleophiles.
The use of N -methylimidazole (NMI), DMSO and DMF all resulted in lower yields of the
desired product, 113 (Entries 4–6). Returning to super-stoichiometric reagent loading, while
also increasing the alkyne/Me2Zn/(S,S)-L4 premix time and the catalyst loading provided
OBz
HO
HO
OTBS
OTBS
H
O
HO
OTBS
OTBS
H
O OTBS
RZnO OTBS
19% yield
HRMS-ESI (m/z): 
[M+H]+ calculated for 
C34H61O6Si2, 621.4001; 
found, 621.3996.
+
Higher Order Oligomers
114
Scheme 4.11 Competing Cross Aldol Side Reactions.
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Table 4.2 Alkynylation Substrate and Reaction Optimization.
OBz
O R
OBz
HO R
X/Y Conditionsa Yieldb eec
1.2/1.5 20 mol% TPPO 22% 54%
2.8/2.95 20 mol% TPPO 39% 62% (57%)d
2.8/2.95 - 35% 45%
1
2
3
1.2/1.3 30 mol% NMI 11% 72%4
1.2/1.4 4 eq. DMSO 4% 14%5
1.2/1.4 4 eq. DMF 10% 17%6
2.8/2.95 20 mol% TPPO, 24 h alkyne premix 58% 50%
d7
2.8/2.95
40 mol% TPPO, 
20 mol% L4, 
24 h alkyne premix
69% 67%d8
10 mol% (S,S)-L4,
X eq. (±)-9
Y eq. Me2Zn, Toluene
4 oC, 48 hours
                R
11a -(CH2)3OTBS
11b -(CH2)3OPMBo
11c -(E)-CH=CHCH2OTBS
11d -(E)-CH=CHCH(OMe)2
(±)-
All reactions were run on 0.1625 mmol scale using the standard ProPhenol alkynylation procedure. a All reactions were run 
at a concentration of 0.5 M with respect to alkyne unless otherwise noted. b Isolated yield. c Enantiomeric excess determined 
by chiral HPLC analysis. d Enantiomeric excess determined by 1H-NMR analysis of the corresponding (S)-methyl mandelate. 
e
 Reaction performed with (–)-9tttt    on a 0.45 mmol scale. TPPO = triphenylphosphine oxide, NMI = N-methylimidazole
AldehydeEntry
2.8/2.95 c = 0.35 M 84% 95%
1.2/1.5 20 mol% TPPO 56% 95%
1.0/1.3 20 mol% TPPO 54% 95%
9
10
11
1.0/1.3 20 mol% TPPOe 82% 90%12
H
                R
12a -(CH2)3OTBS
12b -(CH2)3OPMBo
12c -(E)-CH=CHCH2OTBS
12d -(E)-CH=CHCH(OMe)2
111
111
111
1 2
112
112
112
112
112
112
1 5
115
115
142
142
142
142
141
141
1 3
1 6
121
1 8
improved yields of propargylic alcohol 116 (Entries 7–8). While the excess alkyne could be
recovered quantitatively, this inefficiency along with the moderate yield and enantioselectivity
prompted the investigation of the analogous unsaturated aldehyde, 142. The ProPhenol-
catalyzed addition of (±)-111 to 142 provided a much improved 84% yield and 95% ee (Entry
9). Reducing the stoichiometry of the alkyne to either 1.2 or 1.0 equivalents provided lower
yield, although excellent ee was maintained in both cases (Entries 10–11). The moderate yield
was presumably a consequence of poor reactivity and a solution to this problem was found in
the use of fumaraldehyde dimethyl acetal (141). The inductive effects of the dimethyl acetal
are presumed to create a more electrophilic aldehyde, and as a result, the desired propargylic
alcohol 118 was obtained in 82% yield using a single equivalent of alkyne (Entry 12).
The results in Table 4.2 provide a number of new insights into the proposed reaction
mechanism for ProPhenol-catalyzed alkyne addition (see Chapter 2, Section 2.2.3). Incomplete
formation of the alkynylzinc nucleophile was confirmed by 1H-NMR analysis of a standard
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premix with 1-octyne, Me2Zn and (S,S)-L4 in toluene-d8. Despite the entropically favored
release of methane gas, deprotonation of the terminal alkyne was not observed in the absence of
ProPhenol ligand. The presence of significant amounts of dimethylzinc in the reaction mixture
appears to have little effect on the outcome of alkyne additions to α,β-unsaturated aldehydes.
However, enolizable aldehydes suffer from undesired aldol side reactions and typically only
produce moderate yields of the desired propargylic alcohol. Methyl propiolate, a more acidic
alkyne, has been shown to give significantly higher yields in additions to enolizable aldehydes
under the standard conditions. As a result of this observation and the results in Table 4.2, the
two alkyne additions in the planned synthesis of aspergillide B were ordered such that methyl
propiolate would be added second, to an enolizable aldehyde, despite the reduced convergence
imparted to the synthetic route. Additionally, it was discovered that the addition of methyl
propiolate to fumaraldehyde dimethyl acetal (141) produces the unstable propargylic alcohol
198. Attempts to convert 198 into a more stable compound via silyl protection of the alcohol
were unsuccessful and silyl ether 199 was not observed. Instead, an allenyl side product was
observed, as evidenced by a characteristic 13C NMR signal at 220 ppm. The formation of this
functionality is presumably a consequence of the combined inductive effects of the propiolate
ester and dimethyl acetal.
O
MeO OMe
(R,R)-L4,
Me2Zn, Toluene,
4 oC, 48 h
MeO2C
HO OMe
OMe
(1.2 eq.)
MeO2C
MeO2C
TBDPSO OMe
OMe
TBDPS-Cl, 
AgNO3, pyridine,
 THF
(unstable to silica and NEt3) not observed
141 198 199
Scheme 4.12 Attempted Addition of Methyl Propiolate to Fumaraldehyde Dimethyl Acetal.
4.2.3 Linchpin-Based Synthesis of Aspergillide B
The synthesis of aspergillide B commenced with the preparation of chiral alkyne (–)-111
(Scheme 4.13).16 The challenging nature of the enantioselective reduction of ketone 196, the
product of Eschenmoser fragmentation, prompted the use of a different route to synthesize
(–)-111. While the enantioselective reduction of linear alkyl/alkyl ketones (i.e. 196) is
notoriously difficult due to the relatively small steric difference between substituents,17 the
reduction of alkyl/alkynyl ketones has been achieved with a number of chiral catalysts.18
The required ynone was prepared by nucleophilic addition of lithiated 1-pentyne (200) to
N,N -dimethylacetamide (DMA), with acidic workup to liberate dimethylamine (Scheme 4.13).
Enantioselective reduction of ynone 201 was achieved using Noyori’s asymmetric transfer
hydrogenation methodology.19 The desired propargylic alcohol was formed in 70% yield and
97% ee using just 1 mol% of the chiral ruthenium catalyst 202. The ynone starting material
was prone to decomposition and the best results were obtained when the ynone was used
immediately. The literature yields for this exact transformation vary from 30–60% yield, and
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N
H
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Scheme 4.13 Enantioselective Preparation of Alkyne (–)-111.
this is presumably a result of partial ynone decomposition.20 The acetylene zipper reaction was
then used to carry out a multiposition isomerization of 203 to the terminal alkyne 197.21 In
this case, direct formation of the superbase, potassium 3-aminopropylamide (KAPA), from 1,3-
diaminopropane and KH provided a clean and high yielding reaction whereas the formation of
KAPA via transmetallation of lithium aminopropylamide with KOtBu gave 30–55% yield and
required multiple rounds of chromatography to separate the product from various undesired
internal alkynes.22 Lastly, protection of the alcohol as a benzoyl ester provided enantiomerically
pure material for use in the first key alkyne addition step. One of the benefits of using a Zn-
alkynylide is that ester functional groups, such as the benzoate in 111, are typically inert to
nucleophilic addition, whereas the corresponding Mg- or Li-alkynylide will often react with
esters. Using the optimized conditions from Table 4.2, the desired enantioenriched propargylic
alcohol 118 was prepared in excellent yield (Scheme 4.14). With fumaraldehyde identified as
a potential linchpin in the synthesis of aspergillide B, investigation of the required functional
group interconversions ensued.
OBz
O
MeO OMe
10 mol% (S,S)-L4,
Me2Zn, TPPO,
Toluene
4 oC, 48 h
82% yield
19:1 dr
(1 equiv)
BzO
HO OMe
OMe
(1 equiv)(–)- 111
141
118
Scheme 4.14 Alkynylation of Fumaraldehyde using a Single Equivalent of (–)-111.
Initial attempts to convert the gem-dimethoxypropene moiety into a propanal group were
based around the use of a protection, hydrolysis, conjugate reduction sequence (Scheme 4.15).
Conversion of propargylic alcohol 118 into the corresponding acetate and hydrolysis of the
resulting acetal provided the α,β-unsaturated aldehyde 204 in excellent yield. Unfortunately,
this compound ws found to be unstable and provided an early indication that the doubly
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TBS
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imidazole, DMF H2O, 65 ◦C dioxane/H2O trace aldehyde
41% yield 0% yield
Hantzch Ester, THF, trace SM, no
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Scheme 4.15 Optimization of Enal Conjugate Reduction.
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activated, propargylic and allylic, oxymethine would require special consideration. With
this in mind, the less reactive TBS-ether 205 was formed. Careful control of the reaction
temperature was required during the acetal hydrolysis step – performing the reaction at
65 ◦C resulted in removal of the TBS group, whereas performing the reaction at 45 ◦C
provided 90% yield of the desired aldehyde 205. Initial attempts to chemoselectively reduce
the alkene using either sodium dithionite (Na2S2O4) or an organocatalytic reduction using
5 mol% of Bn2NH2+CF3COO- and the Hantzch ester were unsuccessfull.23,24 However, the
use of the ‘Hot’ Strkyer’s reagent reported by Lipshutz and coworkers, 5 mol% Cu(OAc)2,
1,2-bis(diphenylphosphino)benzene (BDP), and diethoxymethylsilane (DEMS), provided the
desired aliphatic aldehyde 208 in 15% yield.25 The low yield of the desired product led to
the hypothesis that the KOH workup conditions may be unecessarily harsh and, therefore,
detrimental to yield. Consequently, the (BDP)CuH conditions were used on a more robust
silyl ether, TBDPS-ether 206, in conjuction with a mild 1M HCl workup. Unfortunately,
these conditions provided a similarly low yield, providing 18% yield of the aliphatic aldehyde
209. These poor results prompted the investigation of an alternative approach in which the
alkene reduction is performed under hydrogenation conditions prior to hydrolysis of the acetal.
The use of a ruthenium-catalyzed hydrosilylation and subsequent protodesilylation provides
a versatile method by which E-selective alkyne reduction can be achieved.27 However, by
postponing protodesilylation to later in the synthesis and leaving the C8-C9 alkene protected
as a vinyl silane, an opportunity for chemoselective hydrogenation of the C5-C6 alkene
was envisioned (aspergillide numbering). With this new strategy in mind, initial attempts
were made to achieve concomitant alkyne hydrosilylation and alcohol protection through
the formation of cyclic siloxane 210 (Scheme 4.16). Hydrosilylation of alkyne 211 with
BzO
HO OMe
OMe
Si
O
BzO
OMe
MeO
Conditions
5
6
8
9
118 210
Entry Conditions Results
1
5 mol% CpRu(CH3CN)3PF6,
1.2 equiv Me2(EtO)SiH, CH2Cl2
(0.5M), 0 ◦C – rt, 45 minutes
20% yield
2
5 mol% CpRu(CH3CN)3PF6,
3.0 equiv Me2(EtO)SiH, CH2Cl2
(0.5M), 0 ◦C – rt, 60 minutes
0% yield
3
5 mol% Cp*Ru(CH3CN)3PF6,
1.5 equiv Me2(EtO)SiH, CH2Cl2
(0.5M), 0 ◦C – rt, 60 minutes
40% yield as a
ca. 1:1 mixture
of regioisomers
Scheme 4.16 Ru-Catalyzed Cyclic Siloxane Formation.
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Me2(EtO)SiH and 5 mol % CpRu(CH3CN)3PF6 provided the desired siloxane in 20% yield
(Entry 1). The use of excess ethoxy(dimethyl)silane was found to be detrimental to the
reaction (Entry 2). However, switching to the more reactive Cp*Ru(CH3CN)3PF6 catalyst
provided 1:1 miture of regioisomers, one cyclic (210) and one acyclic, in 40% combined yield
(Entry 3).
The modest yields obtained in these reactions prompted a switch to benzyldimethylsilane
(BDMS-H), and it was discovered that by using just 1.05 equivalents of silane an excellent 89%
yield of 212 could be obtained (Scheme 4.17). Performing the reaction under similar conditions
with the CpRu(CH3CN)3PF6 catalyst provided only 63% yield. The regioselectivity of this
reaction was confirmed by analysis of the 1H/1H COSY NMR spectrum.
BzO
BDMS
HO OMe
OMe
COSYBzO
HO OMe
OMe
2 mol%
Cp*Ru(CH3CN)3PF6,
1.05 eq. BDMS-H,
DCE (0.5 M), 0 oC - r.t.
60 minutes
89% yield
118 212
Scheme 4.17 Ru-Catalyzed Hydrosilylation with Benzyldimethylsilane.
Hydrosilylation of propargylic alcohols under these conditions typically results in silylation
at the β-position, providing the products shown in Figure 4.3.27 The similar steric environment
around these vinyl silanes and 212 suggests that electronic factors are responsible for the
dramatic reversal in regioselectivity observed in Scheme 4.17. Thus, the regioselective
formation of 212 is thought to be a consequence of a coordinative interaction between the
ruthenium catalyst and electron poor alkene.
OH BDMS
58% yield
5:1
MeO2C
TES
OH
91% yield
>20:1
TES
OH4
99% yield
13:1
BDMSOH
92% yield
SiO
O
TIPS
quant.
Figure 4.3 Examples of β-Selectivity in Hydrosilylations with CpRu(CH3CN)3PF6 and
Cp*Ru(CH3CN)3PF6.
To recap, alkynylation of fumaraldehyde dimethyl acetal (141) using just 1 equivalent
of alkyne (–)-111 and 10 mol% of the (S,S)-ProPhenol Ligand (L4) provided 118 in 82%
yield and 90% de (Scheme 4.18). Alkyne trans-hydrosilylation using benzyldimethylsilane
(BDMS-H) and 2 mol% of Cp*Ru(CH3CN)3PF6, provided vinyl silane 212 regioselectively.
The presence of the silicon on one of the double bonds provides a key for their differentiation
towards hydrogenation. Moving forward, the disubstituted olefin of allylic alcohol 212 was
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Scheme 4.18 First Alkyne Addition in the Synthesis of Aspergillide B.
chemoselectively hydrogenated using Wilkinson’s catalyst, RhCl(PPh3)3, and the resulting
alcohol was silyl protected to give 213.28 Hydrolysis of the dimethyl acetal was performed
under mild acid-catalyzed conditions, providing the desired aldehyde 214 for the second alkyne
addition.
ProPhenol-catalyzed addition of methyl propiolate (192) to aldehyde 214 provided the de-
sired propargylic alcohol 215 in 71% yield as a 5.2:1 mixture of diastereomers (Scheme 4.19).29
MOM-protection of the propargylic alcohol was followed by a chemoselective alkyne reduction
using the hydrosilylation/protodesilylation protocol for formation of E-double bonds.30 The
basic reaction conditions used for this transformation resulted in spontaneous intramolecular
oxy-Michael addition. Consequently, the desired 2,6-anti tetrahydropyran 190 was isolated
in 38% yield (77% brsm) over 2 steps. The preparation of compound 190 constitutes a
formal total synthesis of aspergillide B. Compound 190 has been previously transformed into
aspergillide B in 3 additional steps (bis-saponification, Yamaguchi macrolactonization and
MOM-deprotection).11
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Scheme 4.19 Formal Total Synthesis of Aspergillide B.
4.3 Summary
In summary, an enantioselective formal total synthesis of aspergillide B has been accom-
plished using sequential Zn-catalyzed alkyne addition and Ru-catalyzed trans-hydrosilylation-
desilylation to access E-alkenes.31 The hydrosilylation–desilylation protocol not only provides
the E geometry but also allows chemoselective differentiation of the two double bonds in a
subsequent hydrogenation step. This synthesis of an aspergillide B precursor has led to the
development of new conditions for Zn-ProPhenol catalyzed alkynylation that provide excellent
yield and enantioselectivity using just a single equivalent of alkyne. This synthetic route
provides access to aspergillide B from inexpensive and commercially available materials in just
16 total steps, with a longest linear sequence of 15 steps, and the use of 6 highly efficient
transition metal-catalyzed reactions.
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4.4 Experimental Data for Chapter 4
4.4.1 General Experimental Methods
Unless otherwise noted, the following conditions apply. All reactions were performed in flame-
dried septumsealed glassware with magnetic stirring under an atmosphere of argon or nitrogen.
Moisture- and oxygen-sensitive liquids and solutions were transferred using an oven-dried
stainless steel syringe or cannula. Toluene, tetrahydrofuran, diethyl ether, dimethylformamide
(DMF), dimethylsulfoxide (DMSO), dimethoxyethane (DME) and dichloromethane were
purified with a Solv-Tek solvent purification system by passing through a column of activated
alumina. 1,2-Dichloroethane and N,N -Diisopropylethylamine were distilled from calcium
hydride. 1,3- Diaminopropane was distilled from barium oxide immediately before use.
Benzyldimethylsilane, ethoxy(dimethyl)silane and triethoxysilane were distilled immediately
before use. All other commercially available chemicals were used as received, without
further purification. Organic solutions were concentrated by rotary evaporation below 40
◦C. All isolated compounds were >90% pure as judged by 1H-NMR. Analytical thin
layer chromatography (TLC) was performed on EMD silica gel 60 F254 plates (0.25 mm).
Visualization was achieved by UV irradiation (254 nm) or by heating after treatment with a
potassium permanganate or ceric ammonium molybdate dip. Purification of products by flash
column chromatography (FCC) was conducted using Silicycle silica gel (particle size 0.040-0.063
mm) with the solvent systems indicated. 1HNMR spectra were recorded on either: a Varian
Unity Inova 600 spectrometer at 600 MHz, a Varian Unity Inova 500 spectrometer at 500 MHz,
a Varian Mercury NMR spectrometer at 400 MHz, Varian Direct Drive 400 spectrometer at
400 MHz or a Varian Inova 300 at 300 MHz. Data are listed as follows: chemical shift in ppm
using chloroform as an internal standard (7.26 ppm), multiplicity (s = singlet, d = doublet, t
= triplet, q = quartet, quint = quintet, m = multiplet or overlap of non-equivalent resonances,
br = broad, app. = apparent, obs. = (partially) obscured), integration, peak assignment.
13C-NMR spectra were recorded on a Varian Unity Inova 500 spectrometer at 126 MHz or a
Varian Mercury NMR spectrometer at 101 MHz and the data are listed as follows: chemical
shift in ppm using chloroform as an internal standard (77 ppm), peak assignment. All 13C-
NMR spectra were proton decoupled. Infrared spectroscopic data was recorded as a thin
film on a sodium chloride plate using a Thermo Scientific Nicolet IR100 FT-IR spectrometer.
High resolution mass spectrometry (HRMS) was performed on a Waters Micromass Q-TOF
API-US mass spectrometer. Chiral HPLC analysis was performed on a Thermo Separation
Products Spectra Series P-100 and Agilent Technologies 1200 Series HPLC using the indicated
Chiralcel R© and Chiralpak R© columns. Optical rotations were measured using a Jasco DIP-
1000 digital polarimeter using 5 cm glass cells with a Na 589 nm filter. The reported specific
rotations are an average of 10 measurements and are reported as [α]D25, concentration (g/100
mL), and solvent.
General Procedure for Zn-ProPhenol-Catalyzed Addition of Alkynes to Alde-
hydes
To a solution of (S,S)-ProPhenol ligand (10 or 20 mol%) and alkyne (1.2 equiv or 2.8 equiv)
in toluene (0.48 M with respect to alkyne) was added dimethyl zinc (as a 1.2 M solution in
toluene, 1.5 equiv or 2.95 equiv) at 0 ◦C. The reaction was warmed to room temperature and
stirred for 60 minutes before addition of the aldehyde substrate (1 equiv) at 0 ◦C. The reaction
was stirred for 48 hours at 4 ◦C before quenching with saturated, aqueous NH4Cl. The organic
phase was extracted three times with Et2O and the combined organics were concentrated in
vacuo. The crude product was purified by flash column chromatography.
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General Procedure for the Preparation of Racemic Propargylic Alcohols for
the Determination of Enantiomeric Excess
To a solution of (±)-ProPhenol ligand (10 mol%) and alkyne (1.2 equiv or 2.8 equiv) in toluene
(0.25 M with respect to alkyne) was added dimethyl zinc (as a 1.2 M solution in toluene,1.5
equiv or 2.95 equiv) at 0 ◦C. The reaction was warmed to room temperature and stirred for
60 minutes before addition of the aldehyde substrate (1 eq.) at 0 ◦C. The reaction was stirred
overnight at room temperature before quenching with saturated, aqueous NH4Cl. The organic
phase was extracted three times with Et2O and the combined organics were concentrated in
vacuo. The crude product was purified by flash column chromatography.
4.4.2 Experimental Details and Characterization Data
Alkyne Synthesis
Preparation of Alkyne (±)-111
O O
O
O OH OBz
H2O2, MeOH,
5N NaOH,
10 oC, 2.5 h
88% yield
pTsNHNH2,
CH2Cl2/AcOH,
-20 oC - rt
BzCl, DMAP,
NEt3, CH2Cl2
58% yield 82% yield
LiAlH4,
Et2O
87% yield
194 195 196 197 111
Preparation of 6-Methyl-7-oxabicyclo[4.1.0]heptan-2-one, 195.
O
O
To a solution of 3-methylcyclohex-2-enone (6.80 mL, 59.9 mmol, 1.0 equiv) in methanol
(60 mL) at 0 ◦C was added 30% aqueous H2O2 (18.3 mL) over a 10 minute period. This
was followed by the dropwise addition of 5N NaOH (0.4 mL). After stirring at ca. 10 ◦C for
2.5 hours, the reaction was quenched with brine, extracted with CH2Cl2 and concentrated in
vacuo. The crude product was purified by Kugelrohr distillation to yield the title compound
as a clear, colorless oil (6.64 g, 88% yield). 1H-NMR (300 MHz; CDCl3): δ 3.07 (s, 1H),
2.52-2.44 (m, 1H), 2.14-1.85 (m, 4H), 1.67-1.61 (m, 1H), 1.44 (s, 3H). 13C-NMR (75 MHz,
CDCl3): δ 207.1, 62.7, 62.2, 35.9, 28.6, 22.4, 17.4. Characterization data matches that reported
in the literature.14
Preparation of Hept-6-yn-2-one, 196.
O
To a solution of 6-methyl-7-oxabicyclo[4.1.0]heptan-2-one 195 (6.5 g, 51.5 mmol, 1.0 eq.) in
CH2Cl2/ AcOH (2:1 mixture, 75 mL total) at –20 ◦C was added a solution of pTsNHNH2 (9.65
g in 75 mL of 2:1 CH2Cl2/ AcOH). The reaction mixture was stirred at –20 ◦C for 7 hours,
–15 ◦C for 2 hours, 0 ◦C for 3 hours and room temperature for 4 hours before quenching with
H2O. The reaction mixture was extracted twice with Et2O and the combined organic layers
were dried over MgSO4, filtered and concentrated in vacuo. The crude product was purified by
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flash column chromatography (10% Et2O/ pet. ether). The final traces of AcOH were removed
by dissolving the product in Et2O and washing with saturated aqueous NaHCO3. The title
compound was isolated as a clear, colorless oil (3.28 g, 58% yield). Rf = 0.26 (5% EtOAc/pet.
ether). 1H-NMR (400 MHz; CDCl3): δ 2.55 (t, J = 7.2 Hz, 2H), 2.19 (td, J = 6.9, 2.6 Hz,
2H), 2.12 (s, 3H), 1.92 (t, J = 2.7 Hz, 1H), 1.75 (quintet, J = 7.1 Hz, 2H). 13C-NMR (101
MHz, CDCl3): δ 208.4, 83.7, 69.2, 42.2, 30.2, 22.4, 17.9. Characterization data matches that
reported in the literature.14
Preparation of (±)-Hept-6-yn-2-ol, 197.
OH
To a suspension of LiAlH4 (0.053 g, 1.40 mmol) in Et2O (7 mL) at 0 ◦C was added a solution
of hept-6-yn-2-one (0.300 g, 2.72 mmol, 1 equiv) in Et2O (0.7 mL). The reaction was stirred
at 0 ◦C for 30 minutes before quenching with water. The reaction mixture was extracted with
Et2O and the combined organics were dried over MgSO4, filtered and concentrated in vacuo.
The desired product was isolated as a clear colorless oil (0.265 g, 87% yield) and was used
without further purification. 1H-NMR (400 MHz; CDCl3): δ 8.03-8.01 (m, 2H), 7.56-7.51
(m, 1H), 7.44-7.40 (m, 2H), 5.21-5.13 (m, 1H), 2.23 (td, J = 7.0, 2.6 Hz, 2H), 1.94 (t, J =
2.5 Hz, 1H), 1.87-1.58 (m, 4H), 1.34 (d, J = 6.3 Hz, 3H). Characterization data matches that
reported in the literature.14
Preparation of (±)-Hept-6-yn-2-yl benzoate, 111.
OBz
111
See below for experimental details and characterization data. Characterization data
matches that reported in the literature.14
Preparation of Alkyne (–)-111
Preparation of Hept-3-yn-2-one, 201.
O
To a solution of 1-pentyne, 13 (5.0 g, 73 mmol, 1.0 eq.) in Et2O (200 mL) at –78 ◦C
was added nBuLi (29.2 mL of a 2.5 M solution in hexanes, 73 mmol, 1.0 eq.). The reaction
was stirred for 30 minutes before addition of N,N -dimethylacetamide (8.48 mL, 91.25 mmol,
1.25 eq.) in 7 portions over 35 minutes. The reaction was then warmed to 4 ◦C and stirred
overnight before being quenching with water and acidified with saturated aqueous NH4Cl. The
reaction mixture was then extracted twice with Et2O and the combined organics were dried
over MgSO4, filtered and concentrated in vacuo. The crude product was purified by flash
column chromatography (5% Et2O/ pet. ether). The title compound was isolated as a yellow
oil (5.138 g, 64% yield). Rf = 0.6 (15% Et2O/ pet. ether). 1H NMR (400 MHz; CDCl3):
δ 2.32 (m, 2H), 2.30 (s, 3H), 1.59 (m, 2H), 0.99 (t, J = 7.4 Hz, 3H). 13C NMR (101 MHz,
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CDCl3): δ 185.19, 94.15, 81.73, 32.99, 21.43, 21.06, 13.68. Characterization data matches
literature.20
Preparation of (S)-Hept-3-yn-2-ol, 203.
OH
To a solution of freshly prepared hept-3-yn-2-one 201 (2.0 g, 18.16 mmol, 1.0 eq.) in
degassed iPrOH (51 mL, freeze-pump-thaw degassing) was added a solution of Ru[(1S,2S)-
pTsNCH(Ph)CH(Ph)NH](η6-p-cymene) (0.108 g, 1 mol %) in degassed iPrOH (40 mL) at
room temperature. The reaction was stirred for 20 hours before careful removal of iPrOH
in vacuo. The crude product was purified by flash column chromatography (15% Et2O/pet.
ether). The title compound was obtained as a yellow oil (1.435 g, 70% yield). Rf = 0.32 (15%
Et2O/pet. ether). 1H NMR (500 MHz; CDCl3): δ 4.56-4.53 (m, 1H), 2.22-2.18 (m, 2H), 1.55
(sextet, J = 7.2 Hz, 2H), 1.45 (d, J = 6.5 Hz, 3H), 1.00 (t, J = 7.4 Hz, 3H). 13C NMR (101
MHz, CDCl3): δ 84.75, 82.57, 58.81, 24.97, 22.26, 20.82, 13.66. [α]D25 = –29.2 ◦ (c = 1.13,
CHCl3). Enantiomeric excess was determined by chiral HPLC analysis of the subsequently
prepared hept-6-yn-2-yl benzoate (Chiral HPLC: Chiralcel R© AD column, heptane:iPrOH
= 150:1, 0.6 mL/min, λ = 254 nm; tR = 14.86 (minor), 16.85 (major) minutes: 97% ee).
Characterization data matches literature.20
Preparation of (S)-Hept-6-yn-2-ol, 197.
OH
A 30% dispersion of potassium hydride in mineral oil (4.0 g, 30 mmol, 4.0 eq.) was washed
twice with Et2O under an atmosphere of nitrogen, triturating the ether washings (for a detailed
description of the safe use of KH, see: Brown, C. A. J. Org. Chem. 1974, 39, 3913.). Residual
solvent was removed in vacuo. Freshly distilled 1,3-diaminopropane (23 mL) was added and the
reaction was stirred at room temperature for an hour. (S)-Hept-3-yn-2-ol (0.839 g, 7.48 mmol,
1.0 eq.) was then added dropwise at ca. 15 ◦C (water bath). The reaction was subsequently
warmed to room temperature and stirred for 2 hours. The reaction was then cooled to 0 ◦C
and quenched carefully with water, while under an atmosphere of nitrogen. The reaction
mixture was extracted with Et2O, dried over MgSO4, filtered and concentrated in vacuo. The
crude product was purified by flash column chromatography (30% Et2O/pet. ether). The title
compound was isolated as a clear, colorless oil (0.682 g, 81% yield). Rf = 0.20 (25% Et2O/
pet. ether). 1H NMR (500 MHz; CDCl3): δ 3.87 (m, 1H), 2.25 (m, 2H), 1.99 (t, J = 2.6 Hz,
1H), 1.71-1.58 (m, 4H), 1.35 (s, 1H), 1.24 (d, J = 6.2 Hz, 3H). 13C NMR (101 MHz, CDCl3):
δ 84.55, 68.71, 67.83, 38.40, 24.88, 23.81, 18.58. Characterization data matches literature.20
Preparation of (S)-Hept-6-yn-2-yl benzoate, 111.
OBz
To a solution of (S)-hept-6-yn-2-ol, 17 (0.426 g, 3.80 mmol, 1.0 eq.) in CH2Cl2 (19 mL) was
added NEt3 (0.95 mL, 6.83 mmol, 1.8 eq.), DMAP (0.232 g, 1.9 mmol, 0.5 eq.) and benzoyl
chloride (0.617 mL, 5.32 mmol, 1.4 eq.) at room temperature. The reaction was stirred for
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6 hours before being quenched with water and extracted twice with CH2Cl2. The combined
organics were dried over MgSO4, filtered and concentrated in vacuo. The crude product was
purified by flash column chromatography (5% Et2O/pet. ether) to produce the title compound
as a colorless oil (0.688 g, 84% yield). Rf = 0.38 (5% Et2O/Pet. Ether). 1H NMR (400 MHz;
CDCl3): δ 8.03-8.01 (m, 2H), 7.56-7.51 (m, 1H), 7.44-7.40 (m, 2H), 5.21-5.13 (m, 1H), 2.23 (td,
J = 7.0, 2.6 Hz, 2H), 1.94 (t, J = 2.5 Hz, 1H), 1.87-1.58 (m, 4H), 1.34 (d, J = 6.3 Hz, 3H).
13C NMR (101 MHz, CDCl3): δ 166.37, 133.01, 130.93, 129.74, 128.52, 84.21, 71.32, 68.92,
35.27, 24.63, 20.35, 18.53. [α]D25 = –39.4 ◦(c = 1.10, CHCl3). Chiral HPLC: Chiralcel R© AD
column, heptane:iPrOH = 150:1, 0.6 mL/min, λ = 254 nm; tR = 14.86 (minor), 16.85 (major)
minutes: 97% ee. Characterization data matches literature.32
Preparation of Aldehyde Substrates
Preparation of 4-((tert-Butyldimethylsilyl)oxy)butan-1-ol.
HO OTBS
To a suspension of NaH (4.9 g as a 60% dispersion in mineral oil, 120 mmol, 4.0 equiv)
in THF (160 mL) at 0 ◦C was added 1,4-butanediol (10.03 mL, 120 mmol, 4.0 equiv). After
stirring the reaction mixture for 15 minutes at 0 ◦C, a solution of tert-butyldimethylsilyl
chloride (4.5 g, 30 mmol, 1.0 equiv) in THF (40 mL) was added. The reaction mixture
was slowly warmed to room temperature and stirred for 3 hours before quenching with H2O.
The reaction mixture was extracted with EtOAc and the combined organics were dried over
MgSO4, filtered and concentrated in vacuo. The crude product was purified by silica gel
chromatography (20% EtOAc/ pet. ether). The title compound was isolated as a clear,
colorless oil (5.3 g, 87% yield). Rf = 0.26 (15% EtOAc/pet. ether). 1H-NMR (400 MHz;
CDCl3): δ 3.68-3.60 (m, 4H), 2.44-2.41 (m, 1H), 1.66-1.60 (m, 4H), 0.88 (s, 9H), 0.05 (s, 6H).
13C-NMR (101 MHz, CDCl3): δ 63.6, 63.0, 30.5, 30.1, 26.1, 18.5, -5.2. Characterization data
matches that reported in the literature.33
Preparation of 4-((tert-Butyldimethylsilyl)oxy)butanal, 112.
O
OTBS
To a solution of 4-((tert-butyldimethylsilyl)oxy)butan-1-ol (3.0 g, 14.68 mmol, 1.0 equiv) in
CH2Cl2 (70 mL) was added H2O (70 mL), KBr (0.176 g, 1.47 mmol, 0.1 equiv), NaHCO3 (0.321
g, 3.82 mmol, 0.26 equiv) and TEMPO (0.046 g, 0.29 mmol, 2 mol%). The reaction mixture
was cooled to 0 ◦C and NaOCl (16.18 mL of 10-15% aqueous solution, 16.15 mmol, 1.1 equiv)
was added slowly over 10 minutes. The reaction was stirred at 0 ◦C for an hour, slowly warmed
to room temperature and quenched with 10% aqueous Na2S2O3. The reaction mixture was
extracted twice with CH2Cl2 and the combined organic layers were dried over MgSO4, filtered
and concentrated in vacuo. The crude product was purified by silica gel chromatography (10%
Et2O/ pet. ether) followed by Kugelrohr distillation. The title compound was isolated as a
clear, colorless oil (0.548 g, 18% yield - unoptimized). Rf = 0.59 (5% EtOAc/ pet. ether).
1H-NMR (400 MHz; CDCl3): δ 9.78 (t, J = 1.7 Hz, 1H), 3.64 (t, J = 6.0 Hz, 2H), 2.50 (td,
J = 7.1, 1.7 Hz, 2H), 1.88-1.82 (m, 2H), 0.88 (s, 9H), 0.03 (s, 6H). 13C-NMR (101 MHz,
CDCl3): δ 202.9, 65.2, 62.3, 41.0, 26.1, 18.5, -5.2. Characterization data matches that reported
in the literature.34
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Preparation of 4-((4-Methoxybenzyl)oxy)butan-1-ol
HO OPMB
To a suspension of NaH (4.9 g as a 60% dispersion in mineral oil, 120 mmol, 4.0 equiv)
in THF (200 mL) at 0 ◦C was added 1,4-butanediol (10.03 mL, 120 mmol, 4.0 equiv). After
the reaction was warmed to room temperature and stirred for 15 minutes, p-methoxybenzyl
chloride (2.31 g, 14.75 mmol, 1.0 equiv) was added and the reaction was stirred overnight.
The reaction was then quenched with H2O, extracted with Et2O and the combined organics
were dried over MgSO4, filtered and concentrated in vacuo. The crude product was purified
by silica gel chromatography (60% EtOAc/ pet. ether). The title compound was isolated as
a clear, colorless oil (0.412 g, 13% yield - unoptimized). Rf = 0.10 (15% EtOAc/ pet. ether).
1H-NMR (400 MHz; CDCl3): δ 7.24 (m, 2H), 6.88-6.84 (m, 2H), 4.43 (s, 2H), 3.78 (s, 3H),
3.62 (t, J = 5.7 Hz, 2H), 3.47 (t, J = 5.7 Hz, 2H), 1.70-1.62 (m, 4H). 13C-NMR (101 MHz,
CDCl3): δ 159.4, 130.4, 129.4, 114.0, 73.0, 70.3, 62.8, 55.5, 30.7, 27.0. Characterization data
matches that reported in the literature.35
Preparation of 4-((4-Methoxybenzyl)oxy)butanal, 115.
O
OPMB
To a solution of 4-((4-methoxybenzyl)oxy)butan-1-ol (0.412 g, 1.96 mmol, 1.0 equiv) in
CH2Cl2 (3.45 mL) was added DMSO (0.46 mL) and NEt3 (0.45 mL, 3.23 mmol, 1.6 equiv).
The reaction mixture was then cooled to 0 ◦C and SO3·pyridine (0.518 g, 3.25 mmol, 1.7
equiv) was added in one portion. The reaction was warmed to room temperature and stirred
for 4 hours before quenching with H2O. The reaction mixture was subsequently extracted with
Et2O and the combined organics were dried over MgSO4, filtered and concentrated in vacuo.
The crude product was purified by flash column chromatography (20→ 30% Et2O/ pet. ether)
to give the title compound as a clear, colorless oil (0.2113 g, 52% yield - unoptimized). Rf =
0.10 (15% EtOAc/ pet. ether). 1H-NMR (300 MHz; CDCl3): δ 9.80 (t, J = 1.6 Hz, 1H),
7.30-7.24 (m, 2H), 6.93-6.88 (m, 2H), 4.44 (s, 2H), 3.83 (s, 3H), 3.50 (t, J = 6.1 Hz, 2H), 2.56
(td, J = 7.1, 1.6 Hz, 2H), 1.96 (tt, J = 7.1, 6.1 Hz, 2H). 13C-NMR (126 MHz, CDCl3): δ
202.6, 159.4, 130.6, 129.5 (2C), 114.0 (2C), 72.9, 69.1, 55.5, 41.3, 22.8. Characterization data
matches that reported in the literature.36
Preparation of (E)-4-((tert-Butyldimethylsilyl)oxy)but-2-enal, 142.
OTBS
O
OTBSOH
NaH, TBSCl,
THF
71% yield 39% yield
(unoptimized)
HO SO3 pyr,DMSO, NEt3,
CH2Cl2
HO
(Z)-4-((tert-Butyldimethylsilyl)oxy)but-2-en-1-ol
To a suspension of NaH (4.9 g as a 60% dispersion in mineral oil, 120 mmol, 4.0
equiv) in THF (160 mL) at 0 ◦C was added (Z )-but-2-ene-1,4-diol (9.86 mL, 120 mmol,
4.0 equiv). The reaction mixture was stirred at 0 ◦C for 15 minutes before the addition of
tert-butyldimethylsilyl chloride (4.5 g, 30 mmol, 1.0 equiv). The reaction was warmed to
room temperature and stirred overnight before quenching with H2O. The reaction mixture
was extracted twice with Et2O, the combined organics were dried over MgSO4, filtered and
concentrated in vacuo. The crude product was purified via silica gel chromatography (20%
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OTBS
HO
EtOAc/ pet. ether). The title compound was isolated as a clear, colorless oil (4.34 g, 71%
yield). Rf = 0.34 (20% EtOAc/pet. ether). 1H-NMR (400 MHz; CDCl3): δ 5.72-5.61 (m,
2H), 4.23 (d, J = 4.9 Hz, 2H), 4.17 (t, J = 4.9 Hz, 2H), 0.88 (s, 9H), 0.06 (s, 6H). 13C-NMR
(101 MHz, CDCl3): δ 131.5, 130.3, 59.8, 59.0, 26.1, 18.5, -5.1. Characterization data matches
that reported in the literature.37
Preparation of (E)-4-((tert-Butyldimethylsilyl)oxy)but-2-enal, 142.
O
OTBS
To a solution of (Z )-4-((tert-butyldimethylsilyl)oxy)but-2-en-1-ol (1.15 g, 5.68 mmol),
DMSO (0.67 mL) and NEt3 (1.3 mL) in CH2Cl2 (10 mL) at 0 ◦C was added SO3·pyr (1.5 g).
The reaction was warmed to room temperature and stirred for 5 hours before quenching with
H2O. The reaction mixture was extracted twice with CH2Cl2 and the combined organic layers
were dried over MgSO4, filtered and concentrated in vacuo. The crude product was purified
by silica gel chromatography (5 → 10% Et2O/ pet. ether). The title compound was isolated
as a clear, colorless oil (0.44 g, 39% yield). Rf = 0.24 (5% Et2O/pet. ether). 1H-NMR (300
MHz; CDCl3): δ 9.62 (d, J = 8.1 Hz, 1H), 6.91 (dt, J = 15.5, 3.3 Hz, 1H), 6.42 (ddt, J =
15.4, 8.1, 2.2 Hz, 1H), 4.47 (dd, J = 3.3, 2.2 Hz, 2H), 0.94 (s, 9H), 0.11 (s, 6H). 13C-NMR
(75 MHz, CDCl3): δ 193.7, 156.8, 130.8, 62.5, 26.1, 18.6, -5.2. Characterization data matches
that reported in the literature.35
Preparation of (E)-4,4-Dimethoxybut-2-enal, 141.
OMe
OMe
MeO
OMe
MeO
OMe
OAmberlyst-15,
Acetone/H2O
73% yield
H
To a solution of fumaraldehyde bis(dimethyl acetal) (2.0 g, 11.35 mmol, 1.0 equiv) in
acetone (45 mL) was added water (0.68 mL), followed by Amberlyst-15 (0.44 g). The reaction
mixture was stirred vigorously at room temperature for 5 minutes before removal of the
acidic resin by filtration. The filtrate was concentrated in vacuo and prurified by silica gel
chromatography (15% Et2O/ pet. ether). The title compound was isolated as a clear, colorless
oil (1.073 g, 73% yield). Rf = 0.24 (20% Et2O/pet. ether). 1H-NMR (400 MHz; CDCl3): δ
9.60 (d, J = 7.8 Hz, 1H), 6.61 (dd, J = 15.9, 3.9 Hz, 1H), 6.35 (ddd, J = 15.9, 7.8, 1.3 Hz,
1H), 5.03 (dd, J = 3.9, 1.3 Hz, 1H), 3.34 (s, 6H). 13C-NMR (126 MHz, CDCl3): δ 193.47,
150.70, 134.51, 100.69, 53.30. Characterization data matches literature.38
Alkynylation Products
Preparation of (2S/R,8R)-11-((tert-Butyldimethylsilyl)oxy)-8-hydroxyundec-6-yn-
2-yl benzoate, 113.
Using the standard procedure for Zn-ProPhenol-catalyzed addition of alkynes to aldehydes,
the reaction was performed with 0.011 g (S,S)-ProPhenol ligand (0.01625 mmol, 10 mol%),
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OBz
HO
TBSO
0.009 g triphenylphosphine oxide (0.0325 mmol, 20 mol %), 1 mL of toluene, 0.099 g of (±)-
hept-6-yn-2-yl benzoate (0.455 mmol, 2.8 equiv), 0.399 mL of dimethyl zinc (as a 1.2 M solution
in toluene, 0.479 mmol, 2.95 eq.) and 0.033 g of 4-((tert-butyldimethylsilyl)oxy)butanal (0.1625
mmol, 1.0 eq.). The crude product was purified by silica gel chromatography (10 → 15%
EtOAc/Pet. Ether) and the title compound was obtained as a clear, colorless oil (0.0262 g,
39% yield). Rf = 0.38 (20% EtOAc/ pet. ether). 1H-NMR (400 MHz; CDCl3): δ 8.02 (m,
2H), 7.53 (m, 1H), 7.42 (m, 2H), 5.18 (sextet, J = 6.3 Hz, 1H), 4.37 (app. s, 1H), 3.65 (m, 2H),
3.04 (t, J = 5.4 Hz, 1H), 2.24 (t, J = 7.0 Hz, 2H), 1.83-1.57 (m, 8H), 1.33 (d, J = 6.3 Hz, 3H),
0.87 (s, 9H), 0.04 (s, 6H). 13C NMR (101 MHz, CDCl3): δ 166.42, 133.00, 130.92, 129.73,
128.51, 84.68, 82.05, 71.37, 63.41, 62.50, 35.79, 35.76, 35.39, 28.81, 26.12, 24.73, 20.32, 18.83,
18.51, -5.16, -5.18. IR (film): 3415, 2930, 2857, 2236, 1717, 1451, 1385, 1359, 1315, 1275,
1176, 1108, 1027, 836, 777, 713 cm−1. [α]D25 = +5.85 ◦(c = 2.5, CHCl3). Chiral HPLC:
Chiralpak R© IB column, heptane:iPrOH = 92:8, 0.4 mL/min, = 254 nm; tR = 26.97 (major),
27.76 (minor), 28.34 (ent-major + ent-minor) minutes: 62% ee (57% ee by 1H NMR analysis
of the corresponding (S)-methyl mandelate). HRMS–ESI (m/z): [M + Na]+ calculated for
C24H38O4SiNa+, 441.2432; found, 441.2428.
Representative Procedure for the Preparation (S)-Methyl Mandelate Deriva-
tives for the Determination of Enantiomeric Excess
(major)
OBz
O
O
OTBS
Ph
OMe
(minor)
3.623.48
2.27 2.18H
H
H
H
OBz
O
O
OTBS
Ph
OMe
H
H
H
H
Resolved 1H NMR Signals Anisotropic Shielding of the
Propargylic Methylene
To a solution of 11-((tert-butyldimethylsilyl)oxy)-8-hydroxyundec-6-yn-2-yl benzoate (0.0175
g, 0.042 mmol, 1.0 eq.) in CH2Cl2 (1 mL) was added EDCI·HCl (0.024 g, 0.126 mmol, 3.0 eq.),
NEt3 (0.035 mL, 0.252 mmol, 6.0 eq.), (S)-methoxyphenylacetic acid (0.0278 g, 0.167 mmol,
4.0 eq.) and DMAP (0.0005 g, 0.004 mmol, 10 mol%). The reaction was stirred overnight
at room temperature before being quenched with saturated aqueous NaHCO3. The reaction
mixture was then extracted with CH2Cl2 and the combined organic layers were dried over
MgSO4, filtered and concentrated in vacuo. The crude product was purified by preparative
TLC and the title compound was obtained as a clear, colorless oil (0.0179 g, 75% yield). Rf
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= 0.37 (10% EtOAc/Pet. Ether). 1H NMR analysis shows a 1 : 0.2715 ratio of diastereomers,
indicating 57% ee in the starting material.
(2S/R,8R)-8-Hydroxy-11-((4-methoxybenzyl)oxy)undec-6-yn-2-yl benzoate, 116.
OBz
HO
OPMB
Standard procedure with 24 hour premix. To a solution of (S,S)-ProPhenol ligand (0.021
g, 0.0325 mmol, 20 mol%), triphenylphosphine oxide (0.018 g, 0.065 mmol, 40 mol%) and
(±)-hept-6-yn-2-yl benzoate (0.099 g, 0.455 mmol, 2.8 eq.) in toluene (1 mL) was added
dimethyl zinc (0.399 mL as a 1.2 M solution in toluene, 0.479 mmol, 2.95 eq.) at 0 ◦C. The
reaction was warmed to room temperature and stirred for 24 hours before addition of 4-((4-
methoxybenzyl)oxy)butanal (0.034 g, 0.1625 mmol, 1 eq.) at 0 ◦C. The reaction was stirred
for 48 hours at 4 ◦C before quenching with saturated, aqueous NH4Cl. The organic phase was
extracted three times with Et2O and the combined organics were concentrated in vacuo. The
crude product was purified by flash column chromatography (25% EtOAc/Pet. Ether) and the
title compound was obtained as a clear, colorless oil (0.047 g, 69% yield, 67% ee determined
by 1H NMR analysis of the corresponding (S)-methyl mandelate). Rf = 0.26 (30% EtOAc/
pet. ether). 1H NMR (400 MHz; CDCl3): δ 8.02 (d, J = 7.9 Hz, 2H), 7.53 (t, J = 7.4 Hz,
1H), 7.41 (t, J = 7.7 Hz, 2H), 7.23 (d, J = 8.5 Hz, 2H), 6.85 (d, J = 8.4 Hz, 2H), 5.18 (sextet,
J = 6.2 Hz, 1H), 4.42 (s, 2H), 4.36 (app. s, 1H), 3.78 (s, 3H), 3.48 (m, 2H), 2.80 (br. s, 1H),
2.24 (t, J = 6.8 Hz, 2H), 1.83-1.57 (m, 8H), 1.33 (d, J = 6.3 Hz, 3H). 13C NMR (101 MHz,
CDCl3): δ 166.42, 159.40, 133.01, 130.91, 130.39, 129.73 (2C), 128.52, 114.01, 84.84, 81.96,
72.84, 71.37, 70.06, 62.52, 55.48, 35.75, 35.38, 25.82, 24.70, 20.32, 18.81. IR (film): 3423, 2936,
2863, 2232, 1714, 1612, 1513, 1451, 1358, 1275, 1248, 1115, 1029, 821 cm−1. [α]D25 = +2.51 ◦(c
= 0.78, CHCl3). HRMS-ESI (m/z): [M + Na]+ calculated for C26H32O5Na, 447.2142; found,
447.2134.
(2S/R,8R,E)-11-((tert-Butyldimethylsilyl)oxy)-8-hydroxyundec-9-en-6-yn-2-yl
benzoate, 217.
OBz
HO OTBS
Using the standard procedure for Zn-ProPhenol-catalyzed addition of alkynes to aldehydes,
the reaction was performed with 0.011 g (S,S)-ProPhenol ligand (0.01625 mmol, 10 mol%),
0.009 g triphenylphosphine oxide (0.0325 mmol, 20 mol %), 0.149 mL of toluene, 0.035 g of (±)-
hept-6-yn-2-yl benzoate (0.1625 mmol, 1.0 eq.), 0.176 mL of dimethyl zinc (as a 1.2 M solution
in toluene, 0.211 mmol, 1.3 eq.) and 0.033 g of (E)-4-((tert-butyldimethylsilyl)oxy)but-2-enal
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(0.1625 mmol, 1.0 eq.). The crude product was purified by flash column chromatography (15%
EtOAc/pet. ether) and the title compound was obtained as a clear, colorless oil (0.0365 g, 54%
yield). Rf = 0.37 (20% EtOAc/ pet. ether). 1H NMR (400 MHz; CDCl3): δ 8.02 (m, 2H),
7.53 (tt, J = 7.4, 1.6 Hz, 1H), 7.42 (m, 2H), 5.92 (m, 1H), 5.80 (dddt, J = 15.2, 5.5, 3.7, 1.8 Hz,
1H), 5.20 (m, 1H), 4.86 (m, 1H), 4.17 (ddt, J = 6.2, 4.6, 1.6 Hz, 2H), 2.27 (tt, J = 6.9, 1.7 Hz,
2H), 1.96 (t, J = 5.6 Hz, 1H), 1.84-1.59 (m, 4H), 1.33 (d, J = 6.3 Hz, 3H), 0.88 (s, 9H), 0.05
(s, 3H), 0.04 (s, 3H). 13C NMR (101 MHz, CDCl3): δ 166.45, 133.03, 131.88, 130.89, 129.74,
129.27, 128.52, 86.49, 80.12, 71.33, 62.93, 62.86, 35.40, 26.15, 24.59, 20.32, 18.86, 18.61, -5.03.
IR (film): 3423, 2930, 2856, 2236, 1716, 1602, 1451, 1379, 1275, 1117, 1071, 836 cm−1. [α]D25
= -3.85 ◦(c = 1.09, CHCl3). Chiral HPLC: Chiralpak R© IB column, heptane:EtOAc = 98:2,
0.8 mL/min, λ = 254 nm; tR = 65.90 (major), 78.07 (minor) minutes: 95% ee. HRMS-ESI
(m/z): [M + Na]+ calculated for C24H36O4SiNa, 439.2275; found, 439.2271.
(2S,8R,E)-8-Hydroxy-11,11-dimethoxyundec-9-en-6-yn-2-yl benzoate, 118.
BzO
HO OMe
OMe
Standard procedure with buffered quench. To a solution of (S)-hept-6-yn-2-yl benzoate
(0.097 g, 0.45 mmol, 1.0 eq.), (S,S)-ProPhenol ligand (0.029 g, 0.045 mmol, 10 mol %) and
triphenylphosphine oxide (0.025 g, 0.090 mmol, 20 mol %) in toluene (0.45 mL) was added
dimethyl zinc (0.488 mL of 1.2 M solution in toluene, 0.585 mmol, 1.3 eq.) at 0 ◦C. The
reaction mixture was warmed to room temperature and stirred for 1 hour before addition of
(E)-4,4-dimethoxybut-2-enal (0.059 g, 0.45 mmol, 1.0 eq.) at 0 ◦C. The reaction was then
stirred at 4 ◦C for 48 hours before quenching with pH 7 phosphate buffer. The reaction mixture
was extracted with twice with Et2O, the combined organics were dried over MgSO4, filtered
and concentrated in vacuo. The crude product was purified by flash column chromatography
(30% EtOAc/ pet. ether with 1% NEt3). The title compound was isolated as a clear colorless
oil (0.129 g, 82% yield). Rf = 0.31 (30% EtOAc/pet. ether). 1H NMR (400 MHz; CDCl3):
δ 8.04 (m, 2H), 7.56 (tt, J = 7.4, 1.6 Hz, 1H), 7.44 (m, 2H), 5.97 (m, 1H), 5.84 (app. dtd, J
= 15.6, 4.4, 1.3 Hz, 1H), 5.23 (m, 1H), 4.90 (m, 1H), 4.82 (dd, J = 8.6, 4.6 Hz, 1H), 3.31 (m,
6H), 2.29 (tt, J = 6.9, 2.0 Hz, 2H), 2.07 (br. s, 1H), 1.88-1.55 (m, 4H), 1.35 (d, J = 6.3 Hz,
3H). 13C NMR (126 MHz, CDCl3): δ 166.53, 134.28, 133.10, 130.88, 129.79, 128.58, 128.32,
102.24, 86.92, 79.61, 71.35, 62.43, 53.00, 35.44, 24.54, 20.36, 18.88. IR (film): 3430, 2939,
2831, 2234, 1714, 1602, 1584, 1451, 1356, 1315, 1276, 1192, 1129, 1070, 973 cm−1. [α]D25 =
+3.41 ◦(c = 1.05, CHCl3). Chiral HPLC: Chiralpak R© IB column, heptane:iPrOH = 90:10,
0.8 mL/min, λ = 254 nm; tR = 10.2 (minor), 11.7 (major) minutes: 19:1 dr. HRMS-ESI
(m/z): [M + Na]+ calculated for C20H26O5Na, 369.1672; found, 369.1669.
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Chiral HPLC trace:
racemic alkyne addition 19:1 dr
Conjugate Reduction of α-β-unsaturated Aldehydes
(2S,8R,E)-8-Acetoxy-11,11-dimethoxyundec-9-en-6-yn-2-yl benzoate.
BzO
AcO OMe
OMe
To a solution of (2S,8R,E)-8-hydroxy-11,11-dimethoxyundec-9-en-6- yn-2-yl benzoate
(0.107g, 0.307 mmol, 1.0 eq.) in pyridine (1 mL) was added acetic anhydride (1 mL) at room
temperature. The reaction was stirred for 1 hour before quenching with pH 7 phosphate buffer
at 0 ◦C. The reaction mixture was extracted with CH2Cl2, the combined organics were washed
with 1 M HCl, dried over MgSO4, filtered and concentrated in vacuo. The title compound was
isolated as a clear, colorless oil (0.105 g, 88% yield) and was used without further purification.
Rf = 0.33 (20% EtOAc/Pet. Ether). 1H NMR (500 MHz; CDCl3): δ 8.07-8.05 (m, 2H),
7.59-7.56 (m, 1H), 7.46 (t, J = 7.6 Hz, 2H), 5.94 (m, 3H), 5.19 (m, 1H), 4.86 (app. s, 1H), 3.33
(s, 6H), 2.31 (t, J = 7.0 Hz, 2H), 2.11 (s, 3H), 1.83-1.63 (m, 4H), 1.37 (d, J = 6.3 Hz, 3H).
13C NMR (126 MHz, CDCl3): δ 169.95, 166.39, 133.05, 130.91 (2C), 130.11, 129.77, 128.57,
101.71, 76.02, 71.31, 63.83, 52.96, 52.93, 35.40, 24.59, 21.33, 20.36, 18.93. IR (film): 2938,
2831, 2245, 1742, 1715, 1602, 1584, 1451, 1371, 1314, 1275, 1229, 1193, 1130, 1070, 1025, 963,
715 cm−1. [α]D25 = +17.34 ◦(c = 1.2, CHCl3). HRMS-ESI (m/z): [M + Na]+ calculated for
C22H28O6Na, 411.1778; found, 411.1775.
(2S,8R,E)-8-Acetoxy-11-oxoundec-9-en-6-yn-2-yl Benzoate, 204.
BzO
AcO O
H
To a solution of (2S,8R,E)-8-acetoxy-11,11-dimethoxyundec-9-en-6- yn-2-yl benzoate (0.105
g, 0.270 mmol, 1.0 eq.) in acetone (40 mL) was added water (1.25 mL) and pyridinium p-
toluenesulfonate (0.040 g) at room temperature. The reaction mixture was heated to reflux
and stirred for 3 hours. The reaction mixture was cooled to room temperature and the acetone
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was removed in vacuo. The crude product was redissolved in CH2Cl2, 20 mL of water was
added before extracting twice with CH2Cl2. The combined organics were dried over MgSO4,
filtered and concentrated in vacuo. The title compound was isolated as a yellow oil (0.0793g,
86% yield) and was used without further purification. Rf = 0.34 (20% EtOAc/ pet. ether).
1H NMR (400 MHz; CDCl3): δ 9.59 (dd, J = 7.7, 1.5 Hz, 1H), 8.03-8.00 (m, 2H), 7.56-7.52
(m, 1H), 7.44-7.40 (m, 2H), 6.69 (ddd, J = 15.6, 4.7, 1.1 Hz, 1H), 6.40-6.34 (m, 1H), 6.09-6.06
(m, 1H), 5.17 (m, 1H), 2.29 (app. td, J = 7.0, 2.0 Hz, 2H), 2.11 (s, 3H), 1.84-1.58 (m, 4H),
1.34 (d, J = 6.3 Hz, 3H). 13C NMR (101 MHz, CDCl3): δ 192.94, 169.59, 166.34, 149.46,
133.11, 133.06, 130.85, 129.73, 128.55, 89.18, 74.28, 71.13, 62.75, 35.34, 24.39, 21.04, 20.31,
18.85. IR (film): 2936, 2244, 1747, 1710, 1694, 1602, 1451, 1371, 1274, 1220, 1114, 1068, 1023,
974 cm−1. [α]D25 = +34.63 ◦(c = 1.15, CHCl3). HRMS-ESI (m/z): [M + Na]+ calculated
for C20H22O5Na, 365.1359; found, 365.1355.
Note: This product was found to decompose at ambient temperatures.
(2S,8R,E)-8-((tert-Butyldimethylsilyl)oxy)-11,11-dimethoxyundec-9-en-6-yn-2-
yl Benzoate
BzO
TBSO OMe
OMe
To a solution of (2S,8R,E)-8-hydroxy-11,11-dimethoxyundec-9-en-6- yn-2-yl benzoate
(0.342 g, 0.987 mmol, 1.0 eq.), imidazole (0.101 g, 1.48 mmol, 1.5 eq.) and tetra-N -
butylammonium iodide (0.109 g, 0.296 mmol, 0.3 eq.) in DMF (30 mL) was added a solution
of tert-butyldimethylsilyl chloride (0.223 g, 1.48 mmol, 1.5 eq.) in DMF (5 mL) at room
temperature. The reaction mixture was heated to 60 ◦C and stirred for 3 hours. The
reaction was cooled to room temperature, diluted with H2O and CH2Cl2, and extracted
twice with CH2Cl2. The combined organics were washed with water, then brine, dried over
MgSO4, filtered and concentrated in vacuo. The crude product was purified by flash column
chromatography (5% EtOAc/pet. ether with 1% NEt3). The title compound was isolated as a
clear, colorless oil (0.1875 g, 41% yield). Rf = 0.35 (5% EtOAc/pet. ether). 1H NMR (400
MHz; CDCl3): δ 8.03-8.00 (m, 2H), 7.55-7.51 (m, 1H), 7.44-7.40 (m, 2H), 5.88 (ddd, J = 15.5,
4.6, 1.1 Hz, 1H), 5.75 (ddd, J = 15.5, 4.5, 1.4 Hz, 1H), 5.19-5.11 (m, 1H), 4.92-4.90 (m, 1H),
4.81 (m, J = 1.0 Hz, 1H), 3.29 (s, 6H), 2.24 (td, J = 6.9, 2.0 Hz, 2H), 1.84-1.52 (m, 4H), 1.33
(d, J = 6.3 Hz, 3H), 0.88 (s, 9H), 0.10 (d, J = 2.6 Hz, 6H). 13C NMR (101 MHz, CDCl3): δ
166.35, 135.12, 132.97, 130.94, 129.73, 128.50, 126.71, 102.32, 85.68, 80.2, 71.35, 62.89, 52.80,
35.41, 26.0, 24.69, 20.34, 18.88, 18.56, -4.34, -4.63. IR (film): 2932, 2857, 2232, 1718, 1603,
1451, 1274, 1192, 1116, 1070, 973, 838, 779, 713 cm−1.
(2S,8R,E)-8-((tert-Butyldimethylsilyl)oxy)-11-oxoundec-9-en-6-yn-2-yl
Benzoate, 205.
To a solution of (2S,8R,E)-8-((tert-butyldimethylsilyl)oxy)-11,11- dimethoxyundec-9-en-6-
yn-2-yl benzoate (0.069 g, 0.150 mmol, 1.0 eq.) in acetone (22 mL) was added water (0.69
mL) and pyridinium p-toluenesulfonate (0.022 g) at room temperature. The reaction mixture
stirred at 45 ◦C for 4.5 hours. The reaction mixture was cooled to room temperature and
the acetone was removed in vacuo. The crude product was redissolved in CH2Cl2, 20 mL
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BzO
TBSO O
H
of water was added before extracting twice with CH2Cl2. The combined organics were dried
over MgSO4, filtered and concentrated in vacuo. The title compound was isolated as a clear,
colorless oil (0.056 g, 90% yield) and was used without further purification. Rf = 0.30 (5%
EtOAc/pet. ether). 1H NMR (500 MHz; CDCl3): δ 9.65 (dd, J = 7.9, 0.5 Hz, 1H), 8.07-8.05
(m, 2H), 7.60-7.56 (m, 1H), 7.48-7.45 (m, 2H), 6.78 (dd, J = 15.4, 4.0 Hz, 1H), 6.39 (dddd,
J = 15.4, 8.0, 1.8, 0.5 Hz, 1H), 5.24-5.18 (m, 1H), 5.15 (app. dq, J = 3.9, 1.9 Hz, 1H), 2.31
(td, J = 7.0, 2.0 Hz, 2H), 1.88-1.61 (m, 6H), 1.38 (d, J = 6.3 Hz, 3H), 0.94 (s, 9H), 0.16 (d,
J = 4.8 Hz, 6H). 13C NMR (126 MHz, CDCl3): δ 193.74, 166.39, 155.65, 133.09, 130.90,
130.72, 129.76, 128.57, 87.20, 78.26, 71.24, 62.36, 35.43, 25.97, 24.56, 20.39, 18.86, -4.33, -4.77.
IR (film): 2931, 2857, 22220, 1716, 1694, 1602, 1462, 1314, 1275, 1102, 1071, 973, 838, 713
cm−1. HRMS-ESI (m/z): [M + H]+ calculated for C24H34O4SiNa, 437.2119; found, 437.2123.
(2S,8R,E)-8-((tert-Butyldiphenylsilyl)oxy)-11,11-dimethoxyundec-9-en-6-yn-
2-yl Benzoate
BzO
TBDPSO OMe
OMe
To a solution of (2S,8R,E)-8-hydroxy-11,11-dimethoxyundec-9-en-6- yn-2-yl benzoate
(0.2496 g, 0.72 mmol, 1.0 eq.), imidazole (0.074 g, 1.08 mmol, 1.5 eq.) and tetra-N -
butylammonium iodide (0.080 g, 0.216 mmol, 0.3 eq.) in DMF (7.2 mL) was added tert-
butyldiphenylsilyl chloride (0.297 g, 1.08 mmol, 1.5 eq.) at room temperature. The reaction
mixture was heated to 50 ◦C and stirred for 9 hours. The reaction was cooled to room
temperature and the DMF was removed in vacuo. The reactions mixture was redissolved
in Et2O and water, and extracted twice with Et2O. The combined organics were dried over
MgSO4, filtered and concentrated in vacuo. The crude product was purified by flash column
chromatography (5% EtOAc/pet. ether with 1% NEt3). The title compound was isolated as
a clear, colorless oil (0.1752 g, 42% yield). Rf = 0.27 (5% EtOAc/ pet. ether). 1H NMR
(400 MHz; CDCl3): δ 8.03-8.00 (m, 2H), 7.74-7.72 (m, 2H), 7.68-7.64 (m, 2H), 7.55-7.51 (m,
1H), 7.43-7.30 (m, 8H), 5.88 (dd, J = 15.5, 4.9 Hz, 1H), 5.73-5.67 (m, 1H), 5.12-5.07 (m, 1H),
4.87 (m, J = 0.7 Hz, 1H), 4.78 (d, J = 4.7 Hz, 1H), 3.27-3.26 (m, 6H), 2.10 (td, J = 7.0,
1.9 Hz, 2H), 1.72-1.42 (m, 4H), 1.29 (dd, J = 6.2, 2.1 Hz, 3H), 1.05 (s, 9H). 13C NMR (101
MHz, CDCl3): δ 166.34, 136.19, 135.98, 135.72, 134.80, 133.75, 132.98, 130.95, 129.93, 129.83,
129.80, 129.73, 128.51, 127.88, 127.76, 127.57, 126.98, 102.30, 86.40, 79.99, 71.38, 63.78, 52.78,
35.37, 27.07, 26.98, 24.56, 20.33, 19.52, 18.86. IR (film): 2933, 2858, 1716, 1587, 1451, 1428,
1359, 1314, 1274, 1191, 1112, 1070, 998, 973, 823, 741, 708 cm−1. HRMS-ESI (m/z): [M +
H] + calculated for C36H44O5SiNa, 607.2850; found, 607.2842.
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(2S,8R,E)-8-((tert-Butyldiphenylsilyl)oxy)-11-oxoundec-9-en-6-yn-2-yl Benzoate,
206.
BzO
TBDPSO O
H
To a solution of (2S,8R,E)-8-((tert-butyldiphenylsilyl)oxy)-11,11- dimethoxyundec-9-en-6-
yn-2-yl benzoate (0.175 g, 0.299 mmol, 1.0 eq.) in acetone (40 mL) was added water (1.37
mL) and pyridinium p-toluenesulfonate (0.045 g) at room temperature. The reaction mixture
stirred at 45 ◦C for 5 hours. The reaction mixture was cooled to room temperature and
the acetone was removed in vacuo. The crude product was redissolved in CH2Cl2, 20 mL
of water was added before extracting twice with CH2Cl2. The combined organics were dried
over MgSO4, filtered and concentrated in vacuo. The title compound was isolated as a clear,
colorless oil (0.120 g, 84% yield) and was used without further purification. 1H NMR (400
MHz; CDCl3): δ 9.56 (dd, J = 7.9, 4.0 Hz, 1H), 8.02-8.00 (m, 2H), 7.72-7.62 (m, 4H), 7.56-7.52
(m, 1H), 7.44-7.31 (m, 8H), 6.68 (dt, J = 15.4, 4.5 Hz, 1H), 6.33 (dddd, J = 15.4, 7.9, 3.0,
1.7 Hz, 1H), 5.12-5.08 (m, 1H), 5.05 (tt, J = 3.8, 1.9 Hz, 1H), 2.10 (td, J = 7.0, 2.0 Hz, 2H),
1.73-1.54 (m, 2H), 1.50-1.40 (m, 2H), 1.29 (dd, J = 6.3, 1.9 Hz, 3H), 1.07 (d, J = 1.4 Hz,
9H). 13C NMR (101 MHz, CDCl3): δ 193.67, 155.13, 136.15, 135.90, 133.04, 130.79, 130.26,
130.08, 129.72, 128.54, 127.96, 127.69, 87.98, 71.22, 63.20, 35.34, 27.02, 26.97, 24.36, 20.32,
19.52, 18.78. IR (film): 2933, 2858, 1715, 1694, 1451, 1428, 1314, 1274, 1113, 972, 822, 741, 703
cm−1. HRMS-ESI (m/z): [M + H]+ calculated for C34H36O4SiNa, 561.2432; found, 561.2425.
Hydrosilylation and Hydrogenation Experiments
(S)-5-((R)-5-((E)-3,3-Dimethoxyprop-1-en-1-yl)-2,2-dimethyl-2,5-dihydro-
1,2-oxasilol-3-yl)pentan-2-yl Benzoate, 210.
Si
O
OBz
OMe
MeO
To a solution of (2S,8R,E)-8-hydroxy-11,11-dimethoxyundec-9-en-6-yn-2- yl benzoate
(0.055 g, 0.159 mmol, 1.0 eq.) in CH2Cl2 (0.25 mL) at 0 ◦C was added freshly distilled
dimethylethoxysilane (0.026 mL, 0.020 g, 0.191 mmol, 1.2 eq.), immediately followed by a
solution of CpRu(CH3CN)3PF6 (0.0035 g, 0.008 mmol, 5 mol %) in CH2Cl2 (0.1 mL). The
reaction was warmed to room temperature and stirred for 30 minutes before being diluted with
pet. ether (0.5 mL) and passed through a florasil plug - rinsing with 30% EtOAc/pet. ether.
The filtrate was concentrated in vacuo and the crude product was purified by flash column
chromatography (5% EtOAc/ pet. ether with 1% NEt3). The title compound was isolated as
a clear, colorless oil (0.013 g, 20% yield). Rf = 0.74 (30% EtOAc/pet. ether). 1H NMR (400
MHz; CDCl3): δ 8.03-8.00 (m, 2H), 7.53 (tt, J = 7.4, 1.6 Hz, 1H), 7.44-7.40 (m, 2H), 6.26 (d,
J = 1.5 Hz, 1H), 5.78 (ddd, J = 15.6, 5.9, 1.0 Hz, 1H), 5.63 (ddd, J = 15.6, 4.6, 1.3 Hz, 1H),
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5.20-5.12 (m, 1H), 5.08 (d, J = 5.8 Hz, 1H), 4.78 (d, J = 4.6 Hz, 1H), 3.28 (s, 6H), 2.26-2.22
(m, 2H), 1.73-1.50 (m, 4H), 1.32 (d, J = 6.3 Hz, 3H), 0.22-0.21 (m, 6H). 13C NMR (101
MHz, CDCl3): δ 166.38, 143.44, 142.29, 136.14, 132.98, 130.96, 129.70, 128.51, 126.18, 102.40,
81.55, 71.53, 52.80, 52.67, 52.05, 36.06, 30.85, 25.56, 20.34, 1.38, 0.48, 0.21. IR (film): 2934,
2831, 1716, 1451, 1314, 1276, 1113, 1070, 1055, 1027, 864, 785, 713 cm−1. [α]D25 = –13.06 ◦
(c = 1.3, CH2Cl2). HRMS-ESI (m/z): [M + H]+ calculated for C22H32O5SiNa, 427.1911;
found, 427.1915.
Preparation of (2S,6Z,8R,9E)-7-(Benzyldimethylsilyl)-8-hydroxy-11,11-
dimethoxyundeca-6,9-dien-2-yl Benzoate, 212.
BzO
BDMS
HO OMe
OMe
To a solution of (2S,8R,E)-8-hydroxy-11,11-dimethoxyundec-9-en-6-yn-2-yl benzoate (0.229
g, 0.662 mmol, 1.0 equiv) in 1,2-dichloroethane (1.0 mL) at 0 ◦C was added benzyldimethyl-
silane (0.110 mL, 0.104 g, 0.695 mmol, 1.05 equiv), immediately followed by a solution of
Cp*Ru(CH3CN)3PF6 (0.0067 g, 0.013 mmol, 2 mol%) in 1,2-dichloroethane (0.32 mL). The
reaction was warmed to room temperature and stirred for 30 minutes before being diluted
with pet. ether (0.5 mL) and passed through a florasil plug, rinsing with 30% EtOAc/ pet.
ether. The filtrate was concentrated in vacuo and the crude product was purified by silica gel
chromatography (20% EtOAc/ pet. ether with 1% NEt3). The title compound was isolated as
a clear, colorless oil (0.2923 g, 89% yield). Rf = 0.41 (30% EtOAc/ pet. ether). 1H-NMR
(400 MHz; CDCl3): δ 8.04 (m, 2H), 7.55 (m, 1H), 7.43 (m, 2H), 7.20 (m, 2H), 7.07 (m, 1H),
6.98 (m, 2H), 6.24 (t, J = 7.4 Hz, 1H), 5.80 (ddd, J = 15.8, 5.0, 1.0 Hz, 1H), 5.59 (ddd, J
= 15.8, 4.9, 1.5 Hz, 1H), 5.17 (m, 1H), 4.75 (d, J = 4.9 Hz, 1H), 4.62 (m, 1H), 3.30-3.29 (m,
6H), 2.23 (s, 2H), 2.16 (app. q, J = 7.5 Hz, 2H), 1.77-1.45 (m, 4H), 1.35 (d, J = 6.3 Hz, 3H),
0.16 (s, 6H). 13C-NMR (101 MHz, CDCl3): δ 166.39, 145.42, 140.08, 139.92, 137.38, 133.00,
130.93, 129.72, 128.51, 128.47, 128.39, 126.91, 124.43, 102.81, 76.60, 71.55, 52.91, 52.88, 36.05,
31.95, 26.95, 25.75, 20.32, -1.04. IR (film): 3425, 2936, 1716, 1601, 1493, 1451, 1355, 1276,
1114, 1055, 974, 834, 713 cm−1. [α]D25 = +21.46 ◦(c = 1.4, CH2Cl2). HRMS-ESI (m/z): [M
+ Na]+ calculated for C29H40O5SiNa, 519.2537; found, 519.2530.
Preparation of (2S,8R,Z)-7-(Benzyldimethylsilyl)-8-
((tert-butyldimethylsilyl)oxy)-11,11-dimethoxyundec-6-en-2-yl Benzoate, 213.
BzO
BDMS
HO OMe
OMe
1)10 mol% RhCl(PPh3)3,
H2, THF/tBuOH
2) TBSCl, DMF,
 imidazole
BzO
BDMS
TBSO OMe
OMe
65% yield
over 2 steps
To a flask containing (2S,6Z,8R,9E)-7-(benzyldimethylsilyl)-8-hydroxy-11,11-dimethox-
yundeca-6,9-dien-2-yl benzoate 212 (0.0615 g, 0.124 mmol, 1.0 eq.) was added a RhCl(PPh3)3
(0.012 g, 0.0124 mmol, 10 mol%) in degassed THF/tBuOH (1:1, 0.244 mL, freeze-pump-thaw
degassing). The reaction flask was then evacuated and backfilled with hydrogen (balloon) three
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times and the reaction was stirred for 10 hours at room temperature. The reaction mixture was
then diluted with Et2O and passed through a florasil plug. The filtrate was concentrated in
vacuo and used immediately in the next step. A pure analytical sample (purified by preparative
TLC on basic alumina, 10% EtOAc/ pet. ether) gave the following characterization data: Rf
= 0.44 (30% EtOAc/ pet. ether). 1H-NMR (400 MHz; CDCl3): δ 8.02 (m, 2H), 7.53 (m,
1H), 7.40 (t, J = 7.7 Hz, 2H), 7.17 (t, J = 7.5 Hz, 2H), 7.04 (t, J = 7.4 Hz, 1H), 6.96
(d, J = 7.1 Hz, 2H), 6.23 (t, J = 7.3 Hz, 1H), 5.16 (m, 1H), 4.30 (t, J = 5.6 Hz, 1H),
4.00 (m, 1H), 3.27 (s, 6H), 2.20 (s, 2H), 2.15 (q, J = 7.4 Hz, 2H), 1.75-1.38 (m, 8H), 1.33
(d, J = 6.3 Hz, 3H), 0.13-0.11 (m, 6H). 13C-NMR (101 MHz, CDCl3): δ 166.40, 142.77,
141.48, 140.09, 132.97, 130.96, 129.72, 128.51, 128.46, 128.37, 124.41, 104.64, 76.24, 71.60,
53.03, 52.87, 36.05, 32.59, 31.89, 29.36, 26.99, 25.88, 20.32, -1.11. IR (film): 3447, 2933,
1716, 1601, 1493, 1452, 1315, 1276, 1205, 1175, 1125, 1070, 1027, 831, 713 cm−1. [α]D25 =
+23.11 ◦(c = 1.0, CH2Cl2). HRMS-ESI (m/z): [M + Na]+ calculated for C29H42O5SiNa,
521.2694; found, 521.2688. The crude product, (2S,8R,Z )-7-(benzyldimethylsilyl)-8-hydroxy-
11,11-dimethoxyundec-6-en-2-yl benzoate), was dissolved in DMF (1.2 mL). Imidazole (0.025
g, 0.372 mmol, 3.0 equiv) and tert-butyldimethylsilyl chloride (0.049 g, 0.372 mmol, 3.0 equiv)
were added at room temperature. The reaction was stirred at room temperature for 9 hours
before being diluted with Et2O and water. The reaction mixture was then extracted with
Et2O, dried over MgSO4, filtered and concentrated in vacuo. The crude product was purified
by silica gel chromatography (2.5% EtOAc/pet. ether with 1% NEt3). The title compound
was isolated as a clear, colorless oil (0.049g, 65% yield over 2 steps.). Rf = 0.29 (5% EtOAc/
pet. ether). 1H-NMR (400 MHz; CDCl3): δ 8.02 (m, 2H), 7.52 (tt, J = 7.4, 1.5 Hz, 1H),
7.40 (m, 2H), 7.17 (m, 2H), 7.04 (m, 1H), 6.97 (m, 2H), 6.18 (t, J = 7.3 Hz, 1H), 5.14 (m,
1H), 4.25 (t, J = 5.8 Hz, 1H), 4.04 (t, J = 5.9 Hz, 1H), 3.26 (s, 3H), 3.25 (s, 3H), 2.23 (s,
1H), 2.21 (s, 1H), 2.13 (m, 2H), 1.76-1.43 (m, 8H), 1.33 (d, J = 6.2 Hz, 3H), 0.86 (s, 9H), 0.09
(s, 6H), -0.02 (s, 3H), -0.07 (s, 3H). 13C-NMR (101 MHz, CDCl3): δ 166.39, 142.87, 141.38,
140.16, 132.93, 131.01, 129.72, 128.55, 128.48, 128.33, 124.27, 104.54, 71.7, 71.67, 52.81, 52.39,
36.06, 33.91, 31.82, 29.00, 27.12, 26.17, 25.94, 20.32, 18.41, -1.08, -1.26, -3.93, -4.72. IR (film):
2931, 2857, 1718, 1602, 1493, 1452, 1383, 1360, 1314, 1274, 1252, 1113, 1070, 1027, 833, 775,
712 cm−1. [α]D25 = +14.32 ◦(c = 1.5, CH2Cl2). HRMS-ESI (m/z): [M + Na]+ calculated
for C35H58O5Si2Na, 635.3558; found, 635.3549.
Formal Total Synthesis of Aspergillide B
Preparation of ((2S,8R,Z)-7-(Benzyldimethylsilyl)-8-((tert-butyldimethylsilyl)oxy)-
11-oxoundec-6-en-2-yl Benzoate, 214.
BzO
BDMS
TBSO
O
To a solution of (2S,8R,Z )-7-(benzyldimethylsilyl)-8-((tert-butyldimethylsilyl)oxy)-11,11-
dimethoxyundec-6-en-2-yl benzoate 213 (0.0548 g, 0.089 mmol) in acetone (10 mL) was added
0.25 mL of water and 0.007 g of pyridiunium p-toluenesulfonate (30 mol%, 0.028 mmol).
The reaction was stirred at 60 ◦C (bath temperature) for 4 hours. After cooling to ambient
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temperature, the reaction mixture was concentrated in vacuo, diluted with CH2Cl2 and H2O,
and extracted with CH2Cl2. The combined organic layers were dried over MgSO4, filtered
and concentrated in vacuo. The title compound was isolated as a clear, colorless oil (0.0405
g, 80% yield) and was used without further purification. Rf = 0.26 (5% EtOAc/pet. ether).
1H-NMR (400 MHz; CDCl3): δ 9.64 (t, J = 1.7 Hz, 1H), 8.05-8.03 (m, 2H), 7.57-7.53 (m,
1H), 7.42 (t, J = 7.6 Hz, 2H), 7.18 (t, J = 7.5 Hz, 2H), 7.05 (t, J = 7.4 Hz, 1H), 6.98 (d, J =
7.0 Hz, 2H), 6.23 (t, J = 7.4 Hz, 1H), 5.17 (m, 1H), 4.11 (t, J = 5.6 Hz, 1H), 2.29 (td, J = 7.3,
1.6 Hz, 2H), 2.23 (m, 2H), 2.17 (t, J = 7.4 Hz, 2H), 1.80-1.43 (m, 6H), 1.36 (d, J = 6.2 Hz,
3H), 0.87 (s, 9H), 0.14 (s, 3H), 0.12 (s, 3H), -0.02 (s, 3H), -0.06 (s, 3H). 13C-NMR (101 MHz,
CDCl3): δ 203.08, 166.41, 143.55, 140.43, 139.96, 133.00, 130.97, 129.73, 128.52, 128.42 (2C),
124.42, 71.66 (2C), 40.11, 36.08, 31.93, 31.06, 27.09, 26.14, 25.92, 20.36, 18.41, -1.00, -1.31,
-4.00, -4.79. IR (film): 2953, 2930, 2856, 1718, 1601, 1493, 1452, 1274, 1253, 1112, 1070, 1026,
834 cm−1. [α]D25 = +1.09 ◦(c = 2.1, CH2Cl2). HRMS-ESI (m/z): [M + H]+ calculated for
C33H50O4Si2Na, 589.3140; found, 589.3133.
Preparation of (2S,8R,11S,Z)-7-(Benzyldimethylsilyl)-8-((tert-
butyldimethylsilyl)oxy)-11-hydroxy-14-methoxy-14-oxotetradec-6-en-12-yn-2-yl
Benzoate, 215.
BzO
BDMS
TBSO
OH
MeO2C
To a solution of (R,R)-ProPhenol ligand (L4) (0.0091 g, 0.014 mmol, 20 mol%) and methyl
propiolate (0.0178 mL, 0.0168 g, 0.20 mmol, 2.8 equiv) in toluene (0.15 mL) was added
dimethyl zinc (0.176 mL of a 1.2 M solution in toluene, 0.211 mmol, 2.95 equiv) at 0 ◦C.
The reaction was warmed to room temperature and stirred for 60 minutes before addition of
a solution of (2S,8R,Z )-7-(benzyldimethylsilyl)-8-((tert-butyldimethylsilyl)oxy)-11-oxoundec-
6-en-2-yl benzoate 214 (0.0405 g, 0.0714 mmol, 1 equiv) in toluene (0.15 mL) at 0 ◦C. The
reaction was stirred for 48 hours at 4 ◦C before quenching with saturated, aqueous NH4Cl.
The organic phase was extracted three times with Et2O and the combined organics were
concentrated in vacuo. The crude product was purified by silica gel chromatography (5% 15%
EtOAc/ pet. ether) to give the title compound as a clear, colorless oil (0.033 g, 71% yield).
Rf = 0.50 (20% Et2O/pet. ether). 1H NMR (400 MHz; CDCl3): δ 8.02 (d, J = 7.1 Hz, 2H),
7.52 (t, J = 7.4 Hz, 1H), 7.40 (t, J = 7.6 Hz, 2H), 7.17 (t, J = 7.5 Hz, 2H), 7.04 (t, J = 7.3 Hz,
1H), 6.96 (m, 2H), 6.20 (t, J = 7.4 Hz, 1H), 5.15 (m, 1H), 4.34 (app. q, J = 6.2 Hz, 1H), 4.12
(m, 1H), 3.74 (s, 3H), 2.38 (dd, J = 5.4, 0.3 Hz, 1H), 2.21-2.14 (m, 4H), 1.77-1.46 (m, 8H),
1.34 (d, J = 6.3 Hz, 3H), 0.85 (s, 9H), 0.12 (s, 3H), 0.09 (s, 3H), -0.02 (s, 3H), -0.06 (s, 3H).
13C NMR (101 MHz, CDCl3): δ 166.48, 154.03, 143.34, 140.10 (2C), 133.01, 130.94, 129.74,
128.63, 128.53, 128.42, 124.35, 88.48, 71.76, 62.37 (2C), 52.99, 35.98, 33.92, 33.11, 31.88, 27.10,
26.15, 26.12, 25.85, 20.28, 18.45, -1.02, -1.32, -4.00, -4.76. IR (film): 3450, 2930, 2856, 2236,
1717, 1601, 1493, 1452, 1435, 1315, 1274, 1252, 1113, 1070, 1027, 834, 775, 713 cm−1. [α]D25
= +9.05 ◦(c = 1.44, CH2Cl2). HRMS-ESI (m/z): [M + Na]+ calculated for C37H54O6Si2Na,
673.3351; found, 673.3341.
4.4. EXPERIMENTAL DATA FOR CHAPTER 4 132
Preparation of (2S,8R,11S,Z)-7-(Benzyldimethylsilyl)-8-((tert-
butyldimethylsilyl)oxy)-14-methoxy-11-(methoxymethoxy)-14-oxotetradec-
6-en-12-yn-2-yl Benzoate, 216.
BzO
BDMS
TBSO
OMOM
MeO2C
To a solution of (2S,8R,11S,Z )-7-(benzyldimethylsilyl)-8-((tert-butyldimethylsilyl)oxy)-11-
hydroxy-14-methoxy-14-oxotetradec-6-en-12-yn-2-yl benzoate 215 (0.0226 g, 0.0347 mmol, 1.0
eq.) in DME (0.35 mL) was added N,N -diisopropylethylamine (0.021 mL, 0.016 g, 0.121 mmol,
3.5 eq.), sodium iodide (0.002 g, 0.010 mmol, 0.3 eq.) and lastly, methyl chloromethyl ether
(0.008 mL, 0.0084 g, 0.104 mmol, 3.0 eq.). The reaction was heated to 80 ◦C (bath temp.) in
a sealed vessel and stirred for 7 hours. After cooling to room temperature, the reaction was
diluted with CH2Cl2 and water, and was subsequently extracted with CH2Cl2. The combined
organic layers were dried over MgSO4, filtered and concentrated in vacuo. The crude product
was purified by flash column chromatography (5% EtOAc/pet. ether). The title compound
was isolated as a clear, colorless oil (0.0149 g, 62% yield). Rf = 0.32 (5% EtOAc/pet. ether).
1H NMR (500 MHz; CDCl3): δ 8.07-8.05 (m, 2H), 7.57 (tt, J = 7.4, 1.5 Hz, 1H), 7.45 (t, J =
7.8 Hz, 2H), 7.21 (t, J = 7.6 Hz, 2H), 7.09 (t, J = 7.4 Hz, 1H), 7.01 (d, J = 7.0 Hz, 2H), 6.24
(t, J = 7.5 Hz, 1H), 5.18 (m, 1H), 4.88 (d, J = 6.9 Hz, 1H), 4.60 (d, J = 6.9 Hz, 1H), 4.38 (t,
J = 6.5 Hz, 1H), 4.13 (t, J = 5.8 Hz, 1H), 3.78 (s, 3H), 3.38 (s, 3H), 2.27 (s, 1H), 2.25 (s, 1H),
2.20-2.15 (m, 2H), 1.80-1.46 (m, 8H), 1.37 (d, J = 6.2 Hz, 3H), 0.90 (s, 9H), 0.14 (m, 6H),
0.03 (s, 3H), -0.02 (s, 3H). 13C NMR (126 MHz, CDCl3): δ 166.43, 153.90, 143.13, 140.11
(2C), 132.99, 131.02, 129.76, 128.57, 128.54, 128.40, 124.37, 94.88, 86.70, 77.14, 71.73, 71.70,
65.62, 56.05, 52.98, 36.10, 34.20, 31.86, 31.43, 27.09, 26.19, 25.97, 20.37, 18.46, -1.11, -1.28,
-3.93, -4.71. IR (film): 2953, 2930, 2856, 2235, 1719, 1601, 1451, 1253, 1152, 1111, 1070, 1028,
834 cm-1. [α]D25 = –27.56 ◦(c = 1.49, CH2Cl2). HRMS-ESI (m/z): [M + Na]+ calculated
for C39H58O7Si2Na, 717.3613; found, 717.3604.
Preparation of (S,E)-7-((2R,5S,6S)-6-(2-methoxy-2-oxoethyl)-5-
(methoxymethoxy)tetrahydro-2H-pyran-2-yl)hept-6-en-2-yl benzoate, 190.
O
MOMO
MeO2C
BzO
To a solution of (2S,8R,11S,Z )-7-(benzyldimethylsilyl)-8-((tert-butyldimethylsilyl)oxy)-14-
methoxy-11-(methoxymethoxy)-14-oxotetradec-6-en-12-yn-2-yl benzoate 216 (0.0177 g, 0.0255
mmol, 1.0 eq.) in DCE (0.1 mL) at 0 ◦C was added freshly distilled triethoxysilane (0.007 mL,
0.0063 g, 0.0383 mmol, 1.5 eq.), immediately followed by 0.0013 g of RuCp*(CH3CN)3PF6
(0.003 mmol, 10 mol%). The reaction was allowed to warm to room temperature and stirred
for 1 hour before being diluted with Et2O and passed through a plug of florasil. The desired
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vinylsilanes were isolated as a clear, colorless film (0.018g, 43% yield based on 1H NMR, 88%
based on recovered starting material).
The crude reaction product was dissolved in 0.33 mL of THF and 0.017 g of CuI (0.089 mmol,
8 eq.) was added. The reaction mixture was cooled to 0 ◦C and TBAF (0.179 mL as a 1M
solution in THF, 0.179 mmol, 16 eq.) was added dropwise. The reaction was stirred at 0
◦C for 2 hours before warming to room temperature and stirring for 8 additional hours. The
reaction was then diluted with Et2O and passed through a silica plug. The crude product was
purified by preparative TLC (25% EtOAc/pet. ether) and the title compound was isolated as a
clear, colorless film (0.0042 g, 88% yield, 38% yield over 2 steps). Rf = 0.25 (20% EtOAc/pet.
ether). 1H NMR (600 MHz; CDCl3): δ 8.03 (d, J = 7.1 Hz, 2H), 7.54 (t, J = 7.4 Hz, 1H),
7.43 (t, J = 7.7 Hz, 2H), 5.66 (dt, J = 14.8, 6.9 Hz, 1H), 5.48 (dd, J = 15.7, 5.1 Hz, 1H),
5.16 (m, 1H), 4.67 (d, J = 6.9 Hz, 1H), 4.61 (d, J = 6.8 Hz, 1H), 4.32 (ddd, J = 8.7, 5.0,
3.6 Hz, 1H), 4.26 (q, J = 4.9 Hz, 1H), 3.69 (dt, J = 7.1, 3.5 Hz, 1H), 3.67 (s, 3H), 3.37 (s,
3H), 2.73 (dd, J = 15.4, 8.7 Hz, 1H), 2.58 (dd, J = 15.4, 5.2 Hz, 1H), 2.09 (m, 2H), 1.95 (m,
1H), 1.80-1.62 (m, 4H), 1.50-1.45 (m, 3H), 1.34 (d, J = 6.3 Hz, 3H). 1H-NMR (600 MHz;
Benzene-d6 ): δ 8.15 (d, J = 7.5 Hz, 2H), 7.07 (t, J = 7.3 Hz, 1H), 7.02 (t, J = 7.4 Hz, 2H),
5.62 (m, 1H), 5.44 (m, 1H), 5.20 (m, 1H), 4.53 (dt, J = 9.0, 4.4 Hz, 1H), 4.39 (d, J = 6.7 Hz,
1H), 4.32 (d, J = 6.8 Hz, 1H), 4.16 (m, 1H), 3.53 (dt, J = 7.7, 3.8 Hz, 1H), 3.31 (s, 3H), 3.06
(s, 3H), 2.82 (dd, J = 15.2, 9.2 Hz, 1H), 2.55 (dd, J = 15.2, 4.6 Hz, 1H), 1.89 (q, J = 6.4
Hz, 2H), 1.70 (m, 1H), 1.60-1.22 (m, 8H), 1.13 (d, J = 6.4 Hz, 3H). 13C NMR (150 MHz,
CDCl3): δ 172.17, 166.33, 132.88, 132.73, 130.96, 129.72, 129.66, 128.43, 95.38, 72.00, 71.65,
71.38, 70.40, 55.83, 51.83, 35.67, 34.80, 32.37, 26.26, 25.07, 24.01, 20.23. IR (film): 2917, 2849,
1740, 1714, 1575, 1538, 1463, 1452, 1276, 1150, 1111, 1070, 1037 cm−1. [α]D25 = –3.21 ◦(c =
0.42, CH2Cl2). LRMS-ESI (m/z): [M + Na]+ calculated for C24H34O7Na, 457.22; found,
457.17. Characterization Data matches that reported in the literature.11
Comparison of 190 to the Reported Literature NMR data.11
δH (600 MHz; CDCl3) Lit. δH (500 MHz; CDCl3) δC Lit. δC
8.03 (d, J = 7.1 Hz, 2H) 8.04-7.99 (m, 2H) 172.17 172
7.54 (t, J = 7.4 Hz, 1H) 7.52 (m, 1H) 166.33 166.1
7.43 (t, J = 7.7 Hz, 2H) 7.44-7.38 (m, 2H) 132.88 132.7
5.66 (dt, J = 14.8, 6.9 Hz, 1H) 5.64 (m, 1H) 132.73 132.5
5.48 (dd, J = 15.7, 5.1 Hz, 1H) 5.47 (dd, J = 15.5, 4.5 Hz, 1H) 130.96 130.8
5.16 (m, 1H) 5.14 (m, 1H) 129.72 129.5
4.67 (d, J = 6.9 Hz, 1H) 4.66 (d, J = 7 Hz, 1H) 129.66 129.5
4.61 (d, J = 6.8 Hz, 1H) 4.59 (d, J = 7 Hz, 1H) 128.43 128.2
4.32 (ddd, J = 8.7, 5.0, 3.6 Hz, 1H) 4.30 (ddd, J = 9, 5.5, 4 Hz, 1H) 95.38 95.2
4.26 (q, J = 4.9 Hz, 1H) 4.24 (m, 1H) 72 71.8
3.69 (dt, J = 7.1, 3.5 Hz, 1H) 3.70-3.62 (m, 4H) 71.65 71.43.67 (s, 3H) 71.38 71.2
3.37 (s, 3H) 3.35 (s, 3H) 70.4 70.2
2.73 (dd, J = 15.4, 8.7 Hz, 1H) 2.71 (dd, J = 15.5, 9 Hz, 1H) 55.83 55.6
2.58 (dd, J = 15.4, 5.2 Hz, 1H) 2.57 (dd, J = 15, 5 Hz, 1H) 51.83 51.6
2.09 (m, 2H) 2.12-2.03 (m, 2H) 35.67 35.5
1.95 (m, 1H) 1.93 (m, 1H) 34.8 34.6
1.80-1.62 (m, 4H) 1.82-1.56 (m, 4H) 32.37 32.2
1.50-1.45 (m, 3H) 1.55-1.38 (m, 3H) 26.26 26.1
1.34 (d, J = 6.3 Hz, 3H) 1.31 (d, J = 6.5 Hz, 3H) 25.07 24.9
24.01 23.8
20.23 20
4.4. EXPERIMENTAL DATA FOR CHAPTER 4 134
4.4.3 Spectra
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5.1 Labillarides E-H: Target Driven Reaction Development
5.1.1 Isolation and Structure of Labillarides E-H
The labillarides are a family of recently discovered oxylipin natural products isolated from
the New Zealand red algae, Phacelocarpus labillardieri (Figure 5.1).1 Labillarides E-H (218)
are particulary interesting as these four compounds display virtually identical 1H and 13C
NMR spectra. Analysis of the 3JH6-H7 coupling constant and NOE correlation between H6
and H8 provides strong evidence that all four compounds have a trans-relationship between
substituents on the furan ring. This conclusion suggests that the structures of labillarides
E-H differ with respect to the configuration of the C3 and C8 hydroxyl groups. The use of
benzene-d6 to generate solvent-induced shifts of proton resonances resulted in the tentative
assignment of labillaride F as 3,8-bis-epi-labillaride E, labillaride H as 3-epi-labillaride E, and
labillaride G as 8-epi-labillaride E. The discovery of diastereomeric natural products that differ
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Figure 5.1 Natural Products from Phacelocarpus labillardieri:
Labillarides E-H
with respect to the configuration of pairs of adjacent stereocenters but still exhibit virtually
the same 1H and 13C NMR spectra is both highly unusual and very interesting. This is
especially true when one considers that the use of NMR databases to assign 1,2- and 1,3-
stereochemical relationships depends on each stereochemical permutation having distinctly
different 1H and 13C NMR shifts.2 The NMR database approach, which was pioneered by
Kishi, has been successfully applied to a variety of acyclic natural product fragments, including
oasomycin A, shown in Figure 5.2.3 This example highlights the typically significant differences
in 13C chemical shift observed between diastereomers varying at three adjacent stereocenters.
The unusual spectroscopic properties of labillarides E-H are likely derived from a highly
interesting macrocyclic structure. A structurally similar α-pyrone macrolide, neurymenolide
A (Figure 5.3), exists as two atropisomers due to a relatively high barrier to rotation about
the α-pyrone ring system, however the slightly larger macrocycle of neurymenolide B does
not exhibit atropisomerism.4 Given the atropisomerism exhibited by neurymenolide A, the
15-membered macrocyclic ring of labillarides E-H may also suffer from hindered rotation
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Figure 5.2 NMR Database Approach to the Structural Assignment of Oasomycin A:
Typical 13C NMR Differences Between Diastereomeric Compounds.
about the α-pyrone ring system. However, the challenging task of confirming or refuting
atropisomerism would likely require a scalable total synthesis of these natural products. A
successful enantioselective synthesis of labillarides E-H would also provide the opportunity to
deduce the absolute configuration of these compounds.
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(16-membered macrocycle)
Neurymenolide B
not atropisomeric
(18-membered macrocycle)
221 222
Figure 5.3 Atropisomerism in the Neurymenolide Natural Products.
Biological testing of the original labillaride E (218) sample repeatedly showed potent
cytotoxicity (ca. 600 nM) against human leukaemia cells (HL-60). However, subsequent
repurification by HPLC resulted in an inactive sample. Presumably, a very minor impurity was
responsible for the potent cytotoxicity and it is believed that further synthetic research into
labillarides E-H may provide additional clues to the identity of this highly potent compound.
5.1.2 Strategy and Major Disconnections
With the aim of designing a highly efficient and concise synthesis of labillarides E-H, we chose to
investigate retrosynthetic disconnections that remove a large amount of structural complexity.
Structural complexity can be defined by six general categories:5
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• molecular size • cyclic connectivity
• functional group content • stereochemistry
• highly reactive centers • centers of kinetic instability
These criteria led to the identification of three major structural features, which arguably
represent the most challenging aspects of constructing labillarides E-H (Scheme 5.1). Namely,
the 15-membered macrocyclic ring (A), the bicyclic furanopyrone core (B) and the four
stereogenic centers (C). Analysis of the common red areas of structures A, B and C from
O
O
O
OH
OH
O
O
O
OH
OH O
O
O
OH
OH
A B C
Scheme 5.1 Challenging Structural Elements of Labillarides E-H.
Scheme 5.1 reveals six bonds (shown in red) that would dramatically simplify the molecule. In
each case bond cleavage would remove a stereocenter and break some form of cyclic connectivity
(Scheme 5.2). Of the six possible disconnections identified, the three shown in boxes lead to
synthons with attractive synthetic equivalents: synthon 223 represents the addition of a vinyl
anion equivalent to an aldehyde, synthon 224 represents the displacement of a leaving group
with a nucleophilic enolate equivalent, and synthon 225 represents the attack of an oxyanion
on an allylic cation. These reactive modes can be achieved using a number of different synthetic
methodologies and are good choices as preliminary disconnections. Disconnections II and III
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Scheme 5.2 Disconnection of Common Bonds Shared by A, B and C.
can be translated into the inter- and intramolecular palladium-catalyzed allylic alkylations
(Pd-AA) shown in Scheme 5.3. These palladium-catalyzed reactions are key transformations
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in the first and second generation approaches to labillarides E-H, respectively, and would
provide a highly efficient method of utilizing a three-carbon allyl linchpin in the construction
of labillarides E-H.
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Scheme 5.3 First and Second Generation Pd-AA Linchpin Strategies.
5.2 Palladium-Catalyzed Allylic Alkylations
5.2.1 Mechanistic Introduction
Palladium is recognized as one of the most useful and versatile metals in organic synthesis.6
The facile interconversion between Pd(0) and Pd(II) oxidation states has allowed palladium
complexes to be used as catalysts for a variety of different reactions.7 The use of pi-allyl
palladium complexes as electrophiles in alkylation reactions was first reported by Jiro Tsuji
in 1965 (Scheme 5.4).8 This methodology quickly evolved into the catalytic asymmetric
methodology known today as the Tsuji-Trost reaction (see Section 1.3.2).9
EtO
O
OEt
O
EtO
O
OEt
ONa
EtO
O
OEt
O
Pd
Cl
Pd
Cl DMSO/ EtOH,
ethyl malonate ++
Scheme 5.4 Seminal Pd-AA Reported by Tsuji.
Some of the most interesting and unique aspects of Pd-AA reactions are the many
mechanistic intricacies of this process. Two distinct mechanisms have been proposed
for this reaction depending on whether hard or soft nucleophiles are used (Scheme 5.5).
Soft nucleophiles, derived from conjugate acids with a pKa of less than 2˜5, add to the
electrophilic carbon directly, resulting in a double inversion (net retention) of configuration.
Examples of soft nucleophiles include: sodium dimethyl malonate, morpholide and sodium
cyclopentadienide.10 Hard nucleophiles on the other hand, attack the metal center and the
resulting complex undergoes reductive elimination to form the alkylated product with an
overall inversion of configuration. Examples of hard nucleophiles include: phenylzinc chloride,
(E)-(2-methylhex-1-enyl)dimethylalane and ammonium formate.11 However, stereospecificity
is not always guaranteed, and varying degrees of chirality transfer have been observed in
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Scheme 5.5 Pd-AA Mechanism with Soft and Hard Nucleophiles.
certain cases (Scheme 5.6). The racemization of pi-allyl palladium intermediates has been
proposed to occur via two main mechanisms: attack of a Pd(0) species on the pi-allyl palladium
complex, and racemization of the starting material through cis-attack of the departed acetate
anion via coordination with palladium. These two problems have be overcome by keeping the
concentration of Pd(0) low (using low catalyst loading or high dilution) and through the use of a
carbonate leaving group, respectively. The intramolecular Pd-AA reaction shown in Scheme 5.6
provides only 41% chirality transfer when 20 mol% Pd(0) is used.12 However, reducing the
catalyst loading to 3 mol% provides a dramatic increase in stereospecificity, delivering the
desired product with 78% chirality transfer. Thus, a significant increase in chirality transfer
was observed when the concentration of Pd(0) is reduced. Ultimately, the use of 5 mol
% Pd2(dba)3·CHCl3, THF and NaH was found to provide near perfect chirality transfer.
Additionally, palladium-catalyzed allylic alkylations can lose stereospecificity through pi-σ-
O CO2Me
O
OCO2Me
Am
O
O
CO2Me
Am
Pd2(dba)3-CHCl3,
 40 oC
P
O
O
O
Entry Pd(0) mol% Solvent/ Base Yield Chirality Transfer
1 20 DMSO 71% 41%
2 10 DMSO 62% 58%
3 3 DMSO 88% 78%
4 10 THF/NaH 53% 96%
Scheme 5.6 Chirality Transfer in Pd-AA Reactions.
pi isomerization of the intermediate Pd(II) complex (Scheme 5.7). Thus, pi-allyl-Pd complexes
with identical substituents on one end quickly lose stereochemical information via reversible
formation of the achiral σ-Pd complex 229. This process is also responsible for the Z -to-E-
alkene isomerization observed during alkylations of Z -allyl acetates and Z -allyl carbonates. In
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this case, the initially formed syn-Pd complex 230 often converts to the thermodynamically
favored anti-Pd complex 231 via pi-σ-pi isomerization and σ-bond rotation.
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Scheme 5.7 pi-σ-pi Isomerization Mechanisms.
Regioselectivity in Pd-AA reactions can be driven by the steric or electronic properties of:
the electrophile, the nucleophile, the palladium catalyst, or combinations of the aforementioned
possibilities. Additionally, simple changes in the reaction conditions (solvents, additives
etc.) have been shown to enable the complete reversal of regioselectivity (Scheme 5.8).13
Analysis of the steric and electronic properties associated with the pi-allyl-Pd intermediate
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Scheme 5.8 Regiocontrol in Pd-AA using Different Reaction Conditions.
provides, arguably, the most reliable means of predicting and understanding the regiochemical
outcome of these reactions.14 In many cases, ionization of an allyl acetate or carbonate
provides a ‘symmetric’ η3 complex, where the metal resides symmetrically over the allyl ligand
(Scheme 5.9).14 This situation typically favors nucleophilic addition to the least hindered
carbon, and therefore the 1,4-substituted regioisomer 232, shown in Scheme 5.9, is heavily
favored over the 1,2-regioisomer 233. However, the formation of a ‘distorted’ pi-allyl-Pd
complex, that leads to very different regiochemical outcomes, has been proposed in situations
where unfavorable steric interactions between palladium and neigbouring substituents are likely
(i.e. 234 and 235). These ‘distorted’ pi-allyl complexes can be thought of as a σ,η2 species
that undergo nucleophilic addition in an SN2’-like manner, giving rise to the 1,2-regioisomer
as the major product. Thus, the allyl benzoates 234 and 235 provided the 1,2-substituted
regioisomer as the major product, in a regioisomeric ratio of 4:1 (Scheme 5.9).
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Palladium-catalyzed allylic alkylations are extremely versatile and frequently used in
natural product synthesis.9 Successful reactions have been reported with a variety of
nucleophiles and pi-allyl-Pd precursors. These nucleophiles include: enolates, alkoxides,
carboxylates, nitronates, thiolates and amines. The different types of pi-allyl-Pd precursors
include: allylic acetates, allylic carbonates, vinyl epoxides, benzyl phosphonates, and
propargylic acetates. Scheme 5.10 provides a small sample of what can be achieved in natural
product synthesis using this reaction.
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Scheme 5.10 Selected Pd-AA Examples in Natural Product Synthesis.
5.2.2 Pd-AA with 4-Hydroxy-α-Pyrone Nucleophiles
The proposed synthesis of labillarides E-H aims to use a Pd-AA reaction to exploit the inherent
nucleophilicity of a 4-hydroxy-α-pyrone. Highly acidic 1,3-dicarbonyl compounds such as 4-
hydroxy-α-pyrones [pKa (6-methyl-4-hydroxy-α-pyrone) = 4.83 (H2O), 6.83 (80% w/w DMSO–
H2O)] and tetronic acids, often exist primarily as the enol tautomer and can be difficult to
selectively C -alkylate without undesired O-alkylation. However, in the presence of Pd(0), O-
alkylation products have been shown to undergo ionization to form pi-allyl palladium complexes
and this suggests that the formation of these products in a Pd-AA reaction is reversible
(Scheme 5.11). In contrast, the corresponding C -alkylation is irreversible under these reaction
conditions, and thus, the product distribution is expected shift to the desired C -alkylation
product over time. Moreno-Mañas and coworkers have shown that, in the presence of a Pd(0)
catalyst, the allyl ether 240 reacts to give the C -alkylated product, 241 (Scheme 5.12).15
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Scheme 5.12 Reversible O-Alkylation in the Presence of Pd(0).
Additionally, O-alkylation products can participate in a thermal Claisen rearrangements,
which would result in formation of the alternative C -alkylation regioisomer.15 Pd-catalyzed
allylic alkylations with 4-hydroxy-α-pyrones are typically less facile than those with traditional
β-dicarbonyl nucleophiles, and often require elevated temperatures.16 The relatively high
activation barrier is likely to be a consequence of the temporary loss of aromaticity during
the alkylation step. Additionally, the high energetic cost to breaking aromaticity disfavors the
undesired bis-C -alkylation pathway, often prominent in Pd-AA reactions with Meldrum’s acid
and barbituric acid.19
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Scheme 5.13 Pd-AA Reactions with 4-Hydroxy-α-pyrones.
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5.3 First Generation Approach to Labillarides E-H
The first generation approach to labillarides E–H centered around the use of a Pd-catalyzed
allylic alkylation to selectively couple a 4-hydroxy-α-pyrone with an allylic carbonate linchpin
242 (Scheme 5.14). The functionality present in this 4-carbon linchpin was envisioned to
enable formation of the macrocyclic ring and the embedded dihydrofuran, as well as provide a
synthetic handle for installation of the side chain.
Retrosynthetic disconnection of labillarides E-H (218) began with removal of the side chain
to enable late-stage stereochemical divergence. A Grignard addition to the optically active
aldehyde 243 and Peterson olefination were envisioned,18 thus leading back to bromosilane
244. Compound 244 would, in turn, be formed through the intramolecular bromo-
etherification of vinyl silane 245. Formation of the 15-membered macrocyclic ring from Z -
vinyl iodide 246 was envisioned using a Nozaki-Hiyama-Kishi reaction, after the necessary
protecting group and redox manipulations. As mentioned previously, the key C–C bond
joining the heterocyclic nucleus would be forged using a stereospecific Pd-catalyzed allylic
alkylation between allylic carbonate 242 and 4-hydroxy-α-pyrone 247. The regioselectivity
of this transformation would be controlled by the silyl group, which is known to direct
nucleophilic addition to the distal end of the pi-allyl-Pd complex.17 Lastly, formation of the
α-pyrone heterocycle was envisaged using the β,δ-diketoester derived from addition of methyl
acetoacetate (248) and carboxylic acid 249.
OPG
H
O
Pd-AA w/
Bromo-
etherification
Grignard Addition/
Peterson Olefination w/
O
O
OH
OCO2Me
TMS
I
OPG
O
O
OH
I
TMS
OPG
O
O OH
TMS
OH
H
HO
I
OH
O
OMe
O
Nozaki-
Hiyama-
Kishi Reaction
O
O OPGH
O TMS
BrHO
O
O
OH
OH
218 244 245
246
242
247
249
248
243
Scheme 5.14 Labillarides E-H First Generation Retrosynthesis.
Two different allylic carbonate substrates were used to evaluate this approach; one derived
from benzaldehyde, the other from a protected α-hydroxy aldehyde (Scheme 5.15). These
Pd-AA substrates were prepared in three steps, commencing with the addition of TMS-
acetylene to the respective aldehydes to form propargylic alcohols 250a and 250b. A hydroxyl-
directed alkyne reduction, using Vitride, gave the desired (E)-vinyl silane selectively. Methyl
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Scheme 5.15 Initial Pd-AA with 6-Methyl-4-hydroxy-α-pyrone.
chloroformate was then used to convert the alcohol to a methyl carbonate and provide the key
substrate for Pd-catalyzed allylic alkylation.
Pd-catalyzed allylic akylations with 4-hydroxy-α-pyrones are typically less facile than
those with traditional β-dicarbonyl nucleophiles, and often require elevated temperatures.16
Nonetheless, the model substrate 251a cleanly underwent allylic alkylation at room temper-
ature to produce pyrone 252 selectively. Unfortunately the corresponding reaction on the
real system, with allyl carbonate 251b, resulted in no reaction under a variety of conditions
(Scheme 5.16). The activating effect of the phenyl substituent in the ionization of the allyl
carbonate appears critical for reactivity under these conditions. While the phenyl-substituted
product 252 is unsuitable for the synthesis of the labillarides, it afforded an opportunity to
evaluate the second key step in this sequence – bromo-etherification.
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O
Me OH
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PMBOO
Me
O
OH
Conditions
b
253
251
252
Entry Conditions Results
1 Pd2(dba)3, PPh3, THF, rt Recovered SM
2 Pd2(dba)3, PPh3, NaOtBu, Toluene, 80 ◦C Recovered SM
3 Pd2(dba)3, PPh3, dppe, DMSO, 120 ◦C Recovered SM
Scheme 5.16 Attempted Pd-AA with Vinyl Silane 251b.
Cyclization of 252 using NBS provided the desired furopyrone in moderate yield as
a 1.2:1 mixture of cis- and trans-substituted furan diastereomers 254 and 255. The
postulated mechanism for bromoetherification proceeds via a bromonium species, followed
by attack of a nucleophile in a stereospecific SN2-like fashion and therefore, the same
relative stereochemical relationship between the C2 oxygen and C1 bromine atom is expected
(Scheme 5.17 numbering). The relative stereochemistry of the two products obtained from the
halo-cyclization reaction was assigned by analysis of the 3JHH coupling constants between
the three contiguous stereocenters (Table 5.1). Using the Karplus equation to relate the
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observed 3JHH coupling constant to dihedral angle, a 4.1 Hz coupling corresponds to a 48 ◦
dihedral angle and a 7.9 Hz coupling corresponds to a 9 ◦ dihedral angle.20 This suggests
that the major product is the trans-substituted furan 254. However, the configuration of
five-membered rings can often be challenging to assign correctly,21 and therefore density
functional calculations (B3LYP, 6-31G(d)) were performed to provide further evidence to
support this assignment.22 Geometry optimization of a range of possible conformers for
each diastereomer revealed that the (R*,R*,R*)-diastereomer has three conformers of similar
relative energy. In contrast, the (S*,R*,R*)-diastereomer appears to suffer from an unfavorable
steric interaction between the phenyl ring and the bromo-silane moiety and, as a result,
exists predominantly as the conformer where both Br and TMS point away from the phenyl
ring. These conformational differences explain the difference in the 3JHbHc coupling constants
observed for each diastereomer. Additionally, the calculated GIAO 1H NMR shifts for
each diastereomer are in good agreement with the proposed assignment, providing a CP3
probability of >99%.23 Thus, the proposed (R*,R*,R*)- and (S*,R*,R*)-diastereomers result
from an approximately equal preference for bromonium formation from each face of the alkene,
despite the potential directing effect of the adjacent stereocenter. Literature examples of
Table 5.1 Stereochemical Assignment of Bromosilanes 254 and 255.
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Compound
1H NMR Shifts (δ, ppm) HH Coupling (Hz)
Ha Hb Hc 3JHaHb 3JHbHc
Experimental 1H NMR data
Major 4.55 5.10 3.54 4.1 7.1
Minor 4.68 5.25 2.84 7.9 11.7
Calculated 1H NMR data
R*R*R* 4.52 4.89 3.60 5.9 5.7
S*R*R* 4.35 5.06 2.84 6.6 9.6
diastereoselective intramolecular haloetherification typically rely on 1,3-allylic strain or the
inside alkoxy effect to elicit stereoselectivity.24,25 The reaction shown in Scheme 5.18 illustrates
the structural features that lead to a diastereoselective halocyclization.26 With this in mind, the
pi-allyl-Pd precursors 256 and 257 were prepared with the aim of generating a C3-substituted
4-hydroxy-α-pyrone that will undergo diastereoselective intramolecular halocyclization.
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The allylic alkylation of gem-diacetate 256 with 6-methyl-4-hydroxy-α-pyrone (258) would
provide access to a pyrone-based compound with a suitable hydroxyl directing group for
subsequent cyclization. Unfortunately, this reaction did not produce the desired product 259
despite screening a variety of reaction conditions.27 With the same ultimate goal in mind,
the use of bis-vinylsilane 257 was investigated. This trisubstituted alkene was designed to
invoke A1,3-strain and stereoselectivity in the subsequent bromoetherification. Unfortunately,
this substrate was also found to be unreactive in Pd-AA reactions with 4-hydroxy-α-pyrone
260. Since both of the aforementioned electrophiles have been shown to participate in Pd-AA
reactions with malonate derivatives, the poor reactivity observed with 4-hydroxy-α-pyrones
is presumably a consequence of using a relatively inert nucleophile in combination with a
relatively inert electrophile.
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Scheme 5.19 Attempted Incorporation of Directing Groups for Haloetherification.
The characteristics required for reactivity in the Pd-AA reaction and those that engender
stereoselectivity in the intramolecular bromoetherification seemed to be somewhat in oppo-
sition to each other. The difficulty in designing a substrate that fits these narrow criteria
prompted the investigation of an alternative approach to constructing a C3-substituted α-
pyrone.
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5.4 Second Generation Approach to Labillarides E-H
The short-comings of the first generation approach led to a revised synthetic strategy
based around the use of an intramolecular palladium-catalyzed allylic alkylation to form the
furanopyrone core of labillarides E-H (Scheme 5.20). This strategy utilizes the three-carbon
linchpin 262 to fuse the labillaride fragments using a Rh-catalyzed conjugate addition, Pd-
catalyzed allylic alkylation and Ru-catalyzed alkene metathesis.
Late-stage introduction of the chiral side chain was envisioned using Ru-catalyzed alkene
cross metathesis. This would enable access to two of the labillaride E-H diastereomers, as either
of the known compounds (R)- or (S)-pent-1-en-3-ol could be used as the coupling partner. The
prerequisite vinyl dihydrofuran intermediate would be formed using an intramolecular Pd-
catalyzed allylic alkylation of 4-hydroxy-α-pyrone 263. The use of achiral phosphine ligands
in this reaction is likely to lead to substrate controlled stereoselectivity. However, if poor
selectivity for the desired trans-substituted dihydrofuran is observed, a chiral phosphine ligand
could be used to provide improved stereoselectivity. To avoid the chemoselectivity issues
O
O
OTBS
O
OH
Br
OH O
N
OMe
O
O
O
TBSO
O
O
O
O
OTBS
O
O
Br
O
N
OMe
O
O
O
TBSO
O
O
Bu3Sn OCO2Me
HO
O
O
OH
OH
H
H
O
O OH
H
OCO2MeOH
Alkene Cross 
Metathesis,
Intramolecular
Pd-AA
OCO2Me
B-alkyl Suzuki, 
Oxidation,
Stork-Zhao 
Olefination
Rh-cat. Conjugate 
Addition
Intra-
molecular
Acylation
218
262
264
265
263
266
267
268
Scheme 5.20 Labillarides E-H Second Generation Retrosynthesis.
associated with selectively functionalizing one of two terminal alkenes later in the route, the
B-alkyl Suzuki macrocyclization will be performed prior to the intramolecular Pd-AA. This
reaction has been used successfully in the synthesis of a number of macrocyclic natural products
including phomactin A and 4-hydroxydictyolactone.28 However, the use of Z -vinyl iodides in
Pd-catalyzed cross coupling has been shown to be sensitive to steric hindrance at the allylic
carbon and this may necessitate the use of a smaller protecting group in place of the TBS-
ether shown in Scheme 5.20.29 The macrocyclization will be preceded by Stork-Zhao olefination
and oxidation of the δ-lactone to provide a 4-hydroxy-α-pyrone.30 These transformations lead
back to the cyclic β-keto ester 266, which was envisioned to arise from the Rh-catalyzed
conjugate addition of vinyl stannane 262 to the highly reactive alkylidene dicarbonyl 267.
An intramolecular acylation, which occurs after lithium-halogen exchange, will give rise to
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alkylidene 267 from the vinyl bromide 268. This highly functionalized intermediate will be
prepared by the coupling of carboxylic acid 264 and β-hydroxy amide 265.
The forward synthesis began with the preparation of β-hydroxy amide 265 in three steps
from commercially available 1,7-octadiene (Scheme 5.21). Mono hydroboration-oxidation using
an excess of 1,7-octadiene (269) provided the desired primary alcohol 270 in good yield with
minimal bis-hydroboration side products. In this reaction, borane-dimethylsulfide complex
provides three equivalents of hydride and the excess 1,7-octadiene could be recovered from the
reaction, making this a highly efficient and atom economic transformation in comparison to the
use of 9-BBN or (Sia)2BH as boron hydride sources. The primary alcohol 270 was then oxidized
using either a TEMPO/BAIB or Moffat-Swern oxidation to provide aldehyde 271, which serves
as the acceptor in the subsequent Reformatsky reaction. The donor component of this reaction,
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Entry X Conditions Yield
1 Cl CoCl2, dppe, ZnI2, Zn, CH3CN no reaction
2 Br Zn, CuI2, THF, overnight 58%
3 Br Zn activated w/ 5 mol% DIBAL-H, THF, 1 hour 48%
Scheme 5.21 Synthesis of β-hydroxy Amide 265.
an α-halo amide, was prepared in a single step from either chloroacetyl chloride or bromoacetyl
bromide. Initial attempts to use the α-chloroamide, along with a catalytic amount of a Co(II)-
phosphine complex to facilitate formation of the organozinc halide nucleophile, resulted in
recovered starting materials (Entry 1).31 Using the more reactive α-bromo amide and Zn-Cu
couple, which was generated in situ from Zn and CuI2, provided the desired β-hydroxy amide
in 58% yield.32 Unfortunately, this reaction suffered from a relatively long induction period,
presumably due to the presence of passivated Zn. This was overcome by activating the Zn
dust with 5 mol% DIBAL-H prior to addition of the aldehyde, which provided the desired
product in 48% yield.33 Ultimately, this Reformatsky reaction proved somewhat capricious;
however, the use of high purity aldehyde immediately after its preparation, and moderate to
large amounts (> 0.75 g) of α-bromoamide, provided the desired product consistently.34 With
β-hydroxyamide 265 in hand, the preparation of the α-bromo-α-β-unsaturated carboxylic acid
was undertaken.
The known aldehyde 272 was prepared in five steps from (L)-ascorbic acid, 273
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(Scheme 5.22).35 Conversion of the vicinal diol to an acetonide under acidic conditions provided
5,6-O-isopropylidene-L-ascorbic acid (274), which was subsequently transformed into the α-
hydroxy carboxylate salt 275 using a biomimetic oxidative degradation. This compound was
transformed into the ethyl ester 276 upon exposure to ethyl iodide and K2CO3 in DMF. It is
interesting to note that carboxylates are typically poor nucleophiles, however, the presence of
an α-hydroxy group polarizes the carboxylate group via an internal hydrogen bond and enables
efficient addition to electrophiles such as alkyl iodides. TBS-protection of the α-hydroxy ester
276 provided silyl ether 277, which was reduced to the corresponding aldehyde, 272, using
DIBAL-H. In this case, the presence of a chelating substituent at the α-position and low
reaction temperature (–100 ◦C) prevent the breakdown of the tetrahedral aluminum alkoxide
intermediate which often leads to over-reduction.
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Scheme 5.22 Synthesis of Aldehyde 272 from (L)-Ascorbic Acid.
The optically active aldehyde 272 was then used in a Wittig olefination to provide vinyl
bromide 278 (Scheme 5.23). In this reaction, ethyl triphenylphosphorylacetate (279), NBS
and K2CO3 are combined in CH2Cl2 to generate the corresponding bromo-substituted ylide (X
= Br) in situ at –20 ◦C, followed by addition of aldehyde 272 at room temperature. Initially,
only 25% yield of the desired vinyl bromide was obtained, along with a 25% recovery of aldehyde
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 9:1
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Entry Solvent Temperature[a] Comments[b] Yield[c]
1 CH2Cl2 –20 ◦C, rt, rt 25% RSM 25%
2 THF –20, rt, 50 ◦C 10% RSM + 5% des-bromo 278 48%
3 DCE –20, rt, 60 ◦C 10% RSM 60%
[a] The initial mixing of the phosphorus ylide and NBS was performed at –20 ◦C, the reaction was
then stirred overnight at room temperature. The third temperature describes the 3 hour period at
the end of the reaction. [b] Determined by 1H NMR. [c] Isolated yield.
Scheme 5.23 Synthesis of α-Bromo-α-β-unsaturated Carboxylic Acid 264.
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272 (Entry 1). By changing the reaction solvent to THF and heating the reaction mixture
to 50 ◦C for 3 hours, an improved yield of 48% was obtained (Entry 2). Unfortunately, these
conditions produced 5% yield of the des-bromo side product which could not be separated from
the desired product. Finally, performing the reaction in 1,2-dichloroethane (DCE) produced
vinyl bromide 278 in 60% yield without formation of the unwanted des-bromo side product
(Entry 3).
Coupling of the two fragments, 265 and 264, was achieved in moderate yield using EDCI to
activate the acid towards nucleophilic addition. The synthesis of the highly functionalized ester
268 provided the starting material for an intramolecular acylation to form the key intermediate,
alkylidene dicarbonyl 267.
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Scheme 5.24 Coupling of Carboxylic Acid 264 and Alcohol 265.
A similar intramolecular acylation was employed by Sorensen and coworkers in their
synthesis of the natural product FR182877 (Scheme 5.25).36 Interestingly, they discovered that
both the Z - and E-bromoalkene starting materials 280 and 281 provide the same product,
282, stereoselectively. This stereoconvergence led to the postulate that the reaction proceeds
through a common lithium allenolate intermediate, and the stereoselectivity is a consequence
of the bulky hydrindene ring system blocking attack from one face. The resulting alkylidene
dicarbonyl 282 was found to be highly reactive and decomposed under a number of subsequent
reaction conditions and also on silica gel. The intramolecular acylation of compound 268 was
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Scheme 5.25 Sorensen’s Intramolecular Acylation in the Synthesis of FR182877.
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attempted with the knowledge that the product dicarbonyl alkylidene was likely to be relatively
unstable. Thus, the reaction was quenched with pH 7 phosphate buffer and 1H NMR analysis
of the crude reaction mixture was performed in benzene-d6 to avoid the traces of acid often
present in CDCl3. Rapid and complete consumption of the starting material occurred but
unfortunately none of the desired product was observed. 1H NMR analysis suggested that
the major side product from this reaction was a trimer generated by sequential intermolecular
nucleophilic additions. The predominance of this side reaction is surprising given that the
reaction was performed at high dilution (0.01 M). However, subsequent molecular modelling
(semi-empirical, MM2) revealed that the combination of -OTBS and acetonide groups adjacent
to the nucleophilic center, create unfavorable steric interactions in the conformation required for
intramolecular nucleophilic addition.37 This insight led to the hypothesis that the bulky nature
of the α,β-unsaturated ester was, in part, responsible for the intermolecular side reactions and
the absence of the desired product. Consequently, the intramolecular acylation of compounds
with smaller β-substituents was investigated.
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Scheme 5.26 Attempted Intramolecular Acylation of 268.
The same reaction sequence used to prepare the carboxylic acid 264 was used in the
attempted preparation of an alternative carboxylic acid, 283 (Scheme 5.27). Interestingly,
saponification of the α-bromo-α,β-unsaturated ester 284 did not provide the desired carboxylic
acid 283, but instead provided enol ether 285 as a mixture of alkene isomers. This undesired
product presumably arises from oxy-Michael addition followed by elimination to regenerate an
α,β-unsaturated carbonyl. Given that this side reaction was not observed in the formation of
the previous carboxylic acid 264, this result suggests that this new substrate has considerably
less steric hinderance around the β-position, and therefore is more reactive towards nucleophilic
addition. To circumvent this problem, a new route, where coupling of the carboxylic acid occurs
prior to olefination, was pursued.
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Scheme 5.27 Attempted Formation of Carboxylic Acid 283.
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The new route to alternative substrates for intramolecular acylation was centered around
the use of the α-bromophosphonate 287 as a linchpin to couple β-hydroxy amide 265 to various
aldehydes. This phosphonate linchpin was prepared in 4 steps from t-butyl bromoacetate, 288
(Scheme 5.28). 31P NMR was extremely useful in the characterization of various intermediates
en route to compound 287.
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Scheme 5.28 Synthesis of the α-Bromophosphonate Linchpin 287.
EDCI-mediated coupling of carboxylic acid 287 and β-hydroxy amide 265 provided
phosphonate ester 289 (Scheme 5.29). This intermediate was used in Horner-Wadsworth-
Emmons olefinations with either (R)-glyceraldehyde acetonide (290) or benzaldehyde to
provide two new substrates with which to investigate the key intramolecular acylation reaction.
Unfortunately, attempts to promote the intramolecular acylation of either compound 291 or
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Scheme 5.29 Synthesis of Alternative Substrates for Intramolecular Acylation.
292 were unsuccessful (Scheme 5.30). In both cases complete consumption of the starting
material occurred but 1H NMR analysis of the crude reaction mixture showed no downfield
peaks characteristic of the alkenyl protons of α,β-unsaturated carbonyls. Additionally, the
crude 1H NMR spectra contained signals that correspond with the terminal alkene and aliphatic
chain present in the starting material, however, no significant peaks matching the oxymethine
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(β to the amide) or the methyl groups of the Weinreb amide were observed. The disappearance
of 1H NMR signals associated with specific functional groups led to the hypothesis that the
structure of vinyl bromides 291 and 292 is incompatible with the aforementioned reaction
conditions. Specifically, elimination of the β-acyloxy group is potentially problematic and
Paquette and coworkers have reported this problem while attempting a similar transformation
in studies towards the synthesis of cochleamycin A.37 Additionally, successful intramolecular
acylations reported in the literature seem to contain a substituent (i.e. -CH3 or -OMe) α to
the carbonyl, which is likely to disfavor β-elimination under basic conditions.36,38
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Scheme 5.30 Attempted Intramolecular Acylation with 291 and 292.
The direct preparation of the desired alkylidene dicarbonyl via a Knovenagel condensation
was briefly examined using 4-hydroxy-6-methyl-α-pyrone and aldehyde 272 (Scheme 5.31).
Unfortunately, all of the attempted conditions provided complex mixtures from which the
desired alkylidene dicarbonyl could not be isolated. These results are consistent with a number
of literature reports that describe failed attempts to perform Knovenagel condensations with
aliphatic aldehydes.36,39
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Conditions
253 272 295
Entry Conditions Result
1 EtOH, rt no product, some SM remains
2 TEBAC, H2O, 95 ◦C no product, complex mixture
3 Pyridine, Toluene, 95 ◦C no product, complex mixture
3 Piperidine, EtOAc, reflux no product, complex mixture
Scheme 5.31 Attempted Knovenagel Condensation with 4-Hydroxy-6-methyl-α-pyrone.
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5.5 Summary
In summary, labillarides E-H are a group of diastereomeric oxylipin natural products with
very interesting structural features and spectroscopy properties. The use of a Pd-catalyzed
allylic alkylation to utilize the inherent nucleophilicity of a 4-hydroxy-α-pyrone has been
identified as a potentially powerful method of constructing the furopyrone core of these natural
products. The first generation synthetic strategy was based on the use of an intermolecular
Pd-AA reaction to selectively couple a functionalized vinyl silane. While a model compound
provided excellent yield in the key Pd-AA, the actual substrate displayed poor reactivity under
a variety of reaction conditions. Additionally, the subsequent bromo-etherification provided
poor diastereoselectivity with the model system. The second generation approach to labillarides
E-H was centered around the use of vinylstannane 262 as a three-carbon linchpin. Coupling
of the linchpin was envisioned using a Rh-catalyzed conjugate addition to the highly reactive
alkylidene dicarbonyl 267. Unfortunately, attempts to utilize an intramolecular acylation to
prepare the key alkylidene intermediate were unsuccessful. The shortcomings of this reaction
were hypothesized to be a consequence of the reactive nature of the β-acyloxy moiety.
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5.6 Experimental Data for Chapter 5
5.6.1 General Experimental Methods
Unless otherwise noted, the following conditions apply. All reactions were performed in flame-
dried septum-sealed glassware with magnetic stirring under an atmosphere of argon. Moisture-
and oxygen-sensitive liquids and solutions were transferred using a stainless steel syringe or
cannula. Before use, solvents were refluxed over the appropriate drying agent and distilled
under argon: tetrahydrofuran from sodium benzophenone ketyl radical; dichloromethane,
acetonitrile and triethylamine from calcium hydride; methanol and toluene from sodium.
NBS was recrystallized from H2O and dried in a vacuum desiccator. All other commercially
available chemicals were used as received, without further purification. Analytical thin layer
chromatography (TLC) was performed using plastic-backed pre-coated silica TLC plates
(Polygram SilG/UV254). Visualization was achieved by UV irradiation (254 nm) or by heating
after treatment with a potassium permanganate dip (1.5 g KMnO4, 10 g K2CO3, 1.25 mL
of 10% aqueous NaOH solution and 200 mL of water) or p-anisaldehyde dip (0.7 mL p-
anisaldehyde, 9.5 mL conc. H2SO4, 2.7 mL of acetic acid and 250 mL of EtOH). The
purification of products by flash column chromatography (FCC) was conducted using silica
gel 60 (220-240 mesh) with the solvent systems indicated. 1H NMR spectra were recorded
on either: a Varian Unity Inova 500 spectrometer at 500 MHz, or a Varian Inova 300 at 300
MHz. Data are listed as chemical shift in ppm using CDCl3 as internal standard (7.26 ppm).
13C NMR spectra were recorded on a Varian Unity Inova 500 spectrometer at 125 MHz and
the data are listed as chemical shift in ppm using CDCl3 as internal standard (77 ppm). All
13C experiments were 1H decoupled. IR bands were measured as a thin film on a Bruker FT-
IR Tensor 27 spectrometer with ATR sampling accessory. High-resolution mass spectrometry
(HRMS) was performed on a Waters QTOF Premier Tandem mass spectrometer.
5.6.2 Experimental Details and Characterization Data
First Generation Approach to Labillarides E-H
Preparation of 1-Phenyl-3-(trimethylsilyl)prop-2-yn-1-ol, 250a.
Ph
OH
TMS
To a solution of TMS-acetylene (1 mL, 7.08 mmol, 1 equiv) in THF (5.3 mL) at -78 ◦C was
added n-BuLi (4.43 mL of a 1.6 M solution, 7.08 mmol, 1 equiv). The reaction mixture was
stirred at –78 ◦C for 30 minutes before the addition of benzaldehyde (0.72 mL, 7.08 mmol, 1
equiv). The reaction was slowly warmed to room temperature and stirred for 1 hour before
quenching with sat. aq. NH4Cl. The reaction mixture was then extracted twice with Et2O,
dried over MgSO4, filtered and concentrated in vacuo. The crude product was purified by
silica gel chromatography (20% EtOAc/pet. ether) and the desired product was isolated as a
yellow oil (1.26 g, 87% yield). Rf =0.45 (25% EtOAc/PE). 1H-NMR (500 MHz, CDCl3): δ
7.56 (m, 2H), 7.40 (m, 2H), 7.34 (m, 1H), 5.47 (s, 1H), 0.22 (s, 9H). 13C-NMR (126 MHz,
CDCl3): δ 140.3, 128.6, 128.4, 126.8, 104.9, 91.6, 65.0, -0.2. Characterization data matches th
reported in the literature.40
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Preparation of (E)-1-Phenyl-3-(trimethylsilyl)prop-2-en-1-ol.
Ph
OH
TMS296
To a solution of 1-phenyl-3-(trimethylsilyl)prop-2-yn-1-ol (0.932 g, 4.56 mmol, 1 equiv) in
THF (24 mL) at 0 ◦C was added Vitride R© (1.95 mL of a 3.5 M solution, 6.84 mmol, 1.5
equiv). The reaction was slowly warmed to room temperature and then quenched with sat.
aq. Rochelle’s salt after 4 hours. The reaction mixture was subsequently extracted twice with
Et2O, dried over MgSO4, filtered and concentrated in vacuo. The crude product was purified
by column chromatography (15% EtOAc/PE) and the desired product was obtained as a yellow
oil (0.671 g, 71% yield). Rf = 0.4 (15% EtOAc/PE). 1H-NMR (500 MHz, CDCl3): δ 7.37
(m, 4H), 7.31 (m, 1H), 6.21(dd, J = 18.7, 5.2 Hz, 1H), 6.01 (dd, J = 18.6, 1.4 Hz, 1H), 5.20
(dd, J = 5.3, 1.4 Hz, 1H), 0.08 (s, 9H). 13C-NMR (126 MHz, CDCl3): δ 147.0, 142.6, 130.0,
128.6, 127.7, 126.5, 76.9, -1.3. Characterization data matches that reported in the literature.41
Preparation of (E)-Methyl (1-Phenyl-3-(trimethylsilyl)allyl) Carbonate, 251a.
Ph
OCO2Me
TMS297
To a solution of (E)-1-phenyl-3-(trimethylsilyl)prop-2-en-1-ol (0.617 g, 3.25 mmol, 1 equiv)
and DMAP (0.397 g, 3.25 mmol, 1 equiv) in CH2Cl2 (30 mL) at 0 ◦C was added methyl
chloroformate (0.30 mL, 0.369 g, 3.9 mmol, 1.2 equiv). The reaction was slowly warmed to
room temperature and stirred overnight. The reaction was quenched with sat. aq. NH4Cl,
extracted twice with CH2Cl2, dried over MgSO4, filtered and concentrated in vacuo. The crude
product was purified by column chromatography (10% EtOAc/PE) and the desired product
was isolated as a clear colorless oil (0.442 g, 51% yield). Rf=0.75 (25% EtOAC/PE). 1H-NMR
(500 MHz, CDCl3): δ 7.42 – 7.29 (m, 5H), 6.16 (dd, J = 18.6, 5.2 Hz, 1H), 6.07 (dd, J = 5.2,
1.4 Hz, 1H), 5.98 (dd, J = 1.87, 1.4 Hz, 1H), 3.79 (s, 3H), 0.07 (s, 9H). 13C-NMR (126 MHz,
CDCl3): δ 155.0, 142.2, 138.4, 132.8, 128.6, 128.4, 127.3, 81.6, 54.8, -1.5. Characterization
data matches that reported in the literature.42
Preparation of 2-((4-Methoxybenzyl)oxy)ethanol.
OHPMBO298
To a neat ethylene glycol (11.87 g, 171.8 mmol, 2 equiv) at 0 ◦C was added NaH (3.78 g
of a 60% dispersion, 94.5 mmol, 1 equiv). A think grey suspension formed and the reaction
was slowly warmed to room temperature. The reaction mixture was cooled back to 0 ◦C
and TBAI (3.49 g, 9.5 mmol, 0.11 equiv) and freshly prepared 4-methoxybenzyl chloride (15
mL, 85.9 mmol, 1 equiv). The reaction was slowly warmed back to room temperature and
stirred overnight before quenching with sat. aq. NH4Cl. The reaction mixture was extracted
with EtOAc, dried over MgSO4 and concentrated in vacuo.The crude product was purified by
column chromatogarphy (50% EtOAc/PE) and the desired product was isolated as a yellow oil
(8.07 g, 52% yield). Rf = 0.35 (50% EtOAC/PE). 1H-NMR (500 MHz, CDCl3): δ 7.29 (m,
2H), 6.90 (m, 2H), 4.50 (s, 2H), 3.82 (s, 3H), 3.79 (m, 2H), 3.59 (m, 2H), 1.98 (m, 1H). 13C-
NMR (126 MHz, CDCl3): δ 159.3, 130.1, 129.5, 113.9, 73.0, 71.0, 61.9, 55.3. Characterization
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data matches that reported in the literature.43
Preparation of 1-((4-Methoxybenzyl)oxy)-4-(trimethylsilyl)but-3-yn-2-ol, 250b.
OH
TMS
PMBO
299
To a solution of DMSO (0.6 mL, 8.47 mmol, 1 equiv) in CH2Cl2 (28 mL) at –78 ◦C
was added oxalyl chloride (0.35 mL, 3.88 mmol, 1.1 equiv). Vigorous gas evolution was
observed. The reaction mixture was stirred at -78 ◦C for 15 minutes before addition of 2-
((4-methoxybenzyl)oxy)ethanol (0.643 g, 3.53 mmol, 1 equiv). The reaction was stirred at -78
◦C for 45 minutes before addition of NEt3 (2.46 mL, 17.64 mmol, 5 equiv). The reaction was
then slowly warmed to room temperature before quenching with H2O. The reaction mixture
was extracted twice with CH2Cl2, dried over MgSO4, filtered, concentrated in vacuo. The
crude product was used immediately in the next step. 1H-NMR (500 MHz, CDCl3): δ 9.69
(app. s, 1H), 7.28 (m, 2H), 6.89 (m, 2H), 4.55 (s, 2H), 4.06 (app. s, 2H), 3.80 (s, 3H).
Characterization data matches that reported in the literature.44
To a solution of TMS-acetylene (0.695 mL, 5.3 mmol, 1.5 equiv) in THF (10 mL) at -78 ◦C
was added n-BuLi (3.31 mL of a 1.6 M solution, 5.3 mmol, 1.5 equiv). The reaction mixture
was stirred at –78 ◦C for 30 minutes before the addition of aldehyde (0.636 mmol, 3.53 mmol,
1 equiv). The reaction was slowly warmed to room temperature and stirred for 1 hour before
quenching with sat. aq. NH4Cl. The reaction mixture was then extracted twice with Et2O,
dried over MgSO4, filtered and concentrated in vacuo. The crude product was purified by
column chromatography (30% EtOAc/PE) and the desired product was isolated as a clear
colorless oil (0.77 g, 78% yield over two steps). Rf = 0.27 (25% EtOAC/PE). 1H-NMR (500
MHz, CDCl3): δ 7.28 (m, 2H), 6.90 (m, 2H), 4.58–5.42 (m, 3H), 3.82 (s, 3H), 3.63 (dd, J =
9.85, 3.46 Hz, 1H), 3.53 (dd, J = 9.83, 7.79 Hz, 1H), 0.18 (s, 9H). 13C-NMR (126 MHz,
CDCl3): δ 159.4, 129.7, 129.5, 113.9, 102.9, 90.6, 73.2, 73.0, 62.1, 55.3 -0.2. IR (film): 3426,
2958, 2862, 2174, 1613, 1513, 1302, 1247, 1174, 1091, 1033, 839, 759 cm−1. HRMS - ESI
(m/z): [M+Na]+ calculated for C15H22O3SiNa+, 301.1236; found, 301.1230.
Preparation of (E)-1-((4-Methoxybenzyl)oxy)-4-(trimethylsilyl)but-3-en-2-ol.
OH
PMBO TMS300
To a solution of 1-((4-methoxybenzyl)oxy)-4-(trimethylsilyl)but-3-yn-2-ol (0.77 g, 2.77
mmol, 1 equiv) in THF (14 mL) at 0 ◦C was added Vitride (1.19 mL of a 3.5 M solution, 4.15
mmol, 1.5 equiv). The reaction was slowly warmed to room temperature and then quenched
with sat. aq. Rochelle’s salt after 4 hours. The reaction mixture was subsequently extracted
twice with Et2O, dried over MgSO4, filtered and concentrated in vacuo. The crude product was
purified by column chromatography (30% EtOAc/PE) and the desired product was obtained
as a clear colorless oil (0.44 g, 57% yield). Rf = 0.37 (25% EtOAC/PE). 1H-NMR (500
MHz, CDCl3): δ 7.27 (m, 2H), 6.90 (m, 2H), 6.01–5.98 (m, 2H), 4.33 (dt, J = 8.31, 3.39 Hz,
1H), 3.82 (s, 3H), 3.53 (dd, J = 9.60, 3.24 Hz, 1H), 3.32 (dd, J = 9.50, 8.46 Hz, 1H), 0.07 (s,
9H). 13C-NMR (126 MHz, CDCl3): δ 159.3, 143.5, 131.7, 130.0, 129.4, 113.9, 73.6, 73.0 (2C),
55.3, -1.4. IR (film): 3438, 2953, 2857, 1613, 1513, 1302, 1245, 1173, 1100, 1035, 990, 864,
834 cm−1. HRMS - ESI (m/z): [M+Na]+ calculated for C15H24O3SiNa+, 303.1392; found,
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303.1386.
Preparation of (E)-1-((4-Methoxybenzyl)oxy)-4-(trimethylsilyl)but-3-en-2-yl
Methyl Carbonate, 251b.
OCO2Me
PMBO TMS301
To a solution of (E)-1-((4-methoxybenzyl)oxy)-4-(trimethylsilyl)but-3-en-2-ol (0.44 g, 1.57
mmol, 1 equiv) and DMAP (0.19 g, 1.57 mmol, 1 equiv) in CH2Cl2 (13 mL) was added methyl
chloroformate (0.146 mL, 1.88 mmol, 1.2 equiv). The reaction was stirred overnight at room
temperature before being quenched with sat. aq. NH4Cl. The reaction mixture was extracted
twice with CH2Cl2, dried over MgSO4, filtered and concentrated in vacuo. The crude product
was purified by column chromatography (20% EtOAc/PE) and the desired product was isolated
as a clear colorless oil (0.322g, 61% yield). Rf = 0. (25% EtOAc/PE). 1H-NMR (500 MHz,
CDCl3): δ 7.26 (m, 2H), 6.88 (m, 2H), 6.01 (dd, J = 18.9, 0.7 Hz, 1H), 5.95 (dd, J = 18.9,
4.6 Hz, 1H), 5.32 (tdd, J = 5.4, 4.7, 0.7 Hz, 1H), 4.50 (m, 2H), 3.81 (s, 3H), 3.80 (s, 3H), 3.55
(d, J = 5.6 Hz, 2H), 0.07 (s, 9H). 13C-NMR (126 MHz, CDCl3): δ 159.2, 155.2, 139.4, 134.0,
130.0, 129.3, 113.8, 78.6, 72.8, 70.8, 55.3, 54.8, -1.5. IR (film): 2956, 2860, 1748, 1613, 1513,
1442, 1246, 1090, 1034, 988, 837, 735 cm−1. HRMS - ESI (m/z): [M+Na]+ calculated for
C17H26O5SiNa+, 361.1447; found, 361.1455.
Preparation of (E)-4-Hydroxy-6-phenyl-3-(1-phenyl-3-(trimethylsilyl)allyl)-
2H -pyran-2-one, 252.
Ph
TMSO
Ph OH
O
302
To a solution of 6-phenyl-4-hydroxy-α-pyrone (0.030 g, 0.161 mmol, 1 equiv) in THF (3
mL) at 0 ◦C was added NaH (0.007 g of a 60% dispersion, 0.161 mmol, 1 equiv). The reaction
mixture was warmed to room temperature and Pd2(dba)3 (0.015 g, 0.016 mmol, 10 mol%)
and PPh3 (0.017 g, 0.064 mmol, 40 mol%) were added, followed by E)-methyl (1-phenyl-3-
(trimethylsilyl)allyl) carbonate (0.043 g, 0.161 mmol, 1 equiv) as a solution in THF (2 mL).
The reaction was stirred overnight at room temperature before being quenched with sat. aq.
NH4Cl. The reaction mixture was extracted twice with EtOAc, dried over MgSO4, filtered
and concentrated in vacuo. The crude product was purified by column chromatography (30%
EtOAc/PE) and the desired product was isolated as an yellow solid (0.049 g, 80% yield). Rf
= 0.17 (25% EtOAC/PE). 1H-NMR (500 MHz, CDCl3): δ 7.80 (m, 2H), 7.51 – 7.40 (m, 2H),
7.37 (m, 2H), 7.33 – 7.27 (m, 2H), 6.62 (dd, J = 19.0, 5.0 Hz, 1H), 6.48 (s, 1H), 5.87 (dd, J =
19.0, 2.0 Hz, 1H), 5.23 (dd, J = 5.0, 2.1 Hz, 1H), 0.11 (s, 9H). 13C-NMR (126 MHz, CDCl3):
δ 165.96, 164.62, 159.28, 145.33, 139.70, 134.65, 130.98, 130.86, 128.90, 128.88, 128.24, 127.17,
125.52, 104.49, 98.44, 46.63, -1.26. IR (film): 3417, 2951, 1648, 1564, 1493, 1402, 1286, 1244,
1118, 1028, 992, 834, 763 cm−1. HRMS - ESI (m/z): [M+H]+ calculated for C23H25O3Si+,
377.1573; found, 377.1568.
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Preparation of (2S*/R*,3R*)-2-((S*/R*)-Bromo(trimethylsilyl)methyl)-6-
methyl-3-phenyl-2H -furo[3,2-c]pyran-4(3H )-one, 254 and 255.
O
O
O
Ph
Ph
Br
TMS
O
O
O
Ph
Ph
Br
TMSH H
H
MAJOR MINOR
To a solution of E)-4-hydroxy-6-phenyl-3-(1-phenyl-3-(trimethylsilyl)allyl)-2H -pyran-2-one
(0.078 g, 0.207 mmol, 1 equiv) in CH2Cl2 (8 mL) at 0 ◦C was added NBS (0.055 g, 0.311
mmol, 1.5 equiv). The reaction was slowly warmed to room temperature and stirred for 2
hours before quenching with H2O. The reaction mixture was subsequently extracted twice
with CH2Cl2, dried over MgSO4, filtered and concentrated in vacuo. The crude product was
purified by silica gel chromatography (10% EtOAc/PE) and the desired product was isolated as
a yellow oil (0.054 g, 57% yield, 1.2:1 mixture of diastereomers). Rf = 0.68 (15% EtOAc/PE).
MAJOR – 1H-NMR (500 MHz, CDCl3): δ 7.86 (m, 2H), 7.51-7.43 (m, 2H), 7.40-7.25 (m,
6H), 6.63 (s, 1H), 5.10 (dd, J = 7.1, 4.2 Hz, 1H), 4.55 (d, J = 4.1 Hz, 1H), 3.54 (d, J = 7.1
Hz, 1H), 0.20 (s, 9H).MINOR – 1H-NMR (500 MHz, CDCl3): δ 7.86 (m, 2H), 7.51-7.43
(m, 2H), 7.40-7.25 (m, 2H), 7.20 (m, 2H), 6.63 (s, 1H), 5.25 (dd, J = 11.7, 7.9 Hz, 1H), 4.68
(d, J = 7.9 Hz, 1H), 2.84 (d, J = 11.7 Hz, 1H), 0.21 (s, 9H). HRMS - ESI (m/z): [M+H]+
calculated for C23H24O3SiBr+, 455.0678; found, 455.0682.
Preparation of E-3-Phenylprop-2-ene-1,1-diyl Diacetate, 256.
OAc
OAc
256
To neat acetic anhydride at 0 ◦C was added (E)-cinnamaldehyde (1.90 mL, 15.1 mmol, 1
equiv). The reaction mixture was stirred at 0 ◦C for 15 minutes before the addition of FeCl3
(0.003 g, 0.015 mmol, 0.1 mol %). The reaction was stirred at 0 ◦C for 45 minutes before
quenching with water. The reaction mixture was extracted twice with Et2O, the combined
organics were dried over MgSO4, filtered and concentrated in vacuo. The crude product was
purified by silica gel chromatography (15% EtOAc/PE). The desired product was isolated as
a white solid (2.86 g, 81% yield). 1H-NMR (500 MHz, CDCl3): δ 7.43 (m, 2H), 7.39–7.28
(m, 4H), 6.88 (d, J = 16.1 Hz, 1H), 6.22 (dd, J = 16.0, 6.5 Hz, 1H), 2.13 (s, 6H). 13C-NMR
(126 MHz, CDCl3): δ 168.70, 135.63, 135.11, 128.84, 128.68, 127.02, 121.67, 89.73, 20.93.
Characterization data matches that reported in the literature.27
Preparation of Z-3-Bromo-1-phenyl-3-(trimethylsilyl)prop-2-en-1-ol.
OH
TMS
Br
To a solution of 1-phenyl-3-(trimethylsilyl)prop-2-yn-1-ol (0.40 g, 1.96 mmol, 1 equiv) in
THF (10 mL), at room temperature, was added Vitride (0.95 mL of a 3.5 M solution, 3.33
mmol, 1.7 equiv). The reaction mixture was stirred at room temperature for 45 minutes before
cooling to –78 ◦C and addition of NBS (0.628 g, 3.53 mmol, 1.8 equiv) as a solution in 2 mL
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of THF. The reaction was stirred at –78 ◦C for 30 additional minutes before being quenched
with saturated aqueous Rochelle’s salt. The reaction mixture was subsequently extratced with
Et2O, the combined organics were dried over MgSO4, filtered and concentrated in vacuo. The
crude product was purifiec by silica gel chromatography (5% EtOAc/PE). The desired product
was isolated as a yellow oil (0.208 g, 37% yield). 1H-NMR (500 MHz, CDCl3): δ 7.48 (m,
2H), 7.38 (m, 2H), 7.32 (m, 1H), 6.49 (d, J = 7.5 Hz, 1H), 5.81 (d, J = 7.5 Hz, 1H), 0.20 (s,
9H). 13C-NMR (126 MHz, CDCl3): δ 142.83, 141.79, 132.79, 128.62, 127.84, 126.06, 73.68,
-2.07. IR (film): 3333, 2958, 2899, 1601, 1493, 1451, 1249, 1018, 897, 838, 752 cm−1. HRMS
- ESI (m/z): [M+H]+ calculated for C12H17OSiBrNa+, 307.0130; found, 307.0127.
Preparation of 1-Phenyl-3,3-bis(trimethylsilyl)prop-2-en-1-ol.
OH
TMS
TMS
To a solution of Z -3-bromo-1-phenyl-3-(trimethylsilyl)prop-2-en-1-ol (0.208 g, 0.729 mmol,
1 equiv) and NEt3 (0.203 mL, 1.46 mmol, 2.0 equiv) in CH2Cl2 (7 mL) was added
chlorotrimethylsilane (0.185 mL, 1.46 mmol, 2.0 equiv). The reaction was stirred at room
temperature overnight before beong diluted with additional CH2Cl2, filtered and concentrated
in vacuo. The crude product was dissolved in THF (5 mL), cooled to -78 ◦C and n-BuLi (0.401
mL, 0.802 mmol, 1.1 equiv) was added. The reaction was slowly warmed to room temperature
and stirred overnight before being quenched with H2O. The reaction mixture was extracted
with Et2O, the combined organics were dried over MgSO4, filtered and concentrated in vacuo.
The desired product was isolated as a yellow oil (0.122 g, 60% yield over 2 steps). 1H-NMR
(500 MHz, CDCl3): δ 7.44–7.34 (m, 4H), 7.31 (m, 1H), 6.69 (d, J = 8.9 Hz, 1H), 5.47 (d, J =
8.9 Hz, 1H), 0.26 (s, 9H), 0.13 (s, 9H). 13C-NMR (126 MHz, CDCl3): δ 155.81, 144.57, 142.53,
128.55, 127.59, 126.22, 74.16, 2.31, 0.22. IR (film): 3368, 2953, 2899, 1567, 1493, 1450, 1248,
1011, 884, 860, 832 cm−1. HRMS - ESI (m/z): [M+Na]+ calculated for C15H26OSi2Na+,
301.1420; found, 301.1426.
Preparation of Methyl (1-Phenyl-3,3-bis(trimethylsilyl)allyl) Carbonate, 257.
MeO2CO
TMS
TMS
To a solution of 1-phenyl-3,3-bis(trimethylsilyl)prop-2-en-1-ol (0.120 g, 0.431 mmol, 1.0
equiv) and DMAP (0.079 g, 0.647 mmol, 1.5 equiv) in CH2Cl2 (5 mL) was added methyl
chloroformate (0.050 mL, 0.647 mmol, 1.5 equiv). The reaction was stirred overnight at room
temperature before being quenched with H2O. The reaction mixture was extracted twice with
CH2Cl2, the combined organics were dried over MgSO4, filtered and concentrated in vacuo.
The crude product was purified by silica gel chromatography (5% EtOAc/PE). The desired
product was isolated as a yellow oil (0.121 g, 83% yield). 1H-NMR (500 MHz, CDCl3): δ
7.43–7.35 (m, 4H), 7.33 (m, 1H), 6.78 (d, J = 9.0 Hz, 1H), 6.36 (d, J = 9.0 Hz, 1H), 3.78 (s,
3H), 0.24 (s, 9H), 0.13 (s, 9H). 13C-NMR (126 MHz, CDCl3): δ 154.92, 150.31, 146.91, 138.97,
128.64, 128.31, 127.14, 79.53, 54.79, 1.91, 0.19. IR (film): 2955, 2899, 1747, 1572, 1441, 1246,
939, 879, 861, 835 cm−1. HRMS - ESI (m/z): [M+Na]+ calculated for C17H28O3Si2Na+,
359.1475; found, 359.1474.
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Second Generation Approach to Labillarides E-H
Preparation of Oct-7-en-1-ol, 270.
OH
To a solution of octa-1,7-diene (30 mL, 22.38g, 203 mmol, 6.0 equiv) in CH2Cl2 (30.8
mL) was added BH3·SMe2 (16.92 mL of a 2M solution in THF, 33.8 mmol, 1.0 equiv) via
syringe pump, at 0 ◦C, over 30 minutes. The reaction was then warmed to room temperature
and stirred for an additional hour before being cooled back to 0 ◦C. A 3N solution of
aqueous NaOH (75mL, 225 mmol, 6.65 equiv) was added dropwise via addition funnel. Ethanol
(10mL) was added to the reaction mixture as a cosolvent, followed by the addition of hydrogen
peroxide (75 mL of a 30 wt% solution, 735 mmol, 21.7 mmol) then added dropwise via addition
funnel. The reaction was then allowed to warm to room temperature and stirred overnight.
The reaction mixture was subsequently diluted with H2O and extracted with CH2Cl2. The
combined organics were dried over MgSO4, filtered and concentrated in vacuo. The crude
product was purified by silica gel chromatography (Pet. Ether then 20% EtOAc/Pet. Ether).
The title compound was isolated as a clear colorless oil (7.42 g, 57% yield). Rf = 0.13 (10%
EtOAc/Pet. Ether). 1H NMR (500 MHz, CDCl3) δ 5.81 (ddt, J = 16.9, 10.2, 6.7 Hz, 1H),
5.00 (ddt, J = 17.1, 2.2, 1.6 Hz, 1H), 4.94 (ddt, J = 10.2, 2.3, 1.2 Hz, 1H), 3.65 (t, J = 6.6 Hz,
2H), 2.12-2.00 (m, 2H), 1.57 (ddt, J = 7.8, 6.5, 5.2 Hz, 2H), 1.47-1.30 (m, 6H). 13C NMR
(126 MHz, CDCl3) δ 139.05, 114.25, 63.03, 33.70, 32.72, 28.88, 28.85, 25.58. Characterization
data matches those reported in the literature.45
Preparation of Oct-7-enal, 271.
O
H303
To a solution of oxalyl chloride (0.512 mL, 5.85 mmol, 1.5 equiv) in CH2Cl2 (39 mL) at
–78 ◦C was added DMSO (0.83 mL, 11.7 mmol, 3.0 equiv). The reaction mixture was stirred
at –78 ◦C for 40 minutes before the addition of oct-7-en-1-ol (0.5 g, 3.90 mmol, 1.0 equiv).
The reaction was stirred for another 40 minutes before the addition of NEt3 (3.26 mL, 23.4
mmol, 6.0 equiv). The reaction was stirred at –78 ◦C for an additional 30 minutes before
quenching with NH4Cl and warming to room temperature. The reaction mixture was diluted
with H2O and extracted with CH2Cl2. The combined organics were dried over MgSO4, filtered
and concentrated in vacuo. The crude product was purified by silica gel chromatography (5%
EtOAc/Pet. Ether). The title compound was isolated as a clear colorless oil (0.452 g, 92%
yield). Rf = 0.28 (5% EtOAc/Pet. Ether). 1HNMR (500 MHz, CDCl3) δ 9.77 (t, J = 1.7
Hz, 1H), 5.80 (ddt, J = 16.9, 10.2, 6.7 Hz, 1H), 5.12-4.87 (m, 2H), 2.44 (td, J = 7.4, 1.7
Hz, 2H), 2.10-2.01 (m, 2H), 1.65 (p, J = 7.4 Hz, 2H), 1.48-1.22 (m, 4H). 13C NMR (126
MHz, CDCl3) δ 202.81, 138.68, 114.50, 43.84, 33.50, 28.58(2C), 21.90. Characterization data
matches those reported in the literature.46
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Preparation of 2-Bromo-N -methoxy-N -methylacetamide.
N
O
OMeBr
303
To a solution of N,O-dimethylhydroxylamine hydrochloride (2.0 g, 20.5 mmol, 1.0 equiv)
in Et2O/H2O (1:1, 50 mL) at 0 ◦C was added K2CO3 (6.24 g, 45.2 mmol, 2.2 equiv), followed
by 2-bromoacetyl chloride (1.96 mL, 4.56 g, 22.57 mmol, 1.2 equiv). The reaction was allowed
to warm to room temperature and stirred for 3 hours before diluting with H2O and extracting
with Et2O. The combined organics were dried over MgSO4, filtered and concentrated in vacuo.
The crude product was purified by silica gel chromatography (40% EtOAc/Pet. Ether). The
title compound was isolated as a clear colorless oil (1.95 g, 52% yield). Rf = 0.31 (40%
EtOAc/Pet. Ether). 1H NMR (500 MHz, CDCl3) δ 4.02 (s, 2H), 3.80 (s, 3H), 3.24 (s, 3H).
13C NMR (126 MHz, CDCl3) δ 167.70, 61.67, 32.56, 25.12. Characterization data matches
those reported in the literature.47
Preparation of 2-Chloro-N -methoxy-N -methylacetamide.
N
O
OMeCl
303
To a solution of N,O-dimethylhydroxylamine hydrochloride (0.7 g, 7.18 mmol, 1.0 equiv)
in Et2O/H2O (1:1, 18 mL) at 0 ◦C was added K2CO3 (2.18 g, 15.79 mmol, 2.2 equiv), followed
by 2-chloroacetyl chloride (0.685 mL, 0.973 g, 8.61 mmol, 1.2 equiv). The reaction was allowed
to warm to room temperature and stirred for 3 hours before diluting with H2O and extracting
with EtOAc. The combined organics were dried over MgSO4, filtered and concentrated in
vacuo. The title compound was isolated as a faint yellow solid (0.819 g, 83% yield) and was
used without further purification. 1H NMR (500 MHz, CDCl3) δ 4.26 (s, 2H), 3.76 (s, 3H),
3.25 (s, 3H). Characterization data matches those reported in the literature.48
Preparation of 3-Hydroxy-N -methoxy-N -methyldec-9-enamide, 265.
OH
N
O
OMe
303
To a suspension of zinc dust (0.185 g, 2.83 mmol, 3.57 equiv) in THF (2 mL) was added
0.013 g of 2-Bromo-N -methoxy-N -methylacetamide, followed by DIBAL-H (28 µL, 0.028 mmol,
0.04 equiv). The reaction was heated to 50 ◦C and the remaining 2-Bromo-N -methoxy-N -
methylacetamide (0.26 g, 1.43 mmol, 1.8 equiv) was added. The reaction was stirred at 50
◦C for 1 hour before cooling to room temperature. Oct-7-enal (0.1 g, 0.792 mmol, 1 equiv)
was added and the reaction stirred at room temperature. Complete conversion by TLC was
observed after an hour and the reaction was quenched with saturated aqueous NH4Cl. The
reaction mixture was extracted with Et2O, dried over MgSO4, filtered and concentrated in
vacuo. The crude product was purified by silica gel chromatography (40% EtOAc/Pet. Ether).
The title compound was isolated as a clear colorless oil (0.087 g, 48% yield). Rf = 0.19 (40%
EtOAc/Pet. Ether). 1H NMR (500 MHz, CDCl3) δ 5.81 (ddt, J = 16.9, 10.2, 6.7 Hz, 1H),
5.6. EXPERIMENTAL DATA FOR CHAPTER 5 187
5.00 (d, J = 17.1 Hz, 1H), 4.94 (dd, J = 10.2, 1.0 Hz, 1H), 4.02 (app. s, 1H), 3.79 (d, J =
3.1 Hz, 1H), 3.70 (s, 3H), 3.20 (s, 3H), 2.67 (d, J = 16.7 Hz, 1H), 2.45 (dd, J = 16.9, 9.6 Hz,
1H), 2.05 (q, J = 6.9 Hz, 2H), 1.67-1.27 (m, 8H). 13C NMR (126 MHz, CDCl3) δ 173.98,
139.09, 114.22, 67.84, 61.24, 38.15, 36.47, 33.73, 31.83, 29.07, 28.85, 25.40. HRMS - ESI
(m/z): [M+Na]+ calculated for C12H24NO3+, 230.1751; found, 230.1742.
Preparation of (S,Z)-2-Bromo-4-((tert-butyldimethylsilyl)oxy)-4-((S)-2,2-dimethyl-
1,3-dioxolan-4-yl)but-2-enoic Acid, 264.
O
O
OTBS
O
OH
Br
To a solution of ethyl-2-(triphenylphosphoranylidene)acetate (0.459 g, 1.317 mmol, 1.5
equiv) in DCE (2.9 mL) at –20 ◦C was added NBS (0.266 g, 1.49 mmol, 1.7 equiv). The
reaction was stirred at –20 ◦C for an hour before being warmed to room temperature. K2CO3
(0.303 g, 2.195 mmol, 2.5 equiv) was added, followed by (R)-2-((tert-butyldimethylsilyl)oxy)-2-
((S)-2,2-dimethyl-1,3-dioxolan-4-yl)acetaldehyde (0.241 g, 0.878 mmol, 1 equiv). The reaction
was stirred overnight at room temperature before being heated to 60 ◦C for 3 hours, cooled
back to room temperature and quenched with H2O. The reaction mixture was extracted with
CH2Cl2 and the combined organics dried over MgSO4, filtered and concentrated in vacuo.
The crude product was purified by silica gel chromatography (10% EtOAc/Pet. Ether). The
desired ester was isolated as a clear colorless oil (0.223 g, 60% yield). 1H NMR (500 MHz,
CDCl3) δ 7.20 (d, J = 8.5 Hz, 1H), 4.67 (dd, J = 8.5, 4.6 Hz, 1H), 4.37-4.25 (m, 2H), 4.21 (ddd,
J = 6.7, 5.8, 4.7 Hz, 1H), 4.09-3.93 (m, 2H), 1.41 (d, J = 0.8 Hz, 3H), 1.39-1.32 (m, 6H), 0.90
(s, 9H), 0.11 (s, 3H), 0.06 (s, 3H). This product was dissolved in MeOH/CH2Cl2 (1:9, 5 mL)
and NaOH (0.084 g, 2.1 mmol, 4 equiv) was added at room temperature. The reaction was
stirred overnight before being diluted with H2O and washed with CH2Cl2. The aqueous layer
was then acidified by the dropwise addition of saturated aqueous KHSO4 and extracted with
EtOAc. The combined organics were concentrated in vacuo and the title compound isolated
as a clear oil (0.114 g, 55% yield). 1H NMR (500 MHz, CDCl3) δ 7.35 (d, J = 8.5 Hz, 1H),
4.69 (dd, J = 8.5, 4.3 Hz, 1H), 4.25 (ddd, J = 6.6, 5.7, 4.3 Hz, 1H), 4.03 (qd, J = 8.7, 6.1 Hz,
2H), 1.42 (s, 3H), 1.36 (s, 3H), 0.90 (s, 9H), 0.11 (s, 3H), 0.07 (s, 3H). 13C NMR (126 MHz,
CDCl3) δ 165.73, 146.52, 115.44, 110.10, 77.92, 72.60, 64.94, 26.09, 25.68, 25.20, 18.08, -4.51,
-4.97. HRMS - ESI (m/z): [M–H]– calculated for C15H26BrO5Si–, 393.0738; found, 393.0720.
Preparation of (4S,Z)-1-(methoxy(methyl)amino)-1-oxodec-9-en-3-yl 2-bromo-
4-((tert-butyldimethylsilyl)oxy)-4-((S)-2,2-dimethyl-1,3-dioxolan-4-yl)but-2-enoate,
268.
O
O
OTBS
O
O
Br
O
N
OMe
To a solution of (S,Z )-2-bromo-4-((tert-butyldimethylsilyl)oxy)-4-((S)-2,2-dimethyl-1,3-
dioxolan-4-yl)but-2-enoic acid (0.053 g, 0.134 mmol, 1.0 equiv), 3-Hydroxy-N -methoxy-N -
methyldec-9-enamide (0.034 g, 0.147 mmol, 1.1 equiv) and DMAP (1.6 mg, 0.013 mmol, 0.1
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equiv) in CH2Cl2 (0.67 mL) at 0 ◦C was added EDCI·HCl (0.028 g, 0.147 mmol, 1.1 equiv). The
reaction was allowed to warm to room temperature and stirred for 5 hours before concentration
under a stream of nitrogen and purification using silica gel chromatography (30% EtOAc/Pet.
Ether). The title compound was isolated as a clear film (0.035 g, 43% yield). Rf = 0.38 (30%
EtOAc/Pet. Ether). 1H NMR (600 MHz, CDCl3) δ 7.15 (t, J = 8.9 Hz, 1H), 5.83-5.72 (m,
1H), 5.35 (td, J = 6.4, 3.7 Hz, 1H), 5.01-4.94 (m, 1H), 4.92 (d, J = 10.1 Hz, 1H), 4.65 (td, J
= 8.5, 4.6 Hz, 1H), 4.22-4.16 (m, 1H), 3.99 (ddd, J = 8.7, 6.7, 3.4 Hz, 1H), 3.94 (ddd, J =
8.4, 5.8, 2.2 Hz, 1H), 3.68 (s, 3H), 3.19-3.11 (m, 3H), 2.92-2.81 (m, 1H), 2.65 (ddd, J = 15.8,
5.9, 2.9 Hz, 1H), 2.02 (tt, J = 6.6, 3.1 Hz, 3H), 1.77-1.67 (m, 2H), 1.44-1.26 (m, 14H), 0.88 (s,
11H). 13C NMR (151 MHz, CDCl3) δ 170.76, 161.34, 161.27, 143.78, 143.55, 138.91, 138.89,
116.91, 116.83, 114.32, 114.31, 109.87, 109.86, 78.02, 73.92, 73.85, 72.75, 72.72, 65.03, 65.00,
61.33, 36.50, 36.43, 33.98, 33.93, 33.62, 33.60, 32.07, 28.76, 28.70, 28.67, 26.18, 26.17, 25.74,
25.73, 25.72, 25.70, 25.69, 25.37, 25.30, 25.02, 24.97, 18.09, -4.50, -4.51, -4.93, -4.95. HRMS
- ESI (m/z): [M+Na]+ calculated for C27H48BrNO7SiNa+, 628.2276; found, 628.2244.
Preparation of tert-butyl 2-(diethoxyphosphoryl)acetate.
tBuO
O
P
O
OEt
OEt
303
To neat tert-butyl 2-bromoacetate (9.46 mL, 64.1 mmol, 1.005 equiv) was added triethyl
phosphite (11.1 mL, 63.8 mmol, 1 equiv). The reaction was heated to 100 ◦C and refluxed
for 3 hours before cooling to room temperature and removal of bromoethane, the reaction
byproduct, in vacuo. The desired product was isolated as a clear, colorless oil (16 g, 99%
yield) and used without further purification. 1H-NMR (300 MHz, CDCl3): δ 4.15 (m, 4H),
2.87 (dd, J = 21.4, 5.0 Hz, 2H), 1.46 (s, 9H), 1.33 (m, 6H). 13C-NMR (126 MHz, CDCl3): δ
164.90 (d, J = 6.3 Hz), 81.99 , 62.46 (d, J = 6.2 Hz), 35.57 (d, J = 133.1 Hz), 16.34 (d, J =
6.4 Hz).31P-NMR (121 MHz, CDCl3): δ 20.56. Characterization data matches that reported
in the literature.49
Preparation of tert-butyl 2,2-dibromo-2-(diethoxyphosphoryl)acetate.
tBuO
O
P
O
OEt
OEt
Br Br
To a solution of NaOH (18.8 g, 470 mmol, 9.4 equiv) in water (60 mL) at 0 ◦C was added
bromine (11.85 mL, 230 mmol, 4.6 equiv) dropwise ovre 30 minutes enusring the internal
temperature does not exceed 10 ◦C. Tert-butyl 2-(diethoxyphosphoryl)acetate (12.61 g, 50
mmol, 1 equiv) was then added to the reaction mixture dropwise over 10 minutes, once again
ensuring the internal temperature does not exceed 10 ◦C. The reaction was stirred for an
additional 30 minutes at 0 ◦C before being extracted with chloroform three times. The
combined organic layers were washed with water, dried over MgSO4, filtered and concentrated
in vacuo. The desired product was isolated as a yellow oil (18.12 g, 88% yield) and was used
without further purification. 1H-NMR (300 MHz, CDCl3): δ 4.38 (m, 4H), 1.53 (s, 9H), 1.39
(m, 6H). 13C-NMR (126 MHz, CDCl3): δ 162.21 (d, J = 3.6 Hz), 85.82 , 66.21 (d, J = 7.2
Hz), 49.02 (d, J = 158.5 Hz), 27.45 , 16.42 (d, J = 6.0 Hz). 31P-NMR (121 MHz, CDCl3):
δ 8.33. Characterization data matches that reported in the literature.50
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tBuO
O
P
O
OEt
OEt
Br
Preparation of tert-butyl 2-bromo-2-(diethoxyphosphoryl)acetate.
To a solution of tert-butyl 2,2-dibromo-2-(diethoxyphosphoryl)acetate (18.14 g, 44.2 mmol,
1 equiv) in ethanol (50 mL) at 0 ◦C was added a suspension of SnCl2 (7.97 g, 42.0 mmol, 0.95
equiv) in water (70 mL), dropwise using an addition funnel. The reaction mixture was stirred at
0 ◦C for 20 minutes before warming to room temperature and extracting twice with chloroform.
The combined organics were dried over MgSO4, filtered and concentrated in vacuo. The desired
product was isolated as a clear, colorless oil (12.11, 83% yield) and was used without further
purification. 1H-NMR (300 MHz, CDCl3): δ 4.46-4.07 (m, 5H), 1.49 (s, 9H), 1.37 (t, J =
7.1 Hz, 6H). 13C-NMR (126 MHz, CDCl3): δ 163.79 , 84.05 , 64.51 (m), 37.36 (d, J = 145.1
Hz), 27.80 (d, J = 28.3 Hz), 16.37 (d, J = 6.1 Hz). 31P-NMR (121 MHz, CDCl3): δ 13.09.
Characterization data matches that reported in the literature.50
Preparation of 2-Bromo-2-(diethoxyphosphoryl)acetic Acid, 287.
HO
O
P
O
OEt
OEt
Br
To tert-butyl 2-bromo-2-(diethoxyphosphoryl)acetate (4.0 g, 12.08 mmol, 1 equiv) was
added a solution of CH2Cl2/TFA/H2O (20:10:1, 150 mL). The reaction mixture was stirred
at room temperature for 4 hours before being concentrated in vacuo (< 40 ◦C). The title
compound was obtained as a slight yellow oil (2.54 g, 76% yield). 1H-NMR (300 MHz,
DMSO-d6): δ 4.98 (d, J = 14.5 Hz, 1H), 4.22-3.92 (m, 5H), 1.23 (m, 6H). 13C-NMR (126
MHz, DMSO-d6): δ 166.44 , 79.41 (d, J = 66.4 Hz), 64.02 , 16.57. 31P-NMR (121 MHz,
DMSO-d6): δ 18.78. Characterization data matches that reported in the literature.51
Preparation of 1-(Methoxy(methyl)amino)-1-oxodec-9-en-3-yl 2-bromo-2-
(diethoxyphosphoryl)acetate, 289.
O
O O
N
OMe
Br
PO OEt
OEt
To a solution of 2-bromo-2-(diethoxyphosphoryl)acetic acid (0.148 g, 0.536 mmol, 1.5
equiv) and 3-hydroxy-N -methoxy-N -methyldec-9-enamide (0.082 g, 0.358 mmol, 1 equiv) in
CH2Cl2 (1.8 mL) was added EDCI·HCl (0.099 g, 0.518 mmol, 1.45 equiv) and DMAP (4 mg,
0.036 mmol, 0.1 equiv). The reaction was sealed and stirred overnight before being diluted
with CH2Cl2, filtered through a silica plug (EtOAc wash), and concentrated in vacuo. The
crude product was purified by silica gel chromatography (60% EtOAc/Pet. Ether), The title
compound was isolated as a clear colorless oil (0.113 g, 65% yield). Rf = 0.14 (60% EtOAc/Pet.
Ether). 1H NMR (500 MHz, CDCl3) δ 5.80 (ddt, J = 16.9, 10.3, 6.8 Hz, 1H), 5.37 (h, J =
6.4 Hz, 1H), 4.99 (dd, J = 17.3, 2.2 Hz, 1H), 4.93 (d, J = 10.1 Hz, 1H), 4.46-4.21 (m, 5H),
3.71 (s, 3H), 3.18 (s, 3H), 2.86 (ddd, J = 21.6, 15.9, 6.7 Hz, 1H), 2.71-2.59 (m, 1H), 2.04 (q,
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J = 7.0, 5.6 Hz, 2H), 1.71 (q, J = 6.9 Hz, 2H), 1.39 (dt, J = 12.2, 7.1 Hz, 12H). 13C NMR
(126 MHz, CDCl3) δ 170.57, 165.49, 164.23, 138.91, 114.32, 74.07, 73.99, 65.67, 65.61, 64.89,
64.83, 64.81, 64.75, 64.68, 61.36, 36.69, 36.41, 36.31, 35.53, 35.16, 35.10, 33.94, 33.66, 32.11,
28.78, 28.72, 24.85, 16.38, 16.33, 16.31, 16.29, 16.26, 16.24. HRMS - ESI (m/z): [M+H]+
calculated for C18H34BrNO7P+, 486.1251; found, 486.1257.
Preparation of (Z)-1-(Methoxy(methyl)amino)-1-oxodec-9-en-3-yl 2-bromo-3-
((R)-2,2-dimethyl-1,3-dioxolan-4-yl)acrylate, 291.
O
O
Br
O
N
OMe
O
O
To a solution of 1-(methoxy(methyl)amino)-1-oxodec-9-en-3-yl 2-bromo-2-
(diethoxyphosphoryl)acetate (0.060 g, 0.123 mmol, 1 equiv) in THF/H2O (40:1, 0.6 mL) at
0 ◦C was added activated Ba(OH)2 (0.036 g, 0.21 mmol, 1.7 equiv). The reaction mixture
was stirred for 30 minutes before the addition of (S)-2,2-dimethyl-1,3-dioxolane-4-carbaldehyde
(0.032 g, 0.247 mmol, 2 equiv). The reaction was stirred overnight at room temperature before
quenching with saturated aqueous NaHCO3. The reaction mixture was extracted with Et2O
and the combined organics were dried over MgSO4, filtered and concentrated in vacuo. The
crude product was purified by silica gel chromatography (30% EtOAc/Pet. Ether). The title
compound was isolated as a clear film (0.011 g, 19% yield). Rf = 0.3 (30% EtOAc/Pet. Ether).
1H NMR (600 MHz, CDCl3) MIXTURE OF ALKENE ISOMERS: δ 7.34 (d, J = 6.7 Hz,
1H), 6.77 (d, J = 7.0 Hz, 1H), 5.79 (m, 2 x 1H), 5.36 (m, 2 x 1H), 4.99 (ddd, J = 17.2, 3.4, 1.7
Hz, 2 x 1H), 4.96-4.90 (m, 2 x 1H), 4.31 (ddd, J = 8.1, 6.7, 1.3 Hz, 2 x 1H), 3.70 (s, 3H), 3.69 (s,
3H), 3.17 (s, 3H), 3.16 (s, 3H), 2.85 (m, 2 x 1H), 2.71-2.59 (m, 2 x 1H), 2.08-1.98 (m, 2 x 2H),
1.76-1.65 (m, 2 x 2H), 1.45 (m, 2 x 6H), 1.42-1.29 (m, 2 x 6H). 13C NMR (151 MHz, CDCl3)
MIXTURE OF ALKENE ISOMERS: δ 170.72, 161.58, 160.99, 160.97, 148.43, 147.90, 143.93,
138.94, 138.91, 138.87, 118.60, 114.37, 114.34, 110.30, 110.04, 75.60, 75.58, 74.57, 73.85, 73.82,
73.66, 73.64, 69.10, 69.07, 68.08, 61.66, 61.38, 61.34, 36.45, 36.36, 34.00, 33.67, 33.63, 32.44,
32.11, 28.77, 28.75, 28.67, 28.64, 28.14, 26.53, 26.40, 25.52, 25.37, 25.01, 24.99. IR (film):
2984, 2930, 2858, 1729, 1666, 1640, 1461, 1373, 1219, 1154, 1062 cm−1. HRMS - ESI (m/z):
[M+H]+ calculated for C20H33BrNO6+, 462.1486; found, 462.1499.
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Preparation of (Z)-1-(methoxy(methyl)amino)-1-oxodec-9-en-3-yl 2-bromo-3-
phenylacrylate, 292.
O
O
Br
O
N
OMe
To a solution of 1-(methoxy(methyl)amino)-1-oxodec-9-en-3-yl 2-Bromo-2-
(diethoxyphosphoryl)acetate (0.047 g, 0.097 mmol, 1 equiv) in THF/H2O (40:1, 0.48 mL) at 0
◦C was added activated Ba(OH)2 (0.028 g, 0.164 mmol, 1.7 equiv). The reaction mixture was
stirred for 30 minutes before the addition of benzaldehyde (0.021 g, 0.193 mmol, 2 equiv). The
reaction was stirred overnight at room temperature before quenching with saturated aqueous
NaHCO3. The reaction mixture was extracted with Et2O and the combined organics were
dried over MgSO4, filtered and concentrated in vacuo. The crude product was purified by
silica gel chromatography (20% EtOAc/Pet. Ether). The title compound was isolated as a
clear film (0.011 g, 26% yield). Rf = 0.32 (20% EtOAc/Pet. Ether). 1HNMR (500 MHz,
CDCl3) δ 8.20 (s, 1H), 7.85 (m, 2H), 7.43 (m, 2H), 7.32 (app. s, 1H), 5.80 (ddt, J = 12.9, 10.2,
6.7 Hz, 1H), 5.44 (app. dt, J = 12.6, 6.2 Hz, 1H), 4.99 (app. d, J = 17.2 Hz, 1H), 4.93 (app.
d, J = 10.2 Hz, 1H), 3.72 (s, 3H), 3.19 (s, 3H), 2.93 (dd, J = 15.5, 7.0 Hz, 1H), 2.72 (dd, J =
15.6, 5.9 Hz, 1H), 2.03 (m, 3H), 1.78 (q, J = 7.3 Hz, 2H), 1.48-1.27 (m, 6H). 13C NMR (126
MHz, CDCl3) δ 170.91, 162.72, 140.79, 138.95, 133.79, 130.29, 130.12, 128.80, 128.41, 128.38,
128.23, 128.06, 114.33, 73.74, 61.37, 34.11, 33.65, 28.83, 28.71, 25.07. IR (film): 2929, 2857,
1720, 1665, 1611, 1447, 1388, 1256, 1198, 999 cm−1. HRMS - ESI (m/z): [M+H]+ calculated
for C21H29BrNO4+, 438.1274; found, 438.1292.
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5.6.3 Spectral Data
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6.1 Alkylation Cascade in the Synthesis of Labillarides E-H
Building on the research described in Chapter 5, the use of a Pd-AA cascade reaction with
a 4-hydroxy-α-pyrone bis-nucleophile was investigated with the ultimate goal of preparing
labillarides E-H (Scheme 6.1). This cascade reaction consists of two sequential allylic
alkylations and passes through an initial C -alkylated product to ultimately form a substituted
furopyrone. The ability of this reaction to enable rapid and stereospecific formation of
substituted furopyrones has great potential in the development of a concise total synthesis
of labillarides E-H.
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LG
O
O
OH
+
Pd-cat.
O
O
OH
R
R
O
O
OH
R
R
LG
Pd-cat.
Scheme 6.1 Pd-AA Cascade with a 4-Hydroxy-α-pyrone.
6.2 Introduction
6.2.1 Pd-AA Cascades with Acyclic Bis-Electrophiles
Palladium-catalyzed allylic alkylation (Pd-AA) cascades involve the sequential addition of a
bis-nucleophile (B) to an allylic bis-electrophile (A) to ultimately achieve a net annulation
(Scheme 6.2).1 Various combinations of nitrogen, oxygen and carbon bis-nucleophiles (B)
have been used previously in highly efficient syntheses of vinyl-substituted ring systems (C)
(vide infra). Given the numerous regiochemical possibilities that exist during the course of
Nuc1 = Nuc2  OR  Reactivity: Nuc1 >> Nuc2
LG = OAc, OCO2Me, OBoc, OTroc etc.
n = 1, 2
PdLn
LG
LG
+
Nuc2
Nuc1
n
Nuc2
Nuc1
n
PdLn
LG
Nuc1
Nuc2n
A B C
Scheme 6.2 Generic Pd-AA Cascade.
these reactions, strict regioselectivity is required to produce a single product (Scheme 6.3).
Selectivity in the first alkylation is often driven by the preference for alkylation to occur
at the less hindered terminal position of the pi-allyl palladium complex. Regioselectivity in
the second alkylation is due to 5(or 6)-exo cyclization being kinetically favoured over the
competing 7(or 8)-endo cyclization.2 These reactions are typically performed with symmetric
bis-electrophiles and therefore regioselectivity is, for the most part, dependent on one
nucleophile being more reactive than the other (Scheme 6.2).
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Scheme 6.3 Regiochemical Possibilities of a Pd-AA casade with a Symmetric
Bis-Electrophile.
Palladium allylic alkylation cascades have been successfully applied to the synthesis of
substituted piperazines,3 piperidines,4 morpholines,5 dioxanes,6 oxazolidinones,7 dihydropy-
rans,8 dihydrofurans,9 cyclohexanes,10,11 cyclopentanes,12 and cyclopropanes (Scheme 6.4).13
The majority of these methodologies use butene-1,4-dicarbonate substrates rather than the
less reactive butene-1,4-diacetates. The enantioselective formation of substituted morpholines
and dihydrofurans was achieved using the chiral phosphine ligands L10 and L11 Scheme 6.5.
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Scheme 6.4 Product Diversity in Pd-AA Cascades.
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Scheme 6.5 Enantioselective Synthesis of Morpholines and Dihydrofurans using Pd-AA
Cascades.
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6.2.2 Pd-AA Cascade Reactions in Total Synthesis
Palladium-catalyzed allylic alkylation cascades have been used in a number of elegant natural
product syntheses. Cook and coworkers have reported a diastereoselective Pd-AA cascade to
prepare the core of neosarpagine (305, Scheme 6.6).14 In this reaction, the amine nucleophile
of 306 adds to the first pi-allyl palladium complex, followed by intramolecular addition of the
stabilized enolate nucleophile to the second pi-allyl palladium complex. Notably, the use of
a ketone substrate devoid of the unwanted ester functionality (307) resulted in a significant
drop in reactivity. However, the desired annulation was eventually achieved through the use of
a Pd(dba)2/DPEphos catalyst system, forming a zinc enolate and employing a more reactive
dicarbonate electrophile.
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85% yield
AcO OAc
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H
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Pd(dba)2, DPEphos,
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H
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305
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307
Scheme 6.6 Synthesis of the Core Structure of Neosarpagine using Pd-AA cascades.
Palladium-catalyzed allylic alkylation cascades have also been utilized in both racemic and
enantioselective syntheses of huperzine A, a potent acetylcholinesterase (AChE) inhibitor used
in the treatment of Alzheimer’s disease.10 In the presence of a Pd(0) catalyst, the β-keto-
ester 308 reacts with 2-methylene-1,3-propanediol diacetate (309) to form a 6-membered ring
(Scheme 6.7). After extensive optimization, Bai and coworkers achieved an 82% yield and 92%
ee.11 Interestingly, the use of -Cl, -OBz or -OCOCF3 as allylic leaving groups was found to be
detrimental to both yield and ee.
Trost and Dong use an impressive enantioselective Pd-AA cascade in a recent total
synthesis of agelastatin A (311, Scheme 6.8).15 Initial attempts to form piperazinone 312
under basic conditions produced none of the desired product. It was hypothesized that the
dinucleophile 313 could act as a bidentate ligand for palladium and therefore halt the reaction
by forming 314. Acetic acid was added to the reaction to overcome this problem and the
desired piperazinone was ultimately obtained in 82% yield and 98% ee. These optimized
conditions required the addition of a second batch of Pd2(dba)3·CHCl3/racemic-L1 after the
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Scheme 6.7 Pd-AA Cascade in the Synthesis of Huperzine A.
first enantioselective allylic alkylation. This is attributed to the fact that ent–L1 is better
at facilitating the second allylic alkylation. The chiral steric environment of the substrate
and ent–L1 are matched, whereas L1 that facilitated the first alkylation is mismatched. The
relative stereochemistry is substrate dependent and the cis–orientation of the starting materials
ensures the second addition will occur from the same face as the first addition.
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10mol% HOAc
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Scheme 6.8 Pd-AA Cascade in the Synthesis of Agelastatin A.
6.3 Development of a Pd-AA Cascade with a 4-Hydroxy-α-
pyrone.
To examine the feasibility of a Pd-catalyzed allylic alkylation cascade in the synthesis of
labillarides E-H, we first investigated the annulation of 6-methyl-4-hydroxy-α-pyrone (253)
with dicarbonate 315 (Scheme 6.9). This simple symmetric substrate was investigated in
the hope of gaining valuable information about the conditions required to obtain the desired
reactivity. Optimization experiments began with the screening of a variety of reaction solvents
in conjunction with the use of Pd2(dba)3/PPh3 to generate the active Pd(0) catalyst in situ
(Table 6.1). The use of THF, CH3CN, CH2Cl2, and DMF all provided modest yields of
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Scheme 6.9 4-Hydroxy-α-pyrone Pd-AA Cascade.
furopyrone 316, ranging from 37–52% (Entries 1 & 4–6), while toluene, DME and DMSO
provided poor yields (0–14%, Entries 2, 5, and 7). Interestingly, 6-methyl-4-hydroxy-α-pyrone
(253) was only sparingly soluble in some of the less polar solvents such as toluene and CH2Cl2.
However, in the case of dichloromethane this did not seem to impact negatively on the yield of
the desired product 316. Additionally, an excess of the 4-hydroxy-α-pyrone proved essential
for a successful reaction, and the use of excess bis-electrophile 315 did not provide the desired
furanopyrone (Entry 8).
One of the major concerns borne out of the initial solvent screening experiments was
the apparent inability of the palladium catalyst to exceed two or three turnovers, based on
the yield obtained. This observation prompted the investigation of a number of alternative
palladium precursors and phosphine ligands, including Pd(OAc)2, Pd(PPh3)4, dppe, P(oTol)3
and (S,S)-DACH-phenyl Trost ligand, L2 (Entries 10–16). Unfortunately, the majority of
these conditions gave significantly lower yields of the desired product 316 than the original
Pd2(dba)3/PPh3 conditions, with the exception of Entries 10 and 15. Entry 10 utilized the
bidentate chiral phosphine ligand (S,S)-DACH-phenyl Trost ligand and produced the desired
furopyrone in 49% yield.∗ This result did not prove to be general for bidentate ligands, as
experiments with dppe showed a complete lack of reactivity (Entries 11& 12). Interestingly,
performing the reaction with Pd2(dba)3/P(oTol)3 provided none of the desired product, but
instead generated a relatively stable organopalladium complex that was isolated using silica gel
chromatography and appeared as a single spot by TLC (Entry 14). The presence of Pd in this
side product was confirmed by the observation of a six-isotope pattern in the mass spectrum,
characteristic of palladium.16 It is well known that P(oTol)3 displays special intramolecular
reactivity, forming the palladacyclic complex known as Hermann’s catalyst (317) via a C–
H insertion process (Scheme 6.10).17 With this in mind, palladacycle 318 is hypothesized
to be the organopalladium side product generated under these conditions.18 NMR analysis
of the proposed palladacycle revealed the expected 31P resonance, while also displaying 1H
NMR resonances indicative of the pyrone heterocycle and an alkenyl fragment. Unfortunately,
the exact structure of this complex could not be elucidated and attempts at crystallization
were unsuccessful. This result shed light on the previous issues associated with catalyst
turnover and suggested the possibility that the Pd may be trapped as a relatively stable
palladacyclic complex, which would ultimately halt the catalytic cycle. The plausibility of
this hypothesis was augmented by the observation that performing the reaction with 10 mol
% Pd(PPh3)4 gave 31% yield, whereas the same reaction with 20 mol % Pd(PPh3)4 provided
∗Unfortunately, the enantioselectivity of this reaction was not determined.
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Table 6.1 Pd-AA Cascade Optimization: Annulation of 4-Hydroxy-6-methyl-α-pyrone.
O
OH
O
O
O
OOCO2Me
OCO2Me
Conditions
253 315 316
Entry[a] Pd Source Ligand Solvent Additives[b] Comments Yield[c]
Solvent Screening
1 Pd2(dba)3 PPh3 THF – – 38%
2 Pd2(dba)3 PPh3 Toluene – – 14%
3 Pd2(dba)3 PPh3 DME – RSM 0%
4 Pd2(dba)3 PPh3 CH3CN – – 37%
5 Pd2(dba)3 PPh3 CH2Cl2 – – 46%
6 Pd2(dba)3 PPh3 DMF – – 52%
7 Pd2(dba)3 PPh3 DMSO – – 16%
Miscellaneous
8 Pd2(dba)3 PPh3 THF – 1.5 equiv 315 0%
9 none PPh3 THF – control, RSM 0%
Pd/Ligand Screening
10 Pd2(dba)3 (S,S)-L2 CH2Cl2 – – 49%
11 Pd2(dba)3 dppe THF – RSM 0%
12 Pd(OAc)2 dppe THF – RSM 0%
13 Pd(OAc)2 PPh3 CH2Cl2 RSM 0%
14 Pd2(dba)3 P(oTol)3 THF – – 0%
15 Pd(PPh3)4 – CH2Cl2 – – 31%
16 Pd(PPh3)4 – CH2Cl2 – 20 mol% Pd 13%
Base/Additive Screening
17 Pd2(dba)3 PPh3 THF DBU 1 hour 56%
18 Pd2(dba)3 PPh3 THF NEt3 1 hour 56%
19 Pd2(dba)3 PPh3 THF 5 equiv NEt3 1 hour 31%
20 Pd2(dba)3 PPh3 DMF NEt3 – 57%
21 Pd2(dba)3 PPh3 CH3CN NEt3 1 hour 84%[e]
22 Pd2(dba)3 PPh3 CH3CN NEt3 4 mol% Pd 14%
23 Pd2(dba)3 PPh3 THF Cs2CO3 – 0%
24 Pd2(dba)3 PPh3 THF TEBAC RSM 0%
25 Pd2(dba)3 PPh3 THF LiCl RSM 0%
26 Pd2(dba)3 PPh3 THF 2 equiv AcOH – 0%
27 Pd2(dba)3 PPh3 THF K2CO3 – 4%
[a] Unless otherwise stated the following conditions apply: 2.2 equiv. of 253, 10 mol% Pd precursor
complex, and a Pd:P ratio of 1:2 was used. Reactions were performed at room temperature on a
0.4 mmol scale and were stirred overnight before workup. [b] Unless otherwise stated 1 equivalent of
additive was used. [c] Isolated yields are reported. [d] An organopalladium side product was isolated
from this reaction, see Scheme 6.10 for details. [e] This reaction proved somewhat capricious upon
scale up. Nonetheless, with careful solvent degassing 60-75% yield could be obtained consistently on
a 150–300 mg scale. RSM = Recovered Starting Material.
NH HN
O O
PPh2 Ph2P
L2
(S,S)-DACH-phenyl Trost ligand316
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Scheme 6.10 Potential Palladacycle Formation with P(oTol)3.
only 13% yield of furopyrone 316 along with another relatively stable organopalladium complex
(Entry 16). Once again the structure of this complex could not be fully elucidated, although
spectroscopic data once again suggests that both a pyrone and alkenyl moiety are present in
this Pd-complex. A number of unexpected palladacyclic side products have been reported
in the literature during attempted intramolecular Pd-catalyzed reactions.18 Broggini and
coworkers reported the isolation of the palladacyclic compound 319 while attempting to
convert vinyl iodide 320 into tetrahydroisoquinoline 321 (Scheme 6.11).19 In this case, the
I
N NN
Pd
I
PPh3
H
1 equiv
Pd(PPh3)4,
NEt3, CH3CN,
reflux
NEt3, CH3CN,
reflux
55% yield 38-46% yield
320 319 321
Scheme 6.11 Literature Example of a Stable Palladacyclic Intermediate.
stability of palladacycle 319 is problematic, preventing β-hydride elimination and catalyst
turnover. However, prolonged exposure of 319 to triethylamine in refluxing acetonitrile caused
the breakdown of the palladacyclic species and formation of the desired product 321. It is
interesting to note that this problem was significantly less prominent when Pd(OAc)2/PPh3
or Pd2(dba)3/PPh3 were used to generate the active palladium catalyst, which is consistent
with the result obtained with Pd(PPh3)4 in this work (see Table 6.1, Entry 16).
The palladacycle hypothesis led to the use of an amine base as a stoichiometric additive,
in the hope of improving both catalyst turnover and product yield. The use of either DBU or
NEt3 provided a nice improvement in both yield and the rate of the reaction (Entries 17 &
18). Under these conditions, the reaction showed complete consumption of starting material
after just an hour, whereas the earlier solvent screening experiments contained significant
amounts of starting material after an hour and often required stirring overnight to consume
the majority of the bis-electrophile 315. Ultimately, it was discovered that performing the Pd-
AA cascade reaction with one equivalent of NEt3 and catalytic Pd2(dba)3/PPh3 in CH3CN
6.4. SYNTHESIS OF THE CORE OF LABILLARIDES E-H 216
provided a gratifying 84% yield (Entry 21). Unfortunately, the good yield obtained with 10
mol% Pd2(dba)3 did not enable the use of lower catalyst loadings, and only 14% yield was
obtained when 2 mol % Pd2(dba)3 was used. Additional additive screening experiments with
inorganic bases or salts provided poor yields (Entries 23–27) and thus far, conditions which
achieve higher Pd turnover numbers have yet to be discovered.
6.4 Synthesis of the Core of Labillarides E-H
6.4.1 A Linchpin-Based Approach to the Core of Labillaride E-H
Development of the Pd-AA cascade shown in Table 6.1 enabled a linchpin-based approach to
the synthesis of the furanopyrone and alkenyl side chain of labillaride E-H (Scheme 6.12).20
This sequence constitutes a multi-tether linchpin strategy, forming three bonds to a four carbon
O
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R
O
O
O
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OH
O
OCO2Me
OCO2Me
Pd-AA
Cascade
Alkene Cross
Metathesis
316
Scheme 6.12 A Linchpin-Based Approach to the Core of Labillaride E-H.
linchpin while also forming a heterocyclic ring. We sought to evaluate this strategy and also
gain valuable insight into the spectroscopic challenges associated with the differentiation of
labillarides E, F, G, and H.
Ru-catalyzed alkene cross metathesis between Pd-AA cascade product 316 and pent-1-en-
3-ol (322) provided the desired product 323 in 45% yield (Scheme 6.13). Initially, this reaction
was performed using a large excess (7 equiv) of allylic alcohol 322 to minimize homo-coupling
of the precious alkene 316. However, the large excess of alkene 322 proved detrimental to
the conversion of 316 to 323, and 53% of the furopyrone starting material was recovered
(91% yield BRSM). The desired cross metathesis product was obtained as a mixture of syn-
323 and anti-323 diastereomers. A partial kinetic resolution was observed, providing a 66:34
ratio of diastereomers, as determined by LC-MS (Figure 6.1). The alkene cross metathesis
was also performed with a smaller excess (2 equiv) of 1-penten-3-ol (322), which provided
323 in 40% yield as a 59:41 ratio of diastereomers. In this case, complete consumption of
starting material was observed, however, the minor amounts of the furanopyrone homo-coupling
product generated during the reaction were very challenging to separate from the desired
product. In analogy with labillarides E-H, the syn- and anti-diastereomers of 323 displayed
very similar 1H and 13C NMR spectra. As a result, structural assignment of the major and
minor product from Scheme 6.13 was not possible with simple NMR analysis.
The sequential application of a Pd-catalyzed allylic alkylation cascade and ruthenium-
catalyzed alkene cross metathesis enabled the rapid construction of the furanopyrone core
and alkenyl side chain of labillarides E-H. In just two steps, over half of the natural product
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Scheme 6.13 Installation of the Labillaride Side Chain using Alkene Cross Metathesis.
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Figure 6.1 LC-MS Analysis of the Furopyrones syn-, and anti-323.
was assembled including the heterocyclic core and two stereogenic centers. Additionally, the
ability to generate substantial quantities of the furanopyrone 323 affords the opportunity
to investigate both the biological and spectroscopic properties of labillaride fragments and
analogues.
6.4.2 Biological Testing of Labillaride Analogues syn- and anti-323
The two furopyrone diastereomers were separated using normal phase HPLC and the
cytotoxicity of each compound was testing against an HL-60 (human promyelocytic leukemia)
cancer cell line.† Unfortunately, the major diastereomer was inactive at all concentrations up to
250 µM. However, the minor diastereomer was biologically active and displayed cytotoxicity in
the low µM range (IC50 = 27 µM). These results are consistent with the HL-60 results obtained
with labillarides E, F, G, and H, which were all inactive at concentrations below 10 µM –
higher concentrations were not tested.21 The promising biological activity of the labillaride
analogue 323 and the ability to generate and purify substantial quantities of material provides
an excellent platform for future research into the medicinal properties of the labillarides and
†Cell biology assays were performed by Arun Kanakkanthara
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related analogues.
6.4.3 NMR Analysis of the Labillaride E-H Side Chain
One of the most fascinating aspects of labillarides E, F, G, and H is the almost identical
1H and 13C NMR spectra of these diastereomeric natural products. As discussed previously,
the structure assigned to labillarides E-H seems to contradict a number of fairly common
assumptions made in regards to the spectroscopic properties of diastereomers pertaining to a
group of contiguous stereocenters (for additional details see Section 5.1). With furanopyrone
323 in hand, one of the two major structural uncertainties could be investigated – namely,
how different configurations at C3 affect the spectroscopic properties of these compounds.
The 1H NMR spectra obtained from a mixture of syn- and anti-323 shows that these
compounds exhibit remarkably similar chemical shifts and coupling constants (Figure 6.2). In
Figure 6.2 Comparison of the 1H NMR Spectra of a Mixture of syn- and anti-323 in CDCl3
and Benzene-d6.
CDCl3, subtle twinning of just two signals alluded to the presence of two diastereomers. How-
ever, the use of benzene-d6 provided significantly improved separation of the diastereomeric
resonances, and twinning was observed in numerous cases, including the oxymethines that
differentiate the compounds structurally. The 13C NMR spectra also show only very small
differences between the two diastereomers – the largest differences were observed in the alkene
carbons (C4 and C5) of each diastereomer, which differed by 0.11 and 0.17 ppm, respectively
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(Figure 6.3). Overall, these results, and a full suite of 2D NMR experiments (see Section 7.5),
agree with those reported for labillarides E-H and support the assignment of these natural
products as two pairs of epimers, each differing in the configuration at C3.
Figure 6.3 Selected 13C NMR Resonances of syn- and -anti-323 Diastereomers.
The results shown in Figure 6.2 and Figure 6.3 provide useful insight into the difficulty
faced in trying to assign the structures of labillarides E-H. Spectroscopic differences of <0.02
ppm in the 1H spectra and <0.2 ppm in the 13C spectra mean that, even with a successful total
synthesis, isolated 1H and 13C NMR analysis is likely to provide only a speculative estimate
as to the exact structure of these natural products. However, preparation of all possible
labillaride E-H diastereomers and analysis of the relative differences in 13C chemical shifts
should provide a reasonable means of differentiating each diastereomer. It is important that
the NMR data for each diastereomer is obtained at approximately equal sample concentrations,
as different concentrations can lead to slightly shifted NMR resonances.21 Analysis of the
relative differences in 13C NMR shifts of syn- and anti-323 show an excellent correlation
with the differences reported for labillarides E and F, particularly with respect to C3,
C4, C5, and C6, which are the most significant for the differentiation of these compounds
(Table 6.2). These results imply that the structure of the major diastereomer of 323 matches
best with labillaride E and the structure of the minor diastereomer of 323 matches that of
labillaride F. To gain additional insight into the relative stereochemistry of the diastereomers
of 323, their spectroscopic properties were predicted using density functional calculations.22
Geometry optimization (B3LYP/6-31G(d)) and GIAO NMR calculation (B3LYP/6-31G(d),
TMS referencing) of both syn- and anti-323 gave two data sets that were an excellent match
to the experimental data from major and minor diastereomers, respectively.23 The relative
differences between the calculated 13C NMR shifts of the two diastereomers correlate well with
the differences observed in the experimental data and the assignment of the major diastereomer
as syn-323 and the minor diastereomer as anti-323 has a CP3 probability of >99%.24
Overall, the use of density functional calculations to assign the relative stereochemistry of
syn-323 and anti-323 has provided good evidence that labillarides E and G have a 3,6-syn
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Figure 6.4 Tentative Assignment of the Relative C3/C6 Configuration of Labillarides E-H
by Comparison with Furopyrone 323.
configuration, whereas labillarides F and H have a 3,6-anti configuration (Figure 6.4). However,
the small difference in the NMR chemical shifts of these compounds leaves a very small margin
for error, a margin that is smaller than the error typically associated with calculated NMR
shifts.22 Thus, despite the excellent correlation between calculated and experimental data,
the proposed assignment of the relative stereochemistry of labillarides E-H remains tentative.
A definitive stereochemical assignment of this very challenging structural motif would likely
require parallel spectroscopic analysis of both synthetic and naturally derived material along
with an X-ray crystal structure of a synthetic intermediate or natural product derivative to
provide a structural point of reference.25
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6.5 Computational Investigations into Labillaride E-H
Atropisomerism
The successful computational analysis of furopyrone 323, prompted an in silico investigation
of labillarides E-H with the hope of gaining insight into how two different configurations
in a set of three contiguous stereocenters (viz. C6, C7 and C8 in labillarides E-H) could
result in virtually identical 1H and 13C NMR chemical shifts and coupling constants. At
the outset, we recognized that the labillaride E-H macrocycle may have the potential to
exist in two atropisomeric forms, based on literature precedent from the neurymenolides (see
Figure 5.3). However, initial molecular modeling showed that the furopyrone core of the
labillarides is fixed in a way such that rotation of the macrocyclic ring about the heterocyclic
nucleus provides an awkward and highly unlikely ‘pac-man’ shaped macrocyclic conformation.
Closer examination of the macrocyclic ring revealed surprisingly hindered rotation about the
Z -alkene. Rotation in one direction engenders a large amount of macrocyclic ring strain,
whereas rotation in the other direction encounters a significant steric interaction with the
furopyrone ring. Density functional calculations (B3LYP/TZVP) modelling the rotation of
the Z -alkene revealed a distinct transition state between two relatively low energy macrocyclic
ring conformers, a defining characteristic of atropisomerism (Figure 6.5). These calculations
suggest an activation energy of around 30 kcal/mol for conformer interconversion, which
is in good agreement with values associated with stable atropisomers that experience very
slow interconversion (t1/2 = years). Adding an element of axial chirality to the proposed
structure of labillarides E-H means that additional diastereomeric combinations need to be
considered (Figure 6.6). Molecular modelling of the Ra,8S,7R,6R,3R-, Sa,8S,7R,6R,3R-,
Ra,8R,7R,6R,3R-, and Sa,8R,7R,6R,3R-diastereomers of the labillaride E-H scaffold revealed
a number of interesting structural relationships.26 Firstly, the key H–H coupling constants,
3JHaHb and 3JHbHc, reported for labillarides E-H match very well with those calculated
for the Sa,8R,7R,6R,3R-diastereomer.27 Additionally, the calculated 3JHH values for the
Sa,8S,7R,6R,3R- and Ra,8R,7R,6R,3R-diastereomers were both a poor match with the
experimental data, while the Ra,8S,7R,6R,3R-diastereomer had one good match and one
poor match. Interestingly, the layout of Figure 6.6 resembles that typically used when
defining stereochemical relationships between the stereoisomers of a compound containing
two stereocenters, where the vertically and horizontally adjacent structures are related as
diastereomers and the structures that lie on the same diagonal are related as enantiomers. To
a certain extent, the diastereomers shown in Figure 6.6 mirror this relationship – by inverting
both the axial and C8 point chirality, in conjunction with a reorientation of the macrocycle to
minimize unfavourable gauche interactions, one observes a new structure that conserves many
of the spatial relationships present in the original structure – these ’pseudo-enantiomers’ are
shown in Figure 6.7.
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Figure 6.5 Axial Chirality in Labillarides E-H: Calculated Atropisomeric Transition State
and Intrinsic Reaction Coordinate.
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Figure 6.7 Structural Similarities Resulting from Inversion of Axial and C8 Point Chirality.
While this computational analysis does not provide a complete explanation of the unusual
spectroscopic similarities displayed by labillarides E-H, it does shed light on how such similar
1H and 13C NMR spectra might result from these diastereomeric compounds. This new-found
awareness of the potential structural nuances of labillarides E-H is likely to be valuable in
research towards the total synthesis of these compounds.
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6.6 Experimental Data for Chapter 6
6.6.1 General Experimental Methods
Unless otherwise noted, the following conditions apply. All reactions were performed in flame-
dried septum-sealed glassware with magnetic stirring under an atmosphere of argon. Moisture-
and oxygen-sensitive liquids and solutions were transferred using a stainless steel syringe or
cannula. Before use, solvents were refluxed over the appropriate drying agent and distilled
under argon: tetrahydrofuran from sodium benzophenone ketyl radical; dichloromethane,
acetonitrile and triethylamine from calcium hydride; toluene from sodium. All other
commercially available chemicals were used as received, without further purification. Analytical
thin layer chromatography (TLC) was performed using plastic-backed pre-coated silica TLC
plates (Polygram SilG/UV254). Visualization was achieved by UV irradiation (254 nm) or
by heating after treatment with a potassium permanganate dip (1.5 g KMnO4, 10 g K2CO3,
1.25 mL of 10% aqueous NaOH solution and 200 mL of water) or p-anisaldehyde dip (0.7
mL p-anisaldehyde, 9.5 mL conc. H2SO4, 2.7 mL of acetic acid and 250 mL of EtOH). The
purification of products by flash column chromatography (FCC) was conducted using silica
gel 60 (220-240 mesh) with the solvent systems indicated. 1H NMR spectra were recorded
on either: a Varian Unity Inova 500 spectrometer at 500 MHz, or a Varian Inova 300 at 300
MHz. Data are listed as chemical shift in ppm using CDCl3 as internal standard (7.26 ppm).
13C NMR spectra were recorded on a Varian Unity Inova 500 spectrometer at 125 MHz and
the data are listed as chemical shift in ppm using CDCl3 as internal standard (77 ppm). All
13C experiments were 1H decoupled. IR bands were measured as a thin film on a Bruker FT-
IR Tensor 27 spectrometer with ATR sampling accessory. High-resolution mass spectrometry
(HRMS) was performed on a Waters QTOF Premier Tandem mass spectrometer or an Agilent
6530 Accurate-Mass Q-TOF LC/MS.
6.6.2 Experimental Details and Characterization Data
Preparation of Z-But-2-ene-1,4-diyl dimethyl dicarbonate, 315
OCO2Me
OCO2Me
315
To a solution of 1,4-butene diol (1.12 mL, 13.62 mmol, 1.0 equiv) and DMAP (4.16 g, 34.05
mmol, 2.5 equiv) in CH2Cl2 (30 mL) was added methyl chloroformate (2.63 mL, 34.05 mmol,
2.5 equiv), portionwise, at 0 ◦C. The reaction was subsequently warmed to room temperature
and stirred overnight before being quenched with H2O. The reaction mixture was diluted with
CH2Cl2 and washed with saturated aqueous CuSO4. The organic layer was subsequently dried
with MgSO4, filtered and concentrated in vacuo. The crude product was purified by silica
gel chromatography (20% EtOAc/Pet. Ether). The title compound was isolated as a clear
colorless oil (2.661 g, 96% yield). Rf = 0.49 (20% EtOAc/Pet. Ether). 1H NMR (500 MHz,
CDCl3) δ 5.82 (ddd, J = 5.2, 4.0, 1.2 Hz, 1H), 4.76 (m, 2H), 3.80 (s, 3H). 13C NMR (126
MHz, CDCl3) δ 155.54, 127.98, 63.18, 54.92. Characterization data matches the literature.28
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Preparation of 6-Methyl-2-vinyl-2H -furo[3,2-c]pyran-4(3H )-one, 316
O
O
O316
1H-NMR (500 MHz, CDCl3): δ 5.96 (m, 1H, HC=), 5.94 (d, J = 0.5 Hz, 1H, PyH), 5.40
– 5.32 (m, 2H, one of =CH2 and PyOCH), 5.29 (dt, J = 10.4, 1.0 Hz, 1H, one of =CH2), 3.22
(dd, J = 14.9, 10.1 Hz, 1H, one of PyCH2), 2.81 (dd, J = 14.9, 7.5 Hz, 1H, one of PyCH2), 2.26
(d, J = 0.7 Hz, 3H, PyCH3). 13C-NMR (126 MHz, CDCl3): δ 171.06, 165.28, 162.13, 135.55,
118.06, 99.03, 95.65, 86.75, 31.64, 20.39. IR (film): 3084, 2924, 1714, 1636, 1579, 1451, 1416,
1254, 1165, 1108, 976, 919 cm−1. HRMS - ESI (m/z): [M+Na]+ calculated for C10H10O3+,
179.0708; found, 179.0711.
Preparation of Pent-1-en-3-ol, 322
OH
322
To a solution of propionaldehyde (1 g, 17.22 mmol, 1.0 equiv) in THF (86 mL) at 0 ◦C
was added vinyl magnesium bromide (22.38 mL of a 1M solution, 22.38 mmol, 1.3 equiv). The
reaction was subsequently warmed to room temperature and stirred for 10 hours before being
quenched with saturated aqueous NH4Cl. The reaction mixture was diluted with H2O and
Et2O, extracted twice with Et2O, and the combined organics were dried over MgSO4, filtered,
and concentrated in vacuo. The crude product was purified by silica gel chromatography (20%
Et2O/Pet. Ether). The title compound was isolated as a clear yellow oil (0.46 g, 31% yield).
Rf = 0.18 (20% Et2O/Pet. Ether). 1H NMR (500 MHz, CDCl3) δ 5.87 (ddd, J = 16.9, 10.4,
6.2 Hz, 1H), 5.23 (d, J = 17.2 Hz, 1H), 5.12 (d, J = 10.4 Hz, 1H), 4.04 (q, J = 5.6 Hz, 1H),
1.57 (m, 2H), 0.94 (t, J = 7.5 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 140.94, 114.79, 74.57,
29.85, 9.59. Characterization data matches the literature.29
Preparation of (E)-2-(3-hydroxypent-1-en-1-yl)-6-methyl-2H -furo[3,2-c]pyran-
4(3H )-one, 323
O
O
O
OH O
O
O
OH
syn- anti-
+
323323
To a solution of Grubbs 2nd generation catalyst (0.014 g, 0.017 mmol, 10 mol %) in CH2Cl2
(7.46 mL) was added a solution of 6-methyl-2-vinyl-2H -furo[3,2-c]pyran-4(3H )-one (0.030 g,
0.169 mmol, 1.0 equiv) and pent-1-en-3-ol (0.102 g, 1.184 mmol, 7 equiv) in CH2Cl2 (1 mL).
The reaction mixture was heated to 45 ◦C and was stirred overnight. The reaction was then
cooled to room temperature, concentrated in vacuo (note: the title compound showed visible
signs of decomposition when concentrated at temperatures above 45 ◦C.) and purified by silica
gel chromatography. The title compound was isolated as a clear colorless oil (0.018 g, 45%
yield, 66:34 ratio of syn- and anti-diastereomers, 0.016 g RSM). Rf = 0.21 (60% EtOAc/Pet.
Ether). IR (film): 3400, 2963, 2927, 1704, 1638, 1580, 1453, 1256, 978, 919 cm−1. The two
diastereomers were separated using HPLC: Diol (Analytical, 250 mm x 4.6 mm, 5 micron),
45% EtOAc/nHexane (isocratic), flow rate = 1 mL/min, λ = 230/300 nm, Rt(major) = 10.6
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min, Rt(minor) = 11.4 min. (Note: The order of elution of the major and minor diastereomer
in the HPLC trace below is the opposite to that shown in the LC-MS trace (Figure 6.1) because
the later uses a reverse phase column and the products were eluted using 12% MeCN/H2O
(isocratic) with 0.05% ammonium formate.
O
O
O
OH O
O
O
OH+HPLC: Diol (Analytical, 250 mm x 4.6 mm, 5 micron), 45\% EtOAc/\textit{n}Hexane (isocratic), ow rate = 1 mL/min
Major diastereomer (syn-323): 1H-NMR (600 MHz, CDCl3): δ 5.92 (m, 1H), 5.86
(dd, J = 18, 6 Hz, 1H), 5.83 (dd, J = 12, 6 Hz, 1H), 5.37 (m, 1H), 4.11 (m, 1H), 3.22 (dd, J
= 14.9, 10.0 Hz, 1H), 2.80 (dd, J = 14.9, 7.6 Hz, 1H), 2.26 (app. d, J = 0.7 Hz, 3H), 1.58 (m,
2H), 0.95 (t, J = 7.5 Hz, 3H). 13C NMR (151 MHz, CDCl3) δ 171.01, 165.29, 162.12, 137.06,
127.76, 99.07, 95.66, 86.29, 72.94, 31.95, 29.96, 20.42, 9.61. HRMS - EI (m/z) calculated for
C13H16O4+ [M+H]+: 236.1049, found: 236.1059.
Minor diastereomer (anti-323): 1H-NMR (600 MHz, CDCl3): δ 5.93 (s, 1H), 5.85 (dd,
J = 18, 6 Hz, 1H), 5.82 (dd, J = 18, 6 Hz, 1H), 5.38 (m, 1H), 4.11 (m, 1H), 3.22 (dd, J =
14.9, 10.0 Hz, 1H), 2.79 (dd, J = 14.9, 7.5 Hz, 1H), 2.26 (s, 3H), 1.58 (m, 2H), 0.94 (t, J = 7.5
Hz, 3H). 13C NMR (151 MHz, CDCl3) δ 171.00, 165.31, 162.12, 136.89, 127.87, 99.05, 95.66,
86.21, 73.03, 31.97, 29.92, 20.42, 9.63. HRMS - EI (m/z) calculated for C13H16O4+ [M+H]+:
236.1049, found: 236.1056.
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6.6.3 Spectra
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7.1 Initial Investigations Into The Use of Substituted Bis-
Electrophiles in Pd-AA Cascades.
The use of a Pd-AA cascade in the synthesis of labillarides E-H is contingent on the introduction
of a synthetic handle at C7 (labillaride numbering) to enable the construction of the macrocyclic
ring. One method by which this can be achieved is through the use of a substituted butene-
1,4-dicarbonate bis-electrophile in the Pd-AA cascade reaction. With this in mind, the use of
the D-mannitol derived substrate 324 in a Pd-AA cascade with 4-hydroxy-6-methyl-α-pyrone
(253) was investigated. The aforementioned substituted bis-electrophile was prepared in five
steps from D-mannitol (Scheme 7.1). Unfortunately, 324 was found to be unreactive under
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Scheme 7.1 Synthesis of a Mannitol-Derived, Substituted Bis-Electrophile.
the previously optimized Pd-AA conditions (Scheme 7.2). This observation is not dissimilar to
previous results obtained during the first generation approach to labillarides E-H (see Section
5.3). The poor reactivity of this substrate is presumably a consequence of steric hinderance
preventing the formation of the pi-allyl-Pd intermediate required for alkylation to occur.
OCO2Me
OCO2MeOTBS
OTBS
O
OH
O
O
O
O
OTBS
OTBS
+
Pd2(dba)3, PPh3
NEt3, CH3CN
253 324
Scheme 7.2 Attempted Pd-AA Cascade with the Substituted Bis-Electrophile, 324.
In an attempt to overcome this problem, a number of cyclic bis-electrophiles were
investigated with the hope that tying back some of the steric bulk of the substrate, in the
form of a ring, would enable substituted bis-electrophiles to participate in the desired Pd-AA
cascade.§ Using the Pd-AA conditions shown in Scheme 7.2, the tetrasubstituted cyclohexenes
326 and 327 did not react with 4-hydroxy-6-methyl-α-pyrone, despite reports in the literature
describing Pd-AA reactions with very similar substrates.1 Use of the less sterically encumbered
§See Section 7.5 for details on the synthesis of these substrates.
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Figure 7.1 Attempted Pd-AA Cascades with Cyclic Bis-Electrophiles.
substrate, bis-epoxide 328 resulted in the isolation of an unwanted isomerization product, 1,2-
catechol. Moving on to a disubstituted cyclohexene, acetate 329, again gave no reaction.
However, the corresponding carbonate, 330, provided the desired reactivity and produced
tetrahydrobenzofuran 331 in 51% yield (Scheme 7.3).
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Scheme 7.3 A Cyclohexene-Based Pd-AA Cascade.
Unfortunately, tetrahydrobenzofuran 331 lacks the functionality necessary for the synthesis
of labillarides E-H, and attempts to perform an allylic oxidation were unsuccessful. With a new
found awareness of the substrate limitations inherent to the Pd-AA cascade, our focus shifted
away from substituted cyclohexenes and towards finding effective non-symmetric heterocyclic
bis-electrophiles for the Pd-AA cascade.
7.2 Development of a Non-Symmetric, Regioselective Pd-AA
Cascade
The major challenge of Pd-AA cascade reactions with non-symmetric substrates is the
differentiation of the two nucleophilic and electrophilic centers so that a single product is
formed regioselectively. Scheme 7.4 exemplifies the large number of regiochemical possibilities
that exist in a Pd-AA of a non-symmetric allyl bis-electrophile with a non-symmetric
bis-nucleophile. The initial permutations shown are further compounded by a second
addition. Typically, this challenge has been avoided by employing symmetric electrophiles
or nucleophiles, thereby obviating the need for regioselectivity. Thus, despite the synthetic
efficiency of the Pd-AA cascade, it has found limited use in total synthesis (vide supra). During
the course of our current research into pyrone-based natural products, we have discovered that
certain dihydropyran substrates serve as non-symmetric bis-electrophiles for Pd-AA cascades
with cyclic β-dicarbonyl compounds. This methodology provides rapid access to unsaturated
furopyran ring systems with excellent regio- and diastereoselectivity.
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Scheme 7.4 Regiochemical Permutations for a Non-Symmetric Pd-AA Cascade.
7.2.1 Reaction Optimization
A non-symmetric Pd-AA cascade was attempted using cis-332, which was prepared in four
steps from furfuryl alcohol via known alcohol 333 (Scheme 7.5).2 The relative stereochemistry
of these 3,6-dihydro-2H -pyrans is discussed in detail in Chapter 8. Optimization of the Pd-
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Scheme 7.5 Synthesis of Pyran Substrates, cis-332 and trans-332.
AA cascade reaction began with the conditions from the symmetric Pd-AA cascade (see 6.3),
which provided the desired furopyran 334 in a modest 42% yield (Table 7.1). However, it
soon became evident that a number of conclusions from the previous optimization were not
consistent with the results from the dihydropyran-based substrate 332. Specifically, the use of
2.2 equivalents of 4-hydroxy-α-pyrone was not necessary and, in fact, the use of excess pyrone
was detrimental in some cases (Entries 1–4), leaving unreacted starting material (cis-332)
and producing the undesired O-alkylation side product, 335 (see Scheme 7.8). The disparity
between the two sets of results meant that any assumptions that were carried over from earlier
work needed to be treated lightly, and therefore a new set of solvent screening experiments
was performed. Performing the reaction in THF or CH2Cl2 gave modest yields of 44% and
30% respectively (Entries 6 & 3). The use of CH3CN, without any additives, provided a poor
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12% yield (Entry 5), whereas toluene gave a very promising 65% yield (Entry 7). Changing
to a more reactive palladium complex, Pd(PPh3)4,4 provided a higher yield and enabled the
the Pd loading to be significantly reduced. Ultimately, the use of 5 mol % of Pd(PPh3)4 in
toluene provided an optimized yield of 83% (Entry 9). Unfortunately, reducing the catalyst
loading further (1 mol %) caused a significant decrease in yield. The addition of triethylamine
to these optimized conditions provided no additional improvements in yield (Entry 10).
Table 7.1 Optimization of a Pd-AA Cascade with Dihydropyran cis-332
O
O
OH
O
OTBS
OCO2Me
O
O
O
OH
H
Conditions
+
cis-253 332 334
Entry[a] Catalyst (mol %)[b] Solvent Comments Yield
1 Pd2(dba)3/PPh3 (10) CH3CN
2.2 equiv 253, 42%1 equiv NEt3
2 Pd2(dba)3/PPh3 (10) CH3CN 1 equiv NEt3 40%
3 Pd2(dba)3/PPh3 (10) CH2Cl2 – 30%
4 Pd2(dba)3/PPh3 (10) CH2Cl2 2.2 equiv 253 5%[c]
5 Pd2(dba)3/PPh3 (10) CH3CN – 12%
6 Pd2(dba)3/PPh3 (10) THF – 44%
7 Pd2(dba)3/PPh3 (10) Toluene – 65%
8 Pd(PPh3)4 (10) Toluene – 71%
9 Pd(PPh3)4 (5) Toluene – 83%
10 Pd(PPh3)4 (5) Toluene 1 equiv NEt3 71%
11 Pd(PPh3)4 (1) Toluene – 56%[d]
[a] Isolated yields are reported. [b] 2:1 ratio of P:Pd was used. [c] 39% recovered 332 and 4% of the
O-alkylation side product were also isolated.
The use of an anomeric siloxy group proved crucial to the success of this chemistry as the
relatively low reactivity of the –OTBS group allows for preferential ionization of the allylic
carbonate.3 Alkylation of the resulting pi-allyl-Pd species occurs regioselectively at C5 as a
result of both steric and electronic factors inherent to pyran-based substrates.5
7.2.2 Stereoconvergence and Mechanistic Inferences
Pd-AA with soft nucleophiles typically proceeds via double inversion of configuration,6 such
that the product stereochemistry is dependent on that of the starting material. Interestingly,
the Pd-AA cascade of trans-332 (see Scheme 7.5) with 253 also produced the cis-fused product,
334 (Scheme 7.6). The cis-stereochemistry of 334 was confirmed by X-ray crystallographic
analysis (Figure 7.2, see Appendix B for crystal data).
The formation of the cis-fused product (334) from trans-332 is presumably a consequence
of the prohibitively large amount of strain energy present in the unsaturated trans-fused
furopyran structure of 336.8 The relative energy difference between the cis- and trans-fused
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Entry Catalyst (mol %)[b] Solvent Comments Yield of 334[a]
1 Pd2(dba)3/PPh3 (10) CH3CN 1 equiv NEt3 38%
2 Pd(PPh3)4 (5) Toluene – 10%
3 Pd(PPh3)4 (20) Toluene – 74%
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Scheme 7.6 Inversion of Configuration in the Pd-AA Cascade with Dihydropyran trans-332.
ORTEP drawing shows 50% thermal ellipsoids.7
Figure 7.2 X-Ray Crystal Structure of 334.
products was calculated to be 51 kJ/mol (B3LYP/6-31G*). The higher catalyst loading
required for efficient transformation of trans-332 (Scheme 7.6, Entry 3) suggests that the
initial syn-palladium complex (337) may be isomerized by nucleophilic attack of a transient
Pd(0) species (step VI, Scheme 5).9 Conveniently, the Pd-AA cascade of cyclohexene-based
substrate, trans-330 (Scheme 7.7) can be used to validate this mechanistic hypothesis. This
substrate provides an opportunity to evaluate the putative pi-allyl-Pd isomerization without
the possibility of the reaction proceeding through an oxonium intermediate, as may be the
case for trans-332. Ultimately, 2D NOE spectroscopy and comparison of the 3JHH values of
OCO2Me
OCO2Me
O
O
OH
O
O
O
H
H
trans-
Pd2(dba)3, PPh3,
CH3CN, NEt3
52% yield
+
330 331
Scheme 7.7 Stereochemical Assignment of 331 and Mechanistic Inferences.
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the isosteric compounds 334 and 331 confirmed that trans-330 also provides the cis-fused
product, 331 in a stereoconvergent manner.
Throughout these investigations, double alkylation was observed in almost all instances.
Single O-alkylation was only observed in two cases where reactivity was impaired, either
through low catalyst loading (Table 7.1, Entry 11) or by the presence of excess pyrone,
253 (Table 7.1, Entry 4). 4-Hydroxy-6-methyl-α-pyrone (253) has a pKa of 6.83 (80
w/w% DMSO/H2O)10 and therefore, under effective reaction conditions, the O-alkylation
product (335, Scheme 7.8) can act as an allyl acetate equivalent, reacting with zero-valent
palladium to re-form the previous pi-allyl complex (Scheme 7.8, step III).11 These results
suggest that the excellent regioselectivity observed in most cases is a consequence of the
first substitution operating under thermodynamic control. Based on the aforementioned
experimental observations, a mechanism for the stereoconvergent Pd-AA cascade is proposed
in Scheme 7.8.
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net retention of configuration. (III) Reversion of the O-allylation product to the original pi-allyl
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Scheme 7.8 Proposed Mechanism for the Pd-AA Cascade.
7.2.3 Substrate Scope
The scope of this reaction was explored using the optimized reaction conditions from Table 7.1
and a variety of β-dicarbonyl bis-nucleophiles (Scheme 7.9). In general, nucleophiles with high
enol content, such as α-pyrone 332 and coumarins 338a and 338b, produced the highest
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Scheme 7.9 Bis-Nucleophile Scope in the Pd-AA Cascade.
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yields (68–83% yield). Overall, the parameters that define an effective nucleophile in these
cascade reactions proved relatively complex, and high enol content alone does not seem to
guarantee high yield. For example, the 4-hydroxy-pyridinone 338g provided none of the
desired product 339g under the standard conditions, presumably due to poor solubility in
toluene. However, by performing the reaction in a 3:1 mixture of toluene/DMF, 37% yield
was obtained. Additionally, tetronic acid 344 and tetramic acid 343, which both exist
predominantly in the enol form, provided a complex mixture that did not contain the desired
product. Enolization does however play a crucial role in the intramolecular substitution, and
substrates that are predisposed to the keto form, such as dimedone (338e), Meldrum’s acid
(351), and 1,3-indandione (346), form α-disubstituted β-dicarbonyl side products, as shown
in Scheme 7.10. Despite this competing side reaction, a moderate 51% yield was obtained with
O
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OTBS
52% yield
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OCO2Me
OTBS
cis-
5 mol% Pd(PPh3)4,
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+
332346 352
Scheme 7.10 Formation of α-Disubstituted β-Dicarbonyl Side Products.
dimedone (338e). Additionally, the dihydro-α-pyrone bis-nucleophiles 338c and 338d provide
the desired furopyran products in 55% and 61%, respectively. Unfortunately, both barbituric
acid (347) and N,N -dimethyl barbituric acid did not provide the desired products. As with
the other nitrogen-containing heterocycles, the solubility of bis-nucleophile was a concern in
both of these reactions. It is also interesting to note that use of acyclic nucleophiles, dimethyl
malonate (349) and methyl acetoacetate (350), resulted in a standard allylic alkylation and
the anomeric –OTBS group remained unchanged.
The analogous Pd-AA cascade reaction with Meldrum’s acid provides an atypical γ-lactone
product, 340, in 39% yield. This product is presumably formed through the extrusion of
acetone from the initial dioxinone, followed by trapping of the resulting acylketene intermediate
with methanol liberated from the carbonate, as shown in Scheme 7.11.12 This result is
particularly exciting given the potential of γ-lactone 340 as a synthetic intermediate in the
preparation of α-methylene-γ-butyrolactone natural products.13 The potential utility of this
transformation prompted a separate optimization to reduce the amount of the unwanted α-
disubstituted side product 341 and improve the yield of the desired γ-lactone. At the outset,
two key steps in the reaction sequence were identified as targets for optimization – namely,
improving the preference for intramolecular substitution as opposed to a second intermolecular
alkylation (i.e. formation of 341), and a more effective trapping of the acylketene intermediate.
Given that the Pd-AA cascade produces both MeOH and TBSOH, it is likely that some
acylketene is trapped by the silanol and subsequently hydrolyzed to give a carboxylic acid side
product. In an attempt to improve the acylketene trapping with methanol, the reaction was
performed in a 10:1 mixture of toluene/MeOH – these conditions provided the desired product
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Scheme 7.11 Pd-AA Cascade with Meldrum’s Acid: γ-Lactone Formation.
340 in an improved yield of 46% and supressed formation of the α-disubstuted side product
341 (Entry 2). A number of literature examples show that the use of different solvents can
greatly influence the regioselectivity of enolate alkylation,14 and therefore it’s not surprizing
that the use of methanol as a co-solvent could prevent the formation of the bis-C -alkylated
side product altogether. A brief period of heating (80 ◦C, 2 hours) was added at the end of the
reaction to aid the retroaldol process that produces the acylketene, however, approximately
the same yield was obtained suggesting that acylketene formation goes to completion at room
temperature (Entry 3). While the use of methanol was beneficial in preventing the formation
of the α-disubstuted side product 341, it proved deterimental to the overall rate of the Pd-AA
cascade and the experiments performed in toluene/MeOH often contained unreacted starting
material, even at solvent ratios as low as 100:1 (Entry 4). In a parallel series of experiments,
the effect of concentration was investigated with the aim of disfavoring the intermolecular side
reaction by performing the reaction at higher dilution. Unfortunately, performing the reaction
at 0.017 M, instead of 0.05 M, had little effect on the isolated yields of 340 and 341 (Entries
5 & 6). The use of a less reactive acetate leaving group would also decrease the relative rate
at which the side product 341 is formed, however, this electrophile was unreactive in initial
experiments (Entries 8 & 9). Ultimately, it was discovered that the desired reactivity could be
obtained by performing the reaction at 80 ◦C using 5 equivalents of Meldrum’s acid, 10 mol%
Pd(PPh3)4, 1.5 equivalents MeOH, and THF as the reaction solvent (Entry 10). In this case,
the desired product was obtained in 43% yield, making this experiment the first example of
an allylic acetate participating in a Pd-AA cascade. However, the moderate yield obtained in
this reaction prompted a return to the more reactive carbonate substrates. This decision also
motivated by the observation of Meldrum’s acid degradation products in reactions performed
at elevated temperatures. In theory, the use of an excess of Meldrum’s acid should disfavor
the formation of 341 , as Meldrum’s acid is in direct competition with the mono-alkylated
intermediate for electrophiles to react with. With the results from Table 7.1 in mind, the Pd-AA
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Table 7.2 Optimization of a Pd-AA Cascade with Meldrum’s Acid.
O
OH
HO
O
MeOO
O
O
O
O
LG
OTBS
cis-
+
5 mol % Pd(PPh3)4,
rt, overnight
351 332 340
Entry LG Equiv Solvent (conc.) Comments[a] Yield[b]351
1 -OCO2Me 1.0 Toluene (0.05 M) 53% 341 39%
2 -OCO2Me 1.0 Toluene/MeOH, 10:1 (0.05 M) no 341 46%
3 -OCO2Me 1.0 Toluene/MeOH, 10:1 (0.05 M) rt/80 ◦C[c] 50%
4 -OCO2Me 1.0 Toluene/MeOH, 100:1 (0.05 M) RSM 49%
5 -OCO2Me 1.0 Toluene (0.017 M) 50% 341 48%
6 -OCO2Me 1.0 Toluene (0.017 M) 15 mol % Pd 40%
7 -OCO2Me 1.0 Dioxane (0.05 M) – 0%
8 -OAc 1.0 Toluene (0.05 M) NaOMe, 80 ◦C[d] 0%
9 -OAc 5.0 Toluene (0.05 M) 10 mol % Pd, 0%MeOH, 80 ◦C[e]
10 -OAc 5.0 THF (0.05 M) 10 mol % Pd, 43%MeOH, 80 ◦C[e]
11 -OCO2Me 3.0 Toluene (0.05 M) NEt3[f] 0%
12 -OCO2Me 5.0 Toluene (0.05 M) 80 ◦C 0%
13 -OCO2Me 5.0 THF (0.05 M) 80 ◦C 0%
14 -OCO2Me 5.0 THF (0.1 M) 10 mol % Pd 29%
15 -OCO2Me 5.0 THF/MeOH, 25:1 (0.1 M) 10 mol % Pd 41%
16 -OCO2Me 5.0 THF/MeOH, 10:1 (0.1 M) 10 mol % Pd 69%
17 -OCO2Me 5.0 THF/MeOH, 2:1 (0.1 M) 10 mol % Pd 22%
[a] The α-disubstituted Meldrum’s acid side product, 341, was only isolated in select experiments.
[b] Isolated yields are reported. Pd refers to Pd(PPh[3])[4] [c] The reaction was heated to 80 ◦C for 2
hours after being stirred overnight at room temperature. [d] Reaction performed at 80 ◦C using 1.1
equiv NaOMe. [e] 1.5 equiv MeOH were used. [f] 3 equiv NEt3 were used.
cascade was attempted using an excess of Meldrums acid and NEt3 (Entry 11). Unfortunately,
these conditions gave none of the desired product, nor did those without NEt3 (Entry 12).
Surprisingly, it was discovered that using an excess of Meldrum’s acid in conjunction with THF
as the reaction solvent restored the desired reactivity (Entry 14). Combining this discovery
with the use of MeOH as a co-solvent (10:1, THF:MeOH) provided the desired γ-lactone in a
satisfying 69% yield (Entry 16). The ratio of MeOH proved important, presumably the use of
too much MeOH inhibits the overall reactivity of the allylic alkylation cascade, whereas not
enough methanol leads to poor trapping of the acylketene intermediate (Entries 15 & 17).
The use of C2-substituted bis-electrophiles, such as 353,15 also provides good yields of the
desired furopyrone product (Scheme 7.12). In this case, compound 353 represents a mixture
of C6 epimers, which, given the stereoconvergent nature of the Pd-AA cascade, ultimately
form a single cis-fused product diastereoselectively. However, to facilitate this process a
higher catalyst loading was used (15 mol %). Thus, 6-methyl-4-hydroxy-α-pyrone provided
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the furopyrone 354 in 77% yield. When the same reaction was performed with 5 mol %
Pd(PPh3)4, only 50% yield of 354 was obtained. Additionally, the use of 4-hydroxycoumarin
as a bis-nucleophile provided furopyrone 355 in an excellent 90% yield.
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Scheme 7.12 Pd-AA Cascade with Enantioenriched C2-substituted Bis-Electrophiles.
In summary, a palladium-catalyzed allylic alkylation cascade with non-symmetric pyran-
based substrates has been developed and provides rapid access to substituted cis-fused
furopyrans. The use of an anomeric siloxy leaving group imparts regiochemical control,
providing the desired products in a rapid, selective and stereoconvergent manner. This
methodology leads to a number of versatile synthetic intermediates, whose exploitation
in several synthetic endeavors is being pursued. Additionally, these heterocyclic products
resemble a number of bioactive natural products and contain structural elements that are
often conducive to interesting biological activity.
7.3 Biological Testing of the Furopyrones Generated via a Pd-
AA Cascade
Pyrone and coumarin-based heterocycles are present in a wide range of bioactive natural
products and pharmaceutical agents. These planar motifs enable a conformationally rigid
structure containing both polar and lipophilic elements, and these characteristics are often
essential for effective binding to a biological receptor.16 A wide range of biological activity
has been reported for various α-pyrone-containing compounds, some of which are shown in
Figure 7.3. Warfarin (Coumadin R©) is an important anticoagulant used to prevent formation of
potentially lethal blood clots.17 Pfizer developed U-96988 as a first generation clinical candidate
for the treatment of HIV infection.18 Arisugacin A is a potent inhibitor of acetylcholinesterase
(AChE), which has been linked to the treatment of Alzheimer’s disease.19 TMC-69 is a potent
antitumor agent that has served as the parent compound in a number of SAR studies.20
Brevione B is an allelochemical with potential application as a herbicide.21 Lastly, coumestrol
is a potent phytoestrogen.22
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Figure 7.3 Bioactive Furopyrone and Pyrone-Containing Compounds.
The Pd-AA cascade products shown in Table 7.3 were found to have exciting cytotoxicity
against HL-60, a human leukemia cell line. Surprisingly, the coumarin and pyrone-containing
compounds 334, 339a, and 339b were the least active of all the furopyrones screened. The
furopyrones containing a partially saturated pyrone ring displayed consistently low IC50 values,
with aryl bromide 339d and spirocycle 339c having IC50 values of 97 µM and 94 µM,
respectively. Additionally, the dimedone-derived heterocycle 339e was found to be particularly
active, with an IC50 of 29 µM. The introduction of a carbonate substituent on the dihydropyran
ring produced compounds with significantly improved activity. Pyrone 354 and coumarin 355
provided HL-60 IC50 values of 21 µM and 25 µM, respectively. This constitutes a ten-fold
increase in cytotoxicity relative to the pyrone and coumarin-based compounds lacking the
carbonate moiety. It is interesting to note that the low micro-molar potency observed for some
of these compounds does not correlate with their relative lipophilicity (cLogP). This suggests
that the cytotoxic effects of these compounds may be a consequence of a specific binding
interaction, as opposed to a general non-specific cytotoxicity.
In addition to anti-cancer activity, the anti-bacterial activity of these compounds was also
investigated. Unfortunately, the three compounds, 339a, 339b, and 339c, that were screened
against E. coli, S. aureus, and M. smegmatis bacterial cell lines showed poor activity.
The rapid preparation of furopyrones using a Pd-AA cascade affords the opportunity
for continued investigations into the biological activities of this heterocyclic scaffold. The
promising anti-cancer properties displayed by some of these compounds bodes well for further
testing, and the combination of the dimedone-derived heterocycle with the carbonate moiety
represents a particularly exciting lead.
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Table 7.3 Bioactivity of Select Pd-AA Cascade Products.
O
O
O
O
MeO
O O
OO
O
O
O
H
H H
H
H
H
O
O
O
OH
H
Br
O
O
O
OH
H
O
O
O
O
H
H
a b
cd e
O
O
O
O
H
H
OCO2Me
O
O
O
O
H
H
OCO2Me
354
355339339 339
339339334
Compound cLogP[a] HL-60 (IC50)[b]
Antibacterial IC90[c]
E. coli S. aureus M. smegmatis
334 –1.43 >250 µM – – –
339a –0.54 >100 µM inactive 1.35 mM inactive
339b –0.57 >100 µM inactive inactive inactive
339c 0.31 94 µM – – –
339d 0.74 97 µM inactive inactive inactive
339e 0.08 29 µM – – –
354 –1.40 21 µM – – –
355 –0.52 25 µM – – –
[a] cLogP was calculated using CS ChemBioDraw Ultra 12. [b] HL-60 cytotoxicity testing was
performed by Dora Leahy and Arun Kanakkanthara. [c] Antibacterial screening was performed by
Nathaniel Dasyam.
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7.4 Synthetic Utility of Furopyrones: Third Generation Ap-
proach to the Synthesis of Labillarides E-H
The furopyrone products generated from the Pd-AA cascade reactions contain a rich array
of functionality, and it was envisioned that the potential synthetic utility of these functional
groups could be utilized in the total synthesis of labillarides E-H. To this end, the development
of an efficient method for the fragmentation of the appended dihydropyran ring was crucial, as
this provides access to the two functionalized furan side chains needed to construct labillarides
E-H (Figure 7.4). The second key requirement in this approach is the epimerization of one of the
furan stereocenters, to ultimately provide the desired trans-substitution. Epimerizations of this
general type, 1,2-cis to 1,2-trans on a 5-membered ring, have good literature precendents and an
intermediate containing a C7 formyl substituent would be well suited to this transformation.23
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Figure 7.4 Third Generation Approach to Labillarides E-H: Dihydropyran Fragmentation.
Initial attempts to functionalize the ‘glycal-like’ cyclic enol ether were based around
hydrolysis, to form a hemi acetal, followed by a chemoselective reaction with the aldehyde
functionality present in the open form (356) of this compound (Scheme 7.13). Unfortunately,
hydrolysis under acidic conditions provided a complex mixture of products. The failure of
this seemingly simple reaction is attributed to the presence of a good leaving group (i.e. ring
opening to give a 4-hydroxy-α-pyrone) at the allylic position. A number of literature reports
also mention the difficulties associated with this type of transformation.24 To circumvent these
problems, a bromohydroxylation approach was investigated.
O
O
O
OH
H
O
O
O
OH
H
OH
O
O
O
OHH
H
O
O
O
O
OHH
H
pTsOH,
THF/H2O
O
O
O
OH
H
H+
O
H
H
Postulated 
Side Reaction: Complex
Mixture
334 356
Scheme 7.13 Attempted Dihydropyran Hydrolysis.
Bromohydroxylation of dihydropyran 334, using NBS in CH3CN/H2O, provided bromo-
hydrin 357 in 43% yield (Scheme 7.14). This product is a result of electrophilic attack on the
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more accessible convex face of the molecule and subsequent nucleophilic addition. A moderate
19% yield of another diastereomer was also isolated during silica gel chromatography, however
this material was not taken forward. The reduction of 357 using sodium borohydride did
not produce the expected epoxy alcohol 358, but instead formed the constitutionally isomeric
furan, 359, in 72% yield. Confirming that the product of this reaction was furan 358, and not
O
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Scheme 7.14 Bromohydroxylation and an Unexpected Epoxide Rearrangement.
epoxide 358, proved challenging. Ultimately, the use of benzene-d6 as an NMR solvent, various
1H/1H and 1H/13C 2D NMR experiments, and spectroscopic analysis of the corresponding
acetate 360 were used to assign the structure of this product. Particularly strong evidence of
this structure could be seen in the 1H/1H COSY NMR spectrum in benzene-d6, which showed
a correlation between the hydroxyl proton and the neighbouring oxymethylene, and also a
correlation between the acetyl carbonyl carbon and the exocyclic oxymethylene in the 1H/13C
HMBC spectrum.
While the unwanted formation of furan 359 prevents further progress towards the structures
of labillarides E-H along this route, it also reveals some very interesting reactivity. Coincidently,
the fused bis-furan structure of 359 closely resembles that of a fungicidal natural product,
canadensolide (Scheme 7.15).25 The use of a Pd-catalyzed allylic alkylation cascade, along
with the conditions used to form 359, could potentially be utilized in a total synthesis of this
bioactive α-methylene-γ-butyrolactone natural product and analogues thereof.
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Scheme 7.15 Potential Application of a Pd-AA Cascade in the Synthesis of Canadensolide
and Related Analogues.
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7.5 Experimental Data for Chapter 7
7.5.1 General Experimental Methods
Unless otherwise noted, the following conditions apply. All reactions were performed in flame-
dried septum-sealed glassware with magnetic stirring under an atmosphere of argon. Moisture-
and oxygen-sensitive liquids and solutions were transferred using a stainless steel syringe or
cannula. Before use, solvents were refluxed over the appropriate drying agent and distilled
under argon: tetrahydrofuran from sodium benzophenone ketyl radical; dichloromethane,
acetonitrile and triethylamine from calcium hydride; methanol and toluene from sodium.
NBS was recrystallized from H2O and dried in a vacuum desiccator. All other commercially
available chemicals were used as received, without further purification. Analytical thin layer
chromatography (TLC) was performed using plastic-backed pre-coated silica TLC plates
(Polygram SilG/UV254). Visualization was achieved by UV irradiation (254 nm) or by heating
after treatment with a potassium permanganate dip (1.5 g KMnO4, 10 g K2CO3, 1.25 mL
of 10% aqueous NaOH solution and 200 mL of water) or p-anisaldehyde dip (0.7 mL p-
anisaldehyde, 9.5 mL conc. H2SO4, 2.7 mL of acetic acid and 250 mL of EtOH). The
purification of products by flash column chromatography (FCC) was conducted using silica
gel 60 (220-240 mesh) with the solvent systems indicated. 1H NMR spectra were recorded
on either: a Varian Unity Inova 500 spectrometer at 500 MHz, or a Varian Inova 300 at 300
MHz. Data are listed as chemical shift in ppm using CDCl3 as internal standard (7.26 ppm).
13C NMR spectra were recorded on a Varian Unity Inova 500 spectrometer at 125 MHz and
the data are listed as chemical shift in ppm using CDCl3 as internal standard (77 ppm). All
13C experiments were 1H decoupled. IR bands were measured as a thin film on a Bruker FT-
IR Tensor 27 spectrometer with ATR sampling accessory. High-resolution mass spectrometry
(HRMS) was performed on a Waters QTOF Premier Tandem mass spectrometer.
7.5.2 Experimental Details and Characterization Data
Experimental Data for 7.1
Preparation of (1S,2S)-1,2-Bis((R)-2,2-dimethyl-1,3-dioxolan-4-yl)ethane-1,2-diol
OH
OH
O
O
O
O
To a solution of D-mannitol (11.45 g, 62.9 mmol, 1.0 equiv) and 1,2-dimethoxy propane
(18.51 mL, 151 mmol, 2.4 equiv) in DME (27.5 mL) was added catalytic SnCl2 (0.165 g). The
resulting white suspension was heated to 90 ◦C and stirred for 1.5 hours, during which time
the reaction became a clear homogeneous solution. The reaction mixture was subsequently
cooled to room temperature and two drops of pyridine were addded. The reaction solvent was
removed in vacuo, CH2Cl2 was added to form a white slurry, which was then filtered to remove
the insoluble mono-acetonide side product. The filtrate was then concentrated in vacuo and
purified using silica gel chromatography (50% EtOAc/Pet. Ether). The title compound was
isolated as a white solid (6.58 g, 40% yield). Rf = 0.24 (50% EtOAc/Pet. Ether). 1H-NMR
(500 MHz, CDCl3) δ 4.15 (q, J = 6.3 Hz, 2 x 1H), 4.10 (dd, J = 8.5, 6.3 Hz, 2 x 1H), 3.97
(dd, J = 8.5, 5.3 Hz, 2 x 1H), 3.72 (d, J = 6.7 Hz, 2 x 1H), 2.90 (br. s, 2 x 1H), 1.40 (s, 2
x 3H), 1.34 (s, 2 x 3H). 13C-NMR (126 MHz, CDCl3) δ 109.56, 79.38, 76.33, 66.26, 26.51,
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25.31. Characterization data matches the literature.33
Preparation of (E)-1,2-Bis((S)-2,2-dimethyl-1,3-dioxolan-4-yl)ethene
O
O
O
O
To a solution of (1S,2S)-1,2-bis((R)-2,2-dimethyl-1,3-dioxolan-4-yl)ethane-1,2-diol (0.800 g,
3.05 mmol, 1.0 equiv) in CH2Cl2 (9 mL) was added dimethylformamide dimethyl acetal (0.813
mL, 6.10 mmol, 2.0 equiv). The reaction mixture was stirred overnight at room temperature
and then concentrated in vacuo and redissolved in toluene (9 mL). MeI (1.52 mL, 24.4 mmol, 8.0
equiv) was added to the reaction mixture, which was subsequently stirred at room temperature
for 2 hours, then heated to reflux and stirred for an additional hour. The reaction was then
cooled to room temperature, hexanes was added and the resulting slurry was filtered through
celite. The filtrate was concentrated in vacuo and purified by silica gel chromatography (15%
EtOAc/Pet. Ether). The title compound was isolated as a white solid (0.273 g, 39% yield).
Rf = 0.39 (20% EtOAc/Pet. Ether). 1H-NMR (500 MHz, CDCl3) δ 5.81 (dd, J = 3.8, 1.8
Hz, 2 x 1H), 4.54 (dddd, J = 7.9, 5.9, 3.7, 1.9 Hz, 2 x 1H), 4.10 (dd, J = 8.1, 6.2 Hz, 2 x 1H),
3.60 (t, J = 7.9 Hz, 2 x 1H), 1.44 (s, 2 x 3H), 1.40 (s, 2 x 3H). Characterization data matches
the literature.
Preparation of (2S,5S,E)-Hex-3-ene-1,2,5,6-tetraol
OH
OH
OH
HO
To a solution of (E)-1,2-bis((S)-2,2-dimethyl-1,3-dioxolan-4-yl)ethene (0.99 g, 0.434 mmol,
1.0 equiv) in methanol (5 mL) was added DOWEX-H (0.49 g). The reaction mixture was
stirred overnight at room temperature before being filtered and concentrated in vacuo. The
title compound was isolated as a clear viscous oil (0.064 g, quant.). 1H-NMR (500 MHz,
CD3OD) δ 5.77 (dd, J = 3.2, 1.5 Hz, 2 x 1H), 4.12 (m, 2 x 1H), 3.50 (dd, J = 11.2, 4.9 Hz, 2
x 1H), 3.46 (dd, J = 11.1, 6.7 Hz, 2 x 1H). 13C NMR (126 MHz, CD3OD) δ 135.20, 76.27,
69.69. Characterization data matches the literature.
Preparation of (2S,5S,E)-Hex-3-ene-1,6-di(tert-butyldimethylsilyloxy)-2,5-diol
OTBS
OH
OH
TBSO
To a solution of (2S,5S,E)-hex-3-ene-1,2,5,6-tetraol (0.064 g, 0.432 mmol, 1.0 equiv) in
CH2Cl2/DMF (3.9 mL and 0.4 mL, respectively) was added NEt3 (0.132 mL, 0.950 mmol,
2.2 equiv), DMAP (0.003 g, 0.026 mmol, 6 mol %) and TBS-Cl (0.130 g, 0.864 mmol, 2.0
equiv). The reaction was stirred at room temperature overnight before being diluted with
Et2O, washed with water, then brine, dried over MgSO4, filtered and concentrated in vacuo.
The crude product was purified by silica gel chromatography (20% EtOAc/Pet. Ether). The
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title compound was isolated as a white solid (0.027 g, 17% yield). Rf = 0.23 (25% EtOAc/Pet.
Ether). 1H-NMR (500 MHz, CDCl3) δ 5.77 (dt, J = 2.9, 1.1 Hz, 2 x 1H), 4.20 (m, 2 x 1H),
3.65 (ddd, J = 10.1, 3.6, 1.5 Hz, 2 x 1H), 3.43 (ddd, J = 9.9, 7.9, 1.6 Hz, 2 x 1H), 2.31 (br.
s, 2 x 1H), 0.91 (s, 2 x 9H), 0.08 (s, 2 x 6H). Characterization data matches the literature.
Preparation of (2S,5S,E)-Methyl Hex-3-ene-1,6-di(tert-butyldimethylsilyloxy)-
2,5-carbonate, 324.
OTBS
OCO2Me
CO2Me
TBSO
To a solution of (2S,5S,E)-hex-3-ene-1,6-di(tert-butyldimethylsilyloxy)-2,5-diol (0.027 g,
0.072 mmol, 1.0 equiv) and DMAP (0.027 g, 0.22 mmol, 3.0 equiv) in CH2Cl2 (0.75 mL)
was added methyl chloroformate (0.017 mL, 0.22 mmol, 3.0 equiv). The reaction was stirred
overnight at room temperature before being concentrated in vacuo and purified by silica gel
chromatography (10% EtOAc/Pet. Ether). The title compound was isolated as a clear colorless
oil (0.024 g, 68% yield). Rf = 0.25 (10% EtOAc/Pet. Ether). 1H-NMR (500 MHz, CDCl3)
δ 5.80 (dd, J = 3.3, 1.5 Hz, 2 x 1H), 5.20 (tdt, J = 5.4, 3.3, 1.4 Hz, 2 x 1H), 3.78 (s, 2 x 3H),
3.68 (d, J = 5.9 Hz, 2 x 2H), 0.88 (s, 2 x 9H), 0.05 (d, J = 2.8 Hz, 2 x 6H).
Experimental Data for Non-symmetric Pd-AA Cascade
Palladium-Catalyzed Allylic Alkylation Cascade General Procedures
METHOD A: A reaction vessel was charged with β-dicarbonyl bis-nucleophile (1.0 equiv),
evacuated and back-filled with argon. Toluene (ca. 0.14 M, degassed by sparging with argon
for approximately 20 minutes) was added to the reaction vessel. A separate reaction vessel was
charged with Pd(PPh3)4 (5 mol%), evacuated and back-filled with argon, then charged with
degassed toluene (ca. 0.7 M relative to substrate) followed by the substrate, cis-(±)-6-[(tert-
butyldimethylsilyl)oxy]-3,6-dihydro-2H -pyran-3-yl methyl carbonate (1.0 equiv). The contents
of this flask were stirred for approximately 20 minutes before being added via syringe to the
bis-nucleophile solution. The reaction was stirred overnight at room temperature before being
concentrated in vacuo and purified by flash column chromatography.
METHOD B: A reaction vessel was charged with β-dicarbonyl bis-nucleophile (1.0 equiv)
and Pd(PPh3)4 (5 mol%), evacuated and back-filled with argon. Toluene (ca. 0.05 M, degassed
by sparging with argon for approximately 20 minutes) was added to the reaction vessel,
followed by the substrate, cis-(±)-6-[(tert-butyldimethylsilyl)oxy]-3,6-dihydro-2H-pyran-3-yl
methyl carbonate (1.0 eq.). The reaction was stirred overnight at room temperature before
being concentrated in vacuo and purified by flash column chromatography.
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Pd-AA Cascade Products
cis-(±)-3-Methyl-9,9a-dihydrofuro[3,2-c:4,5-c’]dipyran-1(5aH)-one, 334.
O
O
O
OH
H363
The reaction was performed with 4-hydroxy-6-methyl-α-pyrone (0.040 g, 0.32 mmol)
according to Method A. The crude product was purified by flash column chromatography
(30% EtOAc /pet. ether) to give the title compound as a yellow solid (0.054 g, 83% yield).
Rf = 0.21 (30% EtOAc /Pet. Ether). 1H-NMR (500 MHz, CDCl3): δ 6.78 (d, J = 6.2 Hz,
1H HC=), 5.93 (s, 1H, PyH), 5.19 (dd, J = 6.2, 4.4 Hz, 1H, HC=), 5.10 (dd, J = 7.6, 4.6 Hz,
1H, PyOCH), 4.36 (dd, J = 10.7, 4.9 Hz, 1H, one of CH2OR), 3.53 (t, J = 10.6 Hz, 1H, one of
CH2OR), 3.44 (ddd, J = 10.4, 7.6, 4.8 Hz, 1H, PyCH), 2.26 (s, 3H, PyCH3). 13C-NMR (126
MHz, CDCl3): δ 172.2, 166.0, 161.8, 150.6, 99.9, 98.4, 96.0, 78.6, 64.7, 36.7, 20.5. IR (film):
3099, 2926, 1705, 1630, 1574, 1452, 1252, 975, 954, 838 cm−1. HRMS - ESI (m/z): [M+Na]+
calculated for C11H10O4Na+, 229.0477; found, 229.0473. Melting point = 138–140 ◦C.
4-[cis-(±)-6-[(tert-Butyldimethylsilyl)oxy]-3,6-dihydro-2H -pyran-3-yl]oxy-6-
methyl-2H -pyran-2-one, 335.
O OTBS
O
O
O
363
The reaction was performed with 4-hydroxy-6-methyl-α-pyrone (0.040 g, 0.315 mmol) ac-
cording to Method B. The crude reaction mixture was purified by flash column chromatography
(30% EtOAc /pet. ether) to give furopyran 4 (0.037 g, 56% yield), along with the title
compound as a yellow oil (0.009 g, 9% yield). Rf = 0.24 (30% EtOAc / Pet. Ether). 1H-
NMR (500 MHz, CDCl3): δ 5.95 (app. dt, J = 10.3, 0.9 Hz, 1H, HC=), 5.89 (app. dt, J
= 10.3, 1.9 Hz, 1H, HC=), 5.77 (m, 1H, PyH), 5.41 (d, J = 2.1 Hz, 1H, CHOTBS), 5.30 (s,
1H, PyH), 4.79 (m, 1H, PyOCH), 3.95 (dd, J = 11.1, 8.0 Hz, 1H, one of CH2OR), 3.88 (ddd,
J = 11.1, 5.4, 0.9 Hz, 1H, one of CH2OR), 2.20 (s, 3H, PyCH3), 0.91 (s, 9H, C(CH3)3), 0.13
(s, 6H, Si(CH3)2). 13C-NMR (126 MHz, CDCl3): δ 169.2, 164.7, 162.6, 132.7, 125.2, 100.6,
89.3, 88.4, 68.6, 59.8, 25.7, 19.9, 18.0, -4.4, -5.3. IR (film): 2929, 2857, 1731, 1711, 1650, 1563,
1248, 1035, 838, 781 cm−1. HRMS - ESI (m/z): [M+Na]+ calculated for C17H26O5SiNa+,
361.1447; found, 361.1443.
cis-(±)-3-Methyl-5a,8,9,9a-tetrahydro-1H -pyrano[4,3-b]benzofuran-1-one, 331.
O
O
O
H
H363
To the solid reagents 4-hydroxy-6-methyl-α-pyranone (0.252 g, 1.997 mmol, 2.2 eq.),
Pd2(dba)3 (0.083 g, 0.091 mmol, 10 mol%), triphenylphosphine (0.095 g, 0.364 mmol, 40
mol%) and trans-(±)-4-[(methoxycarbonyl)oxy]cyclohex-2-en-1-yl methyl carbonate (0.209 g,
0.908 mmol, 1.0 eq.) was added 25 mL of anhydrous acetonitrile at room temperature. This was
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followed by the addition of triethylamine (0.127 mL, 0.908 mmol, 1 eq.). The reaction mixture
was stirred at room temperature for 2 hours before concentration in vacuo and purification by
flash column chromatography (20% EtOAc / pet. ether). The desired product was isolated
as a yellow solid (0.095 g, 51% yield). Rf = 0.21 (20% EtOAc /pet. ether). 1H-NMR (500
MHz, CDCl3): δ 6.21 (m, 1H, HC=), 5.91 (m, 1H, HC=), 5.89 (s, 1H, PyH), 5.08 (app. d, J
= 8.5 Hz,* 1H, PyOCH), 3.36 (app. td, J = 9.2, 4.5 Hz, 1H, PyCH), 2.23 (s, 3H, PyCH3),
2.11 (m, 2H, CH2C=), 1.92 (m, 1H, one of CH2CH2C=), 1.53 (m, 1H, one of CH2CH2C=).
13C-NMR (126 MHz, CDCl3): δ 171.1, 165.1, 162.3, 135.5, 122.6, 103.5, 96.1, 82.0, 37.0, 23.4,
22.4, 20.4. IR (KBr): 2938, 1709, 1630, 1578, 1452, 1384, 1255, 1128, 979 cm−1. HRMS -
ESI (m/z): [M+H]+ calculated for C12H13O3+, 205.0864; found, 205.0865. Melting point =
106–109 ◦C.
* Homonuclear decoupling experiments were used to confirm the coupling constant for the
ring-junction protons: J = 8.21 Hz. The homonuclear decoupling spectra can be found in the
Spectra section.
cis-(±)-7,10a-Dihydropyrano[3’,4’:4,5]furo[3,2-c]chromen-6(6bH)-one, 339a.
O
O
O
O
H
H
364
The reaction was performed with 4-hydroxycoumarin (0.045 g, 0.278 mmol) according to
Method A. The crude product was purified by flash column chromatography (10% EtOAc /
pet. ether) to give the title compound as a yellow solid (0.052 g, 77% yield). Rf = 0.16 (10%
EtOAc / pet. ether). 1H-NMR (500 MHz, CDCl3): δ 7.68 (dd, J = 7.8, 1.6 Hz, 1H, ArH),
7.59 (ddd, J = 8.6, 7.2, 1.5 Hz, 1H, ArH), 7.39 (dd, J = 8.4, 0.5 Hz, 1H, ArH), 7.31 (m, 1H,
ArH), 6.85 (d, J = 5.1 Hz, 1H, HC=), 5.33-5.29 (complex m, 2H, HC= and PyOCH), 4.45
(dd, J = 10.2, 4.3 Hz, 1H, one of CH2OR), 3.68-3.60 (complex m, 2H, one of CH2OR and
PyCH). 13C-NMR (126 MHz, CDCl3): δ 167.7, 160.4, 155.1, 150.8, 132.9, 124.0, 123.0, 117.1,
112.6, 102.6, 98.5, 79.2, 64.7, 37.8. IR (KBr): 2918, 1711, 1640, 1416, 1236, 1161, 1066, 1033,
834 cm−1. HRMS (ESI) calculated for C14H10O4Na+ [M + Na]+: 265.0477, found 265.0470.
Melting point = 178–179 ◦C.
cis-(±)-3-Methoxy-7,10a-dihydropyrano[3’,4’:4,5]furo[3,2-c]chromen-6(6bH)-
one, 339b.
O
O
MeO
O
OH
H
365
The reaction was performed with 4-hydroxy-7-methoxycoumarin (0.040 g, 0.208 mmol)
according to Method A. The crude product was purified by flash column chromatography
(20% EtOAc / pet. ether) to give the title compound as a yellow solid (0.038 g, 68% yield).
Rf = 0.38 (30% EtOAc / pet. ether). 1H-NMR (500 MHz, CDCl3): δ 7.57 (d, J = 9.4
Hz, 1H, ArH), 6.88-6.83 (m, 3H, 2 x ArH and HC=), 5.31 (dd, J = 5.9, 4.6 Hz, 1H, HC=),
5.25 (dd, J = 6.1, 5.0 Hz, 1H, ArOCH), 4.44 (m, 1H, one of CH2OR), 3.89 (s, 3H, OCH3),
3.63-3.57 (m, 2H, one of CH2OR and ArCH). 13C-NMR (126 MHz, CDCl3): δ 168.0, 163.7,
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160.7, 157.1, 150.8, 124.0, 112.6, 105.8, 100.8, 99.7, 98.5, 79.1, 64.9, 55.8, 37.5. IR (KBr):
3002, 2968, 1702, 1638, 1290, 1154, 1106, 1071, 1030, 840 cm−1. HRMS (ESI) calculated for
C15H12O5Na+ [M + Na]+: 295.0582, found 295.0589. Melting point = 150–151 ◦C.
cis-(±)-1’,3’,4’,5a’,9’,9a’-Hexahydro-spiro[cyclohexane-1,3’-furo[3,2-c:4,5-c’]dipyran]-
1’-one, 339c.
O
O
O
OH
H
366
The reaction was performed with 1-oxaspiro[5.5]undecane-2,4-dione (0.050 g, 0.277 mmol)
according to Method A. The crude product was purified by flash column chromatography (20%
EtOAc/pet. ether) to give the title compound as a white foam (0.040 g, 56% yield). Rf =
0.29 (20% EtOAc/pet. ether). 1H-NMR (500 MHz, CDCl3): δ 6.78 (d, J = 6.2 Hz, 1H,
HC=), 5.18 (dd, J = 6.2, 4.4 Hz, 1H, HC=), 5.03 (dd, J = 7.9, 4.4 Hz, 1H, PyOCH), 4.35
(dd, J = 10.8, 5.0 Hz, 1H, one of CH2OR), 3.47 (t, J = 10.6 Hz, 1H, one of CH2OR), 3.31
(m, 1H, CHCH2OR), 2.50 (t, J = 1.5 Hz, 2H, =CCH2), 2.03-1.96 (complex m, 2H, cy-CH2),
1.83-1.75 (complex m, 2H, cy-CH2), 1.56 (complex m, 2H, cy-CH2), 1.49-1.45 (complex m,
2H, cy-CH2), 1.35 (complex m, 2H, cy-CH2). 13C-NMR (126 MHz, CDCl3): δ 172.1, 164.2,
150.5, 101.9, 98.7, 80.9, 78.2, 65.5, 37.3, 36.7, 36.5, 25.2, 21.7. IR (film): 2935, 2863, 1762,
1673, 1407, 1210, 1035 cm−1. HRMS (ESI) calculated for C15H19O4+ [M + H]+: 263.1283,
found 263.1292. Melting point = 70–75 ◦C.
cis-(±)-7,7-Dimethyl-4a,6,7,8,9,9b-hexahydro-1H-pyrano[4,3-b]benzofuran-9-one,
339e.
O
O
OH
H
367
The reaction was performed with dimedone (0.039 g, 0.278 mmol) according to Method
B. The crude product was purified by flash column chromatography (20% EtOAc/pet. ether)
to give the title compound as a yellow oil (0.035 g, 57% yield). Rf = 0.24 (20% EtOAc/pet.
ether). 1H-NMR (500 MHz, CDCl3): δ 6.77 (d, J = 6.1 Hz, 1H, HC=), 5.20 (m, 1H, HC=),
4.93 (t, J = 5.6 Hz, 1H, OCH), 4.35 (m, 1H, one of CH2OR), 3.36 (t, J = 10.6 Hz, 1H, one of
CH2OR), 3.30 (m, 1H, CHCH2OR), 2.37-2.18 (complex m, 2 x 2H, (CH3)2CCH2), 1.13 (s, 3H,
CH3), 1.08 (s, 3H, CH3). 13C-NMR (126 MHz, CDCl3): δ 194.6, 177.7, 150.3, 112.8, 98.8,
77.6, 65.5, 51.0, 38.0, 36.8, 34.2, 29.3, 28.0. IR (film): 2958, 2926, 1724, 1614, 1404, 1215,
1033, 842, 733 cm−1. HRMS (ESI) calculated for C13H16O3Na+ [M + Na]+: 243.0997, found
243.0999.
cis-(±)-3-(4-Bromophenyl)-3,4,9,9a-tetrahydrofuro[3,2-c:4,5-c’]-
dipyran-1(1H,5aH)-one, 339d.
The reaction was performed with 6-(4-bromophenyl)oxane-2,4-dione (0.075 g, 0.279 mmol)
according to Method B. The crude product was purified by flash column chromatography (20%
EtOAc / pet. ether.) to give the title compound as a yellow solid (0.059 g, 61% yield, 1:1
mixture of diastereomers). Rf = 0.15 (20% EtOAc / pet. ether). 1H-NMR (500 MHz,
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O
O
O
OH
H
Br368
CDCl3): δ 7.53 (d, J = 8.4 Hz, 2H, ArH), 7.30 (dd, J = 8.4, 2.1 Hz, 2H, ArH), 6.80 (d, J =
5.5 Hz, 1H, HC=), 5.44 (dd, J = 11.2, 5.0 Hz, 1H, ArCH), 5.21 (dd, J = 6.2, 4.5 Hz, 0.5H,
HC=), 5.18-5.14 (m, 2 x 0.5H, HC= and OCH), 5.09 (dd, J = 7.5, 4.5 Hz, 0.5H, OCH), 4.47
(dd, J = 10.7, 4.9 Hz, 0.5H, one of CH2OR), 4.27 (dd, J = 11.0, 4.8 Hz, 0.5H, one of CH2OR),
3.67 (dd, J = 11.0, 9.2 Hz, 0.5H, one of CH2OR), 3.46-3.40 (m, 2 x 0.5H, one of CH2OR
and CHCH2OR), 3.34 (m, 0.5H, CHCH2OR), 2.82-2.69 (m, 2H, ArCHCH2). 13C-NMR (126
MHz, CDCl3): δ 173.0, 164.2, 150.7, 137.1, 131.9, 127.7, 122.7, 103.2, 98.9/98.2, 79.2/78.8,
76.8, 65.4/65.3, 37.5/37.4, 31.4/31.3. IR (KBr): 2926, 1701, 1641, 1400, 1384, 1237, 1107,
1067, 1037 cm−1. HRMS (ESI) calculated for C16H13BrO4Na+ [M + Na]+: 370.9895, found
370.9900. Melting point = 132–135 ◦C.
(cis)-8-Benzyl-7-methyl-8,9b-dihydro-1H -pyrano[3’,4’:4,5]furo[3,2-c]pyridin-9-
(4aH )-one, 339g.
N
O
O
O
H
H
Ph
369
The reaction was performed with 1-benzyl-4-hydroxy-6-methylpyridin-2(1H)-one (0.022 g,
0.104 mmol, 1.0 equiv) according to method B. The crude product was purified by flash column
chromatography (30% EtOAc/Pet. Ether) to give the title compound as a clear film (0.0115
g, 37% yield). Rf = 0.36 (50% EtOAc/Pet. Ether). 1H NMR (500 MHz, CDCl3) δ 7.32 (dd,
J = 8.2, 6.7 Hz, 2H), 7.17-7.12 (m, 2H), 6.80 (dd, J = 6.2, 1.1 Hz, 1H), 5.88 (s, 1H), 5.47
(d, J = 15.8 Hz, 1H), 5.23 (dd, J = 6.2, 4.4 Hz, 1H), 5.17 (d, J = 15.5 Hz, 1H), 5.08-5.01
(m, 1H), 4.51-4.43 (m, 1H), 3.64-3.52 (m, 2H), 2.27 (s, 2H). 13C NMR (126 MHz, CDCl3) δ
150.12, 136.73, 128.81, 127.31, 126.41, 126.35, 98.92, 96.39, 90.30, 64.97, 46.66, 37.94, 29.70,
25.64, 21.35. IR (film): 2925, 2854, 1722, 1650, 1563, 1354, 1253, 1068, 1030, 843 cm−1.
(±)-Methyl (3R*,3aS*,7aR*)-2H-2-Oxo-3,3a,4,7a-tetrahydrofuro[3,2-c]pyran-3-
carboxylate, 340.
O
OH
HO
O
MeO
369
The reaction was performed with 0.040 g (0.277 mmol) of Meldrum’s acid according to
Method A. The crude product was purified by flash column chromatography (25% EtOAc/
pet. ether) to give the title compound as a clear oil (0.0214 g, 39% yield) along with the
bis-adduct (0.0418g, 53% yield). The desired product co-eluted, in part, with the remaining
MeldrumÕs acid and, as a result, the isolated yield was determined by 1H NMR spectroscopy.
An analytical sample was obtained by careful chromatography, using p-anisaldehyde dip to
distinguish the title compound (stained black) and Meldrum’s acid (stained pink). This
provided the title compound, which also contained a small quantity (ca. 14:1 ratio) of a
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diastereoisomer, presumably differing at the doubly α-position (C-3). The stereochemistry of
the major isomer is tentatively assigned on the basis of NOE correlations as shown on the
diagram (see NOESY spectrum). Rf = 0.24 (30% EtOAc/pet. ether). 1H-NMR (500 MHz,
CDCl3): δ 6.62 (d, J = 6.2 Hz, 1H, HC=), 5.11 (dd, J = 7.0, 3.2 Hz, 1H, OCH), 5.01 (dd,
J = 5.7, 3.9 Hz, 1H, HC=), 4.11 (dd, J = 11.8, 3.5 Hz, 1H, one of CH2OR), 3.88 (partially
obs. dd, J = 11.8, 6.1 Hz, 1H, one of CH2OR), 3.85 (s, 3H, CO2CH3), 3.56 (d, J = 7.7 Hz,
1H, CHCO2Me), 3.21 (app. tdd, J = 7.2, 6.6, 3.5 Hz 1H, CHCH2OR). 13C-NMR (126 MHz,
CDCl3): δ 170.6, 167.2, 148.9, 99.6, 70.8, 63.6, 53.3, 47.6, 37.7 ppm. IR (film): 2958, 2880,
1774, 1732, 1642, 1240, 1143, 1080, 970 cm−1. HRMS (ESI) calculated for C9H10O5Na+ [M
+ Na]+: 221.0426, found 221.0422.
5,5-Bis-(cis-6-((tert-Butyldimethylsilyl)oxy)-3,6-dihydro-2H-pyran-3-yl)-2,2-
dimethyl-1,3-dioxane-4,6-dione, 341.
O
O
O
O
O
OTBS
O
OTBS
341
This material was a mixture of two diastereoisomers (ca. 1.2:1 ratio). Rf = 0.71 (30%
EtOAc / pet. ether). 1H-NMR (500 MHz, CDCl3): δ 5.94 (d, J = 10.5 Hz, 2 x 0.55H), 5.88
(d, J = 10.4 Hz, 2 x 0.45H), 5.85-5.83 (m, 2 x 1H), 5.25 (s, 2 x 1H), 4.05 (app. t, J = 10.5
Hz, 2 x 0.45H), 3.97 (app. t, J = 10.4 Hz, 2 x 0.55H), 3.70 (m, 2 x 1H), 3.30-3.25 (m, 2 x 1H),
1.76 (s, 2.7H), 1.75 (s, 3.3H), 0.901 (s, 8.1H), 0.898 (s, 9.9H), 0.11-0.10 (complex m, 12H).
13C-NMR (126 MHz, CDCl3): δ 165.58, 131.13, 130.85, 125.25, 125.20, 106.24, 106.14, 88.83,
88.75, 58.91, 58.66, 55.40, 55.08, 38.52, 38.50, 29.91, 29.77, 25.69, 17.99, 17.98, -4.48, -5.10,
-5.11. HRMS (ESI) calculated for C28H48O8Si2Na+ [M + Na]+: 591.2785, found 591.2794.
Melting point = 55–60 ◦C.
Bis-2,2-(((cis)-6-((tert-butyldimethylsilyl)oxy)-3,6-dihydro-2H -pyran-3-yl)-1H -
indene-1,3(2H )-dione, 352.
O
OTBS
O
OTBS
O
O
341
The reaction was performed with 1H -indene-1,3(2H )-dione (0.029 g, 0.2 mmol, 1.0 equiv)
according to method B. The crude product was purified by flash column chromatography (10%
EtOAc/Pet. Ether) to give the title compound as a clear film (0.0115 g, 37% yield). Rf = 0.44
(15% EtOAc/Pet.) 1H NMR (500 MHz, CDCl3) δ 7.97 (dt, J= 6.0, 3.0 Hz, 2H), 7.89-7.85
(m, 2H), 5.75-5.68 (m, 2H), 5.64 (dt, J = 10.3, 2.8 Hz, 1H), 5.53-5.49 (m, 1H), 5.19 (d, J =
1.5 Hz, 2H), 4.20-4.11 (m, 1H), 3.91 (t, J = 10.6 Hz, 1H), 3.78 (s, 0H), 3.74 (ddd, J = 11.1,
5.2, 1.7 Hz, 1H), 3.64 (t, J = 6.2 Hz, 0H), 3.61-3.54 (m, 1H), 3.16-3.05 (m, 2H), 0.90 (s, 10H),
0.88 (s, 10H), 0.11 (s, 2H), 0.10 (s, 3H), 0.07 (s, 3H), 0.06 (s, 3H). 13C NMR (126 MHz,
CDCl3) δ 201.40, 201.37, 200.97, 142.07, 142.05, 141.92, 136.06, 136.03, 135.98, 130.71, 130.70,
126.00, 125.83, 123.26, 123.15, 122.90, 88.71, 88.53, 58.26, 57.91, 57.86, 57.72, 36.39, 36.32,
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25.74, 25.72, 25.64, 18.01, -4.49, -5.05, -5.06.
Methyl (((1S,4aS,9bS)-7-Methyl-9-oxo-1,4a,9,9b-tetrahydrofuro[3,2-c:4,5-c’]-
dipyran-1-yl)methyl) carbonate, 354.
O
O
O
O
H
H
OCO2Me
341
The reaction was performed with 4-hydroxy-6-methyl-α-pyrone (0.017 g, 0.133 mmol, 1.0
equiv), methyl-(2R,3S,6R)-6-((tert-butyldimethylsilyl)oxy)-2-(hydroxymethyl)-3,6-dihydro-2H-
pyran-3-ol dicarbonate (0.05 g, 0.133 mmol, 1.0 equiv) and Pd(PPh3)4 (0.023 g, 0.020
mmol, 15 mol %) according to Method B. The crude product was purified by flash column
chromatography (40% EtOAc/Pet. Ether) to give the title compound as a yellow solid (0.0299
g, 77% yield). Rf = 0.21 (40% EtOAc/Pet. Ether). 1H NMR (500 MHz, CDCl3) δ 6.81 (d,
J = 6.2 Hz, 1H), 5.96 (s, 1H), 5.30 (dd, J = 6.2, 4.6 Hz, 1H), 5.08 (ddd, J = 7.4, 4.8, 1.4
Hz, 1H), 4.75 (dd, J = 12.4, 2.0 Hz, 1H), 4.43 (dd, J = 12.3, 6.6 Hz, 1H), 3.80 (s, 3H), 3.64
(ddd, J = 11.2, 6.6, 1.9 Hz, 1H), 3.24 (dd, J = 11.2, 7.5 Hz, 1H), 2.28 (s, 3H). 13C NMR
(126 MHz, CDCl3) δ 172.58, 166.70, 161.92, 155.42, 149.46, 99.59, 97.91, 95.91, 79.42, 74.64,
67.72, 54.93, 37.13, 20.56. [α]D25 = –209.9 ◦(c = 0.5, CH2Cl2). IR (film): 2362, 2341, 1750,
1717, 1633, 1577, 1447, 1255 cm−1. HRMS (ESI) calculated for C14H14O7Na+ [M + Na]+:
317.0632, found 317.0633. Melting point = 153–156 ◦C.
Methyl (((6bS,7S,10aS)-6-Oxo-6,6b,7,10a-tetrahydropyrano[3’,4’:4,5]furo[3,2-c]-
chromen-7-yl)methyl) carbonate, 355.
O
O
O
O
H
H
OCO2Me
341
The reaction was performed with 4-hydroxycoumarin (0.022 g, 0.133 mmol, 1.0 equiv),
methyl-(2R,3S,6R)-6-((tert-butyldimethylsilyl)oxy)-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-
ol dicarbonate (0.05 g, 0.133 mmol, 1.0 equiv) and Pd(PPh3)4 (0.023 g, 0.020 mmol, 15 mol %)
according to Method B. The crude product was purified by flash column chromatography (20%
EtOAc/Pet. Ether) to give the title compound as an off-white solid (0.0393 g, 90% yield). Rf
= 0.46 (40% EtOAc/Pet. Ether). 1H NMR (500 MHz, CDCl3) δ 7.69 (dd, J = 7.9, 1.7 Hz,
1H), 7.61 (t, J = 7.9 Hz, 1H), 7.40 (d, J = 8.4 Hz, 1H), 7.31 (t, J = 7.6 Hz, 1H), 6.88 (d,
J = 6.2 Hz, 1H), 5.43 (dd, J = 6.2, 4.6 Hz, 1H), 5.30-5.24 (m, 1H), 4.79 (dd, J = 12.4, 2.1
Hz, 1H), 4.48 (dd, J = 12.4, 6.5 Hz, 1H), 3.84-3.73 (m, 4H), 3.43 (dd, J = 11.2, 7.5 Hz, 1H),
1.56 (s, 2H). 13C NMR (126 MHz, CDCl3) δ 168.32, 160.49, 155.43, 155.16, 149.66, 133.21,
124.13, 123.18, 117.11, 112.26, 102.36, 97.91, 80.18, 74.54, 67.64, 54.96, 38.07. IR (film): 2360,
1753, 1718, 1634, 1499, 1366, 1263, 1193, 1109, 910 cm−1. [α]D25 = –153.5 ◦(c = 1.0, CH2Cl2).
HRMS (ESI) calculated for C17H14O7Na+ [M + Na]+: 353.0632, found 353.0635. Melting
point = 159–162 ◦C.
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Electrophilic Substrate Preparation
Preparation of cis-332
(±)-6-Hydroxy-3,6-dihydro-2H-pyran-3-one
O
O
OH341
To a solution of furfuryl alcohol (4.0 g, 40.8 mmol, 1.0 eq.) in dichloromethane (98 mL)
at 0 ◦C was added mCPBA (11.0 g, 48.9 mmol, 1.2 eq.) in 3 portions over 15 minutes.
The reaction mixture was allowed to slowly warm to ambient temperature and stirring was
continued overnight. The reaction was then cooled to –78 ◦C and stirred for 15 minutes before
removal of insoluble m-chlorobenzoic acid (white precipitate) by filtration. The filtrate was
concentrated in vacuo and purified by flash column chromatography (30% EtOAc/Pet. Ether).
The title compound was isolated as a white crystalline solid (3.6 g, 77% yield). Rf = 0.18 (30%
EtOAc/ Pet. Ether). 1H-NMR (500 MHz, CDCl3): δ 6.96 (dd, J = 10.4, 3.1 Hz, 1H, HC=),
6.17 (d, J = 10.4 Hz, 1H, HC=), 5.65 (dd, J = 4.7, 3.1 Hz, 1H, CHOH), 4.58 (d, J = 16.9 Hz,
1H, one of CH2OR), 4.14 (d, J = 16.9 Hz, 1H, one of CH2OR), 3.08 (d, J = 5.2 Hz, 1H, OH).
13C-NMR (126 MHz, CDCl3): δ 194.4, 145.5, 128.0, 88.2, 66.6. Melting point = 51–53 ◦C
(lit. mp = 55–57 ◦C). These data match values previously reported.26
(±)-6-[(tert-Butyldimethylsilyl)oxy]-3,6-dihydro-2H-pyran-3-one
O
O
OTBS341
To a solution of 6-hydroxy-3,6-dihydro-2H-pyran-3-one (1.0 g, 8.76 mmol, 1.0 eq.) in THF
(60 mL) was added AgNO3 (1.8 g, 10.5 mmol, 1.2 eq.) and pyridine (3.15 mL, 38.9 mmol, 4.44
eq.). The suspension was stirred for 20 minutes to allow the dissolution of any large lumps of
solid. TBSCl (1.72 g, 11.4 mmol, 1.3 eq.) was added at room temperature and precipitation
of a white solid resulted. The reaction was stirred overnight, after which the reaction mixture
was filtered and concentrated in vacuo. The resulting crude product was subjected to flash
column chromatography (5% EtOAc / Pet. Ether) to afford the desired product as a white
crystalline solid (1.76 g, 88% yield). Rf = 0.34 (5% EtOAc / Pet. Ether). 1H-NMR (500
MHz, CDCl3): δ 6.86 (dd, J = 10.3, 3.1 Hz, 1H, HC=), 6.08 (d, J = 10.3 Hz, 1H, HC=),
5.53 (d, J = 3.1 Hz, 1H, CHOTBS), 4.50 (d, J = 16.8 Hz, 1H, one of CH2OR), 4.08 (d, J =
16.8 Hz, 1H, one of CH2OR), 0.92 (s, 9H, C(CH3)3), 0.17 (s, 6H, Si(CH3)2). 13C-NMR (126
MHz, CDCl3): δ 195.0, 147.2, 126.5, 88.4, 66.5, 25.6, 18.1, -4.5, -5.4. IR (film): 2931, 2858,
1706, 1256, 1105, 1040, 994, 876, 836, 780 cm−1. Melting point = 28–31 ◦C. These data
match values previously reported.2b
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cis-(±)-6-[(tert-Butyldimethylsilyl)oxy]-3,6-dihydro-2H-pyran-3-ol, 333.
O
OH
OTBS341
To a solution of (±)-6-[(tert-butyldimethylsilyl)oxy]-3,6-dihydro-2H-pyran-3-one (2.0 g,
8.76 mmol, 1.0 eq.) in 60 mL of methanol was added CeCl3 7H2O (3.92 g, 10.5 mmol, 1.2
eq.). The reaction mixture was cooled to -20 ◦Cand sodium borohydride (0.40 g, 10.5 mmol,
1.2 eq.) was added. The reaction was stirred at -20 ◦C for 30 minutes before quenching with
8 mL of acetone. The reaction mixture was warmed to room temperature, concentrated to
approximately 1/4 the solvent volume, diluted with water, extracted with dichloromethane,
dried over MgSO4, filtered and concentrated in vacuo. The crude product was purified by
flash column chromatography (15% EtOAc / Pet. Ether). The product was isolated as a
clear colorless oil (1.45 g, 72% yield). Rf = 0.33 (20% EtOAc / Pet. Ether). 1H-NMR
(500 MHz, CDCl3): δ 5.95 (dd, J = 10.2, 2.7 Hz, 1H, HC=), 5.75 (dt, J = 10.2, 1.9 Hz, 1H,
HC=), 5.25 (m, 1H, CHOTBS), 4.15 (m, 1H, CHOH), 3.77 (m, 2H, CH2OR), 1.65 (br m, 1H,
OH), 0.91 (s, 9H, C(CH3)3), 0.14 (s, 3H, SiCH3), 0.13 (s, 3H, SiCH3). 13C-NMR (126 MHz,
CDCl3): δ 130.9, 130.8, 89.9, 64.6, 63.1, 25.7, 18.1, -3.6, -4.3. IR (film): 3344, 2955, 2930,
2858, 1253, 1028, 989, 866, 835, 778, cm-1. These data match values previously reported in
the literature.2b The minor trans-diastereomer was also isolated as a clear colorless oil (0.062
g, 3% yield, see below for full characterization).
cis-(±)-6-[(tert-Butyldimethylsilyl)oxy]-3,6-dihydro-2H-pyran-3-yl Methyl
Carbonate, 332.
O
OCO2Me
OTBS341
To a solution of cis-(±)-6-[(tert-butyldimethylsilyl)oxy]-3,6-dihydro-2H-pyran-3-ol (1.34 g,
5.83 mmol, 1.0 eq.) in 70 mL of freshly distilled CH2Cl2 was added DMAP (0.89 g, 7.29
mmol, 1.25 eq.), followed by methyl chloroformate (0.563 mL, 0.689 g, 7.29 mmol, 1.25 eq.).
The reaction was stirred overnight at room temperature before concentration in vacuo and
purification by flash column chromatography (5% EtOAc / Pet. Ether). The desired product
was isolated as a clear colorless oil (1.41 g, 84% yield). Rf = 0.31 (5% EtOAc/Pet. Ether).
1H-NMR (500 MHz, CDCl3): δ 5.92 (ddt, J = 10.3, 2.2, 1.0 Hz, 1H, HC=), 5.85 (ddd, J
= 10.3, 2.2, 1.8 Hz, 1H, HC=), 5.28 (m, 1H, CHOTBS), 5.13 (ddq, J = 7.6, 5.8, 1.9 Hz, 1H,
CHOCO2Me), 3.90 (m, 2H, CH2OR), 3.80 (s, 3H, CO2CH3), 0.91 (s, 9H, C(CH3)3), 0.13 (s,
3H, SiCH3), 0.13 (s, 3H, SiCH3). 13C-NMR (126 MHz, CDCl3): δ 155.3, 132.2, 126.4, 89.2,
68.4, 60.1, 54.9, 25.7, 18.0, -4.4, -5.2. IR (film): 2956, 2931, 2856, 1749, 1258, 1034, 837, 779
cm−1. HRMS (ESI) calculated for C13H24O5SiNa+ [M+Na]+: 311.1291, found: 311.1293.
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Preparation of trans-332
trans-(±)-6-[(tert-Butyldimethylsilyl)oxy]-3,6-dihydro-2H -pyran-3-yl Benzoate
O
OBz
OTBS341
To a solution of cis-(±)-6-[(tert-butyldimethylsilyl)oxy]-3,6-dihydro-2H-pyran-3-ol (0.7243
g, 3.14 mmol, 1.0 eq.), triphenylphosphine (0.907 g, 3.46 mmol, 1.1 eq.) and benzoic
acid (0.461 g, 3.77 mmol, 1.2 eq.) in 18.8 mL of THF, at 0 ◦C, was added 0.67 mL of
diisopropylazodicarboxylate (DIAD, 0.699 g, 3.46 mmol, 1.1 eq.). The reaction was stirred at
0 ◦C for 30 minutes before warming to room temperature and quenching with water. The
reaction mixture was extracted with EtOAc, dried over MgSO4, filtered and concentrated in
vacuo. The crude product was purified by flash column chromatography (10% EtOAc / Pet.
Ether). The desired product was isolated as a clear yellow oil (1.039 g, 99% yield). Rf = 0.15
(20% EtOAc / Pet. Ether). 1H-NMR (500 MHz, CDCl3): δ 8.07-8.05 (m, 2H, ArH), 7.56
(m, 1H, ArH), 7.44-7.41 (m, 2H, ArH), 6.12 (dd, J = 10.0, 5.1 Hz, 1H, HC=), 6.04 (dd, J =
10.0, 3.0 Hz, 1H, HC=), 5.39 (d, J = 3.0 Hz, 1H, CHOTBS), 5.19 (m, 1H, CHOBz), 4.31 (dd,
J = 13.0, 2.9 Hz, 1H, one of CH2OR), 3.97 (dt, J = 13.0, 1.3 Hz, 1H, one of CH2OR), 0.92 (s,
9H, C(CH3)3), 0.15 (s, 6H, Si(CH3)2). 13C-NMR (126 MHz, CDCl3): δ 166.3, 133.4, 133.1,
130.0, 129.8, 128.3, 123.3, 88.0, 64.0, 61.4, 25.7, 21.6, 18.1, -4.5, -5.3. IR (film): 2930, 2858,
1776, 1716, 1265, 1108, 1022, 836, 779, 710 cm-1. HRMS (ESI) calculated for C18H26O4SiNa+
[M+Na]+: 357.1498, found: 357.1493. These data match values previously reported.2b
trans-(±)-6-[(tert-Butyldimethylsilyl)oxy]-3,6-dihydro-2H -pyran-3-ol, 333.
O
OH
OTBS341
To a solution of trans-(±)-6-[(tert-butyldimethylsilyl)oxy]-3,6-dihydro-2H -pyran-3-yl ben-
zoate (1.039 g, 3.106 mmol, 1.0 eq.) in 21 mL of methanol was added potassium carbonate
(0.644 g, 4.66 mmol, 1.5 eq.). The yellow solution quickly became colorless and was stirred
for an hour at room temperature. The reaction mixture was concentrated in vacuo to
half the solvent volume, diluted with EtOAc and water, extracted with EtOAc, dried over
MgSO4, filtered and concentrated in vacuo. The crude product was purified by flash column
chromatography (20% EtOAc/Pet. Ether). The desired product was isolated as a white
crystalline solid (0.483 g, 68% yield). Rf = 0.29 (25% EtOAc / Pet. Ether). 1H-NMR (500
MHz, CDCl3): δ 6.06 (dd, J = 10.0, 5.3 Hz, 1H, HC=), 5.85 (dd, J = 10.0, 3.0 Hz, 1H, HC=),
5.29 (d, J = 3.0 Hz, 1H, CHOTBS), 4.16 (dd, J = 12.2, 2.6 Hz, 1H, one of CH2OR), 3.83 (m,
1H, CHOH), 3.77 (dt, J = 12.2, 1.3 Hz, 1H, one of CH2OR), 1.85 (d, J = 9.2 Hz, 1H, OH),
0.91 (s, 9H, C(CH3)3), 0.14 (s, 6H, Si(CH3)2). 13C-NMR (126 MHz, CDCl3): δ 131.0, 127.5,
88.2, 64.3, 61.6, 25.7, 18.1, -4.5, -5.3. IR (film): 3379, 2929, 2858, 1251, 1105, 1024, 977, 871,
836, 777 cm−1. Melting point = 50–52 ◦C (lit. mp = 39–43 ◦C). These data match values
previously reported.2b
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trans-(±)-6-[(tert-Butyldimethylsilyl)oxy]-3,6-dihydro-2H -pyran-3-yl Methyl Car-
bonate, 332.
O
OCO2Me
OTBS341
To a solution of trans-(±)-6-[(tert-butyldimethylsilyl)oxy]-3,6-dihydro-2H -pyran-3-ol (0.472
g, 2.05 mmol, 1.0 eq.) in dichloromethane (40 mL) was added DMAP (0.313 g, 2.56 mmol, 1.25
eq.), followed by methyl chloroformate (0.198 mL, 0.242 g, 2.56 mmol, 1.25 eq.). The reaction
was stirred overnight at room temperature before concentration in vacuo and purification by
flash column chromatography (5% EtOAc / Pet. Ether). The desired product was isolated
as a clear colorless oil (0.321 g, 54% yield, 70% brsm). Rf = 0.25 (5% EtOAc / Pet. Ether).
1H-NMR (500 MHz, CDCl3): δ 6.03 (ddd, J = 10.0, 4.5, 1.0 Hz, 1H, HC=), 6.00 (dd, J
= 10.0, 2.5 Hz, 1H, HC=), 5.33 (d, J = 2.4 Hz, 1H, CHOTBS), 4.80 (ddd, J = 4.4, 2.9,
1.4 Hz, 1H, CHOCO2Me), 4.20 (dd, J = 13.1, 2.8 Hz, 1H, one of CH2OR), 3.90 (dt, J =
13.1, 1.2 Hz, 1H, one of CH2OR), 3.78 (s, 3H, CO2CH3), 0.90 (s, 9H, C(CH3)3), 0.13 (s, 3H,
SiCH3), 0.13 (s, 3H, SiCH3). 13C-NMR (126 MHz, CDCl3): δ 155.4, 133.9, 122.5, 87.9, 66.9,
61.0, 54.8, 25.7, 18.1, -4.5, -5.3. IR (film): 2956, 2930, 2858, 1743, 1256, 1025, 944, 869, 837,
779 cm−1. HRMS (ESI) calculated for C13H24O5SiNa+ [M+Na]+: 311.1291, found: 311.1294.
Preparation and Reaction of Hemiacetal Substrate
6-Hydroxy-3,6-dihydro-2H -pyran-3-yl Methyl Carbonate
TMP1
O
OCO2Me
OH
341
To a solution of cis-(±)-6-[(tert-butyldimethylsilyl)oxy]-3,6-dihydro-2H -pyran-3-yl methyl
carbonate (0.096 g, 0.33 mmol, 1.0 eq.) in acetonitrile (8 mL), at room temperature, was
added HFěpyridine (0.240 mL, 0.266 g, 13.3 mmol, 40 eq.). The reaction was stirred overnight
before being quenched with saturated aqueous sodium bicarbonate, extracted with EtOAc,
dried over MgSO4, filtered and concentrated in vacuo. The crude product was purified by
flash column chromatography (50% EtOAc / Pet. Ether). The desired product was isolated as
a 3:1 mixture of the two possible diastereomers (0.018 g, 31% yield). Rf = 0.23 (40% EtOAc
/ Pet. Ether). 1H-NMR (500 MHz, CDCl3): δ MAJOR 6.14 (m, 1H, HC=), 6.10 (dd, J
= 10.1, 2.6 Hz, 1H, HC=), 5.42 (dd, J = 4.8, 2.5 Hz, 1H, CHOH), 4.84 (ddd, J = 4.6, 3.0,
1.6 Hz, 1H, CHOCO2Me), 4.28 (dd, J = 13.1, 2.9 Hz, 1H, one of CH2OR), 3.95 (m, 1H, one
of CH2OR), 3.805 (s, 3H, OCO2CH3), 2.77 (d, J = 4.2 Hz, 1H, OH). MINOR 6.04 (dd, J =
10.3, 2.8 Hz, 1H, HC=), 5.96 (dt, J = 10.3, 1.8 Hz, 1H, HC=), 5.33 (m, 1H, CHOH), 5.10
(dddt, J = 6.6, 5.0, 3.1, 1.7 Hz, 1H, CHOCO2Me), 3.98 (dd, J = 11.5, 6.5 Hz, one of CH2OR),
3.93 (ddd, J = 11.5, 5.0, 1.0 Hz, one of CH2OR), 3.812 (s, 3H, OCO2CH3), 2.90 (d, J = 6.4
Hz, 1H, OH). 13C-NMR (126 MHz, CDCl3): δ 155.3, 132.0, 131.0, 127.9, 124.5, 89.3, 87.7,
68.0, 66.5, 61.1, 61.0, 55.0, 54.9. IR (film): 3413, 2959, 2925, 1740, 1443, 1252, 1061, 975, 937
cm−1. HRMS (ESI) calculated for C7H10O5Na+ [M+Na]+: 197.0426, found: 197.0422.
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Attempted Pd-AA Reaction with Hemiacetal
The reaction vessel was charged with 6-hydroxy-3,6-dihydro-2H -pyran-3-yl methyl car-
bonate (0.102 mmol, 0.018 g, 1.0 eq.), 4-hydroxy-6-methyl-α-pyrone (0.102 mmol, 0.013 g,
1.0 eq.) and Pd(PPh3)4 (0.006 g, 0.005 mmol, 5 mol%), evacuated and back-filled with
argon. Toluene (2 mL, degassed by sparging with argon for approximately 20 minutes) was
added to the reaction vessel. The reaction was stirred overnight at ambient temperature
before concentration in vacuo and purification via flash column chromatography. The reaction
produced a complex mixture of undesired products.
Preparation of trans-Cyclohexene Substrate
trans-(±)-4-(Acetoxy)cyclohex-2-en-1-yl Acetate
OAc
OAc341
To a solution of palladium acetate (0.21 g, 0.94 mmol, 15 mol%), LiOAc·2H2O (0.702 g,
6.86 mmol, 1.1 eq.), and p-benzoquinone (0.19 g, 1.75 mmol, 28 mol%) in 10 mL of acetic
acid was added manganese dioxide (0.651 g, 7.49 mmol, 1.2 eq.), followed by a solution of 1,3-
cyclohexadiene (0.50 g, 6.24 mmol, 1 eq.) in 20 mL of pentane. The biphasic reaction mixture
was stirred at room temperature overnight. The pentane layer was separated from the acetic
acid layer. The acetic acid layer was subsequently diluted with 10 mL of brine and extracted
twice with pentane, then twice with 1:1 pentane/ethyl acetate. The combined extracts were
washed three times with brine, three times with water and three times with 2M aqueous NaOH.
The resulting solution was dried with magnesium sulfate, filtered and concentrated in vacuo.
The desired product was isolated as a yellow crystalline solid (1.014 g, 82% yield, 86:14 ratio
of trans:cis diastereomers as determined by 1H-NMR spectroscopy). 1H-NMR (500 MHz,
CDCl3): δ MAJOR 5.89 (d, J = 1.4 Hz, 2H, 2 x HC=), 5.31 (dtd, J = 5.5, 2.8, 1.4 Hz, 2H, 2
x CHOAc), 2.14-2.10 (m, 2H, 2 x one of CH2), 2.05 (s, 6H, 2 x CH3), 1.72-1.67 (m, 2H, 2 x one
of CH2). MINOR 5.91 (d, J = 1.5 Hz, 2H, 2 x HC=), 5.22 (m, 2H, 2 x CHOAc), 2.07 (s, 6H,
2 x CH3), 1.92-1.84 (complex m, 4H, 2 x CH2). 13C-NMR (126 MHz, CDCl3): δ MAJOR
170.6, 130.3, 67.6, 25.7, 21.2. These data match values previously reported.27
trans-(±)-4-[(Methoxycarbonyl)oxy]cyclohex-2-en-1-yl Methyl Carbonate
OCO2Me
OCO2Me341
The 86:14 mixture of trans- and cis-(±)-4-(acetoxy)cyclohex-2-en-1-yl acetate (0.500 g,
2.52 mmol, 1 eq.) was dissolved in 12 mL of methanol and 3 mL of 2M aqueous NaOH was
added. The reaction was stirred at reflux for 15 minutes and then concentrated in vacuo
to approximately 5 mL. The aqueous layer was saturated with NaOH and extracted twice
with ethyl acetate. The combined organics were dried over magnesium sulfate, filtered and
concentrated in vacuo to give a white crystalline solid, presumed to consist mainly of trans-
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(±)-cyclohex-2-ene-1,4-diol (0.267 g).
To a solution of this material (0.178 g, 1.56 mmol, 1 eq.) and DMAP (0.762 g, 6.24 mmol,
4 eq.) in 14 mL of dichloromethane was added methyl chloroformate (0.482 mL, 0.59 g, 6.24
mmol, 4 eq.) at 0 oC. The reaction mixture was slowly warmed to room temperature and stirred
overnight. The reaction was diluted with water and extracted twice with dichloromethane.
The combined organic extracts were dried over magnesium sulfate, filtered and concentrated
in vacuo. The crude reaction mixture was purified using flash column chromatography (15%
EtOAc / Pet. Ether). The desired product trans-8 was isolated as a white solid (0.221 g, 58%
yield over 2 steps), which contained ca. 10% of the cis-isomer. Rf = 0.29 (15% EtOAc / Pet.
Ether). 1H-NMR (500 MHz, CDCl3): δ 5.99 (d, J = 1.6 Hz, 2H, 2 x HC=), 5.18 (dtd, J
= 5.3, 2.7, 1.3 Hz, 2H, 2 x CHOCO2Me), 3.79 (s, 6H, 2 x CO2CH3), 2.21-2.17 (m, 2H, 2 x
one of CH2), 1.79 (ddt, J = 8.6, 4.3, 2.2 Hz, 2H, 2 x one of CH2). 13C-NMR (126 MHz,
CDCl3): δ 155.3, 130.0, 71.0, 54.8, 25.4. IR (film): 2959, 1738, 1446, 1402, 1318, 1268, 1010,
936, 901, 784, 761 cm−1. HRMS (ESI) calculated for C10H14O6Na+ [M + Na]+: 253.0688,
found 253.0686. Melting point = 92–95 ◦C.
Nucleophilic Substrate Preparation
Preparation of 4-hydroxy-7-methoxy-2H -chromen-2-one
HO OH HO OH
O
ZnCl2, AcOH
19% yield
MeI, acetone,
reflux MeO OH
O70% yield
EtO OEt
O
NaH, reflux
MeO O O
OH
R
R = H, R = CO2Et
MeO O O
OH
Ba(OH)2 8H2O,
MeOH, reflux
21% yield
341
1-(2,4-Dihydroxyphenyl)ethanone
HO OH
O
341
To a solution of resorcinol (2.2 g, 20 mmol, 1.0 eq.) in glacial acetic acid (6.3 mL) was
added anhydrous zinc chloride (2.8 g, 20 mmol, 1.0 eq.). The reaction was stirred at reflux
for 5 hours before quenching with ice-water (150 mL). The solvent was gradually evaporated
under a stream of air, producing a red precipitate which was subsequently dried in a vacuum
desiccator over P2O5. The title compound was obtained as a red solid (0.577 g, 19% yield
- unoptimized). 1H-NMR (500 MHz, CDCl3): δ 12.69 (s, 1H), 7.65 (d, J = 8.6 Hz, 1H),
6.41-6.38 (m, 2H), 5.36 (br s, 1H), 2.57 (s, 3H). 13C-NMR (126 MHz, CDCl3): δ 202.6, 165.1,
162.4, 133.0, 114.4, 107.6, 103.5, 26.3. These data match values previously reported.28
1-(2-Hydroxy-4-methoxyphenyl)ethanone
To a solution of 1-(2,4-dihydroxyphenyl)ethanone (0.577 g, 3.79 mmol, 1.0 eq.) and K2CO3
(0.524 g, 3.79 mmol) in acetone (15 mL) was added iodomethane (0.236 mL, 3.79 mmol).
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MeO OH
O
341
The reaction was stirred at reflux overnight before quenching with water. The acetone was
subsequently removed in vacuo and resultant reaction mixture was extracted twice with EtOAc.
The combined organic layers were dried over MgSO4, filtered and concentrated in vacuo. The
crude product was purified by flash column chromatography (10% EtOAc / pet. ether) to give
the title compound as a yellow oil (0.443 g, 70% yield). Rf = 0.5 (20% EtOAc / pet. ether).
1H-NMR (500 MHz, CDCl3): δ 12.76 (s, 1H), 7.64 (d, J = 8.8 Hz, 1H), 6.46-6.43 (m, 2H),
3.85 (s, 3H), 2.57 (s, 3H). 13C-NMR (126 MHz, CDCl3): δ 202.6, 166.1, 165.3, 132.3, 113.9,
107.7, 100.8, 55.6, 26.2. These data match values previously reported.29
4-Hydroxy-7-methoxy-2H-chromen-2-one
MeO O O
OH341
To a suspension of NaH (0.534 g - 60% dispersion in mineral oil, 13.4 mmol, 5 eq.) in diethyl
carbonate (2.2 mL) was added a solution of 1-(2-hydroxy-4-methoxyphenyl)ethanone (0.443 g,
2.67 mmol) in diethyl carbonate (1.5 mL). The reaction was stirred at reflux overnight before
quenching with water. The reaction mixture was Et2O three times to remove excess diethyl
carbonate. The aqueous layer was then acidified using 1N HCl. The resulting cream precipitate
was removed via filtration and washed with water, then pet. ether and dried in a vacuum
desiccator over P2O5. The isolated cream solid (0.279 g) was contaminated with significant
amounts of the undesired ethyl ester and was therefore suspended in methanol and stirred
at reflux for 2 hours in the presence of Ba(OH)2·8H2O. After cooling to room temperature
the reaction mixture was washed with Et2O, then acidified with 1N HCl to produce a white
precipitate. The precipitate was filtered off and washed with water and dried in a vacuum
desiccator over P2O5. The title compound was obtained as a white solid (0.041 g, 21% yield).
1H-NMR (500 MHz, DMSO-d6): δ 12.35 (s, 1H), 7.71 (d, J = 8.7 Hz, 1H), 6.95-6.91 (m,
2H), 5.44 (s, 1H), 3.84 (s, 3H). Melting point = 260–263 ◦C (lit.8 mp = 258–260 ◦C). These
data match values previously reported.30
Preparation of β-Dicarbonyl Compounds from Methyl Acetoacetate
General Procedure for the Aldol Reaction of an Aldehyde/Ketone with Methyl
Acetoacetate and Subsequent Lactonization. To a suspension of NaH (1.96 eq.) in THF
(1M) at 0 ◦C, was added methyl acetoacetate (1.96 eq.). After visible gas evolution had
ceased, the reaction was stirred for 15 minutes at 0 ◦C. nBuLi (1.96 eq., 2M in cyclohexane)
was then added and the reaction mixture stirred for another 15 minutes before the addition
of the ketone or aldehyde (1 eq.). The reaction was stirred for 60 minutes at 0 ◦C before
quenching with saturated aqueous NH4Cl. The reaction mixture was extracted twice with
EtOAc and concentrated in vacuo. The crude product was redissolved in THF (1˜5 mL) and
a 0.1M solution of NaOH (5˜0 mL) was added. The reaction was stirred for 3 hours at room
temperature. The reaction mixture was washed with EtOAc, acidified to pH 3 with 1M HCl
and extracted twice with CH2Cl2. The combined organic layers were dried over MgSO4, filtered
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and concentrated in vacuo. The crude product was purified by flash column chromatography.
1-Oxaspiro[5.5]undecane-2,4-dione
O
O
O
341
The reaction was performed with 2.42 mL (22.4 mmol) of methyl acetoacetate, 0.9 g
(22.4 mmol) of NaH (60% dispersion in mineral oil), 11.2 mL (22.4 mmol) of nBuLi (2M
in cyclohexane) and 1.18 mL (11.4 mmol) of cyclohexanone in a total of 25 mL of THF. The
crude product was purified by flash column chromatography (40% EtOAc / pet. ether) to
give the title compound as a cream solid (0.56 g, 27% yield - unoptimized). Rf = 0.22 (40%
EtOAc / pet. ether). 1H-NMR (500 MHz, CDCl3): δ MAJOR (DIKETO-) 3.37 (d, J =
3.1 Hz, 2H, CH2CO2R), 2.63 (d, J = 2.6 Hz, 2H, CH2C=O), 1.82-1.27 (m, 10H, cyclohexyl-
C6H10). MINOR (ENOL-) 5.17 (s, 1H, HC=), 2.43 (s, 2H, CH2C=), 1.94-1.91 (m, 2H, one
cyclohexyl-CH2), 1.82-1.27 (m, 6H, 3 x cyclohexyl-CH2), 0.86 (dt, J = 6.5, 3.4 Hz, 2H, one
cyclohexyl-CH2). 13C-NMR (126 MHz, CDCl3): δ MAJOR 200.9, 167.6, 80.5, 49.3, 44.4,
36.8, 24.6, 21.5. Melting point = 117–119 ◦C (lit. mp = 118–120 ◦C). These data match
values previously reported.31
(±)-6-(4-Bromophenyl)oxane-2,4-dione
O
O
Br
O
341
The reaction was performed with 1.71 g (15.9 mmol) of methyl acetoacetate, 0.636 g
(15.9 mmol) of NaH (60% dispersion in mineral oil), 7.95 mL (22.4 mmol) of nBuLi (2M
in cyclohexane) and 1.5 g (8.1 mmol) of 4-bromobenzaldehyde in a total of 20 mL of THF.
The crude product was purified by flash column chromatography (40% EtOAc / pet. ether) to
give the title compound as a cream solid (0.37 g, 17% yield - unoptimized). Rf = 0.22 (40%
EtOAc / pet. ether). 1H-NMR (500 MHz, CDCl3): δ 7.59-7.58 (m, 2H, ArH), 7.30-7.29
(m, 2H, ArH), 5.67 (dd, J = 10.8, 3.1 Hz, 1H, ArCHOR), 3.69 (dd, J = 19.1, 1.2 Hz, 1H,
one of RO2CCH2), 3.51 (dd, J = 19.1, 0.7 Hz, 1H, one of RO2CCH2), 2.95 (ddd, J = 18.3,
3.2, 1.3 Hz, 1H, one of CH2C=O), 2.83 (ddd, J = 18.3, 10.8, 0.8 Hz, 1H, one of CH2C=O).
13C-NMR (126 MHz, CDCl3): δ 198.8, 166.5, 135.5, 132.3, 127.5, 123.4, 75.8, 47.0, 45.1. IR
(KBr): 2923, 1746, 1718, 1635, 1490, 1385, 1289, 1062, 1010 cm−1. HRMS (ESI) calculated
for C11H9O3BrNa+ [M + Na]+: 290.9633, found 290.9642. Melting point = 127–130 ◦C.
These data match values previously reported.32
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Derivatization of Pd-AA Cascade Products
Preparation of (5aS*,6R*,9aS*)-6-Bromo-7-hydroxy-3-methyl-6,7,9,9a-
tetrahydrofuro[3,2-c:4,5-c’]dipyran-1(5aH)-one, 357.
O
O
O
OH
H Br
OH
341
To a solution of cis-(±)-3-methyl-9,9a-dihydrofuro[3,2-c:4,5-c’]dipyran-1(5aH )-one (0.025
g, 0.121 mmol, 1.0 equiv) in CH3CN/H2O (1:1, 1.6 mL) was added NBS (0.026 g, 0.145 mmol,
1.2 equiv) at room temperature. The reaction was stirred for 3 hours before being concentrated
in vacuo and purified by flash column chromatography (50% EtOAc/Pet. Ether). The title
compound was isolated as a white amorphous foam (0.0159 g, 43% yield, 1.3:1 dr, 19% yield
of the epi-Br diastereomer (Rf = 0.21 (60% EtOAc/Pet. Ether)) was also isolated from the
column). Rf = 0.28 (60% EtOAc/Pet. Ether). 1H NMR (500 MHz, CDCl3) MAJOR: δ
6.02 (s, 1H), 5.33 (dd, J = 8.7, 6.9 Hz, 1H), 5.20 (d, J = 2.7 Hz, 1H), 4.37 (dd, J = 12.1,
5.2 Hz, 1H), 4.18 (dd, J = 6.9, 2.9 Hz, 1H), 4.17 (dd, J = 12.1, 4.4 Hz, 1H), 3.66 (dt, J =
8.9, 4.5 Hz, 1H), 2.29 (s, 3H). MINOR: δ 6.03 (s, 1H), 5.20 (dd, J = 9.4, 8.5 Hz, 1H), 5.16
(d, J = 6.9 Hz, 1H), 4.33 (dd, J = 12.3, 6.4 Hz, 1H), 4.09 (dd, J = 12.4, 5.8 Hz, 1H), 3.94
(dd, J = 8.3, 7.0 Hz, 1H), 3.73 (dt, J = 9.6, 6.1 Hz, 1H), 2.29 (s, 3H). 13C NMR (126 MHz,
CDCl3) MAJOR: δ 171.38, 166.56, 161.58, 100.62, 95.96, 91.20, 86.33, 60.41, 49.16, 38.26,
20.58. MINOR: δ 171.41, 166.65, 161.49, 99.75, 95.90, 95.36, 87.62, 58.48, 50.20, 39.86, 20.57.
IR (film): 3442, 2988, 1699, 1634, 1578, 1455, 1384, 1078 cm−1. HRMS (ESI) calculated for
C11H12O5Br+ [M + H]+: 302.9868, found 302.9861.
epi-Br Diastereomer – 1H NMR (500 MHz, CDCl3) δ 6.03 (s, 1H), 5.34 (d, J = 7.2
Hz, 1H), 5.25 (dd, J = 9.5, 3.0 Hz, 1H), 4.20 (dd, J = 7.1, 3.0 Hz, 1H), 3.99 (dd, J = 12.4,
3.6 Hz, 1H), 3.80 (dd, J = 12.4, 1.5 Hz, 1H), 3.58 (dd, J = 9.4, 2.4 Hz, 1H), 2.29 (s, 3H).
(3aS,8bS)-3-(Hydroxymethyl)-6-methyl-3,3a-dihydro-1H-furo[3’,4’:4,5]furo[3,2-
c]pyran-8(8bH)-one, 359.
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To a solution of (5aS*,6R*,9aS*)-6-bromo-7-hydroxy-3-methyl-6,7,9,9a-tetrahydrofuro[3,2-
c:4,5-c’]dipyran-1(5aH)-one (0.027 g, 0.089 mmol, 1.0 equiv) in MeOH (1 mL) was added
NaBH4 (0.005 g, 1.2 equiv) at 0 ◦C. The reaction was stirred at 0 ◦C for 30 minutes before
quenching with acetone and warming to room temperature. The solvent was removed in vacuo
and the crude product purified by preparative thin layer chromatography (5% MeOH/CH2Cl2).
The title compound was isolated as a clear film (0.020 g, quantitative yield). Rf = 0.57 (10%
MeOH/CH2Cl2). IR (film): 3412, 2950, 2883, 1700, 1637, 1581, 1454, 1423, 1242, 1042, 982
cm−1. HRMS (ESI) calculated for C11H12O5Na+ [M + Na]+: 247.0582, found 247.0583.
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1H 500 MHz, 13C 125 MHz, CDCl3
Position δC, mult δH (J, Hz) COSY HMBC
1 161.9, C – – –
2 101.5, C – – 5.95, 4.22, 4.01, 2.27
3 171.2, C – – 5.95
4 95.6, CH 5.95, s 2.27 2.27
5 166.0, C – – 5.95, 2.27
6 72.4, CH2 4.22/4.01, m 4.01, 4.22 4.19(weak)
7 44.9, CH 4.00, m 5.32 4.01(weak)
8 91.1, CH 5.32, dd (8.7, 2.5) 4.0 3.78
9 85.2, CH 4.19, m 3.78 4.22, 4.01(weak), 4.00
10 61.4, CH2 3.78, m 4.19 –
11 20.5, CH3 2.27, s 5.95 5.95
1H 500 MHz, C6D6
Position δH (J, Hz) COSY
1 – –
2 – –
3 – –
4 5.16, s 1.44
5 – –
6 3.99, dd (9.2, 3.0) 3.78, 3.44
6b 3.78, dd (9.2, 6.6) 3.99, 3.44
7 3.44, ddd (8.9, 6.8, 3.1) 4.70, 3.99, 3.78
8 4.70, dd (8.8, 2.1) 3.44, 3.91
9 3.91, td (5.6, 2.1) 4.70, 3.12
10 3.12, app. s 3.91, 1.21
11 1.44, s 5.17
12 1.21, s 3.12
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((3aS,8bS)-6-Methyl-8-oxo-3,3a,8,8b-tetrahydro-1H-furo[3’,4’:4,5]furo[3,2-c]-
pyran-3-yl)methyl Acetate, 360.
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To a solution of (3aS,8bS)-3-(hydroxymethyl)-6-methyl-3,3a-dihydro-1H-furo[3’,4’:4,5]furo[3,2-
c]- pyran-8(8bH)-one (0.0094 g, 0.0309 mmol, 1.0 equiv) in pyridine (0.5 mL) was added
acetic anhydride (0.5 mL) at room temperature. The reaction was stirred overnight before
cyclic loading onto HP20ss beads. The resin was washed five times with H2O and the
product was subsequently eluted with acetone. After removal of the solvent in vacuo, the title
compound was isolated as an off-white solid (0.0085 g, 76% yield). HRMS (ESI) calculated
for C13H15O6+ [M + H]+: 276.0869, found 267.0872. Melting point = 120–121 ◦C.
1H 500 MHz, 13C 125 MHz, CDCl3
Position δC, mult δH (J, Hz) COSY HMBC
1 161.9, C – – –
2 101.6, C – – 5.95, 4.16, 4.05, 4.00
3 171.2, C – – 5.95
4 95.6, CH 5.95, d (1.2) 2.28 2.28
5 166.2, C – – 5.95, 2.28
6 72.7, CH2 4.16, m 4.05, 4.00 5.28, 4.34
6b – 4.05, dd, (9.3, 3.1) 4.16, 4.00 5.28, 4.34
7 44.9, CH 4.00, ddd (9.5, 6.7, 3.1) 5.28, 4.16, 4.05 –
8 91.7, CH 5.28, dd (8.7, 2.1) 4.05, 4.00 4.34, 4.26, 4.22
9 82.7, CH 4.34, m 4.25, 4.19 5.28, 4.26, 4.22, 4.16, 4.05
10 63.1, CH2 4.26, dd (11.8, 6.0) 4.22, 4.34 4.34
10b – 4.22, m 4.26, 4.34 –
11 170.7, C – – 4.26, 4.22, 2.12
12 21.0, CH3 2.12, s – –
13 20.6, CH3 2.28, s 5.95 –
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7.5.3 Spectra
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8.1 Introduction
Relative stereochemical relationships have a profound effect on the chemical and physical
properties of a compound.1 Complex molecules often exhibit remarkable differences in
biological activity, reactivity and catalysis with the inversion of just a single stereocenter.
The assignment of atom connectivity and spatial arrangement is, therefore, of fundamental
importance, and NMR spectroscopy has emerged as a powerful tool for structure elucidation.2
However, a number of structural motifs still prove to be particularly challenging and laborious
to assign.3 The distinctive structural properties of 3,6-dihydro-2H -pyrans (i.e. 370) represent
just such a challenge,4 and new methods for NMR-based stereochemical assignment are needed
to facilitate the use of these compounds in chemical research.5 The preparation and use of
various 3,6-dihydro-2H -pyrans as substrates for Pd-catalyzed allylic alkylation cascades (see
Section 7.2) led us to this challenge and we ultimately discovered that the analysis of axial
deshielding effects could be used to assign the remote relative stereochemistry across the pyran
ring system.
The utility of 3,6-dihydro-2H -pyrans stems from their facile preparation in enantioenriched
form and a wide range of potential reactivity (Figure 8.1). Enantioenriched 3,6-dihydro-
2H -pyrans can be prepared from a variety of sources, including chiral allylic sulfoxides
(371),6 furfuryl alcohols (372),7 glycals (373),8 and gem-dichlorocyclopropanes (374),9 as
well as by enzymatic kinetic resolution.10 This heterocyclic motif is present in a number
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Figure 8.1 Synthesis and Utility of 3,6-dihydro-2H -pyrans.
8.2. CONFORMATIONAL ANALYSIS AND 13C NMR SHIELDING EFFECTS 301
of natural products, such as aspergillide C (160),11 and also serves as a robust synthetic
intermediate.12 The versatility of 3,6-dihydro-2H -pyrans has enabled the synthesis of a number
of important synthetic targets such as dysiherbaine (375),13 ethyl deoxymonate B (376),14
and the hNK-1 receptor antagonist 377.15 However, the utility of 3,6-dihydro-2H -pyrans
is often impeded by the challenging task of assigning the relative stereochemistry of two
substituents located on opposite sides of the ring system. Previous stereochemical assignments
have relied on derivatization and, in specific cases, the use of NOE correlations and 3JHH
coupling constants.16
Research into the total synthesis of oxylipin natural products (i.e. labillarides E-H) led
us to prepare dihydropyran 332 as a synthetic intermediate (Scheme 8.1). Preliminary 1H-
O
O
OTBS
NaBH4, 
CeCl3 7H2O,
MeOH, -25oC
O
OH
OTBS
75% yield
24:1 dr
Cl
O
OMe
DMAP, CH2Cl2
84% yield
O
OCO2Me
OTBS
332
Scheme 8.1 Preparation of Dihydropyran 332.
NMR analysis of this compound did not provide sufficient evidence to deduce the relative
stereochemistry at C3 and C6, as the alkene and ring oxygen limit what could be inferred from
3JHH coupling. Additionally, the divalent oxygen and planarity of the alkene remove a number
of potential 1,3-diaxial interactions and, therefore, the effectiveness of NOE correlation is
limited in compounds having substitution patterns that cause bias towards the 2CO cis-332 or
OC2 trans-332 conformers (Figure 8.2).† These conformations are predominant in compounds
with an electronegative atom bound to C6, due to the anomeric effect.17 To overcome these
challenges we sought to develop a facile method for the assignment of relative stereochemistry
by analyzing the shielding effects of axial substituents on the 13C NMR resonances of the
3,6-dihydro-2H -pyran ring system.
8.2 Conformational Analysis and 13C NMR Shielding Effects
13C NMR spectroscopy has been used previously to deduce the stereochemistry of highly
substituted ring systems, such as carbohydrates and inositols.20 Comparing the spectra of two
inositol diastereomers, scyllo- (378) and myo-inositol (379), illustrates the shielding effects
of an axial hydroxyl group on the carbons within the ring system of 379 (Figure 8.3). The
γ-position experiences the largest shielding and is shifted upfield by 2.6 ppm. Additionally, the
α- and β-positions experience moderate shielding and the δ-position actually becomes slightly
deshielded and experiences a downfield shift of 0.6 ppm. In carbohydrates and inositols, these
observations have been referred to as the γ-substituent effect.21 13C NMR resonances are
†A weak NOE correlation to both H2a and H2b was observed upon irradiation of H6 in 332
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[a] 1H NMR (500 MHz, CDCl3) [b] Geometry optimization was performed on the two lowest energy half-chair
conformers using Gaussian ’0918 (mPW1PW91, TZVP) and 3JHH values were calculated using a modified
Karplus equation.19 [c] The compound described was ultimately proven to be cis-332.
Figure 8.2 Challenges in the Structural Assignment of Dihydropyran 332.
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Figure 8.3 Axial Shielding Effects in Inositol and 3,6-Dihydro-2H -pyran Diastereomers.
influenced by the complex interplay of steric effects, hyperconjugation and electronic motion
present in a given molecule, and therefore the distorted geometry and polarization of a 3,6-
dihydro-2H -pyran ring results in significantly different axial shielding effects, relative to that
observed with the inositol diastereomers.25 To interpret the 13C shielding effects of pseudo-axial
substituents on a 3,6-dihydro-2H -pyran ring, one must first understand the conformational bias
inherent to the ring system.22
The planar alkene and divalent oxygen leave only the C2 and C6 substituents with a
potential 1,3-diaxial interaction (Figure 8.4). However, electronegative substituents at the
allylic position of an unsaturated ring have been shown to have a preference for axial orientation
– a phenomenon referred to as the allylic effect.23 This effect is analogous to the anomeric effect
and is a result of stereoelectronic stabilization via delocalization of electron density into the
σ* orbital of the exocyclic C–X bond. Considering anomeric and allylic effects, along with the
reduced number of 1,3-diaxial interactions, led us to postulate that the 3,6-trans diastereomer
should prefer the diaxial conformer trans-A with a high degree of conformational homogeneity.
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3,6-Dihydro-2H -pyrans.
Competition between allylic and anomeric effects in the 3,6-cis diastereomer is likely to result
in a greater amount of conformational heterogeniety, and significant population of both cis-A
and cis-B conformers. In most cases, the stereoelectronic benefits experienced by an axial
C6 electronegative substituent should dictate the major conformer. This conformational
hypothesis is supported by the 1H-NMR spectra of the diastereomeric pyrans, cis-332 and
trans-332 (Figure 8.5). The 3,6-trans diastereomer contains diastereotopic protons at C2
that are significantly differentiated from each other. This is presumably a result of one
proton residing primarily in the sterically congested axial position. In contrast, the 1H-NMR
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Figure 8.5 Conformational Insights from 1H-NMR.
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spectrum of the 3,6-cis diastereomer shows the oxymethylene peaks have significant overlap.
Their appearance as an overlapping multiplet suggests a higher degree of conformational
heterogeneity, although additional conformational differences may also be a contributing
factor.24
Ultimately, the observed 13C chemical shifts represent a weighted average of conformers,
and therefore, the magnitude of axial shielding is dependent on the conformational distribution
of a compound. Dihydropyran trans-332, with a strong preference for the diaxial conformation
(trans-A), should experience 13C shielding effects from both substituents. However, cis-
332, with a greater amount of conformational heterogeneity and a single axial substituent
in each conformer, should experience significantly less shielding of the ring carbons relative
to trans-332. To evaluate the magnitude of axial shielding on each ring carbon the inductive
influences of the substituents need to be removed. This can be achieved, to a certain extent,
by subtracting the chemical shifts of the two diastereomers (i.e. Figure 8.3). The difference
in the 13C chemical shifts of cis-332 and trans-332 show a clear difference in shielding around
the 3,6-dihydro-2H -pyran ring and provides a diagnostic shielding pattern for the assignment
of relative stereochemistry in similar compounds (Figure 8.6).
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Figure 8.6 A Diagnostic Axial Shielding Pattern in 3,6-Dihydro-2H -pyrans: δC(cis-332) –
δC(trans-332).
8.3 Assignment of Relative Stereochemistry using a 13C NMR
Shielding Template
To evaluate the utility of a shielding template in the assignment of relative stereochemistry
in 3,6-dihydro-2H -pyrans, a range of diastereomeric pairs were investigated (Table 8.1).∗∗ In
general, substrates with oxygen-tethered substituents at C3 and C6 fit all five positions of the
template very well. The largest deviation from the average shielding values are seen at C2
and C5, which have root-mean-squared (RMS) differences of 0.43 and 0.29 ppm, respectively.
Interestingly, the varying inductive and steric effects of different substituents, R1 and R2,
caused significant changes in the 13C chemical shifts of the respective ring carbons and, in some
cases, even caused C4 to have a higher chemical shift than C5. This meant that no reliable
∗∗Details of the synthesis of these compounds can be found in Section 8.6
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Table 8.1 Development of a 13C NMR Shielding Template.
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X Substrates δ(cis)–δ(trans) in ppm
[a]
R1 R2 C2 C3 C4 C5 C6
380 CO2Me TBS –1.0 1.5 3.9 –1.7 1.3
381 Ac TBS –0.6 1.5 3.7 –1.2 1.5
382[b] Ac iPr –1.3 1.6 3.9 –1.8 1.2
383 Ac nPr –1.1 1.6 3.8 –1.6 1.4
384 Ac Allyl –1.2 1.7 3.9 –1.7 1.3
385 Ac CH2CCH –1.5 1.8 4.2 –1.9 1.0
386 Ac CH2Ph –1.3 1.7 4.2 –1.6 1.3
387[b] CO2Me H –0.1 1.5 3.4 –1.0 1.6
RMS error[c] 0.43 0.1 0.24 0.29 0.17
[a] Standard Conditions: 13C NMR (126 MHz, CDCl3) chemical shifts were measured relative to
CDCl3 and reported to 1 decimal place. All carbon assignments are based on 1H/1H COSY and
1H/13C HSQC spectra. A full table of 1H and 13C NMR assignments can be found in Section
8.6.3. Initial stereochemical assignments were based on literature data and reaction precedent. [b]
Diastereomers were not separated prior to NMR analysis. [c] RMS error relative to the average 13C
shielding values.
conclusions could be drawn from the magnitude of isolated 13C NMR shifts. Despite the
variance in net chemical shift, the relative difference used to evaluate axial shielding remained
relatively constant. The 13C NMR shielding template, shown in Table 8.1, provides a facile
method by which the relative stereochemistry of disubstituted 3,6-dihydro-2H -pyrans can be
assigned.
This approach is particularly useful in assigning the stereochemical outcomes of trans-
formations such as the Ferrier reaction, shown in Figure 8.7. In this case, a 3:1 mixture
of diastereomers was obtained and the 13C NMR resonances for the ring carbons of each
diastereomer were readily assigned from the 1H/13C HSQC spectrum. Subtracting the 13C
resonances of each ring carbon from their diastereomeric counterpart reveals the magnitude of
axial shielding. These five values were then compared to, and found to match, the shielding
template from Table 8.1, to ultimately reveal the major product from this reaction to be
trans-382.
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Figure 8.7 Assignment of Relative Stereochemistry using the Axial Shielding Template: A
Worked Example.
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Given the propensity of certain carbons in the dihydropyran ring to vary more than others,
we propose the use of the RMS error, from Table 8.1, for each carbon to evaluate how well
a given comparison matches the shielding template (Table 8.2). The diastereomeric pairs of
381–386 provide a very good match to all positions of the shielding template. The hemiacetal
387 displays some variance in ring shielding, but still has a very good match with the template
at C3 and C6, and a good match at C2, C4, and C5, and therefore still provides strong evidence
for the proposed relative stereochemical configuration.
Table 8.2 Using RMS Error to Evaluate Template Matching.
Ring Carbon C2 C3 C4 C5 C6 Template MatchTemplate Value (ppm) -1.0 1.6 3.9 -1.6 1.3
2 x (RMS error) ±0.86 ±0.2 ±0.48 ±0.58 ±0.34 Very Good
3 x (RMS error) ±1.29 ±0.3 ±0.72 ±0.87 ±0.51 Good
4 x (RMS error) ±1.72 ±0.4 ±0.96 ±1.16 ±0.68 ok
Additionally, the analysis of five discrete shielding values serves to both reinforce any
stereochemical conclusions made with this method and enable the rapid detection of anomalies
and inconsistencies. To a certain extent, this provides a safeguard against the misassignment
of relative stereochemistry. One such anomaly was observed in compounds containing a C3
hydroxyl group (Table 8.3). The ring carbons from this series of compounds were a very good
fit for the shielding template with the exception of C2 and C5, which provided a good and ok
match, respectively.
Table 8.3 13C NMR Shielding Effects in C3-Hydroxy Compounds.
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[a]
C2 C3 C4 C5 C6
Template Value -1.0 1.6 3.9 -1.6 1.3
389 TBS 0.3 1.5 3.3 –0.1 1.7
390[b] iPr –0.5 1.6 3.8 –0.7 1.3
391 Allyl –0.5 1.6 3.8 –0.7 1.4
[a]Standard Conditions from Table 8.1 apply. 1H and 13C NMR assignments can be found in Section
8.6.3. [b]Diastereomers were not separated prior to NMR analysis.
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To explore the limitations of this method, a number of 3,6-dihydro-2H -pyrans lacking
certain fundamental axial shielding properties were investigated (Table 8.4). The axial or
Table 8.4 Scope and Limitations of the 13C NMR Shielding Template.
[a] Standard Conditions from Table 8.1 apply. [b] 13C NMR data for cis- and trans-399 was taken
from the literature.26 [c] Diastereomers were not separated prior to NMR analysis.
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pseudo-axial orientation of an electronegative atom (i.e. oxygen) is a prerequisite to the
observation of shielding effects, and therefore replacing one or both of these atoms with carbon
not only reduces shielding effects but also removes the stereoelectronic conformational bias
described previously. 13C NMR analysis of 392 and 393 illustrates the significant change
in the shielding pattern around the ring upon removal of the oxygen atom bound to C6
(Entries 1 & 2). To further this point, Entry 3 shows a drastic reduction in shielding effects
when both electronegative atoms connected to the ring system are removed. In fact, the 13C
resonances of the diastereomers trans-394 and cis-394 show very little difference in chemical
shift. Aditionally, highly substituted ring systems, such as 395 and 396, present a significantly
more complex situation and therefore do not fit the current shielding template.
8.4 Complimentary Calculations of Dihydro-2H -pyran 13CNMR
Resonances
To extend the utility of this methodology, the use of complimentary computational methods
was investigated with the aim of enabling stereochemical assignment using 13C NMR data
from a single diastereomer.27 Given the relatively simple nature of the 3,6-dihydro-2H -pyran
ring system, we envisioned that density functional calculations could be used to accurately
calculate 13C NMR resonances of the ring carbons and distinguish the shielding effects that
characterize each diastereomer. A preliminary evaluation of this method was performed by
attempting to accurately calculate the 13C NMR resonances of the unsubstituted parent ring
system, 3,6-dihydro-2H -pyran.28 GIAO NMR calculations were performed with a range of
functionals and basis sets to ultimately reveal that the use of the mPW1PW91 functional29
and decontracted TZVP basis set (decTZVP),30 in conjunction with a multistandard (MSTD)
referencing method,31 yielded the most accurate results (Table 8.5).32 Adding substituents to
the ring system (i.e. cis- and trans-332) requires consideration and analysis of a number of
possible conformers.33 Using an energy threshold of 1.5 kcal/mol above the global minimum,
only the two half-chair ring conformers, 2Co and oC2, were considered (Figure 8.8). The
substituents of these ring conformers can exist in three different staggered conformations about
each exocyclic C–O bond. Thus, conformers A, B and C represent the three possible staggered
conformations about the C3–O bond, while keeping the C6–O bond constant. Ultimately, 4 out
of a possible 18 conformers of cis-332 were found to meet the selected energy threshold.34 GIAO
NMR calculations for each conformer and subsequent Boltzmann-weighted averaging provided
calculated 13C chemical shifts for the five carbons of the dihydropyran ring system. The
calculated spectra for each diastereomer, cis-332 and trans-332, were in good agreement with
the experimental data, providing CP3 and DP4 assignment probabilities in excess of 95%.35
Additionally, a root-mean-squared error of less than 2.5 ppm was obtained for both cis- and
trans-332. Interestingly, a large percentage of this error stems from the sp2 carbons and very
consistent differences between calculated and experimental values were observed across a range
of dihydropyrans. This observation prompted analysis of the difference between calculated
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Table 8.5 Evaluating Calculated 13C NMR Chemical Shifts for Dihydro-2H -pyrans.
[a] GIAO 13C NMR calculations were performed using Gaussian ’09 at the
mPW1PW91/TZVP//mPW1PW91/decTZVP level on conformers within 1.5 kcal/mol of
the global minima (4 conformers for each cis-diastereomer and 2 conformers for each trans-
diastereomer). These data were subjected to Boltzmann averaging, where appropriate, to provide
the results shown. See Appendix A for full details of the computational methodology used. [b]
Average RMS error between experimental and calculated 13C chemical shifts. [c] 13C NMR data
for 3,6-dihydro-2H -pyran was taken from the literature.28 [d] R and R’ represent the cis- and
trans-distereomers from Table 8.1 (i.e. compounds 332, 381–387).
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and experimental data for all 16 dihydropyrans reported in Table 8.1. These data enabled the
calculation of a correction constant for each position of the 3,6-dihydro-2H -pyran ring, thus
enabling highly accurate 13C NMR calculations.
The 3,6-dihydro-2H -pyrans 397, 398, and 399 were obtained as single diastereomers
during research into Pd-catalyzed allylic alkylation cascades (for additional details, see Chapter
7). With characterization data from only one diastereomer, shielding effects could not be
evaluated by comparison of 13C NMR resonances from the two possible diastereomers, as
shown previously. To overcome this problem the aforementioned computational methodology
was used to predict the absolute chemical shifts of both the cis- and trans-diastereomers. The
differential nature of axial shielding on the ring carbons provides the opportunity to match
experimental and calculated 13C resonances with a high degree of confidence (Table 8.6).
Computational predictions of the 13C chemical shifts for the dihydropyran ring were found
to be in good agreement with experimental data, and provided a DP4 probability in excess
of 95% for all three compounds. This statistical analysis differs from more traditional error
calculations (e.g. RMS error) in that a larger weighting is placed on calculated values with
a greater difference from experimental values. Thus, data pertaining to C4 and C5, which
have the greatest difference between experimental and calculated values, are considered the
most important points of comparison for compounds 397–399.36 Additionally, by applying
the appropriate set of correction constants for either the cis- or trans- diastereomer (from
Table 8.5) a good match (in most cases <1 ppm difference) with the experimental data could
also be obtained.
Overall, by combining the direct comparison of 13C NMR calculations with an awareness of
how axial shielding differentiates the ring carbons of the cis- and trans-3,6-dihydro-2H -pyran
diastereomers, robust evidence to support the assignment of relative stereochemistry can be
obtained with experimental data from just one diastereomer.
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Conformer: A (2CO) B (2CO) C (2CO)
Erel (kcal/mol) = 0 0.16 3.23
% of population = 48% 37% <1%
D (OC2) E (OC2) F (OC2) G (OC2)
1.75 1.67 1.32 1.34
2% 3% 5% 5%
Figure 8.8 Newman Projections for the Lowest Energy Conformers of cis-332.
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Table 8.6 Assignment of Relative Stereochemistry with NMR Data from a Single
Diastereomer.
KEY: Exp. = Experimental 13C NMR resonacnes, Calc. = Calculated 13C NMR resonances, Corr.
= Corrected Calculated 13C NMR resonances, Other = Calculated 13C NMR resonances for the
other possible diastereomer, DP4 = DP4 probability that the calculated 13C NMR resonances match
the experimental data.
[a] All carbon assignments are based on 1H/1H COSY and 1H/13C HSQC spectra. A full table
of 1H and 13C NMR assignments can be found in Section 8.6.3. [b] GIAO 13C NMR calculations
were performed using Gaussian ’09 at the mPW1PW91/TZVP//mPW1PW91/decTZVP level on
conformers within 1.5 kcal/mol of the global minima. These data were subjected to Boltzmann
averaging, where appropriate, to provide the results shown. See Appendix A for full details of the
computational methodology used. [c] cis-Correction constants (ppm): C2 = 1.76, C3 = -0.69, C4 = -
4.34, C5 = -1.63, C6 = -1.93. trans-Correction constants (ppm): C2 = 0.32, C3 = 0.33, C4 = -2.36, C5
= -3.76, C6 = -2.64. [d] The DP4 probability of the uncorrected calculated 13C NMR resonances was
calculated using the web-based applet found at http://www-jmg.ch.cam.ac.uk/tools/nmr/DP4/.35
[e] This pyrone containing 3,6-dihydro-2H -pyran required consideration of only one cis-conformer as
the others were outside of the 1.5 kcal/mol energy threshold.
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8.5 Summary
In conclusion, the use of axial shielding magnitudes in the assignment of remote relative
stereochemistry across 3,6-dihydro-2H -pyran ring systems has been demonstrated. This
approach enables the expeditious characterization of products from stereoselective reactions
such as the Ferrier reaction. Computational analysis has provided a rigorous understanding of
the conformational distribution of these compounds and enabled the accurate prediction of 13C
chemical shifts within the pyran ring. Consequently, reliable stereochemical assignments were
made with experimental data from a single diastereomer. With the accumulation of 1H/13C
HSQC data on a wider range of cyclic compounds, we ultimately hope to be able to extend the
principles of this methodology to the stereochemical assignment of dihydropyran rings with a
wider range of substitution patterns.
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8.6 Experimental Data for Chapter 8
8.6.1 General Experimental Methods
Unless otherwise noted, the following conditions apply. All reactions were performed in flame-
dried septum-sealed glassware with magnetic stirring under an atmosphere of argon. Moisture-
and oxygen-sensitive liquids and solutions were transferred using a stainless steel syringe or
cannula. Before use, solvents were refluxed over the appropriate drying agent and distilled
under argon: tetrahydrofuran from sodium benzophenone ketyl radical; dichloromethane,
acetonitrile and triethylamine from calcium hydride; methanol and toluene from sodium.
Furfuryl alcohol and BF3·OEt2 were distilled under reduced pressure before use. All other
commercially available chemicals were used as received, without further purification. Analytical
thin layer chromatography (TLC) was performed using plastic-backed pre-coated silica TLC
plates (Polygram SilG/UV254). Visualization was achieved by UV irradiation (254 nm) or
by heating after treatment with a potassium permanganate dip (1.5 g KMnO4, 10 g K2CO3,
1.25 mL of 10% aqueous NaOH solution and 200 mL of water) or p-anisaldehyde dip (0.7
mL p-anisaldehyde, 9.5 mL conc. H2SO4, 2.7 mL of acetic acid and 250 mL of EtOH). The
purification of products by flash column chromatography (FCC) was conducted using silica
gel 60 (220-240 mesh) with the solvent systems indicated. 1H NMR spectra were recorded on
either: a Varian Unity Inova 500 spectrometer at 500 MHz, or a Varian Inova 300 at 300 MHz.
Data are listed as chemical shift in ppm using CDCl3 as internal standard (7.26 ppm). 13C
NMR spectra were recorded on a Varian Unity Inova 500 spectrometer at 125 MHz and the
data are listed as chemical shift in ppm using CDCl3 as internal standard (77 ppm). All 13C
experiments were 1H decoupled. The assignment of atom connectivity and spatial relationships
are exclusively based on 2D NMR correlations (1H/1H-COSY, 1H/13C-HMBC and 1H/13C-
HSQC). IR bands were measured as a thin film on a Bruker FT-IR Tensor 27 spectrometer
with ATR sampling accessory. High-resolution mass spectrometry (HRMS) was performed on
a Waters QTOF Premier Tandem mass spectrometer.
8.6.2 Experimental Data
A number of the compounds reported in Chapter 8 were prepared as substrates for palladium-
catalyzed allylic alkylation cascades, or obtained as side products in these reactions. Full
experimental details and characterization data for the following compounds can be found in
Chapter 7:
•cis-(±)-6-[(tert-Butyldimethylsilyl)oxy]-3,6-dihydro-2H -pyran-3-yl methyl carbonate (cis-
380) •trans-(±)-6-[(tert-Butyldimethylsilyl)oxy]-3,6-dihydro-2H -pyran-3-yl methyl carbonate
(trans-380) •cis-(±)-6-((tert-Butyldimethylsilyl)oxy-3,6-dihydro-2H -pyran-3-ol (cis-389)
•trans-(±)-6-((tert-Butyldimethylsilyl)oxy-3,6-dihydro-2H -pyran-3-ol (trans-389) •trans-
(±)-6-((tert-Butyldimethylsilyl)oxy-3,6-dihydro-2H -pyran-3-yl benzoate (trans-400) •cis-(±)-
6-[(tert-Butyl- dimethylsilyl)oxy]-3,6-dihydro-2H -pyran-3-yl benzyl carbonate (cis-401) •4-
(cis-(±)-6-[(tert-Butyldimethylsilyl)oxy]-3,6-dihydro-2H -pyran-3-yl)-6-methyl-2H-pyran-2-one
(cis-402)
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Ultimately, these compounds are derived from furfuryl alcohol, as shown below for the case
of cis-380, trans-380 and cis-389.
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Full 1H and 13C NMR assignments for all compounds in Chapter 8 can be found in
Section 8.6.3.
Preparation of (3R,6S)-6-((tert-Butyldimethylsilyl)oxy)-3,6-dihydro-2H -pyran-
3-yl acetate, cis-381.
O
OAc
OTBS
381
To a solution of cis-(±)-6-((tert-butyldimethylsilyl)oxy)-3,6-dihydro-2H -pyran-3-ol (cis-
333, 0.33 g, 1.43 mmol, 1.0 equiv), 4A molecular sieves and PS-C lipase (0.066 g) in methyl
tert-butyl ether (15 mL) was added vinyl acetate (0.26 mL, 0.25 g, 2.86 mmol, 2.0 equiv) at
room temperature. The reaction was stirred at room temperature for 72 hours before being
filtered through celite and concentrated in vacuo. The crude product was purified by flash
column chromatography (15% EtOAc/Pet. ether). The title compound was isolated as a clear
oil (0.244 g, 63% yield). Rf = 0.50 (15% EtOAc/PE). 1H and 13C NMR data can be found
in Section 8.6.3. [α]D25 = +42.7 ◦ (c = 1.0, CHCl3). Enantioenriched starting material was
also recovered (0.094 g, 29% yield). [α]D25 = +21.9 ◦ (c = 0.44, CHCl3). Characterization
data matches the literature.37
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Preparation of trans-(±)-6-((tert-butyldimethylsilyl)oxy)-3,6-dihydro-2H -
pyran-3-yl acetate, trans-381.
O
OAc
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381
To a solution of (±)-trans-6-((tert-butyldimethylsilyl)oxy-3,6-dihydro-2H -pyran-3-ol (trans-
332, 0.0064 g, 0.028 mmol, 1.0 equiv) in pyridine (0.5 mL) was added acetic anhydride (0.5
mL). The reaction was stirred overnight at room temperature before quenching with 3 mL
of H2O. The reaction mixture was then cyclic loaded onto HP20 resin with MeOH (1 mL
increments up to 5 mL of MeOH). The resin was then washed three times with H2O, and
the product was subsequently eluted with acetone. The volatiles were removed in vacuo, the
product was redissolved in EtOAc, washed with CuSO4, brine, dried over MgSO4, filtered,
and concentrated in vacuo. The title compound was isolated as a clear film (0.007 g, 92%
yield). Rf = 0.29 (10% EtOAc/PE). 1H and 13C NMR data can be found in Section 8.6.3.
IR (film): 2955, 2931, 2858, 1739, 1372, 1237, 1109, 1031, 960, 870, 838 cm−1. HRMS - EI
(m/z): calculated for C13H24O4SiNa [M+Na]+: 295.1342, found: 295.1345, 1.0 ppm.
General Procedure for the Ferrier Reaction of D-O-diacetyl xylal.
Preparation of (3S,6R)-6-propoxy-3,6-dihydro-2H -pyran-3-yl acetate and
(3S,6S)-6-propoxy-3,6-dihydro-2H -pyran-3-yl acetate, cis- and trans-383.
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388 383383
To a solution of 3,4-di-O-acetyl-D-xylal (0.100 g, 0.5 mmol, 1 equiv) and n-propanol (0.045
mL, 0.6 mmol, 1.2 equiv) in CH2Cl2 (5 mL) was added BF3·OEt2 (0.012 mL, 0.014 g, 0.6
mmol, 1.2 equiv) at 0 ◦C. The reaction was slowly warmed to room temperature and stirred
for an hour before being diluted with CH2Cl2 and quenched with water. The reaction mixture
was subsequently extracted with CH2Cl2 and the combined organic layers were dried over
MgSO4, filtered and concentrated in vacuo. The crude product was purified by silica gel
chromatography (10% EtOAc/ pet. ether). The title compounds were isolated separately;
trans-383 was isolated as a clear, colorless oil (0.0216 g, 22% yield), cis-383 was isolated as a
clear colorless oil (0.0094 g, 9% yield). Characterization data for trans-383: Rf = 0.29 (10%
EtOAc/ pet. ether). 1H and 13C NMR data can be found in Section 8.6.3. IR (film): 2964,
2878, 1731, 1371, 1233, 1189, 1104, 1016, 956, 897, 845 cm−1. [α]D25 = +120.7 ◦(c = 1.08,
CHCl3). Characterization data for cis-383: Rf = 0.35 (10% EtOAc/ pet. ether). 1H and
13C NMR data can be found in Section 8.6.3. IR (film): 2964, 2880, 1736, 1371, 1231, 1099,
1030, 960, 895 cm−1. [α]D25 = +107.7 ◦(c = 0.47, CHCl3). HRMS - EI (m/z): calculated
for C10H16O4Na [M+Na]+: 223.0946, found: 223.0951, 2.2 ppm.
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Preparation of (3S,6S)-6-isopropoxy-3,6-dihydro-2H-pyran-3-yl acetate and
(3S,6R)-6-isopropoxy-3,6-dihydro-2H-pyran-3-yl acetate, cis- and trans-382.
O
OAc
OiPr
O
OAc
OiPr
cis- trans-382382
Using the general procedure for the Ferrier reaction, 3,4-di-O-acetyl-D-xylal (0.100 g, 0.5
mmol, 1 equiv), isopropanol (0.046 mL, 0.036 g, 0.6 mmol, 1.2 equiv) and BF3·OEt2 (0.012
mL, 0.6 mmol, 1.2 equiv) were added to the reaction. The crude product was purified by silica
gel chromatography (10% EtOAc/PE) and the title compounds were isolated together as a
clear, colorless oil (0.047 g, 46% yield). 1H and 13C NMR data for both trans- and cis-382
can be found in Section 8.6.3. Characterization data matches the literature.39
Preparation of (3S,6S)-6-(allyloxy)-3,6-dihydro-2H -pyran-3-yl acetate and
(3S,6R)-6-(allyloxy)-3,6-dihydro-2H -pyran-3-yl acetate, cis- and trans-384.
O
OAc
O
O
OAc
O
cis- trans-384384
Using the general procedure for the Ferrier reaction, 3,4-di-O-acetyl-D-xylal (0.100 g, 0.5
mmol, 1 equiv), allyl alcohol (0.041 mL, 0.035 g, 0.6 mmol, 1.2 equiv) and BF3·OEt2 (0.012 mL,
0.014 g, 0.6 mmol, 1.2 equiv) were added to the reaction. The crude product was purified by
silica gel chromatography (10% EtOAc/PE) and the title compounds were isolated separately;
trans-384 was isolated as a clear, colorless oil (0.036 g, 16% yield), cis-384 was isolated as
a clear colorless oil (0.016 g, 37% yield). Characterization data for trans-384: Rf = 0.16
(10% EtOAc/PE) 1H and 13C NMR data can be found in Section 8.6.3. IR (film):
2984, 2920, 1730, 1371, 1232, 1036, 1014, 956 cm−1. HRMS - EI (m/z): calculated for
C10H14O4Na [M+Na]+: 221.0790, found: 221.0790, 0.0 ppm. [α]D25 = +86.1 ◦(c = 1.05,
CHCl3). Characterization data for cis-384: Rf = 0.24 (10% EtOAc/PE) 1H and 13C NMR
data can be found in Section 8.6.3. IR (film): 2886, 1736, 1371, 1230, 1094, 1033, 959 cm−1.
HRMS - EI (m/z): calculated for C10H12O4Na [M+Na]+: 221.0790, found: 221.0792, 0.9
ppm. [α]D25 = +56.66 ◦ (CHCl3, c = 0.8).
Preparation of (3S,6R)-6-(prop-2-yn-1-yloxy)-3,6-dihydro-2H -pyran-3-yl ac-
etate and (3S,6S)-6-(prop-2-yn-1-yloxy)-3,6-dihydro-2H -pyran-3-yl acetate, cis-
and trans-385.
Using the general procedure for the Ferrier reaction, 3,4-di-O-acetyl-D-xylal (0.100 g, 0.5
mmol, 1 equiv), propargyl alcohol (0.034 g, 0.6 mmol, 1.2 equiv) and BF3·OEt2 (0.012 mL,
0.014 g, 0.6 mmol, 1.2 equiv) were added to the reaction. The crude product was purified by
silica gel chromatography (10% EtOAc/PE). The title compounds were isolated separately;
trans-385 was isolated as a clear, colorless oil (0.021 g, 22% yield), cis-385 was isolated as a
clear colorless oil (0.019 g, 20% yield). Characterization data for trans-385: Rf = 0.30 (10%
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O
OAc
O
O
OAc
O
cis- trans-385385
EtOAc/PE). 1H and 13C NMR data can be found in Section 8.6.3. HRMS - EI (m/z):
calculated for C10H12O4Na [M+Na]+: 219.0633, found: 219.0630, –1.4 ppm. [α]D25 = +55.3 ◦
(c = 1.05, CHCl3). Characterization data for cis-385: Rf = 0.24 (10% EtOAc/PE). 1H and
13C NMR data can be found in Section 8.6.3. HRMS - EI (m/z): calculated for C10H12O4Na
[M+Na]+: 219.0633, found: 219.0635, 0.9 ppm. [α]D25 = +23.6 ◦ (c = 0.97, CHCl3).
Preparation of (3S,6R)-6-(benzyloxy)-3,6-dihydro-2H -pyran-3-yl acetate and
(3S,6S)-6-(benzyloxy)-3,6-dihydro-2H -pyran-3-yl acetate, cis- and trans-386.
O
OAc
O
O
OAc
O
cis- trans-
Ph Ph
386386
Using the general procedure for the Ferrier reaction, 3,4-di-O-acetyl-D-xylal (0.100 g, 0.5
mmol, 1 equiv), benzyl alcohol (0.062 mL, 0.6 mmol, 1.2 equiv) and BF3·OEt2 (0.012 mL,
0.014 g, 0.6 mmol, 1.2 equiv) were added to the reaction. The crude product was purified by
silica gel chromatography (10% EtOAc/PE) and the title compounds were isolated together
(Rf = 0.28 and 0.20.) as a clear, colorless oil (0.099 g, 80% yield, ca. 3:1 trans:cis ratio). 1H
and 13C NMR data for cis-385 and trans-385 can be found in Section 8.6.3. Characterization
data matches the literature.39
Preparation of trans-(3S,6S)-6-allyl-3,6-dihydro-2H -pyran-3-yl acetate, trans-
404.
O
OAc
trans-
O
OAc
AcO
BF3 OEt2,
CH2Cl2
TMP1 TMP2
TMS
404
Using the general procedure for the Ferrier reaction, 3,4-di-O-acetyl-D-xylal (0.200 g, 1.0
mmol, 1 equiv), allyl trimethylsilane (0.190 mL, 1.2 mmol, 1.2 equiv) and BF3·OEt2 (0.13 mL,
1.2 mmol, 1.2 equiv) were added to the reaction. The crude product was purified by silica gel
chromatography (10% EtOAc/PE) and the title compounds was isolated as a clear, colorless
oil (0.130 g, 72% yield). Rf = 0.32 (10% EtOAc/PE). 1H and 13C NMR data can be found
in Section 8.6.3. Trace amounts (<10%) of the cis-diastereomer were observed by 1H and 13C
NMR. Characterization data matches the literature.37
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Preparation of ‘cis’-(2R,3S,6S)- and ‘trans’-(2R,3S,6R)- 3-Acetoxy-6-
isopropoxy-3,6-dihydro-2H -pyran-2-yl)methyl acetate, ‘cis’- and ‘trans’-405.
O
OAc
OiPr
O
OAc
OiPr
cis- trans-
O
OAc
AcO
FeCl3,
iPrOH,
CH2Cl2OAc
OAc OAc
MAJOR MINOR
+
406 405405
To a solution of 3,4, 6-tri-O-acetyl-D-glucal (0.100 g, 0.367 mmol, 1 equiv) and 2-propanol
(0.031 mL, 0.404 mmol, 1.1 equiv) was added FeCl3 (0.082 mL of a 0.1 M solution in CH2Cl2,
0.008 mmol, 22 mol %). The crude product was purified by silica gel chromatography (10%
EtOAc/PE) and the title compounds were isolated as a clear, colorless oil (0.031 g, 31% yield,
7.1:1 dr, ‘cis’:‘trans’). Rf = 0.19 (10% EtOAc/PE). 1H and 13C NMR data can be found
in Section 8.6.3. Characterization data matches the literature.38
Preparation of (±)-6-Hydroxy-3,6-dihydro-2H -pyran-3-yl methyl carbonate,
cis-, and trans-387.
O
OCO2Me
OTBS
O
OCO2Me
OH
O
OCO2Me
OH
HF pyr, MeCN
380 387
To a solution of 380 (0.096 g, 0.33 mmol, 1.0 equiv) in acetonitrile (8 mL), at room
temperature, was added HF·pyridine (0.240 mL, 0.266 g, 13.3 mmol, 40 equiv). The reaction
was stirred overnight before being quenched with saturated aqueous sodium bicarbonate,
extracted with EtOAc, dried over MgSO4, filtered and concentrated in vacuo. The crude
product was purified by silica gel chromatography (50% EtOAc / PE). The desired product
was isolated as a ca. 3:1 mixture of trans- and cis-diastereomers, respectively. (0.018 g, 31%
yield). Rf = 0.23 (40% EtOAc / Pet. Ether). 1H and 13C NMR data can be found in
Section 8.6.3. IR (film) 3413, 2959, 2925, 1740, 1443, 1252, 1061, 975, 937 cm−1. HRMS -
EI (m/z) calculated for C7H10O5Na+ [M+Na]+: 197.0426, found: 197.0422.
Representative Procedure for the Saponification of 3,6-Dihydro-2H -pyran-3-yl
acetates.
Preparation of cis-(S,R)- and trans-(S,S)-6-Isopropoxy-3,6-dihydro-2H -pyran-
3-ol, cis- and trans-390.
O
OAc
OiPr
O
OAc
OiPr
cis- trans-
O
OH
OiPr
O
OH
OiPr
cis- trans-
K2CO3,
MeOH
+ +
382382 390390
To a solution of cis-(S,R)- and trans-(S,S)-6-isopropoxy-3,6-dihydro-2H -pyran-3 (382,
0.047 g, 0.232 mmol, 1.0 equiv) in methanol (2.5 mL) was added K2CO3 (0.160 g, 1.16 mmol,
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5.0 equiv). The reaction mixture was stirred at room temperature for 3 hours before being
quenched with H2O and extracted twice with EtOAc. The combined organic layers were dried
over MgSO4, filtered, and concentrated in vacuo. The title compound was isolated as a clear
colorless oil. Characterization data matches the literature.39
Preparation of trans-(3S,6S)-6-Allyloxy-3,6-dihydro-2H -pyran-3-ol, trans-391.
O
OH
O
trans-391
Using the general procedure for acetate saponification, trans-(3S,6S)-6-allyloxy-3,6-dihydro-
2H -pyran-3-acetate (0.036 g, 0.18 mmol, 1.0 equiv) and K2CO3 (0.124 g, 0.90 mmol, 5.0 equiv)
were added to the reaction. The title compound was obtained as a clear colorless oil (0.010
g, 36% yield). 1H and 13C NMR data can be found in Section 8.6.3. IR (film): 3398,
2922, 1399, 1319, 1260, 1188, 1099, 1077, 1033, 964, 930, 833 cm−1. [α]D25 = +68.3 ◦ (c = 0.5,
CHCl3). HRMS - EI (m/z) calculated for C8H12O3Na+ [M+Na]+: 179.0684, found: 179.0688.
Preparation of cis-(3S,6R)-6-Allyloxy-3,6-dihydro-2H -pyran-3-ol, cis-391.
O
OH
O
cis-391
Using the general procedure for acetate saponification, cis-(3S,6R)-6-allyloxy-3,6-dihydro-
2H -pyran-3-acetate (0.016 g, 0.081 mmol, 1.0 equiv) and K2CO3 (0.056 g, 0.40 mmol, 5.0
equiv) were added to the reaction. The title compound was obtained as a clear colorless oil
(0.004 g, 32% yield). 1H and 13C NMR data can be found in Section 8.6.3. IR (film):
3397, 2919, 1395, 1276, 1261, 1186, 1032, 935, 884 cm−1. [α]D25 = +34.7 ◦ (c = 0.19, CHCl3).
HRMS - EI (m/z) calculated for C8H12O3Na+ [M+Na]+: 179.0684, found: 179.0681.
Preparation of trans-(3S,6S)-6-allyl-3,6-dihydro-2H -pyran-3-ol, trans-407.
O
OH
trans-407
Using the general procedure for acetate saponification, trans-(3S,6S)-6-allyl-3,6-dihydro-
2H -pyran-3-ol (trans-407, 0.130 g, 0.716 mmol, 1.0 equiv) and K2CO3 (0.495 g, 3.58 mmol,
5.0 equiv) were added to the reaction. The title compound was obtained as a clear colorless
oil (0.079 g, 79% yield). 1H and 13C NMR data can be found in Section 8.6.3. [α]D25
= +98.6 ◦ (c = 0.52, CHCl3). HRMS - EI (m/z) calculated for C8H12O2Na+ [M+Na]+:
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163.0735, found: 163.0730. Characterization data matches the literature.41
Preparation of cis-(3S,6S)-6-allyl-3,6-dihydro-2H -pyran-3-yl acetate, cis-404.
O
OH
trans-
O
OAc
cis-
DIAD, PPh3,
AcOH, THF
407 404
To a solution of trans-(3S,6S)-6-allyl-3,6-dihydro-2H -pyran-3-ol (trans-407, 0.0688 g, 0.49
mmol, 1.0 equiv), PPh3 (0.142 g, 0.54 mmol, 1.1 equiv), and acetic acid (0.034 mL, 0.59 mmol,
1.2 equiv) in THF (5 mL) at 0 ◦C was added DIAD (0.105 mL, 0.54 mmol, 1.1 equiv). The
reaction was stirred at 0 ◦C for 30 minutes before warming to room temperature, stirring for
an additional hour, and quenching with H2O. The reaction mixture was subsequently extracted
with EtOAc and the combined organics were dried over MgSO4, filtered, and concentrated in
vacuo. The crude product was purified by silica gel chromatography (10% EtOAc/PE) and
the title compound was isolates as a clear colorless oil (0.0464 g, 52% yield). Rf = 0.2 (10%
EtOAc/PE). 1H and 13C NMR data can be found in Section 8.6.3. [α]D25 = –90.6 ◦ (c =
0.42, CHCl3). HRMS - EI (m/z) calculated for C10H14O3Na+ [M+Na]+: 205.0841, found:
205.0840. Characterization data matches the literature.41
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8.6.3 NMR Data and Assignments
cis-(±)-6-[(tert-Butyldimethylsilyl)oxy]-3,6-dihydro-
2H -pyran-3-yl methyl carbonate, cis-380.
4
5 6 O 1
23
O
O Si
7 O
O
9
11 10
12
8
NMR Assignments
C δC, mult δH (J, Hz) COSY
2a 60.1, CH2 3.91, ddd (11.1, 7.9, 0.5) 2b, 3
2b – 3.87, ddd (11.1, 5.7, 0.9) 2a, 3
3 68.4, CH 5.13, m 2a, 2b, 4
4 126.4, CH 5.92, ddt (10.3, 2.3, 1.0) 3, 5
5 132.2, CH 5.85, ddd (10.3, 2.3, 1.8) 4, 6
6 89.2, CH 5.28, m 5
7 155.3, C – –
8 54.9, CH3 3.80, s –
9 –4.4, CH3 0.133, s –
10 –5.2, CH3 0.130, s –
11 18.0, C – –
12 25.7, CH3 0.91, s –
trans-(±)-6-[(tert-Butyldimethylsilyl)oxy]-3,6-
dihydro-2H -pyran-3-yl methyl carbonate, trans-408.
4
5 6 O 1
23
O
O Si
7 O
O
9
11 10
12
8
NMR Assignments
C δC, mult δH (J, Hz) COSY
2a 61.0, CH2 4.20, dd (13.1, 2.8) 2b, 3
2b – 3.90, dt (13.1, 1.2) 2a
3 66.9, CH 4.8, ddd (4.4, 2.9, 1.4) 2a, 4
4 122.5, CH 6.03, ddd (10.1, 4.3, 0.8) 3, 5
5 133.9, CH 6.00, dt (10.0, 2.6) 4, 6
6 87.9, CH 5.33, d (2.4) 5
7 155.4, C – –
8 54.8, CH3 3.78, s –
9 -4.5, CH3 0.13, s –
10 -5.3, CH3 0.13, s –
11 18.1, C – –
12 25.7, CH3 0.91, s –
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(3R,6S)-6-((tert-butyldimethylsilyl)oxy)-3,6-dihydro-
2H -pyran-3-yl acetate, cis-381.
4
5 6 O 1
23
O
O Si
7 8
O
9
11 10
12
NMR Assignments
C δC, mult δH (J, Hz) COSY
2a 60.6, CH2 3.86, dd (9.5, 5.4) 2b, 3
2b – 3.83, dd (9.5, 4.0) 2a, 3
3 65.0, CH 5.24, m 2a, 2b, 4
4 126.9, CH 5.88, dd (10.3, 2.1) 3, 5
5 132.1, CH 5.84, dt (10.3, 1.7) 5, 6
6 89.5, CH 5.28, app. s 5
7 170.61, C – –
8 21.1, CH3 2.08, s –
9 -4.4, CH3 0.141, s –
10 -5.2, CH3 0.139, s –
11 25.7, C – –
12 18.1, CH3 0.92, s –
(3R,6S)-6-((tert-butyldimethylsilyl)oxy)-3,6-dihydro-
2H -pyran-3-yl acetate, trans-381.
4
5 6 O 1
23
O
O Si
7 8
O
9
11 10
12
NMR Assignments
C δC, mult δH (J, Hz) COSY
2a 61.2, CH2 4.2, dd (13.0, 2.8) 2b, 3
2b – 3.82, dd (13.0, 1.2) 2a, 3
3 63.5, CH 4.95, m 2a, 2b, 4
4 123.2, CH 6.01, m 3, 5
5 133.2, CH 6.00, m 5, 6
6 87.9, CH 5.35, d (1.9) 5
7 170.7, C – –
8 21.13, CH3 2.09, s –
9 -4.5, CH3 0.140, s –
10 -5.32, CH3 0.136, s –
11 25.7, C – –
12 18.07, CH3 0.91, s –
(3S,6S)-6-propoxy-3,6-dihydro-2H -pyran-3-yl acetate
(trans-), trans-382.
4
5 6 O 1
23
O
O 7
8
9
10 11
O
NMR Assignments
C δC, mult δH (J, Hz) COSY
2a 61.2, CH2 4.17, dd (13.0, 2.9) 5, 2b
2b – 3.83, dd (13.0, 1.2) 2a
3 63.4, CH 4.95, dt (2.9, 1.6) 4,2a
4 124.9, CH 6.08–6.03, m 2, 3, 5
5 131.0, CH 6.08–6.03, m 2, 4, 5
6 92.9, CH 5.00, d (2.3) 3
7a 70.2, CH2 3.73, dt (9.5, 6.8) 7b, 8
7b – 3.45, dt (9.5, 6.7) 7a, 8
8 22.9, CH2 1.63, m 7a, 7b, 9
9 10.6, CH3 0.94, t (7.4) 8
10 170.6, C – –
11 21.1, CH3 2.10, s –
(3S,6R)-6-propoxy-3,6-dihydro-2H -pyran-3-yl acetate
(cis-), cis-382.
4
5 6 O 1
23
O
O 7
8
9
10 11
O
NMR Assignments
C δC, mult δH (J, Hz) COSY
2a 60.1, CH2 3.86, dd (11.1, 5.7) 2b, 5
2b – 3.82, dd (11.1, 7.9) 2a, 5
3 65.0, CH 5.29, m 3, 4, 6a, 6b
4 128.7, CH 5.95, m 2, 3, 5
5 129.4, CH 5.88, dt (10.3, 2) 2, 4, 5
6 94.3, CH 4.95, app. d 3, 4
7a 70.5, CH2 3.75, dt (9.4, 6.8) 7b, 8
7b – 3.46, dt (9.4, 6.7) 7a, 8
8 23.0, CH2 1.64, sextet (7.2) 7a, 7b, 9
9 10.6, CH3 0.95, t (7.4) 8
10 170.6, C – –
11 21.0, CH3 2.08, s –
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(3S,6R)-6-isopropoxy-3,6-dihydro-2H-pyran-3-yl
acetate, trans-383.
4
5 6 O 1
23
O
O 7
8
10 11
O
9
NMR Assignments
C δC, mult δH (J, Hz) COSY
2a 61.1, CH2 4.19, dd (13.0, 2.8) 2b, 3
2b – 3.84-3.80, m 2a, 3a
3 63.5, CH 4.95, dt (3.6, 1.9) 2a, 2ba, 4
4 124.8, CH 6.06, dd (10.1, 5.1) 3, 5
5 131.5, CH 6.00, dd (10.1, 2.9) 4, 6
6 91.1, CH 5.11, d (3.0) 5
7 70.0, CH 3.98, 7 (6.0) 8, 9
8 23.6, CH3 1.23, d (6.2) 7
9 21.8, CH3 1.18, d (6.1) 7
10 170.7, C – –
11 21.1, CH3 2.09, s –
(3S,6R)-6-isopropoxy-3,6-dihydro-2H-pyran-3-yl
acetate, cis-383.
4
5 6 O 1
23
O
O 7
8
10 11
O
9
NMR Assignments
C δC, mult δH (J, Hz) COSY
2 59.8, CH2 3.83, m 3
3 65.1, CH 5.29, app. t (7.2) –
4 128.7, CH 5.92, dd (10.3, 1.1) 5
5 129.7, CH 5.84-5.81, m 4
6 92.3, CH 5.03, app. s –
7 70.3, CH2 3.98, 7 (6.0) 8, 9
8 23.6, CH2 1.24, m 7
9 21.8, CH3 1.18, m 7
10 170.7, C – –
11 21.1, CH3 2.06, s –
(3S,6R)-6-(allyloxy)-3,6-dihydro-2H-pyran-3-yl
acetate, trans-384.
4
5 6 O 1
23
O
O
7
10 11
O
8
9
NMR Assignments
C δC, mult δH (J, Hz) COSY
2a 61.3, CH2 4.17, dd (13.0, 2.7) 2b, 3
2b – 3.83, d (13.1) 2a, 3
3 63.3, CH 4.95, dd (4.4, 2.5) 2a, 2b, 4
4 125.1, CH 6.08, dd (10.0, 5.0) 3, 5
5 130.8, CH 6.03, dd (10.1, 2.8) 4, 6
6 92.1, CH 5.05, d (2.4) 5
7a 68.9, CH2 4.25, ddt (12.7, 5.2, 1.4) 7b, 8
7b – 4.06, ddt (12.7, 6.4, 1.1) 7a, 8
8 134.1, CH 5.92, dddd 7a, 7b,
(17.1, 10.5, 6.4, 5.3) 9a, 9b
9a 117.7, CH2 5.30, dd (17.2, 1.6) 8, 9b
9b – 5.20, dd (10.3, 1.3) 8, 9a
10 170.6, C – –
11 21.1, CH3 2.08, s –
(3S,6S)-6-(allyloxy)-3,6-dihydro-2H-pyran-3-yl
acetate, cis-384.
4
5 6 O 1
23
O
O
7
10 11
O
8
9
NMR Assignments
C δC, mult δH (J, Hz) COSY
2a 60.1, CH2 3.85, dd (11.0, 5.7) 2b, 3
2b – 3.81, dd (11.0, 8.0) 2a, 3
3 65.0, CH 5.32–5.27, m 2a, 2b, 4
4 129.0, CH 5.97–5.89, m 3, 5
5 129.1, CH 5.87, dt (10.3, 2.1) 4, 6
6 93.4, CH 4.99, s 4, 5
7a 69.1, CH2 4.27, ddt (12.8, 5.2, 1.4) 7b, 8
7b – 4.06, ddt (12.8, 6.3, 1.2) 7a, 8
8 134.2, CH 5.97–5.89, m 7a, 7b,
9a, 9b
9a 117.5 5.32–5.27, m 8, 9b
9b – 5.20, dd (10.4, 1.3) 8, 9a
10 170.6, C – –
11 21.0, CH3 2.06, s –
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(3S,6R)-6-(prop-2-yn-1-yloxy)-3,6-dihydro-2H-pyran-
3-yl acetate,
trans-385.
4
5 6 O 1
23
O
O
7
10 11
O
8 9
NMR Assignments
C δC, mult δH (J, Hz) COSY
2a 61.5, CH2 4.12, dd (13.0, 2.7) 2b, 3
2b – 3.84, d (13.0) 2a, 3
3 63.1, CH 4.94, dd (4.8, 2.7) 2a, 2b, 4
4 125.4, CH 6.10, dd (10.1, 5.2) 3, 5
5 130.3, CH 6.03, dd (10.1, 3.0) 4, 6
6 91.1, CH 5.21, d (2.8) 5
7 54.8 4.29, d (2.3) 9
8 – – –
9 74.7, CH 2.44, t (2.2) 7
10 – – –
11 21.1, CH3 2.08, s –
(3S,6S)-6-(prop-2-yn-1-yloxy)-3,6-dihydro-2H-pyran-
3-yl acetate,
cis-385.
4
5 6 O 1
23
O
O
7
10 11
O
8 9
NMR Assignments
C δC, mult δH (J, Hz) COSY
2a 60.0, CH2 3.87, dd (10.9, 5.7) 2b, 3
2b – 3.77, dd (10.9, 8.5) 2a, 3
3 64.9, CH 5.33–5.30, m 2a, 2b, 4, 5
4 129.6, CH 5.97, dd (10.3, 1.0) 3, 5, 6
5 128.4, CH 5.86, d (10.3) 3, 4, 6
6 92.3, CH 5.16, s 4, 5
7 54.9, CH2 4.31, s 9
8 79.1, C – –
9 74.7, CH 2.44, s 7
10 170.5, C – –
11 21.0, CH3 2.07, s –
(3S,6R)-6-(benzyloxy)-3,6-dihydro-2H -pyran-3-yl
acetate, trans-386.
4
5 6 O 1
23
O
O
7
9 10
O
Ph 8
NMR Assignments
C δC, mult δH (J, Hz) COSY
2a 61.4, CH2 4.21, dd 2b, 3
(13.1, 2.8)
2b – 3.87, m 2a, 3
3 63.3, CH 4.96, m 2a, 2b, 4
4 124.9, CH 6.09, m 3, 5
5 130.7, CH 6.04, dd 4, 6
(10.1, 2.9)
6 92.0, CH 5.10, dt 5
(2.9, 0.6)
7a 69.9, CH2 4.79, d (11.7) 7b
7b – 4.59, d (11.7) 7a
8 137.5, C; 7.38–7.27, m 8
128.5-127.4, 5xCH
9 170.6, C – –
10 21.1, CH3 2.10, s –
(3S,6S)-6-(benzyloxy)-3,6-dihydro-2H -pyran-3-yl
acetate, cis-386.
4
5 6 O 1
23
O
O
7
9 10
O
Ph 8
NMR Assignments
C δC, mult δH (J, Hz) COSY
2 60.1, CH2 3.92, m 3
3 65.0, CH 5.32, m 2, 4
4 129.1, CH 5.94, ddt 3, 5
(10.3, 2.2, 1.0)
5 129.1, CH 5.88, ddd 4, 6
(10.3, 2.4, 1.8)
6 93.3, CH 5.04, dd 5
(2.4, 1.3)
7a 69.3, CH2 4.75, d (11.9) 7b
7b – 4.47, d (11.9) 7a
8 138.4, C; 7.38–7.28, m 8
128.5-127.4, 5xCH
9 170.3, C – –
10 21.1, CH3 2.05, s –
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cis-(±)-6-Hydroxy-3,6-dihydro-2H -pyran-3-yl methyl
carbonate, cis-387.
4
5 6 O 1
23
O
OH
9
7 O
O
8
NMR Assignments
C δC, mult δH (J, Hz) COSY
2 61.0, CH2 3.95, m 3
3 68.0, CH 5.10, dddt 2, 4
(6.6, 5.0, 3.1, 1.7)
4 127.9, CH 6.04, dd (10.3, 2.8) 3, 5
5 131.0, CH 5.96, dt (10.3, 1.8) 4
6 89.3, CH 5.33, m 9
7 155.3, C – –
8 54.9, CH3; 3.80, s –
9 – 2.90, d (6.4) 6
trans-(±)-6-Hydroxy-3,6-dihydro-2H -pyran-3-yl
methyl carbonate, trans-387.
4
5 6 O 1
23
O
OH
9
7 O
O
8
NMR Assignments
C δC, mult δH (J, Hz) COSY
2a 61.1, CH2 4.28, dd (13.1, 2.9) 2b, 4
2b – 3.95, m 2a
3 66.5, CH 4.84, ddd 2a, 4
(4.6, 3.0, 1.6)
4 124.5, CH 6.14, m 3, 5
5 132.0, CH 6.10, dd (10.1, 2.6) 4, 6
6 87.7, CH 5.42, dd (4.8, 2.5) 5, 9
7 155.3, C – –
8 55.0, CH3; 3.80, s –
9 – 2.77, d (4.2) 6
(3S,6R)-6-(allyloxy)-3,6-dihydro-2H-pyran-3-ol,
trans-391.
4
5 6 O 1
23
O
O
7
H 10
8
9
NMR Assignments
C δC, mult δH (J, Hz) COSY
2a 64.30, CH2 4.13, dd (12.2, 2.5) 2b, 3
2b – 3.79, dt (12.2, 1.3) 2a, 3
3 61.54, CH 3.93, app. s 2a, 2b,
4, 10
4 129.22, CH 6.14, ddt 3, 5
(10.0, 5.3, 1.1)
5 128.47, CH 5.90, dd (10.0, 3.3) 4, 6
6 92.31, CH 4.99, d (3.1) 5
7a 68.5, CH2 4.26, ddt 7b, 8
(12.7, 5.2, 1.4)
7b – 4.06, ddt 7a, 8
(12.7, 6.3, 1.2)
8 134.19, CH 5.95, m 7a, 7b,
9a, 9b
9a 117.56, CH2 5.30, ddd 8, 9b
(17.2, 3.6, 2.0)
9b – 5.21, m 8, 9a
10 – 2.00, d (8.9) 3
(3S,6S)-6-(allyloxy)-3,6-dihydro-2H-pyran-3-ol,
cis-391.
4
5 6 O 1
23
O
O
7
H 10
8
9
NMR Assignments
C δC, mult δH (J, Hz) COSY
2a 63.81, CH2 3.82, dd (11.0, 5.3) 2b, 3
2b – 3.72, dd (11.0, 8.0) 2a, 3
3 63.18, CH 4.25, m 2a, 2b, 4
4 133.00, CH 6.04, m 3, 5
5 127.78, CH 5.80, dt (10.3, 2.0) 4, 6
6 93.66, CH 4.98, m 4, 5
7a 69.15, CH2 4.28, m 7b, 8
7b – 4.07, dd (12.7, 6.3) 7a, 8
8 134.22, CH 5.95, m 7a, 7b,
9a, 9b
9a 117.49 5.31, m 8, 9b
9b – 5.21, m 8, 9a
10 – 1.56, br. s 3
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(3S,6R)-6-(isopropoxy)-3,6-dihydro-2H-pyran-3-ol,
trans-390.
4
5 6 O 1
23
O
O 7
8
H 10
9
NMR Assignments
C δC, mult δH (J, Hz) COSY
2a 64.11, CH2 4.14, dd (12.3, 2.6) 2b, 3
2b – 3.77, d (12.3) 2a, 3
3 61.63, CH 3.81, app. s 2a, 2b,
4, 10
4 128.95, CH 6.11, dd 3, 5
(10.0, 5.3)
5 129.07, CH 5.85, dd (10.0, 3.1) 4, 6
6 91.31, CH 5.04, d (3.0) 5
7 69.82, CH 3.98, m 8, 9
8 23.53, CH3 1.23, d (6.4) 7
9 21.82, CH3 1.17, d (6.1) 7
10 – 2.11, br. s 3
(3S,6S)-6-(isopropoxy)-3,6-dihydro-2H-pyran-3-ol,
cis-390.
4
5 6 O 1
23
O
O 7
8
H 10
9
NMR Assignments
C δC, mult δH (J, Hz) COSY
2 63.64, CH2 3.79-3.69, m 3
3 63.208, CH 4.22, app. s 2, 4
4 132.75, CH 6.00, m 3, 5
5 128.38, CH 5.74, dt (10.2, 2.1) 4, 6
6 92.66, CH 5.01, app. s 5
7 70.28, CH 3.98, m 8, 9
8 23.63, CH3 1.24, d (7.0) 7
9 21.88, CH3 1.17, d (6.1) 7
10 – 1.84, br. s 3
4-[cis-±-6[(tert-butyldimethylsilyl)oxy]]-3,6-dihydro-
2H-pyran-3-yl]oxy-6-methyl-2H -pyran-2-one,
cis-409.
4
5
6
O
1
2
3
O
O
Si
7
8
14
9 11
10 12
13O
15
16
O
NMR Assignments
C δC, mult δH (J, Hz) COSY
2a 59.8, CH2 3.95, dd (11.1, 8.0) 2b, 3
2b – 3.88, ddd (11.1, 5.4, 0.9) 2a, 3
3 68.6, CH 4.79, m 2a, 2b, 4
4 125.2, CH 5.95, app. dt (10.3, 0.9) 3, 5
5 132.7, CH 5.89, app. dt (10.3, 1.9) 4, 6
6 89.3, CH 5.41, d (2.1) 5
7 169.2, C – –
8 88.4, CH 5.3, s 14
9 -5.3, CH3 0.13, s –
10 -4.4, CH3 0.13, s –
11 18.0, C – –
12 25.7, CH3 0.91, s –
13 164.7, C – –
14 100.6, CH 5.77, s 8, 16
15 162.6, C – –
16 19.9, CH3 2.2, s 14
trans-(±)-6((tert-butyldimethylsilyl)oxy)-3,6-dihydro-
2H-pyran-3-yl benzoate,
trans-410.
4
5 6 O 1
23
O
O Si
7 Ph
O
9
11 10
12
NMR Assignments
C δC, mult δH (J, Hz) COSY
2a 61.4, CH2 4.31, dd 2b, 3
(13.0, 2.9)
2b – 3.97, dt 2a, 3
(13.0, 1.3)
3 64.0, CH 5.19, m 2a, 2b, 4
4 123.3, CH 6.12, dd 3, 5
(10.0, 5.1)
5 133.4, CH 6.04, dd 4, 6
(10.0, 3.0)
6 88.0, CH 5.39, d (3.0) 5
7 166.3, C – –
8 133.1, 130.0, 8.06, 7.56, –
129.8, 128.3, 7.43, m
Ph - CH
9 -5.3, CH3 0.15, s –
10 -4.5, CH3 0.15, s –
11 18.1, C – –
12 25.7, CH3 0.92, s –
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trans-(±)-6((tert-butyldimethylsilyl)oxy)-3,6-dihydro-
2H-pyran-3-ol,
trans-411.
4
5 6 O 1
23
OH
O Si
9
11 10
12
NMR Assignments
C δC, mult δH (J, Hz) COSY
2a 64.3, CH2 4.16, dd 2b, 3
(12.2, 2.6)
2b – 3.77, dt 2a, 3
(12.2, 1.3)
3 61.6, CH 3.83, m 2a, 2b, 4
4 127.5, CH 6.06, dd 3, 5
(10, 5.3)
5 131.0, CH 5.85, dd 4, 6
(10, 3.0)
6 88.2, CH 5.29, d (3.0) 5
7 – 1.85, d (9.2) 3
9 -5.3, CH3 0.14, s –
10 -4.5, CH3 0.14, s –
11 18.1, C – –
12 25.7, CH3 0.91, s –
cis-(±)-6((tert-butyldimethylsilyl)oxy)-3,6-dihydro-
2H-pyran-3-ol,
cis-411.
4
5 6 O 1
23
OH
O Si
9
11 10
12
NMR Assignments
C δC, mult δH (J, Hz) COSY
2 64.6, CH2 3.77, m 3
3 63.1, CH 4.15, m 2, 4
4 130.8, CH 5.95, dd 3, 5
(10, 2.7)
5 130.9, CH 5.75, dd 4, 6
(10.2, 1.9)
6 89.9, CH 5.25, m 5
7 – 1.65, m 3
9 -4.3, CH3 0.14, s –
10 -3.6, CH3 0.13, s –
11 18.1, C – –
12 25.7, CH3 0.91, s –
(3S,6R)-6-(allyl)-3,6-dihydro-2H-pyran-3-yl acetate,
trans-392.
4
5 6 O 1
23
O
7
8
10 11
O
9
NMR Assignments
C δC, mult δH (J, Hz) COSY
2a 65.1, CH2 4.12, dd (11.4, 5.0) 2b, 3
2b – 3.53, dd (11.4, 6.8) 2a, 3
3 64.9, CH 5.24, m 2a, 2b, 4
4 124.43, CH 5.85-5.78, m 3, 5
5 133.52, CH 5.91, app. d (10.4) 4, 6
6 73.1, CH 4.18, m 5, 7a, 7b
7a 38.64, CH2 4.25, ddt (12.7, 5.2, 1.4) 6, 7b, 8
7b – 4.06, ddt (12.7, 6.4, 1.1) 6, 7a, 8
8 133.86, CH 5.85-5.78, m 7a, 7b, 9
9 117.6, CH2 5.16-5.06, m 8, 9b
10 170.6, C – –
11 21.09, CH3 2.06, s –
(3S,6S)-6-(allyloxy)-3,6-dihydro-2H-pyran-3-yl
acetate, cis-392.
4
5 6 O 1
23
O
7
8
10 11
O
9
NMR Assignments
C δC, mult δH (J, Hz) COSY
2a 67.98, CH2 4.06-4.08, m 2b, 3
2b – 3.76, dd (12.9, 2.6) 2a, 3
3 64.67, CH 5.00, app. s 2a, 2b, 4
4 122.45, CH 5.94, m 3, 5
5 135.7, CH 6.02, app. d (10.3) 4, 6
6 73.5, CH 4.08-4.06, m 4, 5
7a 39.18, CH2 2.43, dt (14.0, 7.4) 7b, 8
7b – 2.33, dt (14.3, 6.7) 7a, 8
8 133.83, CH 5.86, ddt (17.3, 10.2, 7.0) 7a, 7b,
9a, 9b
9 117.69 5.17-5.12, m 8, 9b
10 170.92, C – –
11 21.28, CH3 2.10, s –
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(3S,6R)-6-(allyl)-3,6-dihydro-2H-pyran-3-ol,
trans-393.
4
5 6 O 1
23
O
7
8
H 10
9
NMR Assignments
C δC, mult δH (J, Hz) COSY
2a 68.72, CH2 4.08, dd 2b, 3
(11.2, 4.8)
2b – 3.44, dd 2a, 3
(11.2, 6.9)
3 62.96, CH 4.20, app. s 2a, 2b, 4, 10
4 131.92, CH 5.87-5.79, m 3, 5
5 128.62, CH 5.90, dt 4, 6
(10.4, 2.5)
6 73.34, CH 4.15, ddt 5, 7a, 7b
(8.0, 4.3, 2.1)
7a 38.91, CH2 2.37-2.25, m 6, 7b, 8
7b – 2.37-2.25, m 6, 7a, 8
8 134.21, CH 5.87-5.79, m 7a, 7b, 9
9 117.63, CH2 5.15-5.09, m 8
10 – 1.73, d (7.6) 3
(3S,6S)-6-(allyl)-3,6-dihydro-2H-pyran-3-ol, cis-393.
4
5 6 O 1
23
O
7
8
H 10
9
NMR Assignments
C δC, mult
2 71.04, CH2
3 62.6, CH
4 133.52, CH
5 126.99, CH
6 73.97, CH
7 39.46, CH2
8 134.21, CH
9 117.94, CH2
10 –
cis-393 was produced as a side product of the original
Ferrier reaction and comprises less than 10% of the
trans-393 sample. The small amount of material
prevented full characterization but did provide a set
of 13C NMR data for comparison.
((2R,3S,6S)-3-acetoxy-6-isopropoxy-3,6-dihydro-2H -
pyran-3-yl)methyl acetate,
‘cis’-395.
4
5 6 O 1
23
O
O 7
8
10 11
O
9
12
O 13 14
O
NMR Assignments
C δC, mult δH (J, Hz) COSY
2 66.74, CH 4.14, m 2b, 3, 12
3 65.39, CH 5.29, dd 2a, 2ba, 4
(9.5, 1.5)
4 128.45, CH 5.86, app. d (10.2) 3, 5
5 128.8, CH 5.80, dt 4, 6
(10.2, 2.3)
6 92.82, CH 5.13, m 5
7 70.75, CH 3.98, 7 (6.2) 8, 9
8 23.51, CH3 1.25, d (6.2) 7
9 21.99, CH3 1.18, d (6.1) 7
10 170.78, C – –
11 20.97, CH3 2.09, s –
12a 63.12, CH3 4.23, dd 12b, 2
(11.8, 5.5)
12b – 4.16, m 12a, 2
13 170.31, C – –
14 20.76, CH3 2.09, s –
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((2R,3S,6R)-3-acetoxy-6-isopropoxy-3,6-dihydro-2H-
pyran-3-yl)methyl acetate,
‘trans’-395.
4
5 6 O 1
23
O
O 7
8
10 11
O
9
12
O 13 14
O
NMR Assignments
C δC, mult
2 70.16, CH
3 64.52, CH
4 125.81, CH
5 131.2, CH
6 93.17, CH
7 72.67, CH
8 23.44, CH3
9 21.67, CH3
10 170.69, C
11 21.00, CH3
12 63.49, CH3
13 170.27, C
14 20.83, CH3
‘trans’-412 was produced as a side product of the
original Ferrier reaction and comprises less than 10%
of the ‘cis’-412 sample. The small amount of material
prevented full characterization but did provide a set
of 13C NMR data for comparison.
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A.1 Computational Investigations of Labillarides E-H
labCore_631Gd_opt.log
Created by GaussView 5.0.9
16/11/12 06:03:09
labCoreANTI_631Gd_opt2.log
Created by GaussView 5.0.9
16/11/12 06:13:03
C 2.229302 1.247083 -0.886481 C 2.720687 -1.533666 0.207717
C 1.439026 0.067446 -0.797243 C 1.694862 -0.550671 0.291058
C 1.726779 -0.955729 0.060397 C 1.926259 0.780459 0.082883
C 2.846787 -0.898051 0.938586 C 3.220848 1.268353 -0.254505
C 3.305773 1.308035 -0.055437 C 3.965914 -1.073938 -0.094266
H 1.991586 2.048732 -1.573118 H 2.526034 -2.584177 0.378621
C -0.23508 -1.431581 -1.189767 C -0.340472 0.415938 0.69131
H -0.200913 -2.034614 -2.104761 H -0.550655 0.532021 1.759467
O 0.345397 -0.133315 -1.557403 O 0.415885 -0.856861 0.57648
O 3.234855 -1.701098 1.754577 O 3.58918 2.394805 -0.49286
O 3.610181 0.314612 0.805019 O 4.220415 0.233259 -0.307992
C -1.660742 -1.260269 -0.749266 C -1.616039 0.288902 -0.077099
H -2.161461 -2.1982 -0.503684 H -1.507006 0.151565 -1.153574
C -2.31457 -0.104456 -0.638903 C -2.827336 0.36092 0.476397
H -1.822152 0.828497 -0.904419 H -2.930135 0.508649 1.552178
C -3.726507 0.025633 -0.138688 C -4.12617 0.230136 -0.269311
H -4.180591 -0.978023 -0.067851 H -3.929457 0.292076 -1.353115
C -3.766667 0.678476 1.257491 C -4.803501 -1.122602 0.028905
H -3.186012 0.050166 1.944807 H -4.116357 -1.922715 -0.273953
H -3.255741 1.648531 1.20237 H -4.940139 -1.211551 1.114441
C -5.184997 0.869451 1.806936 C -6.150475 -1.301469 -0.680431
H -5.159142 1.28807 2.818495 H -6.568715 -2.293368 -0.479936
H -5.768821 1.564325 1.190449 H -6.890133 -0.568321 -0.335815
H -5.728804 -0.082625 1.856612 H -6.048431 -1.198787 -1.768416
O -4.425408 0.813234 -1.108774 O -4.937923 1.332112 0.148794
H -5.348072 0.883508 -0.819345 H -5.76228 1.301052 -0.360461
C 4.275564 2.444566 0.024041 C 5.193081 -1.919971 -0.225779
H 4.293199 2.859736 1.038328 H 5.625088 -1.810986 -1.227274
H 5.290077 2.095484 -0.200497 H 5.956055 -1.598209 0.492473
H 4.008031 3.236305 -0.679833 H 4.961928 -2.973472 -0.050714
C 0.700671 -2.044398 -0.092612 C 0.626497 1.531151 0.189335
H 1.140343 -2.994404 -0.417848 H 0.663404 2.369952 0.891998
H 0.156241 -2.24019 0.838625 H 0.305422 1.9385 -0.778583
E(RB3LYP) = —805.8804924 a.u. E(RB3LYP) = —805.881764 a.u.
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labCoreSYN_631Gd_opt.log
Created by GaussView 5.0.9
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labCoreSYN_631Gd_opt2.log
Created by GaussView 5.0.9
16/11/12 06:52:39
C 2.251207 1.43188 -0.619954 C -2.953827 -1.443564 0.106537
C 1.452216 0.255676 -0.660575 C -1.7993 -0.658592 -0.169229
C 1.845174 -0.928254 -0.105014 C -1.831754 0.70646 -0.238185
C 3.094103 -1.056263 0.568228 C -3.033731 1.436321 -0.015205
C 3.450067 1.316864 0.014818 C -4.112342 -0.755258 0.299582
H 1.927951 2.363713 -1.064673 H -2.916842 -2.523803 0.154869
C -0.284772 -1.146135 -1.129177 C 0.342678 -0.10224 -0.747548
H -0.335138 -1.533468 -2.154517 H 0.539409 -0.234368 -1.816494
O 0.243331 0.218615 -1.254804 O -0.585188 -1.199102 -0.379089
O 3.585334 -2.015521 1.11555 O -3.228904 2.629531 -0.012786
O 3.862818 0.160339 0.573216 O -4.17088 0.591187 0.240073
C -1.659526 -1.122275 -0.52673 C 1.606006 -0.257187 0.035534
H -2.128805 -2.105099 -0.459559 H 1.495298 -0.220239 1.120064
C -2.302472 -0.042262 -0.084345 C 2.811557 -0.397659 -0.517297
H -1.83122 0.936173 -0.147089 H 2.915928 -0.448014 -1.601861
C -3.692202 -0.058537 0.489184 C 4.105286 -0.46158 0.245792
C -4.699475 0.605191 -0.471148 C 4.892395 0.859672 0.126822
H -4.350385 1.622315 -0.69161 H 5.046939 1.077922 -0.937873
H -4.68502 0.0502 -1.417896 H 4.268879 1.666775 0.531969
C -6.130599 0.654812 0.075792 C 6.242175 0.835263 0.852723
H -6.816078 1.087043 -0.660775 H 6.739901 1.808206 0.784647
H -6.501445 -0.347944 0.324389 H 6.121635 0.598635 1.917696
H -6.198447 1.277072 0.976713 H 6.924598 0.097198 0.413543
C 4.451397 2.416116 0.180291 C -5.445286 -1.368973 0.591994
H 4.642803 2.599131 1.243929 H -5.835297 -0.995895 1.546044
H 5.406711 2.13307 -0.276612 H -6.169504 -1.093767 -0.183465
H 4.096292 3.340614 -0.281317 H -5.371737 -2.458144 0.639097
C 0.765038 -1.956939 -0.296559 C -0.44029 1.221761 -0.486446
H 1.112976 -2.843935 -0.837683 H -0.372147 1.898751 -1.34432
H 0.34543 -2.299172 0.657027 H -0.040662 1.762809 0.381585
O -3.619444 0.637073 1.738453 O 4.836439 -1.562091 -0.302811
H -4.498501 0.601124 2.145821 H 5.654344 -1.655554 0.209037
H -4.004381 -1.104121 0.655663 H 3.886118 -0.64326 1.311921
E(RB3LYP) = –805.8804339 a.u. E(RB3LYP) = –805.8816521 a.u.
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labillaride1aTS_berny_TZVP.log
Created by GaussView 5.0.9
16/11/12 07:10:01
labillaride1aALKENEdown2_TZVP.log
Created by GaussView 5.0.9
16/11/12 07:32:18
labillaride1aATRO_TZVP.log
Created by GaussView 5.0.9
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C -0.140511 -1.247919 1.972744 C 0.053063 1.736456 -1.140661 C -0.399246 -1.666422 -0.965529
C -0.297338 -1.856127 -0.829054 C -0.450244 0.449547 -0.834154 C 0.280553 -0.473358 -0.620035
C 0.566574 -0.851727 -0.311073 C -0.132855 -0.223288 0.307511 C 0.097812 0.160901 0.573895
C 0.611128 -0.507121 1.012022 C 0.592808 0.405793 1.353552 C -0.755973 -0.368939 1.570221
C -1.190034 -2.381256 0.049436 C 0.865881 2.293648 -0.205816 C -1.258285 -2.159184 -0.036372
H -0.403021 -2.002928 -1.893087 H -0.149667 2.226194 -2.080613 H -0.280119 -2.135912 -1.930011
C 1.612567 1.166333 -0.309854 C -1.68329 -1.447531 -0.948627 C 1.688864 1.306872 -0.727311
H 1.217532 2.064425 -0.786768 H -1.629209 -2.261712 -1.678392 H 1.595151 2.163128 -1.395037
C 0.957253 0.96526 1.087967 C -0.64205 -1.631719 0.196469 C 0.797616 1.48676 0.540703
H 1.662722 1.225493 1.878364 H -1.126514 -1.985909 1.108326 H 1.423787 1.642292 1.423819
O 1.146926 0.038894 -1.130265 O -1.264435 -0.238368 -1.663863 O 1.121899 0.158511 -1.452409
O -0.179745 -1.146102 3.169572 O 0.834594 0.034533 2.472097 O -1.027865 0.058081 2.666134
O -1.054862 -2.195074 1.379958 O 1.085752 1.704717 0.98586 O -1.394645 -1.591801 1.17887
C 3.109225 1.220588 -0.27324 C -3.097855 -1.326992 -0.464594 C 3.136107 1.073441 -0.416587
H 3.50296 2.077979 0.26868 H -3.461231 -2.213023 0.052025 H 3.616698 1.920644 0.068257
C -0.357069 1.840004 1.298505 C 0.475743 -2.652566 -0.193543 C -0.186427 2.688053 0.457526
H -0.569336 1.799436 2.374466 H -0.026059 -3.630601 -0.279837 H -0.809657 2.656716 1.354819
C 3.94215 0.351807 -0.830826 C -3.890858 -0.274925 -0.616975 C 3.832647 -0.024514 -0.679626
H 3.555706 -0.487547 -1.399678 H -3.54033 0.598499 -1.156693 H 3.36597 -0.858668 -1.193099
C 5.435447 0.43623 -0.731769 C -5.285073 -0.184036 -0.073383 C 5.270667 -0.220635 -0.304282
H 5.708706 1.371027 -0.221395 H -5.573532 -1.159482 0.343758 H 5.672958 0.725241 0.085731
C 6.012484 -0.743552 0.065609 C -5.383146 0.872212 1.038446 C 5.423721 -1.300509 0.778666
H 5.548336 -0.737968 1.055824 H -4.672767 0.59971 1.823829 H 4.833121 -0.991171 1.645571
H 5.709246 -1.67392 -0.423763 H -5.057083 1.834457 0.632507 H 4.982167 -2.229985 0.406878
C 7.534427 -0.704327 0.215264 C -6.782759 1.007236 1.641108 C 6.871198 -1.545848 1.208464
H 7.884201 -1.529738 0.837755 H -6.782125 1.723662 2.464302 H 6.916047 -2.270104 2.023681
H 8.044938 -0.799968 -0.747263 H -7.511847 1.369978 0.911036 H 7.477744 -1.952534 0.394646
H 7.865418 0.226466 0.684514 H -7.141811 0.052226 2.034898 H 7.345406 -0.624749 1.559117
O 5.932277 0.462771 -2.079153 O -6.133295 0.131918 -1.18751 O 5.960956 -0.575247 -1.512264
H 6.895095 0.484977 -2.047939 H -7.03528 0.233007 -0.863992 H 6.888563 -0.726491 -1.299961
C -1.51219 1.214688 0.577785 C 1.515487 -2.772059 0.883505 C -1.045874 2.686578 -0.773079
H -1.323167 0.174387 0.412853 H 1.079121 -3.033603 1.843378 H -0.517235 2.927369 -1.690495
O -0.153689 3.197497 0.902845 O 1.074799 -2.323724 -1.443645 O 0.565605 3.915354 0.423342
H 0.308764 3.659607 1.610746 H 0.42493 -2.425535 -2.146674 H 0.970546 4.046455 1.288498
C -2.471258 -3.076358 -0.31081 C 1.644986 3.558921 -0.37176 C -2.169792 -3.326828 -0.253658
H -2.388093 -3.477961 -1.323094 H 1.137729 4.189263 -1.105128 H -1.657581 -4.02514 -0.919251
H -2.60404 -3.920505 0.369308 H 1.638752 4.090521 0.582907 H -2.321913 -3.83675 0.700514
C -3.729273 -2.154503 -0.207345 C 2.838139 -2.607364 0.847874 C -3.542265 -2.981525 -0.887049
H -4.592433 -2.806187 -0.042711 H 3.346426 -2.773609 1.79664 H -3.382201 -2.340382 -1.758155
H -3.641546 -1.541486 0.6929 C 4.961799 -1.389388 0.158434 H -3.938284 -3.922961 -1.278825
C -2.736371 1.495453 0.139098 H 5.657601 -1.311748 -0.684267 C -2.357252 2.465269 -0.848186
H -3.173364 0.600608 -0.269106 H 5.504284 -1.919099 0.949832 H -2.801572 2.533991 -1.839235
C -4.86397 2.125704 -0.888825 C 3.960861 2.417185 0.067948 C -3.341459 2.193154 0.263945
H -4.468838 2.037881 -1.906143 H 4.989151 2.791229 0.087099 H -2.898847 1.580888 1.052094
H -5.640491 2.892799 -0.933297 H 3.600907 2.471345 1.098932 H -3.589018 3.150918 0.738306
C -4.01427 -1.287695 -1.448034 C 3.99655 0.949466 -0.385661 C -4.653545 1.562649 -0.236057
H -3.155756 -0.652323 -1.679139 H 4.560385 0.885629 -1.324395 H -5.028176 2.174601 -1.063503
H -4.108858 -1.963128 -2.306029 H 2.987596 0.601313 -0.619818 H -5.404674 1.635489 0.556709
C -5.326716 -0.45898 -1.407405 C 4.630026 0.023663 0.658702 C -4.61852 -2.384149 0.035799
H -6.134914 -1.161494 -1.174994 H 5.559373 0.481877 1.016488 H -4.679501 -3.001344 0.938657
H -5.524598 -0.118102 -2.42926 H 3.967662 -0.035783 1.528339 H -5.58085 -2.507577 -0.474161
C -5.508679 0.766301 -0.465972 C 3.766288 -2.251915 -0.28408 C -4.497208 -0.910371 0.457583
H -6.588584 0.922261 -0.400529 H 4.169792 -3.186591 -0.694822 H -5.331991 -0.701844 1.135971
H -5.19992 0.508964 0.551526 H 3.22311 -1.780062 -1.09778 H -3.594823 -0.760845 1.048976
C -3.720147 2.615235 0.034154 C 3.112706 3.34522 -0.823392 C -4.562474 0.098293 -0.696454
H -4.123961 2.860857 1.02384 H 3.567411 4.338883 -0.85894 H -3.699397 -0.019881 -1.360223
H -3.27053 3.533981 -0.35052 H 3.116668 2.970961 -1.851886 H -5.44511 -0.128698 -1.305138
E(RB3LYP) = –1232.847618 a.u. E(RB3LYP) = –1232.898052 a.u. E(RB3LYP) = –1232.902962 a.u.
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A.2 13C NMR Analysis of 3,6-Dihydro-2H -pyrans
cis1_anomeric_TZVP_confA.log
Created by GaussView 5.0.9
24/10/12 07:28:35 cis1_anomeric_TZVP_20-4-12.logCreated by GaussView 5.0.9
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cis1_anomeric_TZVP_confC.log
Created by GaussView 5.0.9
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C 1.691688 -1.575285 -1.284129 C 1.909971 -0.496415 -1.354611 C 2.013638 -1.250426 -1.429175
C 0.388225 -1.796314 -1.215715 C 0.633325 -0.672466 -1.659151 C 0.712607 -1.276697 -1.671298
C -0.423209 -1.447649 -0.001686 C -0.375655 -1.150246 -0.655377 C -0.299798 -1.527314 -0.590484
O 0.38117 -1.056096 1.086251 O 0.225225 -1.555148 0.55365 O 0.300454 -1.905493 0.629009
C 1.440588 -0.187052 0.733002 C 1.238345 -0.678973 1.006334 C 1.44514 -1.139616 0.963527
C 2.425786 -0.929704 -0.155719 C 2.406581 -0.720209 0.039025 C 2.534673 -1.472787 -0.043823
O 3.366499 -0.007569 -0.734074 O 3.294258 0.334661 0.450493 O 3.777571 -0.800518 0.222004
O -1.349537 -0.467384 -0.361576 O -1.325427 -0.144362 -0.468846 O -1.096212 -0.390148 -0.462568
Si -2.625527 0.077653 0.612992 Si -2.762618 -0.319057 0.41527 Si -2.531891 -0.282089 0.430549
C -3.906919 0.744322 -0.63523 C -3.91208 1.027508 -0.296428 C -3.399422 1.251231 -0.299575
C -2.003757 1.423057 1.77094 C -2.412094 -0.048619 2.242861 C -2.140655 -0.069644 2.257934
C -3.291191 -1.365966 1.624332 C -3.44143 -2.056895 0.153261 C -3.531673 -1.86065 0.182839
C -4.370292 -0.391263 -1.551173 C -4.143769 0.774652 -1.78843 C -3.679137 1.024454 -1.787648
C -5.111699 1.316573 0.116944 C -5.255639 0.999913 0.438551 C -4.721255 1.502784 0.432347
C -3.267423 1.846097 -1.48558 C -3.2626 2.402825 -0.115383 C -2.4908 2.474262 -0.140339
C 4.436625 0.281436 0.005459 C 4.560311 0.225907 0.053137 C 3.842658 0.522152 0.069157
O 5.193279 1.128301 -0.684923 O 5.231471 1.269309 0.530705 O 5.095314 0.892181 0.328155
O 4.68196 -0.147829 1.101088 O 5.021205 -0.659264 -0.617031 O 2.947833 1.258601 -0.24413
C 6.390057 1.540945 -0.026703 C 6.61709 1.299053 0.191931 C 5.340619 2.293268 0.222672
H 2.269441 -1.845196 -2.160466 H 2.633471 -0.192807 -2.101768 H 2.734452 -1.088978 -2.222655
H -0.154777 -2.239499 -2.041007 H 0.258693 -0.486032 -2.658035 H 0.317693 -1.108492 -2.665253
H -0.941345 -2.340792 0.365261 H -0.858054 -2.062134 -1.024789 H -0.916124 -2.394513 -0.85435
H 1.908958 0.128724 1.662709 H 1.533122 -1.021282 1.996546 H 1.737243 -1.43519 1.970024
H 1.068763 0.691414 0.195899 H 0.868928 0.348071 1.081242 H 1.223967 -0.070994 0.942119
H 2.980869 -1.665838 0.431024 H 2.942087 -1.670018 0.105843 H 2.812443 -2.5221 0.077185
H -2.814781 1.836559 2.37382 H -3.324721 -0.115065 2.838396 H -3.053387 0.038241 2.847565
H -1.539884 2.242008 1.219193 H -1.959878 0.927769 2.422935 H -1.51696 0.808041 2.433696
H -1.256818 1.007031 2.448878 H -1.719695 -0.813096 2.598522 H -1.602296 -0.945405 2.623471
H -2.533755 -1.729232 2.321686 H -2.763004 -2.803657 0.57046 H -3.015691 -2.720993 0.613773
H -4.153123 -1.049875 2.215325 H -4.401459 -2.169736 0.660985 H -4.499189 -1.77988 0.682517
H -3.60591 -2.200911 0.996067 H -3.593107 -2.28546 -0.9029 H -3.716902 -2.067878 -0.872462
H -3.534299 -0.830786 -2.098263 H -3.205482 0.781648 -2.34598 H -2.759225 0.835529 -2.343567
H -5.088122 -0.013682 -2.287616 H -4.785635 1.557208 -2.207696 H -4.154129 1.911669 -2.220464
H -4.866889 -1.188526 -0.993459 H -4.639019 -0.182106 -1.969935 H -4.354575 0.181698 -1.953323
H -5.614022 0.561044 0.725982 H -5.770192 0.043 0.320855 H -5.416456 0.666 0.328238
H -4.829751 2.143338 0.77276 H -5.142806 1.191904 1.5081 H -4.572161 1.686016 1.499043
H -5.850264 1.703306 -0.593405 H -5.918456 1.774755 0.038497 H -5.216012 2.387784 0.018063
H -3.989458 2.221311 -2.219309 H -3.904626 3.180578 -0.543379 H -2.966907 3.354939 -0.585539
H -2.948737 2.697719 -0.88021 H -3.114393 2.648273 0.938675 H -2.29876 2.705984 0.909781
H -2.397306 1.477975 -2.031786 H -2.293359 2.458331 -0.613822 H -1.528395 2.328287 -0.633385
H 6.878118 2.224351 -0.71524 H 7.007425 2.204093 0.647841 H 6.391364 2.422605 0.464892
H 6.160061 2.046627 0.910396 H 7.129619 0.423357 0.588455 H 5.13839 2.645744 -0.788135
H 7.032552 0.685202 0.17729 H 6.749211 1.331413 -0.888913 H 4.718838 2.848053 0.924512
E(RmPW1PW91) = –1175.60808225 a.u. E(RmPW1PW91) = –1175.60782525 a.u. E(RmPW1PW91) = –1175.60293944 a.u.
A.2. 13C NMR ANALYSIS OF 3,6-DIHYDRO-2H-PYRANS 349
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C 1.396011 -1.793776 -1.285606 C 1.699658 -1.266433 -1.311711 C 1.734349 -2.012101 -0.78341
C 0.12196 -1.989989 -0.979943 C 0.395805 -1.490609 -1.391361 C 0.412186 -1.986908 -0.711883
C -0.432095 -1.751322 0.401062 C -0.448573 -1.83797 -0.192989 C -0.319301 -1.128678 0.280137
O 0.44846 -0.954259 1.167325 O 0.218803 -1.511414 1.009365 O 0.511167 -0.086136 0.754955
C 1.768063 -1.446824 1.138656 C 1.533603 -2.01548 1.043971 C 1.72982 -0.588474 1.251103
C 2.381461 -1.366606 -0.247975 C 2.422262 -1.383437 -0.006351 C 2.579517 -1.22316 0.161593
O 2.783006 -0.018331 -0.581707 O 2.817954 -0.081032 0.487104 O 3.279398 -0.235671 -0.627522
O -1.669819 -1.151681 0.36181 O -1.667332 -1.198823 -0.222421 O -1.431753 -0.586529 -0.319155
Si -2.055679 0.498948 0.245952 Si -2.092899 0.31107 0.430747 Si -2.514267 0.506221 0.399424
C -3.8997 0.451097 -0.254232 C -3.76989 0.663453 -0.415631 C -4.143986 0.206904 -0.548491
C -1.812503 1.326799 1.915372 C -2.279891 0.168637 2.295395 C -2.676108 0.099329 2.232184
C -1.001271 1.353727 -1.055603 C -0.812081 1.619688 0.001108 C -1.876514 2.257714 0.176318
C -4.064321 -0.332128 -1.559367 C -3.581318 0.74324 -1.932698 C -3.919939 0.442062 -2.045129
C -4.412872 1.880195 -0.456333 C -4.328992 1.995823 0.093494 C -5.220243 1.170952 -0.039927
C -4.72002 -0.230056 0.844962 C -4.762549 -0.457255 -0.093759 C -4.610564 -1.234066 -0.328907
C 3.967748 0.36497 -0.11088 C 3.906249 0.442798 -0.069144 C 4.408964 0.227292 -0.099601
O 4.18708 1.613295 -0.509121 O 4.126814 1.628358 0.489677 O 4.935984 1.102569 -0.949218
O 4.715273 -0.300564 0.557289 O 4.58211 -0.066874 -0.924425 O 4.879585 -0.089946 0.962164
C 5.426228 2.174898 -0.078541 C 5.27121 2.323455 -0.002963 C 6.160344 1.696252 -0.521085
H 1.763217 -1.937743 -2.295085 H 2.286592 -1.001172 -2.182577 H 2.246969 -2.60565 -1.531196
H -0.591026 -2.339355 -1.717443 H -0.131267 -1.445544 -2.337275 H -0.207009 -2.581502 -1.372091
H -0.558356 -2.721438 0.911321 H -0.649003 -2.923291 -0.197635 H -0.61334 -1.744249 1.152429
H 2.347069 -0.862584 1.850702 H 1.92452 -1.815042 2.039823 H 2.258522 0.240518 1.716483
H 1.792317 -2.496172 1.464077 H 1.52945 -3.102282 0.883512 H 1.544851 -1.347946 2.024512
H 3.274008 -1.995314 -0.273981 H 3.329465 -1.978435 -0.132061 H 3.330375 -1.860062 0.634487
H -2.189366 2.351843 1.906495 H -2.632829 1.106878 2.728436 H -3.413043 0.752008 2.704686
H -0.750523 1.352522 2.160174 H -1.316553 -0.075248 2.743322 H -1.723496 0.256576 2.741144
H -2.326505 0.779968 2.706862 H -2.985978 -0.618259 2.564603 H -2.988574 -0.932817 2.39911
H -1.131498 0.913332 -2.045011 H -0.671821 1.712531 -1.076756 H -1.729279 2.49244 -0.878701
H -1.266889 2.411431 -1.118782 H -1.12244 2.593477 0.38668 H -2.565424 2.991765 0.599133
H 0.056019 1.289656 -0.795498 H 0.151943 1.373901 0.447807 H -0.913508 2.357569 0.678174
H -5.120913 -0.365843 -1.847632 H -4.543217 0.930732 -2.422725 H -4.847204 0.255039 -2.597939
H -3.714665 -1.360628 -1.45541 H -3.179792 -0.188288 -2.335564 H -3.1517 -0.220967 -2.446387
H -3.518032 0.129157 -2.38555 H -2.907307 1.554036 -2.218477 H -3.618403 1.470592 -2.255522
H -5.471341 1.8635 -0.738 H -5.290425 2.208056 -0.386781 H -6.159082 1.004714 -0.579189
H -4.330259 2.478781 0.453894 H -4.502505 1.98392 1.172125 H -5.429678 1.030642 1.023438
H -3.874091 2.401008 -1.25136 H -3.664092 2.833436 -0.13085 H -4.940683 2.215852 -0.192868
H -4.374239 -1.248211 1.032455 H -4.396431 -1.427534 -0.433554 H -3.865415 -1.954622 -0.671253
H -4.674478 0.319798 1.787675 H -4.962863 -0.529911 0.977511 H -4.820203 -1.43824 0.723591
H -5.773957 -0.28443 0.550011 H -5.719761 -0.266798 -0.592044 H -5.534512 -1.42119 -0.88709
H 5.44093 3.18435 -0.478563 H 5.301889 3.258305 0.548766 H 6.441491 2.383534 -1.313501
H 5.482064 2.197082 1.009162 H 6.178751 1.747831 0.175421 H 6.021399 2.23438 0.415886
H 6.265872 1.600431 -0.468041 H 5.174498 2.516538 -1.07073 H 6.930496 0.937526 -0.386474
E(RmPW1PW91) = –1175.60529776 a.u. E(RmPW1PW91) = –1175.60539425 a.u. E(RmPW1PW91) = –1175.60597201 a.u.
A.2. 13C NMR ANALYSIS OF 3,6-DIHYDRO-2H-PYRANS 350
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C -1.972936 -0.932222 1.365869 C -1.851585 1.327318 0.294397 C -1.635627 2.031526 -0.132451
C -0.658685 -0.904507 1.531105 C -0.700249 1.197355 0.936109 C -0.45511 1.984989 0.465419
C 0.298443 -1.060581 0.384748 C 0.162915 -0.024468 0.818995 C 0.219384 0.694814 0.828765
O -0.338271 -0.789927 -0.849374 O -0.492287 -1.084757 0.175074 O -0.633358 -0.410982 0.69204
C -1.520802 -1.540139 -0.997876 C -1.204851 -0.693009 -0.981606 C -1.381076 -0.40084 -0.508081
C -2.579709 -1.158567 0.016793 C -2.31761 0.280276 -0.667 C -2.322827 0.784628 -0.581131
O -3.235754 0.037757 -0.465793 O -3.430864 -0.471827 -0.128196 O -3.48915 0.617149 0.255798
O 1.35552 -0.195674 0.546478 O 1.353606 0.339193 0.1817 O 1.3852 0.572804 0.065915
Si 2.620715 0.037426 -0.561972 Si 2.748691 -0.619866 0.08736 Si 2.573248 -0.615477 0.295234
C 4.055145 0.669446 0.528192 C 4.154179 0.647223 -0.16208 C 4.154104 0.168559 -0.430207
C 3.028104 -1.606001 -1.388258 C 2.937585 -1.599646 1.685402 C 2.731775 -0.98603 2.135407
C 2.104334 1.300152 -1.851602 C 2.599637 -1.808746 -1.362485 C 2.081952 -2.182333 -0.622305
C 3.637551 1.967259 1.226131 C 3.874613 1.474158 -1.420484 C 3.916577 0.532443 -1.899138
C 5.285287 0.936988 -0.34416 C 5.493009 -0.079319 -0.318445 C 5.31694 -0.823494 -0.334809
C 4.400974 -0.381066 1.586296 C 4.218893 1.581562 1.048792 C 4.504302 1.43893 0.34946
C -4.443517 0.277312 0.033504 C -4.614431 0.128496 -0.184832 C -4.471089 -0.115796 -0.261117
O -4.904132 1.397581 -0.514571 O -5.519325 -0.68598 0.350438 O -5.459314 -0.169044 0.626501
O -5.028975 -0.402429 0.83615 O -4.838741 1.217377 -0.646491 O -4.474146 -0.639246 -1.345015
C -6.204224 1.79073 -0.079434 C -6.853103 -0.181172 0.359099 C -6.595882 -0.927904 0.218095
H -2.653392 -0.800837 2.198096 H -2.47743 2.202042 0.419219 H -2.12849 2.975491 -0.332668
H -0.208863 -0.772034 2.507565 H -0.327129 1.978306 1.587766 H 0.075094 2.889599 0.73723
H 0.659747 -2.107033 0.35159 H 0.373838 -0.41514 1.820582 H 0.465429 0.707506 1.896507
H -1.88767 -1.362678 -2.007057 H -0.531585 -0.222863 -1.706058 H -0.715076 -0.360126 -1.376656
H -1.309073 -2.613178 -0.886869 H -1.611449 -1.60371 -1.417234 H -1.933239 -1.337258 -0.543823
H -3.334642 -1.945998 0.075512 H -2.655138 0.755838 -1.590655 H -2.664351 0.886062 -1.61351
H 3.872419 -1.490643 -2.070798 H 2.940835 -0.956204 2.566699 H 2.951122 -0.090958 2.719694
H 2.176654 -1.954923 -1.975127 H 2.127486 -2.323402 1.794623 H 1.810641 -1.427553 2.520941
H 3.286574 -2.380511 -0.664381 H 3.875008 -2.159543 1.677994 H 3.535518 -1.704119 2.310243
H 1.829687 2.248683 -1.388343 H 1.753678 -2.478576 -1.199694 H 1.148177 -2.570584 -0.212608
H 2.90499 1.487685 -2.569907 H 3.498245 -2.419194 -1.471321 H 2.843637 -2.957887 -0.519875
H 1.233352 0.929306 -2.392721 H 2.434547 -1.278222 -2.301426 H 1.932043 -1.994011 -1.686548
H 4.446862 2.322938 1.873382 H 3.852292 0.854325 -2.319779 H 3.707777 -0.349105 -2.50956
H 2.751638 1.824182 1.847243 H 4.66195 2.222929 -1.561163 H 4.808922 1.012417 -2.315873
H 3.420332 2.763151 0.510378 H 2.921529 2.000982 -1.350628 H 3.08133 1.225787 -2.011817
H 6.110243 1.309981 0.272455 H 5.499138 -0.746519 -1.18344 H 5.119021 -1.742695 -0.89093
H 5.639365 0.032441 -0.844584 H 6.300289 0.646521 -0.463905 H 6.225625 -0.379423 -0.755382
H 5.088816 1.690373 -1.110469 H 5.746411 -0.671187 0.564474 H 5.540448 -1.097123 0.699233
H 3.544005 -0.604308 2.224411 H 4.458236 1.043127 1.968772 H 4.717564 1.229668 1.40036
H 4.74124 -1.317459 1.137911 H 4.998376 2.337257 0.902031 H 5.398312 1.907418 -0.076351
H 5.209012 -0.016931 2.230445 H 3.273494 2.105658 1.200012 H 3.695227 2.170531 0.307672
H -6.422144 2.711186 -0.613011 H -7.451968 -0.952948 0.833658 H -7.291501 -0.878532 1.05062
H -6.94105 1.026726 -0.325029 H -6.911057 0.74655 0.927282 H -7.045186 -0.498877 -0.676901
H -6.215005 1.964625 0.995943 H -7.204387 -0.000131 -0.656213 H -6.3179 -1.961957 0.017364
E(RmPW1PW91) = –1175.60594373 a.u. E(RmPW1PW91) = –1175.60864739 a.u. E(RmPW1PW91) = –1175.60876222 a.u.
A.2. 13C NMR ANALYSIS OF 3,6-DIHYDRO-2H-PYRANS 351
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C -2.132021 - 1.05748 1.549908 C 2.285976 -0.372005 -1.349275 C 2.179004 -1.860338 -0.71968
C -0.84373 -1.362516 1.573031 C 1.01853 -0.611695 -1.649262 C 0.859185 -1.920151 -0.624963
C 0.004263 -1.358178 0.333978 C 0.032496 -1.114364 -0.63508 C 0.085173 -1.064892 0.336564
O -0.760182 -1.195025 -0.837173 O 0.651302 -1.472054 0.579254 O 0.854004 0.043423 0.763266
C -1.76785 -0.206859 -0.730928 C 1.624718 -0.54371 1.015524 C 2.112933 -0.358702 1.253077
C -2.809973 -0.652075 0.282935 C 2.793695 -0.542195 0.048218 C 2.983731 -0.965813 0.164855
O -3.692251 0.43965 0.597433 O 3.628072 0.564434 0.433432 O 3.573363 0.044861 -0.681338
O 0.983467 -0.372377 0.47508 O -0.95938 -0.1462 -0.463416 O -1.060647 -0.611788 -0.276072
Si 2.278009 -0.125136 -0.592257 Si -2.394845 -0.368444 0.411472 Si -2.190144 0.457195 0.40452
C 3.583642 0.766439 0.475039 C -3.580677 0.942681 -0.307383 C -3.797562 0.072013 -0.551073
C 1.713695 0.934493 -2.039779 C -2.066398 -0.091789 2.242407 C -2.351576 0.093963 2.246203
C 2.879162 -1.792067 -1.231768 C -3.01849 -2.125963 0.142689 C -1.621109 2.227899 0.143687
C 3.996587 -0.131048 1.644752 C -3.794583 0.682365 -1.800721 C -3.563816 0.273251 -2.051161
C 4.816148 1.09345 -0.373338 C -4.927466 0.8759 0.419044 C -4.913065 1.010873 -0.082116
C 2.988967 2.065541 1.027664 C -2.973868 2.33693 -0.122947 C -4.214316 -1.378558 -0.296438
C -4.754546 0.620314 -0.211403 C 4.922666 0.513442 0.068017 C 4.687859 0.639413 -0.222139
O -4.990524 -0.068663 -1.166673 O 5.401725 -0.390829 -0.561383 O 5.195484 0.377356 0.836786
H -2.736547 -1.083101 2.449318 H 2.994638 -0.051725 -2.103632 H 2.717185 -2.458732 -1.445614
H -0.341298 -1.629727 2.494244 H 0.635995 -0.463565 -2.651595 H 0.271722 -2.588346 -1.24254
H 0.473466 -2.339995 0.204449 H -0.411739 -2.051867 -0.987828 H -0.169577 -1.660187 1.234723
H -2.204295 -0.097329 -1.721232 H 1.935553 -0.857725 2.010396 H 2.589594 0.519495 1.682461
H -1.346499 0.751654 -0.410763 H 1.206138 0.465445 1.076995 H 1.993627 -1.104089 2.052432
H -3.407955 -1.468808 -0.129084 H 3.378472 -1.461317 0.129842 H 3.79897 -1.51601 0.640071
H 2.534936 1.126288 -2.733216 H -2.979564 -0.195585 2.831743 H -3.131316 0.714987 2.691829
H 1.320542 1.895772 -1.705646 H -1.652688 0.900205 2.429763 H -1.416626 0.321456 2.761441
H 0.924105 0.417096 -2.58675 H -1.347615 -0.831148 2.598947 H -2.604053 -0.949672 2.440295
H 2.109234 -2.270137 -1.840525 H -2.323815 -2.853382 0.567222 H -1.485246 2.448747 -0.915964
H 3.760145 -1.662478 -1.863684 H -3.980249 -2.266966 0.64009 H -2.33725 2.942366 0.554525
H 3.146371 -2.473107 -0.422172 H -3.152052 -2.358772 -0.915002 H -0.662136 2.374191 0.641623
H 3.140283 -0.396108 2.267554 H -2.853462 0.720895 -2.35219 H -4.476682 0.036647 -2.608902
H 4.722232 0.3888 2.279767 H -4.459922 1.442673 -2.224284 H -2.766794 -0.371842 -2.424419
H 4.467923 -1.056343 1.305229 H -4.255594 -0.290796 -1.98515 H -3.297577 1.305968 -2.286644
H 5.287599 0.194558 -0.778147 H -5.414411 -0.094749 0.296844 H -5.837625 0.800312 -0.63049
H 4.576942 1.753824 -1.210197 H -4.826772 1.069036 1.489596 H -5.133625 0.889463 0.981262
H 5.567351 1.605136 0.237958 H -5.609351 1.632463 0.016057 H -4.665653 2.060473 -0.256614
H 3.722995 2.573719 1.66263 H -3.635182 3.094897 -0.557014 H -3.438905 -2.079977 -0.610016
H 2.713201 2.760423 0.23106 H -2.841832 2.587579 0.93202 H -4.429398 -1.56192 0.758799
H 2.099783 1.875729 1.631317 H -2.002639 2.420841 -0.613521 H -5.123842 -1.614778 -0.859663
C -5.579095 1.785075 0.247349 C 5.65955 1.727613 0.54741 C 5.194178 1.655627 -1.200545
H -6.46143 1.872669 -0.379501 H 5.530596 1.846997 1.622982 H 4.436893 2.424335 -1.357485
H -5.868047 1.654195 1.289999 H 6.71324 1.630938 0.303323 H 6.106176 2.10434 -0.818238
H -4.988735 2.699973 0.185009 H 5.249454 2.617789 0.068853 H 5.382819 1.183714 -2.164904
E(RmPW1PW91) = –1100.38019629 a.u. E(RmPW1PW91) = –1100.37987057 a.u. E(RmPW1PW91) = –1100.37849516 a.u.
A.2. 13C NMR ANALYSIS OF 3,6-DIHYDRO-2H-PYRANS 352
cisOAcOTBS_allylic_TZVP_confD.log
Created by GaussView 5.0.9
30/08/12 17:14:59
cisOAcOPropyl_anomeric_TZVP_confA.log
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C -2.359827 -0.880009 1.299126 C -1.01654 1.707276 -0.525053 C 1.165176 -1.166619 -0.676492
C -1.045911 -0.955474 1.453023 C 0.285669 1.937985 -0.458842 C -0.101313 -1.522113 -0.829635
C -0.102615 -1.040378 0.287737 C 1.194569 1.126293 0.414656 C -1.165819 -1.123265 0.147681
O -0.726713 -0.611978 -0.907828 O 0.493719 0.253674 1.266778 O -0.639526 -0.524368 1.30724
C -1.957686 -1.26506 -1.1159 C -0.579843 -0.418103 0.635182 C 0.381878 0.416685 1.040185
C -2.983578 -0.904727 -0.061588 C -1.645883 0.592646 0.243427 C 1.590993 -0.297218 0.465103
O -3.529098 0.390799 -0.401887 O -2.624527 -0.023165 -0.611433 O 2.489613 0.734527 0.021077
O 0.998578 -0.250972 0.528496 O 2.095202 0.459299 -0.422355 O -2.069208 -0.295007 -0.526421
Si 2.27098 0.027932 -0.560584 C -3.654663 -0.649095 -0.008863 C 3.79095 0.408845 -0.0906
C 3.731098 0.497483 0.574676 O -3.786268 -0.721453 1.182843 O 4.226698 -0.68426 0.151602
C 2.601608 -1.546436 -1.540757 H -1.668339 2.314542 -1.142546 H 1.93257 -1.499228 -1.365094
C 1.808977 1.426432 -1.725487 H 0.752612 2.727456 -1.033898 H -0.42341 -2.128191 -1.667132
C 3.348917 1.715549 1.42143 H 1.746806 1.781407 1.101186 H -1.69036 -2.011953 0.522341
C 4.959159 0.836269 -0.275476 H -0.964649 -1.13772 1.354469 H 0.620391 0.898652 1.986592
C 4.064729 -0.672741 1.50416 H -0.239533 -0.945434 -0.261959 H 0.040532 1.176618 0.330669
C -4.73244 0.694098 0.110116 H -2.154777 0.962964 1.136927 H 2.098673 -0.895041 1.225574
O -5.365941 -0.050196 0.811842 C -4.590483 -1.230321 -1.025306 C 4.595672 1.582664 -0.561242
H -3.027143 -0.801381 2.148511 H -5.442727 -1.674545 -0.519851 H 4.391217 2.456625 0.056375
H -0.586012 -0.966341 2.433748 H -4.922879 -0.456255 -1.716727 H 5.652173 1.33371 -0.527433
H 0.205665 -2.094296 0.144588 H -4.070846 -1.989439 -1.611093 H 4.310462 1.831472 -1.584467
H -2.31147 -0.971361 -2.102595 C 3.199081 -0.114761 0.261663 C -3.283235 -0.074225 0.175828
H -1.818694 -2.355441 -1.106247 H 2.847897 -0.862026 0.980793 H -3.757198 -1.040382 0.400272
H -3.805766 -1.623743 -0.080504 H 3.726078 0.667268 0.82678 H -3.080451 0.423717 1.129732
H 3.452376 -1.407612 -2.210944 C 4.125981 -0.745643 -0.752357 C -4.194869 0.771673 -0.683524
H 1.735474 -1.795855 -2.156248 H 4.434628 0.018222 -1.470073 H -4.354071 0.260395 -1.635949
H 2.820019 -2.397947 -0.894466 H 3.567792 -1.497416 -1.315514 H -3.685717 1.710719 -0.913333
H 1.568596 2.336471 -1.174095 C 5.344643 -1.377565 -0.096778 C -5.527595 1.048706 -0.004147
H 2.619686 1.651138 -2.421577 H 5.996926 -1.834827 -0.841522 H -6.170307 1.660433 -0.638134
H 0.927236 1.142806 -2.300932 H 5.934576 -0.636762 0.447551 H -6.064766 0.122831 0.21364
H 4.171827 1.976438 2.096078 H 5.056252 -2.15654 0.612439 H -5.39139 1.581674 0.939425
H 2.465622 1.520211 2.031709
H 3.143386 2.5935 0.804958
H 5.800371 1.108782 0.370972
H 5.282687 -0.00954 -0.887208
H 4.775634 1.682482 -0.941439
H 3.207123 -0.956615 2.117024
H 4.391957 -1.555901 0.950421
H 4.879312 -0.394418 2.181755
C -5.158306 2.071624 -0.30027
H -5.011811 2.216947 -1.369693
H -6.199969 2.22376 -0.033117
H -4.539185 2.80586 0.217746
E(RmPW1PW91) = –1100.37829185 a.u. E(RmPW1PW91) = –691.64355783 a.u. E(RmPW1PW91) = –691.64333656 a.u.
A.2. 13C NMR ANALYSIS OF 3,6-DIHYDRO-2H-PYRANS 353
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C -1.059436 1.784823 -0.598681 C 1.235143 -1.290455 -0.698013 C -0.737084 1.642799 -0.594216
C 0.264478 1.822578 -0.603927 C -0.068833 -1.38753 -0.911277 C 0.584021 1.727759 -0.565976
C 1.087454 0.905775 0.24921 C -1.076385 -0.881399 0.075785 C 1.419388 0.845817 0.312163
O 0.342215 -0.218473 0.666424 O -0.504898 0.051933 0.968091 O 0.647008 0.099376 1.222476
C -0.870515 0.164551 1.271104 C 0.663882 -0.455289 1.566932 C -0.510995 -0.473218 0.644913
C -1.809949 0.847123 0.289641 C 1.773774 -0.685387 0.561337 C -1.467417 0.633318 0.228556
O -2.474977 -0.102466 -0.570678 O 2.397973 0.590573 0.29058 O -2.523477 0.095919 -0.586622
O 2.178523 0.488389 -0.48519 O -2.106938 -0.281784 -0.618537 O 2.1929 0.033197 -0.523151
C -3.5684 -0.704769 -0.07243 C -5.551321 1.011484 0.079887 C -3.602676 -0.393609 0.054507
O -4.001451 -0.494846 1.03025 C 3.647829 0.560619 -0.198431 O -3.719428 -0.407542 1.249921
H -1.640889 2.432924 -1.243935 O 4.257738 -0.45508 -0.408806 H -1.333087 2.29834 -1.218689
H 0.815465 2.51844 -1.224448 H 1.956052 -1.647202 -1.423078 H 1.120646 2.439391 -1.18059
H 1.430682 1.441832 1.158156 H -0.470073 -1.847392 -1.80613 H 2.063987 1.457472 0.954276
H -1.327536 -0.733936 1.679559 H -1.472113 -1.726437 0.676494 H -0.956101 -1.112952 1.403745
H -0.683431 0.857188 2.104463 H 0.978802 0.269132 2.315882 H -0.254659 -1.073784 -0.233873
H -2.579432 1.376436 0.856087 H 0.452781 -1.408365 2.072893 H -1.916162 1.091737 1.113378
C -4.154368 -1.658037 -1.069555 H 2.535875 -1.340087 0.990297 C -4.613517 -0.90828 -0.925464
H -3.428556 -2.438507 -1.300262 H -6.346014 1.351314 -0.585063 H -5.496603 -1.245296 -0.390947
H -5.058044 -2.100525 -0.661102 H -5.954677 0.196747 0.685604 H -4.878589 -0.126819 -1.637415
H -4.377304 -1.136325 -2.000247 H -5.309439 1.836325 0.753677 H -4.186287 -1.735426 -1.493469
C 3.133203 -0.252651 0.261966 C 4.159906 1.94754 -0.44611 C 3.301482 -0.60685 0.123485
H 2.689259 -1.190619 0.607108 H 4.023185 2.567826 0.439062 H 3.009153 -0.846451 1.151189
H 3.428221 0.325407 1.149575 H 5.209935 1.902721 -0.719666 C 4.511419 0.311101 0.132374
C 4.332173 -0.521265 -0.617965 H 3.588524 2.403799 -1.255729 H 5.350726 -0.168035 0.639732
H 4.73459 0.432442 -0.968083 C -4.330595 0.566133 -0.711235 H 4.813497 0.546562 -0.889609
H 3.997797 -1.065901 -1.503944 H -4.595913 -0.244641 -1.394023 H 4.303506 1.247666 0.652419
C 5.408141 -1.312228 0.110948 H -3.960166 1.388196 -1.328106 C 3.563807 -1.893664 -0.628645
H 5.030173 -2.278599 0.451753 C -3.210562 0.100252 0.190328 H 3.800181 -1.680222 -1.672591
H 6.26192 -1.503319 -0.539974 H -2.910822 0.896648 0.877266 H 4.405544 -2.429607 -0.187428
H 5.775911 -0.773173 0.986971 H -3.533973 -0.759536 0.794779 H 2.687657 -2.541229 -0.601303
E(RmPW1PW91) = –691.64085674 a.u. E(RmPW1PW91) = –691.64073241 a.u. E(RmPW1PW91) = –691.64667649 a.u.
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Created by GaussView 5.0.9
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C 0.93238 -1.170863 -0.60753 C 0.778384 -1.569946 -0.976941 C 0.995012 -1.189489 -0.823245
C -0.363009 -1.407681 -0.748049 C -0.541962 -1.466177 -1.002067 C -0.309649 -1.141393 -1.049378
C -1.384263 -0.843124 0.192637 C -1.294545 -0.669071 0.020342 C -1.278099 -0.639472 -0.021295
O -0.801237 -0.235623 1.322214 O -0.450261 0.2621 0.668198 O -0.629239 0.14767 0.958392
C 0.309808 0.581116 1.009548 C 0.696497 -0.364984 1.191549 C 0.476916 -0.525643 1.510297
C 1.442277 -0.281316 0.48262 C 1.591846 -0.926344 0.098235 C 1.572694 -0.763878 0.490882
O 2.436749 0.630272 -0.016896 O 2.381438 0.103697 -0.534456 O 2.319276 0.466349 0.347414
O -2.183169 0.04238 -0.537554 O -2.312285 0.008907 -0.616745 O -2.233157 0.126454 -0.65625
C 3.701376 0.176902 -0.098087 C 3.515989 0.463006 0.089946 C -4.417123 -0.634552 0.075959
O 4.03121 -0.936055 0.211844 O 3.889922 -0.02197 1.125637 C 3.567636 0.363319 -0.135142
H 1.663133 -1.619542 -1.269711 H 1.311474 -2.12343 -1.741115 O 4.083322 -0.681836 -0.434702
H -0.742698 -2.02794 -1.550345 H -1.140339 -1.95221 -1.762622 H 1.688101 -1.540432 -1.577708
H -1.994004 -1.650589 0.614145 H -1.702148 -1.349056 0.794226 H -0.740498 -1.47178 -1.986584
H 0.595292 1.089726 1.928672 H 1.230893 0.37548 1.782605 H -1.746168 -1.50083 0.494915
H 0.047302 1.329728 0.256008 H 0.413494 -1.190838 1.860514 H 0.850351 0.089445 2.327149
H 1.89053 -0.879991 1.278905 H 2.282512 -1.642922 0.548278 H 0.169216 -1.498369 1.920766
C 4.615048 1.239982 -0.62944 C 4.228871 1.538163 -0.673142 H 2.263356 -1.52715 0.856717
H 4.500008 2.160295 -0.057605 H 3.611305 2.436836 -0.698746 H -5.277369 -0.38456 0.699602
H 5.642295 0.891009 -0.581945 H 5.177758 1.756255 -0.192126 H -4.020287 -1.587945 0.428639
H 4.350598 1.463083 -1.664043 H 4.389874 1.224987 -1.704436 H -4.761438 -0.765602 -0.95138
C -3.416365 0.405742 0.09774 C -3.286265 0.604821 0.254477 C -3.374811 0.467629 0.145051
H -3.242254 0.469883 1.176988 H -2.780846 0.91771 1.172688 H -3.041998 0.602741 1.178167
C -4.489151 -0.630356 -0.189705 C -4.381241 -0.395261 0.580599 C -3.89251 1.786967 -0.383883
H -4.672428 -0.696191 -1.263549 H -4.89678 -0.702181 -0.331079 H -4.766852 2.109481 0.183473
H -4.20261 -1.619907 0.170047 H -3.980346 -1.287543 1.06444 H -3.123307 2.554799 -0.308987
H -5.423593 -0.358875 0.304813 H -5.112694 0.047837 1.25895 H -4.179208 1.687968 -1.432407
C -3.787405 1.776082 -0.425987 C -3.813329 1.829159 -0.460542 C 4.209497 1.712694 -0.255092
H -3.913592 1.745561 -1.509664 H -4.273681 1.545313 -1.408632 H 4.083836 2.280254 0.666073
H -4.723048 2.116492 0.020279 H -4.563818 2.334884 0.149023 H 5.263404 1.59329 -0.48869
H -3.007534 2.500569 -0.192341 H -3.002646 2.526802 -0.667776 H 3.719868 2.272497 -1.053487
E(RmPW1PW91) = –691.64643695 a.u. E(RmPW1PW91) = –691.64371305 a.u. E(RmPW1PW91) = –691.64357030 a.u.
A.2. 13C NMR ANALYSIS OF 3,6-DIHYDRO-2H-PYRANS 354
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C -0.86326 1.651745 -0.711694 C 1.031322 -1.154511 -0.722143 C -0.723408 -1.430794 1.123846
C 0.436702 1.894118 -0.643904 C -0.231737 -1.52336 -0.872138 C 0.594941 -1.405228 1.000702
C 1.323863 1.196602 0.342316 C -1.28608 -1.182414 0.136721 C 1.265697 -0.821798 -0.204987
O 0.605357 0.436415 1.280227 O -0.753306 -0.625503 1.31244 O 0.402704 0.041081 -0.912041
C -0.453666 -0.31368 0.713363 C 0.250359 0.342428 1.071862 C -0.823405 -0.586604 -1.20791
C -1.509975 0.635789 0.171066 C 1.461149 -0.327382 0.449045 C -1.618767 -0.911822 0.046498
O -2.462324 -0.085673 -0.628837 O 2.336598 0.736666 0.037371 O -2.28522 0.25146 0.580752
O 2.238854 0.428152 -0.388843 O -2.210655 -0.33705 -0.4896 O 2.376826 -0.115958 0.214099
C -3.504761 -0.644239 0.017467 C 3.640776 0.436336 -0.109471 C -3.460711 0.583208 0.018597
O -3.665332 -0.577549 1.2059 O 4.094493 -0.661704 0.068696 O -3.961339 -0.028575 -0.888272
H -1.501166 2.177151 -1.413004 H 1.793218 -1.445857 -1.435008 H -1.194835 -1.828279 2.01497
H 0.916534 2.609891 -1.299127 H -0.557276 -2.098837 -1.729601 H 1.250308 -1.806886 1.763532
H 1.867379 1.92947 0.953459 H -1.796062 -2.092344 0.479754 H 1.577923 -1.632856 -0.894698
H -0.855532 -0.936488 1.509387 H 0.495573 0.786121 2.035034 H -1.383318 0.084837 -1.854672
H -0.091662 -0.950113 -0.100562 H -0.113376 1.126712 0.401206 H -0.652727 -1.522826 -1.758605
H -2.044579 1.110528 0.99777 H 1.989237 -0.94941 1.175558 H -2.386298 -1.645307 -0.210394
C -4.415387 -1.341049 -0.94775 C 4.423251 1.647851 -0.517556 C -4.042089 1.799403 0.673221
H -5.244637 -1.785936 -0.406038 H 4.3118 2.432735 0.230891 H -3.351296 2.637136 0.574292
H -4.788932 -0.630471 -1.685476 H 5.470623 1.382555 -0.625867 H -4.99264 2.042418 0.207839
H -3.864938 -2.111755 -1.487799 H 4.037429 2.038791 -1.459434 H -4.181726 1.61762 1.739028
C 3.31107 -0.078347 0.395734 C -3.407699 -0.149689 0.254373 C 3.187562 0.357554 -0.841566
H 2.943612 -0.790581 1.139636 H -3.819031 -1.134706 0.521952 H 2.653965 1.124597 -1.413664
H 3.782484 0.756457 0.936071 H -3.206121 0.389847 1.18393 H 3.405233 -0.465686 -1.539698
C 4.789706 -1.939746 -0.333621 C -4.383376 0.593714 -0.589676 C 4.464259 0.916128 -0.316306
H 5.537391 -2.353246 -0.998543 H -4.563427 0.175497 -1.575573 H 5.130959 1.297493 -1.084881
H 4.460304 -2.570093 0.485168 C -5.026776 1.682594 -0.197422 C 4.812722 0.981538 0.95885
C 4.304236 -0.720261 -0.508912 H -4.853303 2.124262 0.777825 H 5.760976 1.410145 1.256433
H 4.640138 -0.111163 -1.34291 H -5.75345 2.171955 -0.833491 H 4.158897 0.614017 1.738542
E(RmPW1PW91) = –690.40296120 a.u. E(RmPW1PW91) = –690.40276763 a.u. E(RmPW1PW91) = –690.40046232 a.u.
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C 1.101141 -1.208621 -0.849073 C 0.716757 -1.486629 -0.958956 C 0.898525 -0.973742 -0.91592
C -0.207578 -1.296238 -1.035592 C -0.588436 -1.700431 -0.895738 C -0.376153 -1.282677 -1.098577
C -1.189776 -0.935141 0.03638 C -1.425562 -1.156064 0.220865 C -1.392946 -1.131972 -0.009709
O -0.602491 -0.125831 1.03184 O -0.663815 -0.581439 1.24911 O -0.821984 -0.818052 1.234035
C 0.590847 -0.690837 1.521952 C 0.406301 0.223626 0.784213 C 0.200486 0.159018 1.156768
C 1.670747 -0.762258 0.461876 C 1.417633 -0.651406 0.061659 C 1.378225 -0.400451 0.381028
O 2.261042 0.552141 0.344196 O 2.372864 0.165726 -0.634797 O 2.268939 0.70525 0.158323
O -2.240414 -0.253453 -0.546148 O -2.335306 -0.248591 -0.347326 O -2.32036 -0.166309 -0.434677
C 3.491764 0.617145 -0.188628 C 3.444681 0.585408 0.06759 C 3.562049 0.412787 -0.080372
O 4.111159 -0.347044 -0.555277 O 3.62817 0.318961 1.224135 O 3.992197 -0.707882 -0.124439
H 1.803368 -1.458351 -1.634596 H 1.319751 -1.903955 -1.757016 H 1.63403 -1.132475 -1.695274
H -0.630786 -1.642778 -1.970463 H -1.108386 -2.280746 -1.64698 H -0.738874 -1.670486 -2.041981
H -1.5699 -1.855587 0.5267 H -1.977868 -1.966405 0.714726 H -1.910379 -2.08458 0.164093
H 0.919225 -0.069661 2.353262 H 0.845679 0.693062 1.661236 H 0.479212 0.400891 2.180565
H 0.407409 -1.707105 1.899054 H 0.045074 0.995884 0.097813 H -0.159988 1.065732 0.662058
H 2.458066 -1.450679 0.777558 H 1.956016 -1.272821 0.781837 H 1.907987 -1.163081 0.956685
C 3.968155 2.036274 -0.265374 C 4.350705 1.413974 -0.791552 C 4.361756 1.66365 -0.284135
H 3.857255 2.528108 0.700484 H 5.223926 1.708552 -0.217281 H 4.233259 2.336058 0.563851
H 5.00657 2.053409 -0.582803 H 4.653048 0.847593 -1.672405 H 5.409893 1.407114 -0.405521
H 3.355439 2.584309 -0.982557 H 3.819264 2.299924 -1.140492 H 4.003788 2.186391 -1.171944
C -3.316115 0.018256 0.344236 C -3.350588 0.14907 0.56106 C -3.474096 -0.114931 0.390143
H -3.029603 0.78365 1.068971 H -2.911228 0.649264 1.430044 H -3.955125 -1.102152 0.424259
H -3.556398 -0.900691 0.900309 H -3.89222 -0.733507 0.928367 H -3.199038 0.151363 1.415751
C -5.193313 1.551323 -0.20561 C -5.062959 1.790004 -0.61983 C -5.204117 1.66243 -0.541264
H -6.067713 1.811484 -0.788588 H -5.753482 2.449417 -1.086536 H -5.902568 2.374039 -0.909024
H -4.915475 2.232374 0.591261 C -4.281012 1.045194 -0.099694 C -4.412483 0.860409 -0.13287
C -4.497053 0.452377 -0.452041
H -4.784738 -0.208666 -1.264233
E(RmPW1PW91) = –690.40001531 a.u. E(RmPW1PW91) = –689.14310459 a.u. E(RmPW1PW91) = –689.14283053 a.u.
A.2. 13C NMR ANALYSIS OF 3,6-DIHYDRO-2H-PYRANS 355
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C -0.736187 1.589603 -0.931597 C 0.950695 -1.009716 -1.051103 C -2.1656 -1.275626 1.243945
C 0.586384 1.568633 -0.865714 C -0.364825 -1.021952 -1.206562 C -0.931939 -1.752357 1.181488
C 1.309492 0.818524 0.209587 C -1.300207 -0.84126 -0.05155 C -0.102796 -1.646543 -0.062639
O 0.487905 -0.157733 0.807674 O -0.659264 -0.254215 1.057825 O -0.834939 -1.185242 -1.168317
C -0.733131 0.395272 1.244707 C 0.52909 -0.934377 1.39212 C -1.69453 -0.100118 -0.867762
C -1.581253 0.89576 0.086779 C 1.573555 -0.834684 0.299563 C -2.784555 -0.569452 0.082954
O -2.256775 -0.181781 -0.594446 O 2.204784 0.460432 0.408525 O -3.510408 0.557403 0.602074
O 2.41105 0.203407 -0.360195 O -2.340371 -0.024395 -0.46132 O 0.995845 -0.828754 0.235013
C -3.406223 -0.613719 -0.045663 C 3.426891 0.585079 -0.135515 C -4.545846 1.008844 -0.133772
O -3.874859 -0.15614 0.963347 O 4.004869 -0.314411 -0.686966 O -4.875427 0.529183 -1.184311
H -1.248121 2.110375 -1.732169 H 1.620832 -1.12807 -1.893399 H -2.766524 -1.37708 2.140283
H 1.206649 2.091742 -1.582677 H -0.827982 -1.173676 -2.173691 H -0.469004 -2.243801 2.027767
H 1.643706 1.517834 1.003451 H -1.70405 -1.824735 0.266318 H 0.252929 -2.638299 -0.371082
H -1.257756 -0.378066 1.800717 H 0.901538 -0.488761 2.312508 H -2.114311 0.236348 -1.812971
H -0.549569 1.237734 1.92661 H 0.32154 -1.997427 1.578902 H -1.140606 0.720752 -0.401251
H -2.344927 1.568589 0.483314 H 2.345188 -1.592837 0.451859 H -3.4873 -1.217844 -0.446552
C -4.000756 -1.725256 -0.855702 C 3.949204 1.979403 0.034477 C -5.210574 2.169526 0.542234
H -3.313864 -2.572044 -0.875285 H 3.86746 2.292997 1.07463 H -6.040724 2.515457 -0.066224
H -4.948195 -2.026062 -0.418604 H 4.983211 2.021821 -0.294759 H -5.567898 1.871211 1.52809
H -4.146447 -1.401441 -1.886198 H 3.345604 2.665405 -0.561556 H -4.491501 2.976202 0.686742
C 3.241591 -0.443606 0.592578 C -3.35443 0.121116 0.52167 C 2.002397 -0.850362 -0.760233
H 2.735244 -1.32145 1.003161 H -2.984487 0.712533 1.363642 H 1.618054 -0.44189 -1.699486
H 3.452603 0.238442 1.427953 H -3.641684 -0.865796 0.910288 H 2.293893 -1.893381 -0.954882
C 5.528451 -1.183806 -0.521964 C -5.488053 1.300037 -0.516546 C 3.200569 -0.066311 -0.30902
H 6.446871 -1.486949 -0.962499 H -6.34627 1.77538 -0.925183 C 3.470813 0.139638 1.038982
C 4.489172 -0.841526 -0.032811 C -4.515429 0.767 -0.062231 C 4.087006 0.432934 -1.258909
C 4.6102 0.830052 1.427823
H 2.775639 -0.23252 1.779299
C 5.229587 1.115335 -0.870687
H 3.879498 0.289676 -2.313857
C 5.494879 1.316534 0.476687
H 4.806663 0.989125 2.481203
H 5.909438 1.498222 -1.621921
H 6.383541 1.85453 0.782618
E(RmPW1PW91) = –689.14014340 a.u. E(RmPW1PW91) = –689.13997361 a.u. E(RmPW1PW91) = –844.07247316 a.u.
A.2. 13C NMR ANALYSIS OF 3,6-DIHYDRO-2H-PYRANS 356
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C -2.264314 -0.569582 1.208686 C 2.185821 1.785047 0.517595 C 2.328104 -1.268766 -0.690413
C -1.048423 -1.007951 1.497041 C 0.876564 1.872182 0.337971 C 1.015677 -1.449175 -0.701908
C -0.10289 -1.486797 0.4374 C 0.145871 0.96538 -0.604342 C 0.145838 -1.030527 0.443587
O -0.712143 -1.601988 -0.823609 O 0.894536 -0.194315 -0.892794 O 0.789194 -0.085419 1.269409
C -1.547009 -0.505763 -1.147244 C 2.194522 0.128276 -1.330173 C 2.068805 -0.52528 1.66126
C -2.738643 -0.482507 -0.208274 C 3.015009 0.800841 -0.240933 C 3.017649 -0.651927 0.486964
O -3.413252 0.763468 -0.451639 O 3.520352 -0.149775 0.720154 O 3.499933 0.671446 0.162885
O 0.994567 -0.615419 0.426116 O -1.052398 0.602301 -0.019294 O -1.012773 -0.476516 -0.066842
C -4.717132 0.830544 -0.121538 C 4.645573 -0.804519 0.383861 C 4.654858 0.743845 -0.518701
O -5.325728 -0.080321 0.37148 O 5.226554 -0.63873 -0.656473 O 5.291226 -0.220108 -0.855453
H -2.956056 -0.270352 1.986905 H 2.697568 2.426513 1.225383 H 2.947285 -1.562574 -1.528843
H -0.687918 -1.052106 2.517154 H 0.274059 2.603239 0.862646 H 0.510266 -1.918229 -1.537257
H 0.240977 -2.504536 0.663388 H -0.051926 1.49041 -1.561611 H -0.108648 -1.911916 1.068315
H -1.859924 -0.644539 -2.180379 H 2.666801 -0.796905 -1.651921 H 2.449253 0.200939 2.377163
H -1.002884 0.439777 -1.064237 H 2.151446 0.805176 -2.195466 H 2.001593 -1.502765 2.159736
H -3.430709 -1.29993 -0.423615 H 3.873462 1.290706 -0.706031 H 3.881369 -1.258227 0.769555
C -5.280624 2.179679 -0.450958 C 5.058256 -1.751161 1.469716 C 5.023021 2.169411 -0.799029
H -5.125976 2.403076 -1.50656 H 4.277205 -2.496589 1.623015 H 4.988691 2.758734 0.116683
H -6.340593 2.196304 -0.215826 H 5.987802 -2.238973 1.191876 H 6.015554 2.207879 -1.238096
H -4.760432 2.946617 0.123916 H 5.181597 -1.212233 2.409098 H 4.297981 2.599785 -1.491299
C 2.087248 -1.090325 -0.338761 C -1.900039 -0.147065 -0.872836 C -1.980128 -0.161127 0.920798
H 2.342312 -2.108314 -0.008086 H -1.480257 -1.140855 -1.044769 H -1.656286 0.702881 1.505452
H 1.814202 -1.153314 -1.396132 H -1.960447 0.357781 -1.848894 H -2.072348 -1.011271 1.613376
C 3.275741 -0.189753 -0.164966 C -3.27083 -0.25961 -0.272408 C -3.305503 0.114892 0.273462
C 3.447688 0.571607 0.985656 C -3.788132 0.734978 0.550308 C -3.704632 -0.566454 -0.871646
C 4.253065 -0.146788 -1.154845 C -4.064287 -1.360528 -0.579423 C -4.178108 1.031742 0.850252
C 4.580032 1.357965 1.142977 C -5.076336 0.629352 1.05406 C -4.954323 -0.335483 -1.426478
H 2.681788 0.55413 1.749235 H -3.169022 1.584472 0.805985 H -3.022841 -1.267611 -1.334467
C 5.388816 0.632148 -0.994404 C -5.355644 -1.462408 -0.08436 C -5.432258 1.256932 0.301708
H 4.122868 -0.726233 -2.062443 H -3.665921 -2.149829 -1.207483 H -3.871539 1.579752 1.73439
C 5.555731 1.388261 0.157246 C -5.865941 -0.466283 0.735561 C -5.824067 0.57315 -0.839818
H 4.699773 1.951436 2.04127 H -5.465161 1.407422 1.69972 H -5.250698 -0.867437 -2.32236
H 6.140426 0.655288 -1.773939 H -5.960503 -2.326292 -0.331322 H -6.100074 1.975049 0.761544
H 6.438882 2.002361 0.282468 H -6.8715 -0.546796 1.129448 H -6.799798 0.752391 -1.274107
E(RmPW1PW91) = –844.07221263 a.u. E(RmPW1PW91) = –844.06956601 a.u. E(RmPW1PW91) = –844.06939037 a.u.
A.2. 13C NMR ANALYSIS OF 3,6-DIHYDRO-2H-PYRANS 357
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C -2.21281 1.335525 0.369239 C -2.066905 1.893603 -0.18285 C -1.116876 1.361331 0.003152
C -1.057041 1.183516 0.99839 C -0.886579 1.911685 0.417514 C 0.041816 1.472529 0.635448
C -0.199673 -0.037824 0.839845 C -0.159107 0.659738 0.811463 C 0.986547 0.320555 0.79551
O -0.864041 -1.076912 0.17056 O -0.964133 -0.484242 0.699405 O 0.412695 -0.907606 0.437149
C -1.58359 -0.647265 -0.96932 C -1.708511 -0.532539 -0.503185 C -0.323433 -0.850773 -0.769758
C -2.693134 0.315638 -0.61433 C -2.701819 0.608653 -0.600319 C -1.507656 0.083251 -0.669822
O -3.800943 -0.446044 -0.079764 O -3.856693 0.403486 0.242784 O -2.556274 -0.593061 0.061835
O 0.98772 0.339211 0.203928 O 1.012508 0.569262 0.053074 O 2.141222 0.617908 0.060037
Si 2.376943 -0.622406 0.066049 Si 2.236956 -0.578726 0.296253 C -3.807486 -0.143387 -0.12162
C 3.783279 0.644969 -0.176887 C 3.797054 0.252714 -0.421251 O -4.087723 0.771505 -0.851123
C 2.588157 -1.638411 1.638724 C 2.394657 -0.937198 2.138922 H -1.806138 2.193345 -0.069469
C 2.201367 -1.778963 -1.406823 C 1.804494 -2.163714 -0.619709 H 0.358196 2.410706 1.074739
C 3.492874 1.493536 -1.418286 C 3.556758 0.606679 -1.892173 H 1.246925 0.195261 1.854637
C 5.11826 -0.082564 -0.359648 C 4.989872 -0.701991 -0.317243 H 0.316698 -0.513674 -1.59186
C 3.86355 1.558533 1.048803 C 4.10328 1.535133 0.357496 H -0.65686 -1.866186 -0.975847
C -5.010177 0.134268 -0.127959 C -4.83559 -0.371915 -0.254335 H -1.888476 0.301408 -1.670159
O -5.207863 1.227913 -0.589181 O -4.795887 -0.881401 -1.343389 C -4.785072 -0.92675 0.702119
H -2.833631 2.20923 0.523476 H -2.596325 2.81206 -0.407887 H -5.796988 -0.626956 0.446101
H -0.674817 1.945211 1.667365 H -0.394475 2.843806 0.667244 H -4.651656 -1.995347 0.536699
H 0.018305 -0.458386 1.827872 H 0.084862 0.706957 1.878825 H -4.601858 -0.73498 1.760298
H -0.913198 -0.155959 -1.682292 H -1.041227 -0.48126 -1.370083 C 4.432775 0.221316 -0.465227
H -1.992647 -1.543756 -1.431635 H -2.218596 -1.492927 -0.519284 H 4.165308 0.178651 -1.523811
H -3.043343 0.818982 -1.518387 H -3.049917 0.669489 -1.633722 H 4.640418 1.269457 -0.236836
H 2.606029 -1.014934 2.534107 H 2.581942 -0.033371 2.720919 C 5.664656 -0.630917 -0.199585
H 1.778533 -2.363293 1.743897 H 1.484952 -1.405843 2.51944 H 6.510533 -0.294055 -0.799771
H 3.524222 -2.199601 1.604482 H 3.219459 -1.628886 2.321976 H 5.96504 -0.582329 0.849509
H 1.357798 -2.451732 -1.244008 H 0.879015 -2.579922 -0.218657 H 5.484044 -1.680164 -0.443412
H 3.09753 -2.387066 -1.545069 H 2.588518 -2.915124 -0.506561 C 3.243332 -0.228097 0.352409
H 2.020061 -1.22758 -2.330606 H 1.660038 -1.983873 -1.686182 H 2.990046 -1.268793 0.124476
H 3.460671 0.888942 -2.327597 H 3.377148 -0.281528 -2.50225 H 3.473786 -0.170655 1.42577
H 4.280108 2.2433 -1.554164 H 4.436822 1.112032 -2.305018
H 2.541558 2.02088 -1.330215 H 2.702007 1.274846 -2.010608
H 5.112964 -0.73602 -1.235098 H 4.824897 -1.626943 -0.874516
H 5.925872 0.64338 -0.50268 H 5.886938 -0.229196 -0.731457
H 5.379765 -0.688885 0.510993 H 5.214702 -0.968517 0.718372
H 4.109812 1.00378 1.957234 H 4.321312 1.334363 1.409081
H 4.644576 2.313582 0.90705 H 4.982172 2.032162 -0.067354
H 2.921669 2.083376 1.218029 H 3.270455 2.239451 0.313128
C -6.057433 -0.756143 0.47066 C -5.958048 -0.512726 0.72923
H -7.039809 -0.32607 0.29908 H -6.295839 0.468612 1.06117
H -5.998974 -1.75579 0.041524 H -6.776427 -1.059278 0.269964
H -5.881005 -0.850143 1.543163 H -5.603505 -1.050528 1.60956
E(RmPW1PW91) = –1100.38094619 a.u. E(RmPW1PW91) = –1100.38101640 a.u. E(RmPW1PW91) = –691.64431257 a.u.
A.2. 13C NMR ANALYSIS OF 3,6-DIHYDRO-2H-PYRANS 358
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C -0.971643 1.745036 -0.537636 C -0.922245 1.154107 -0.683892 C -0.720848 1.482981 -1.001273
C 0.222813 1.927546 0.004343 C 0.274014 1.486487 -0.222043 C 0.506747 1.693467 -0.551158
C 1.010028 0.804961 0.609042 C 1.184474 0.498939 0.441428 C 1.224273 0.703644 0.31496
O 0.254982 -0.366619 0.759751 O 0.544258 -0.712611 0.744705 O 0.37754 -0.305175 0.798523
C -0.517049 -0.682002 -0.383362 C -0.258814 -1.200907 -0.312574 C -0.468058 -0.845647 -0.199023
C -1.561024 0.37954 -0.670411 C -1.398415 -0.263685 -0.640998 C -1.426869 0.191487 -0.751191
O -2.682004 0.3071 0.237097 O -2.430854 -0.437013 0.35763 O -2.517885 0.46744 0.154453
O 2.154855 0.61913 -0.176756 O 2.295861 0.326936 -0.39388 O 2.299447 0.196531 -0.425883
C 5.443552 -1.157134 0.089433 C -3.671713 -0.058338 0.014226 C -3.563635 -0.375961 0.113281
C -3.644356 -0.582518 -0.061996 O -3.955662 0.40265 -1.060378 O -3.632113 -1.319431 -0.629825
O -3.617049 -1.295449 -1.030454 H -1.583479 1.887807 -1.127775 H -1.242185 2.235256 -1.581531
H -1.548501 2.579964 -0.917801 H 0.650046 2.499116 -0.302617 H 1.045582 2.604278 -0.781539
H 0.680016 2.90831 0.04879 H 1.496455 0.884477 1.419035 H 1.586318 1.2035 1.220964
H 1.305631 1.067221 1.633421 H 0.344426 -1.342739 -1.215294 H 0.125501 -1.241618 -1.029681
H 0.125272 -0.778826 -1.265171 H -0.642393 -2.166663 0.011379 H -1.010342 -1.669199 0.259812
H -0.985083 -1.644772 -0.191462 H -1.825914 -0.532466 -1.609632 H -1.853351 -0.198946 -1.677733
H -1.939346 0.220729 -1.68256 C -4.632678 -0.279122 1.143732 C -4.608595 0.019028 1.112897
H 5.099458 -2.181711 0.246779 H -5.647089 -0.109843 0.794737 H -4.882526 1.065303 0.980016
H 6.301484 -1.197536 -0.582556 H -4.529453 -1.287583 1.542499 H -5.480506 -0.617897 0.996959
H 5.795599 -0.775263 1.050408 H -4.403626 0.417056 1.952017 H -4.205371 -0.086967 2.120865
C -4.731173 -0.561133 0.97013 C 3.425358 -0.298692 0.22961 C 3.296615 -0.481405 0.350338
H -5.097139 0.455195 1.113314 H 3.056609 -1.050622 0.935123 H 2.797061 -1.001593 1.174311
H -5.540643 -1.214428 0.658186 C 4.265075 0.730412 0.966445 C 4.303421 0.511908 0.903982
H -4.330275 -0.900957 1.926006 H 4.645807 1.477464 0.26779 H 4.813562 1.026919 0.088132
C 3.137114 -0.210052 0.426356 H 3.689613 1.244847 1.737772 H 3.824683 1.261739 1.535995
H 3.421648 0.210099 1.401597 H 5.114202 0.25019 1.456136 H 5.0516 -0.000721 1.511307
H 2.727151 -1.209547 0.604719 C 4.202675 -0.989921 -0.869583 C 3.940487 -1.502675 -0.561982
C 4.339894 -0.282784 -0.486436 H 5.082123 -1.489476 -0.460344 H 4.398324 -1.007895 -1.420418
H 4.710731 0.730038 -0.661321 H 3.583348 -1.733882 -1.370321 H 4.715586 -2.056767 -0.030237
H 4.018801 -0.670566 -1.456226 H 4.534122 -0.263051 -1.61321 H 3.198916 -2.211277 -0.930339
E(RmPW1PW91) = –691.64435047 a.u. E(RmPW1PW91) = –691.64746501 a.u. E(RmPW1PW91) = –691.64753089 a.u.
A.2. 13C NMR ANALYSIS OF 3,6-DIHYDRO-2H-PYRANS 359
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C -0.972678 1.338726 -0.215813 C -0.806696 1.639614 -0.782642 C -0.832995 1.325969 0.156106
C 0.16314 1.552548 0.431439 C 0.365396 1.908956 -0.228228 C 0.30904 1.310074 0.826877
C 1.084731 0.439991 0.827448 C 1.117758 0.89995 0.584211 C 1.184457 0.097198 0.88989
O 0.511747 -0.828127 0.666349 O 0.348494 -0.227214 0.89894 O 0.570942 -1.053137 0.382731
C -0.179093 -0.978576 -0.56023 C -0.379496 -0.729609 -0.2069 C -0.127189 -0.829897 -0.830178
C -1.354727 -0.0354 -0.668842 C -1.39966 0.271049 -0.713647 C -1.266749 0.146838 -0.656956
O -2.437195 -0.56611 0.129941 O -2.561784 0.350527 0.139963 O -2.366373 -0.547121 -0.025279
O 2.271386 0.596528 0.095777 O 2.288456 0.580806 -0.11942 O 2.380702 0.413353 0.219825
C -3.674508 -0.143198 -0.173981 C -3.518662 -0.573231 -0.057107 C -3.587837 -0.011691 -0.18476
O -3.914861 0.632407 -1.061841 O -3.452648 -1.434063 -0.894554 O -3.79776 0.991872 -0.813946
H -1.648397 2.148961 -0.459562 H -1.361842 2.400596 -1.318383 H -1.477216 2.196181 0.153846
H 0.475383 2.551112 0.711661 H 0.827494 2.883485 -0.32614 H 0.6604 2.178286 1.370422
H 1.306432 0.500224 1.901247 H 1.382169 1.327427 1.560543 H 1.406012 -0.152079 1.935922
H 0.495134 -0.791593 -1.402478 H 0.29909 -0.976673 -1.030069 H 0.553003 -0.439634 -1.594068
H -0.515825 -2.012797 -0.599355 H -0.865178 -1.643943 0.125834 H -0.501667 -1.799801 -1.151464
H -1.696291 0.006175 -1.705621 H -1.732485 -0.053761 -1.701837 H -1.607306 0.488483 -1.637058
C -4.691591 -0.7557 0.741395 C -4.652905 -0.381222 0.903817 C -4.627524 -0.825705 0.52467
H -5.689374 -0.536709 0.372595 H -5.01671 0.644962 0.85916 H -5.614059 -0.437471 0.289428
H -4.539931 -1.831522 0.818806 H -5.452164 -1.076618 0.665168 H -4.552692 -1.873481 0.235286
H -4.572866 -0.335563 1.741413 H -4.301055 -0.558365 1.921012 H -4.45807 -0.771491 1.600936
C 3.340349 -0.21438 0.566213 C 3.230385 -0.157497 0.648622 C 3.397441 -0.554301 0.429518
H 3.111187 -1.275051 0.431235 H 3.429643 0.385031 1.585143 H 3.073607 -1.534624 0.065275
H 3.475049 -0.035997 1.643806 H 2.830242 -1.140214 0.912802 H 3.604319 -0.654584 1.50389
C 4.58168 0.157709 -0.167017 C 4.488126 -0.291307 -0.136954 C 5.623611 0.151024 -0.82193
H 4.819863 1.217189 -0.176293 H 4.897967 0.635586 -0.527088 H 6.51993 0.427628 -1.321521
C 5.382458 -0.71303 -0.762138 C 5.110407 -1.44036 -0.351602 C 4.610019 -0.154036 -0.259495
H 5.158258 -1.774111 -0.775178 H 4.712823 -2.379148 0.018374
H 6.294195 -0.400037 -1.254937 H 6.041931 -1.486874 -0.901375
E(RmPW1PW91) = –690.40372835 a.u. E(RmPW1PW91) = –690.40380280 a.u. E(RmPW1PW91) = –689.14389063 a.u.
A.2. 13C NMR ANALYSIS OF 3,6-DIHYDRO-2H-PYRANS 360
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C -0.656016 1.600882 -0.786201 C -2.106444 1.204385 -0.558501 C 2.042247 1.769205 0.238661
C 0.517974 1.826209 -0.216668 C -1.033188 1.578922 0.121685 C 0.932917 1.875698 -0.476647
C 1.213773 0.792782 0.6135 C -0.220429 0.618118 0.934144 C 0.221864 0.680091 -1.03308
O 0.403189 -0.306211 0.91529 O -0.846678 -0.624818 1.097556 O 0.976134 -0.494868 -0.937874
C -0.331556 -0.781572 -0.199781 C -1.414996 -1.126072 -0.098176 C 1.587171 -0.661995 0.329073
C -1.30515 0.257955 -0.718847 C -2.51658 -0.233371 -0.621024 C 2.593049 0.434601 0.619714
O -2.470936 0.387989 0.122304 O -3.705147 -0.471491 0.167825 O 3.825727 0.257527 -0.110421
O 2.388354 0.429729 -0.070471 O 1.039343 0.515155 0.3244 O -1.016601 0.584097 -0.379595
C -3.462291 -0.49836 -0.080913 C -4.880027 -0.142458 -0.394992 C 4.730395 -0.57925 0.428278
O -3.420741 -1.365054 -0.913583 O -4.984787 0.32882 -1.504708 O 4.562137 -1.165224 1.464946
H -1.171948 2.380895 -1.33347 H -2.706677 1.917648 -1.109407 H 2.57436 2.648353 0.582526
H 1.022159 2.779633 -0.312348 H -0.69613 2.608257 0.124404 H 0.498521 2.840463 -0.707744
H 1.476089 1.214744 1.592612 H -0.103673 0.996426 1.958226 H 0.057251 0.810933 -2.110509
H 0.346548 -1.055976 -1.014378 H -0.647502 -1.222431 -0.873238 H 0.831412 -0.654994 1.12138
H -0.856012 -1.675513 0.129016 H -1.806067 -2.114117 0.137233 H 2.067729 -1.637416 0.319638
H -1.640021 -0.056407 -1.709721 H -2.745218 -0.500887 -1.65514 H 2.828005 0.406457 1.685963
C -4.597924 -0.256723 0.866668 C -6.019479 -0.428578 0.537012 C 5.950803 -0.675083 -0.436517
H -4.917293 0.783888 0.816993 H -6.959727 -0.314426 0.005568 H 6.692803 -1.300148 0.051319
H -5.423108 -0.918095 0.619758 H -5.933639 -1.432446 0.950956 H 5.681091 -1.104916 -1.401932
H -4.265396 -0.447351 1.887941 H -5.985419 0.273429 1.371645 H 6.357724 0.318272 -0.624667
C 3.266458 -0.35059 0.726119 C 2.012086 -0.129107 1.141489 C -1.908206 -0.331747 -0.986342
H 3.532638 0.199137 1.639476 H 1.697201 -1.151028 1.367457 H -1.505601 -1.347783 -0.933008
H 2.778802 -1.281057 1.033975 H 2.09548 0.414557 2.092264 H -2.014158 -0.080595 -2.05225
C 4.471808 -0.655264 -0.02194 C 3.327716 -0.134562 0.425213 C -3.251929 -0.274192 -0.318014
C 5.475426 -0.924657 -0.619358 C 4.036129 1.050657 0.244153 C -3.641273 0.820701 0.444192
H 6.363608 -1.159482 -1.153656 C 3.858245 -1.317172 -0.076253 C -4.145977 -1.326999 -0.493438
C 5.248807 1.052073 -0.425462 C -4.904627 0.861922 1.017987
H 3.627655 1.978561 0.62701 H -2.943716 1.633285 0.59442
C 5.075543 -1.321184 -0.743722 C -5.410319 -1.282349 0.072601
H 3.3126 -2.244411 0.056869 H -3.84897 -2.192317 -1.07633
C 5.772438 -0.135797 -0.919924 C -5.794068 -0.185566 0.832257
H 5.790404 1.980344 -0.559982 H -5.193889 1.718419 1.614847
H 5.477894 -2.250534 -1.127634 H -6.094713 -2.109152 -0.0729
H 6.722033 -0.135394 -1.440674 H -6.779298 -0.151339 1.280444
E(RmPW1PW91) = –689.14390951 a.u. E(RmPW1PW91) = –844.07287251 a.u. E(RmPW1PW91) = –844.07328766 a.u.
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C -1.118679 1.394345 -0.472043 C 0.718294 1.164706 -0.036354 C 1.173822 1.542001 0.095128
C -2.419443 1.224381 -0.294539 C 2.016751 1.33833 -0.229252 C 2.411055 1.153941 -0.173173
C -3.029046 -0.137298 -0.154569 C 3.019929 0.280215 0.115836 C 2.851916 -0.263299 0.024856
O -2.119064 -1.174191 -0.418502 O 2.457109 -0.792902 0.827272 O 1.755716 -1.148442 0.066877
C -0.840712 -0.970549 0.156153 C 1.214441 -1.225152 0.306666 C 0.799596 -0.736113 1.01621
C -0.182546 0.230993 -0.502906 C 0.182348 -0.12855 0.493888 C 0.160434 0.593361 0.648315
O 0.994954 0.616419 0.22655 O -0.975748 -0.552527 -0.245939 O -0.86085 0.445671 -0.361613
C 2.122332 -0.01509 -0.101143 C -2.134251 0.003829 0.103164 C -2.059309 0.072966 0.080046
O 3.097771 0.470791 0.658842 O -3.085642 -0.513888 -0.666721 O -2.882289 0.008213 -0.960604
O 2.241532 -0.869686 -0.93787 O -2.295777 0.827257 0.96394 O -2.353261 -0.162113 1.223538
C 4.383124 -0.105504 0.430614 C -4.399741 -0.017447 -0.416717 C -4.218905 -0.38187 -0.650091
H -0.685918 2.380479 -0.593141 H 0.005295 1.952838 -0.246312 H 0.853145 2.561474 -0.082912
H -3.100987 2.063808 -0.243332 H 2.412422 2.259374 -0.638414 H 3.15963 1.841649 -0.546412
H -3.813768 -0.275934 -0.906656 H 3.772482 0.686622 0.80063 H 3.397343 -0.35272 0.98426
H -0.270388 -1.879664 -0.020519 H 0.939613 -2.124949 0.853305 H 0.047781 -1.519304 1.081089
H -0.918033 -0.790747 1.23293 H 1.295487 -1.465506 -0.757262 H 1.263715 -0.629129 2.007243
H 0.110064 -0.015135 -1.526697 H -0.096595 -0.020925 1.544651 H -0.313468 1.009217 1.540226
H 5.050217 0.388892 1.130479 H -5.043792 -0.53601 -1.120673 H -4.743942 -0.397158 -1.60056
H 4.363381 -1.178354 0.618412 H -4.705171 -0.233001 0.606493 H -4.23608 -1.369803 -0.191403
H 4.708726 0.072353 -0.593623 H -4.443872 1.058144 -0.583861 H -4.682126 0.33484 0.027184
O -3.574204 -0.22369 1.138462 O 3.626344 -0.135883 -1.082277 O 3.671332 -0.620373 -1.035392
H -4.061387 -1.050504 1.192894 H 4.347215 -0.728625 -0.852142 H 3.897168 -1.548634 -0.92891
E(RmPW1PW91) = –648.92999370 a.u. E(RmPW1PW91) = –648.92987228 a.u. E(RmPW1PW91) = –648.92690258 a.u.
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C 0.728994 1.274661 0.220806 C -0.725467 1.237884 0.070187 C -1.179969 1.465591 0.453182
C 1.970936 1.282409 -0.239882 C -1.899601 1.244184 -0.54265 C -2.357443 1.249375 -0.11213
C 2.861741 0.083485 -0.132446 C -2.731476 0.008312 -0.696295 C -2.750068 -0.089411 -0.656945
O 2.125165 -1.099765 0.077842 O -2.042836 -1.161839 -0.356195 O -1.678343 -0.987068 -0.726944
C 1.232271 -0.969331 1.15986 C -1.294218 -1.046563 0.838978 C -0.876295 -0.992148 0.438849
C 0.158735 0.067925 0.899382 C -0.20863 -0.000301 0.733003 C -0.212808 0.349913 0.676384
O -0.857966 -0.55459 0.080575 O 0.894266 -0.572301 -0.008207 O 0.905963 0.580147 -0.207757
C -2.052597 0.027707 0.097257 C 2.069314 0.027852 0.149477 C 2.057199 0.022802 0.158308
O -2.863021 -0.666882 -0.694544 O 2.965788 -0.613376 -0.593991 O 2.974095 0.331164 -0.753066
O -2.356211 1.008726 0.725328 O 2.292129 0.981913 0.848743 O 2.243877 -0.641941 1.144047
C -4.195276 -0.165199 -0.783195 C 4.2899 -0.087197 -0.52831 C 4.274175 -0.200538 -0.50412
H 0.084474 2.139887 0.129068 H -0.114381 2.129164 0.136772 H -0.888725 2.454736 0.785733
H 2.403524 2.159079 -0.706135 H -2.309398 2.150238 -0.971811 H -3.086987 2.042101 -0.221836
H 3.551455 0.211351 0.724516 H -2.9893 -0.131053 -1.751926 H -3.075313 0.021092 -1.69732
H 0.779617 -1.945973 1.318831 H -1.949251 -0.780071 1.674701 H -1.481875 -1.234501 1.318393
H 1.774951 -0.682707 2.071855 H -0.85948 -2.026146 1.026993 H -0.132872 -1.774754 0.30653
H -0.309828 0.358917 1.842346 H 0.155075 0.247364 1.732836 H 0.160883 0.368581 1.702462
H -4.713218 -0.837379 -1.460901 H 4.883655 -0.713918 -1.187179 H 4.887547 0.13323 -1.335843
H -4.675148 -0.16903 0.194864 H 4.311236 0.947467 -0.868702 H 4.672492 0.17825 0.436486
H -4.199674 0.849544 -1.179529 H 4.674841 -0.13612 0.489683 H 4.245172 -1.288922 -0.467309
O 3.574567 -0.043029 -1.315272 O -3.898933 0.185589 0.071199 O -3.807359 -0.576609 0.135293
H 4.094747 -0.849301 -1.257033 H -4.485237 -0.55184 -0.120097 H -4.13493 -1.378868 -0.281046
E(RmPW1PW91) = –648.92680581 a.u. E(RmPW1PW91) = –648.93065639 a.u. E(RmPW1PW91) = –648.93067899 a.u.
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C -0.618402 -1.219474 1.899724 C 0.765303 -1.555365 -1.147554 C -0.639521 -1.884619 1.716989
C 0.703545 -1.201799 1.974474 C -0.54279 -1.586263 -1.351574 C 0.662569 -1.645255 1.67217
C 1.578429 -1.399103 0.770427 C -1.535535 -1.510206 -0.228329 C 1.382875 -1.374704 0.382536
O 0.845031 -1.780934 -0.369266 O -0.919588 -1.591356 1.036571 O 0.477911 -0.982877 -0.631989
C -0.363391 -1.064905 -0.543392 C 0.260075 -0.819914 1.146969 C -0.579593 -1.905051 -0.763973
C -1.316669 -1.400835 0.592675 C 1.326177 -1.390629 0.23031 C -1.463145 -1.945056 0.472489
O -2.440994 -0.505534 0.575878 O 2.407721 -0.443688 0.238332 O -2.37678 -0.82912 0.517892
O 2.315739 -0.23089 0.565614 O -2.287812 -0.343863 -0.380841 O 2.306672 -0.37376 0.576398
Si 3.545255 -0.050504 -0.58867 Si -3.672527 0.051666 0.513532 Si 3.282929 0.31554 -0.62996
C 4.651485 1.327105 0.132718 C -4.653531 1.21023 -0.641673 C 4.77759 0.994133 0.342456
C 2.792026 0.448823 -2.237855 C -3.159296 0.913345 2.104528 C 3.777818 -1.02318 -1.858987
C 4.465913 -1.682835 -0.780564 C -4.617142 -1.524557 0.928465 C 2.333994 1.678002 -1.506199
C 5.262089 0.853807 1.454435 C -5.045476 0.456439 -1.91529 C 4.293526 2.001133 1.39031
C 5.77254 1.666663 -0.853475 C -5.918922 1.703325 0.066566 C 5.746251 1.691059 -0.618413
C 3.805965 2.577929 0.391693 C -3.783155 2.412812 -1.020037 C 5.50509 -0.152336 1.05017
C -3.476878 -0.847278 -0.211751 C 3.624369 -0.905733 -0.098317 C -3.511107 -0.954295 -0.188926
O -3.494506 -1.84248 -0.890544 O 3.835244 -2.049796 -0.412039 O -3.7776 -1.928416 -0.849389
H -1.237991 -1.098578 2.780946 H 1.468504 -1.652596 -1.965842 H -1.14976 -2.043455 2.65991
H 1.215874 -1.045251 2.915458 H -0.958134 -1.676711 -2.347685 H 1.272276 -1.630838 2.567199
H 2.253857 -2.245155 0.940746 H -2.190703 -2.388048 -0.255558 H 1.885301 -2.300887 0.04231
H -0.772813 -1.370776 -1.503487 H 0.569868 -0.866346 2.189501 H -1.15656 -1.614489 -1.638882
H -0.183577 0.015028 -0.552141 H 0.073671 0.224508 0.87821 H -0.18632 -2.917096 -0.936724
H -1.689185 -2.42169 0.477559 H 1.700658 -2.346215 0.604356 H -2.060068 -2.859163 0.442687
H 3.562683 0.599788 -2.996408 H -4.026775 1.20767 2.698564 H 4.461883 -0.621213 -2.609054
H 2.216152 1.371649 -2.152419 H -2.567532 1.807333 1.901955 H 2.898603 -1.399636 -2.38505
H 2.12275 -0.337554 -2.590252 H -2.552614 0.23454 2.706191 H 4.272012 -1.865873 -1.373275
H 3.806083 -2.451864 -1.186679 H -4.03026 -2.161498 1.593158 H 1.988813 2.435701 -0.801522
H 5.300125 -1.56828 -1.475883 H -5.547829 -1.283348 1.445979 H 2.947459 2.168381 -2.264744
H 4.869896 -2.044128 0.166662 H -4.870984 -2.102391 0.038365 H 1.456608 1.251352 -1.993218
H 4.490581 0.586861 2.179293 H -4.16804 0.078306 -2.443188 H 5.144034 2.379613 1.968079
H 5.871 1.65052 1.895555 H -5.581592 1.12411 -2.598514 H 3.59048 1.546415 2.09019
H 5.912167 -0.013439 1.317427 H -5.705187 -0.388793 -1.705391 H 3.802368 2.862977 0.93313
H 6.414533 0.806802 -1.06022 H -6.585579 0.881595 0.339664 H 6.605419 2.084603 -0.064585
H 5.383415 2.032084 -1.806489 H -5.689706 2.265545 0.974826 H 6.137195 1.008485 -1.377109
H 6.411565 2.454665 -0.440484 H -6.482969 2.3711 -0.593524 H 5.280093 2.534491 -1.133151
H 4.426738 3.366484 0.831388 H -4.331939 3.073414 -1.700223 H 4.846113 -0.680073 1.742035
H 3.3762 2.978791 -0.529153 H -3.503954 3.006528 -0.146519 H 5.908023 -0.881853 0.343616
H 2.986932 2.372822 1.083075 H -2.865836 2.102599 -1.523197 H 6.349114 0.239044 1.628732
C -4.586665 0.13671 -0.141776 C 4.666683 0.150128 -0.035005 C -4.393333 0.232656 -0.058258
C -4.518474 1.284096 0.64545 C 4.375382 1.464079 0.324219 C -4.032475 1.347453 0.695161
C -5.726408 -0.117274 -0.900949 C 5.974807 -0.208914 -0.350717 C -5.618592 0.207997 -0.719885
C -5.585299 2.167834 0.670056 C 5.388145 2.408646 0.366605 C -4.896133 2.427323 0.784545
H -3.630764 1.477454 1.231319 H 3.35815 1.738125 0.566287 H -3.077853 1.361831 1.202394
C -6.790069 0.767895 -0.872413 C 6.98355 0.737999 -0.306768 C -6.47837 1.288783 -0.626789
H -5.758713 -1.013374 -1.506627 H 6.180058 -1.234618 -0.627724 H -5.878319 -0.667011 -1.301123
C -6.720426 1.911168 -0.086949 C 6.69114 2.047447 0.051895 C -6.11792 2.399002 0.125877
H -5.531476 3.059672 1.28167 H 5.160725 3.429824 0.6455 H -4.615218 3.294121 1.369426
H -7.675091 0.567903 -1.463123 H 7.999632 0.456208 -0.552513 H -7.430826 1.267336 -1.141206
H -7.552528 2.604163 -0.064964 H 7.480531 2.788247 0.085939 H -6.790643 3.244803 0.198442
E(RmPW1PW91) = –1292.13041517 a.u. E(RmPW1PW91) = –1292.13006439 a.u. E(RmPW1PW91) = –1292.12880566 a.u.
A.2. 13C NMR ANALYSIS OF 3,6-DIHYDRO-2H-PYRANS 363
cisOBzOTBS_allylic_TZVP_confD2.log
Created by GaussView 5.0.9
01/02/13 20:39:35
transOBzOTBS_bisAx_TZVP_confA.log
Created by GaussView 5.0.9
02/02/13 07:34:58
transOBzOTBS_bisAx_TZVP_confB.log
Created by GaussView 5.0.9
02/02/13 07:41:32
C 0.813608 -2.08966 -1.021613 C -0.711424 -1.595301 -0.738878 C 0.573945 -0.178331 2.112361
C -0.480574 -1.848572 -1.171638 C 0.365578 -1.0876 -1.31946 C -0.527654 0.532692 1.925582
C -1.354976 -1.412889 -0.031117 C 1.091718 0.109967 -0.78069 C -1.132273 0.748603 0.569028
O -0.582961 -0.894678 1.03646 O 0.369478 0.765564 0.229201 O -0.280385 0.337979 -0.467372
C 0.444907 -1.783032 1.41107 C -0.197317 -0.118232 1.177597 C 0.323637 -0.920432 -0.234973
C 1.474791 -1.964844 0.31547 C -1.219776 -1.040419 0.554507 C 1.229441 -0.898638 0.980811
O 2.356244 -0.820034 0.342242 O -2.440067 -0.29182 0.354711 O 2.483562 -0.234584 0.716842
O -2.230157 -0.444172 -0.466012 O 2.35892 -0.299874 -0.353272 O -2.374665 0.108076 0.531626
Si -3.353529 0.375028 0.508499 Si 3.629745 0.736353 0.077461 Si -3.518215 0.262726 -0.710735
C -4.705155 0.917775 -0.723612 C 5.179062 -0.370989 -0.043283 C -5.181915 -0.102576 0.150755
C -4.0124 -0.809325 1.816888 C 3.681207 2.183681 -1.128527 C -3.44177 2.009358 -1.412671
C -2.521492 1.845164 1.329186 C 3.362447 1.385971 1.822316 C -3.136494 -0.97986 -2.069512
C -4.075519 1.765371 -1.833957 C 5.003057 -1.592381 0.864098 C -5.131661 -1.493472 0.790405
C -5.765244 1.747605 0.006316 C 6.416538 0.415528 0.398257 C -6.320781 -0.054764 -0.871882
C -5.364776 -0.313708 -1.350255 C 5.365002 -0.841542 -1.488313 C -5.43217 0.941529 1.241817
C 3.582794 -0.991213 -0.172015 C -3.574728 -1.000296 0.271272 C 3.443778 -0.973141 0.138427
O 3.970267 -2.036362 -0.633907 O -3.615819 -2.203247 0.35537 O 3.302725 -2.134429 -0.156462
H 1.437036 -2.384478 -1.856753 H -1.243353 -2.437583 -1.163334 H 1.019645 -0.276635 3.095316
H -0.974986 -1.961162 -2.128843 H 0.774401 -1.519425 -2.225112 H -1.040622 1.006288 2.753876
H -1.912407 -2.28798 0.355528 H 1.183597 0.863553 -1.571015 H -1.256709 1.823913 0.398222
H 0.912351 -1.372527 2.304335 H 0.582465 -0.729917 1.64313 H -0.43999 -1.689669 -0.078485
H 0.026396 -2.768679 1.659439 H -0.660817 0.502685 1.941976 H 0.885415 -1.170177 -1.132031
H 2.080052 -2.851312 0.516952 H -1.441639 -1.859708 1.241878 H 1.451208 -1.931241 1.258419
H -4.787633 -0.326448 2.415241 H 3.730975 1.851342 -2.166697 H -3.587959 2.770605 -0.644657
H -3.212599 -1.109091 2.496465 H 2.798513 2.816091 -1.014526 H -2.477825 2.189826 -1.892513
H -4.44287 -1.710306 1.377202 H 4.554927 2.80969 -0.935663 H -4.215056 2.147809 -2.171025
H -2.128287 2.54312 0.588664 H 2.438898 1.965714 1.859941 H -2.16059 -0.758457 -2.504615
H -3.214389 2.385961 1.976824 H 4.183072 2.035207 2.13399 H -3.879468 -0.937714 -2.868435
H -1.685088 1.493645 1.934062 H 3.280356 0.573132 2.54552 H -3.111275 -2.000293 -1.684213
H -4.841525 2.061698 -2.559065 H 4.901325 -1.309671 1.914425 H -4.991236 -2.280474 0.045986
H -3.301854 1.214721 -2.371522 H 5.878257 -2.2471 0.787753 H -6.073142 -1.701838 1.310512
H -3.625648 2.681366 -1.444564 H 4.12425 -2.176285 0.585804 H -4.323161 -1.570923 1.519262
H -6.54189 2.067825 -0.696503 H 6.343203 0.747752 1.436264 H -6.195061 -0.7994 -1.66124
H -6.26062 1.180146 0.798252 H 7.308984 -0.214788 0.321801 H -7.277195 -0.262657 -0.380067
H -5.34202 2.649832 0.453744 H 6.589194 1.295992 -0.225567 H -6.408521 0.926121 -1.345547
H -4.634412 -0.941923 -1.863837 H 5.537917 -0.006134 -2.170695 H -5.52015 1.950067 0.831216
H -5.877257 -0.928928 -0.606987 H 6.233838 -1.50483 -1.56003 H -6.368096 0.721686 1.76702
H -6.113484 -0.004773 -2.087988 H 4.494758 -1.395531 -1.845072 H -4.629858 0.945846 1.981916
C 4.403285 0.244415 -0.098081 C -4.766423 -0.135752 0.07405 C 4.691608 -0.20038 -0.088119
C 5.72578 0.174696 -0.528577 C -4.664815 1.246605 -0.06477 C 5.774988 -0.864811 -0.657666
C 3.889974 1.448815 0.377827 C -6.016164 -0.748273 0.026894 C 4.801246 1.147214 0.247047
C 6.530749 1.29982 -0.480112 C -5.808531 2.006957 -0.24844 C 6.960207 -0.187839 -0.888077
H 6.103342 -0.769774 -0.897897 H -3.691072 1.715178 -0.031623 H 5.667641 -1.911007 -0.912419
C 4.698821 2.573048 0.421904 C -7.156224 0.015672 -0.15493 C 5.989372 1.820859 0.014001
H 2.860303 1.497652 0.703894 H -6.072598 -1.823575 0.134374 H 3.95493 1.657624 0.685073
C 6.017846 2.499828 -0.004795 C -7.053341 1.393827 -0.292746 C 7.068326 1.155462 -0.552131
H 7.559122 1.24295 -0.814035 H -5.728872 3.081254 -0.357685 H 7.801338 -0.706411 -1.330633
H 4.298757 3.509763 0.789175 H -8.126887 -0.46272 -0.190341 H 6.074278 2.868513 0.273963
H 6.647336 3.380521 0.031639 H -7.945434 1.991231 -0.435755 H 7.995594 1.685264 -0.73291
E(RmPW1PW91) = –1292.12865035 a.u. E(RmPW1PW91) = –1292.13133870 a.u. E(RmPW1PW91) = –1292.13119315 a.u.
A.2. 13C NMR ANALYSIS OF 3,6-DIHYDRO-2H-PYRANS 364
cisOCO2BnOTBS_anomeric_TZVP_confA.log
Created by GaussView 5.0.9
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cisOCO2BnOTBS_anomeric_TZVP_confB.log
Created by GaussView 5.0.9
02/02/13 07:55:55
cisOCO2BnOTBS_allylic_NMR_confC.log
Created by GaussView 5.0.9
02/02/13 08:01:58
C 0.317579 -1.6896 1.689149 C -0.195906 -1.663775 -1.269847 C 0.39633 -2.314944 1.536072
C 1.633702 -1.571559 1.769179 C -1.498462 -1.546448 -1.477617 C 1.654606 -1.902875 1.51104
C 2.508605 -1.498034 0.551292 C -2.490389 -1.477308 -0.352775 C 2.30453 -1.389095 0.258387
O 1.796589 -1.757186 -0.635795 O -1.897436 -1.742743 0.897767 O 1.332175 -0.995255 -0.691475
C 0.532247 -1.123956 -0.696078 C -0.65046 -1.102747 1.083931 C 0.40205 -2.025684 -0.929439
C -0.376713 -1.71869 0.367503 C 0.364228 -1.68499 0.117632 C -0.437808 -2.341262 0.297841
O -1.572583 -0.930572 0.501438 O 1.528448 -0.846229 0.22217 O -1.502239 -1.383449 0.49029
O 3.136049 -0.251071 0.536335 O -3.117862 -0.230986 -0.392947 O 3.100056 -0.311255 0.567679
Si 4.387866 0.199643 -0.515007 Si -4.466119 0.215636 0.533474 Si 3.971046 0.635769 -0.539289
C 5.254317 1.632743 0.399515 C -5.250721 1.642891 -0.459694 C 5.396572 1.341289 0.513439
C 3.66725 0.748808 -2.163097 C -3.903907 0.768848 2.240617 C 4.593707 -0.462585 -1.937206
C 5.527096 -1.275551 -0.788366 C -5.615877 -1.267032 0.702414 C 2.861099 1.986763 -1.222973
C 5.809046 1.130625 1.73546 C -5.720349 1.127487 -1.822815 C 4.819684 2.124578 1.697048
C 6.401992 2.177857 -0.455203 C -6.4472 2.213994 0.306873 C 6.258927 2.276121 -0.34049
C 4.241368 2.750243 0.66636 C -4.209913 2.746431 -0.672586 C 6.264539 0.197822 1.046057
C -2.570962 -1.227259 -0.331196 C 2.67926 -1.381214 -0.183243 C -2.599668 -1.588616 -0.234256
O -3.591679 -0.425768 -0.046263 O 3.638508 -0.480146 0.001571 O -3.481172 -0.641757 0.068266
O -2.554952 -2.073785 -1.185234 O 2.826398 -2.486237 -0.634704 O -2.768542 -2.479802 -1.02686
C -4.764822 -0.620808 -0.863491 C 4.95762 -0.908871 -0.39607 C -4.730705 -0.725339 -0.647462
H -0.302618 -1.757821 2.575298 H 0.502764 -1.75493 -2.092884 H -0.070167 -2.645008 2.45677
H 2.140588 -1.521082 2.724625 H -1.910057 -1.502213 -2.478385 H 2.275889 -1.910847 2.398066
H 3.257106 -2.297734 0.58669 H -3.230881 -2.277292 -0.465219 H 2.909325 -2.19575 -0.19968
H 0.140003 -1.302539 -1.694888 H -0.357249 -1.277505 2.117394 H -0.230227 -1.709024 -1.756046
H 0.621996 -0.046147 -0.526946 H -0.728981 -0.024697 0.915306 H 0.919983 -2.946721 -1.233701
H -0.662925 -2.736294 0.090251 H 0.642867 -2.702647 0.40071 H -0.897427 -3.322433 0.159999
H 4.450673 1.079409 -2.848019 H -4.751667 1.064164 2.861874 H 5.223272 0.109538 -2.621814
H 2.958464 1.56871 -2.038222 H -3.214121 1.612221 2.183949 H 3.754693 -0.85669 -2.513288
H 3.140521 -0.085084 -2.629656 H -3.390953 -0.055108 2.739072 H 5.180814 -1.305349 -1.568986
H 5.005911 -2.074224 -1.31985 H -5.145858 -2.054652 1.294651 H 2.451004 2.604934 -0.423142
H 6.384406 -0.984745 -1.398841 H -6.535503 -0.979273 1.215996 H 3.401735 2.635473 -1.915365
H 5.907598 -1.682221 0.149985 H -5.891833 -1.687152 -0.265999 H 2.024099 1.533321 -1.755053
H 5.019199 0.722633 2.368738 H -4.894705 0.705104 -2.398586 H 5.631884 2.509971 2.323372
H 6.27994 1.955436 2.281347 H -6.147244 1.948784 -2.408824 H 4.183752 1.497096 2.323713
H 6.568148 0.356501 1.600307 H -6.493777 0.361558 -1.728048 H 4.226845 2.981452 1.369695
H 7.162327 1.419099 -0.656152 H -7.226918 1.466196 0.471884 H 7.078094 2.685305 0.260572
H 6.052281 2.565409 -1.414897 H -6.156668 2.617085 1.27974 H 6.709714 1.758529 -1.190951
H 6.899662 3.003587 0.064841 H -6.900797 3.033423 -0.26106 H 5.687195 3.123052 -0.726923
H 4.717716 3.565245 1.222409 H -4.641435 3.560536 -1.265271 H 5.682584 -0.500548 1.650307
H 3.84928 3.17571 -0.260171 H -3.872168 3.17777 0.272494 H 6.739858 -0.366127 0.239983
H 3.396091 2.392688 1.256717 H -3.332986 2.373804 -1.204296 H 7.064846 0.597329 1.678673
H -4.50603 -0.411813 -1.902033 H 5.223664 -1.799515 0.173686 H -4.520823 -0.717642 -1.717524
H -5.07036 -1.664999 -0.793145 H 4.933161 -1.177041 -1.452849 H -5.212408 -1.672629 -0.403472
C -5.834334 0.299466 -0.368239 C 5.910967 0.213324 -0.135778 C -5.578662 0.438786 -0.245186
C -5.98491 1.568821 -0.916424 C 6.617496 0.276781 1.060486 C -5.418106 1.67426 -0.865237
C -6.687339 -0.099551 0.656063 C 6.097773 1.213926 -1.084549 C -6.534317 0.30512 0.756138
C -6.967869 2.427443 -0.447753 C 7.49388 1.322812 1.307689 C -6.195358 2.75797 -0.488353
H -5.325553 1.887116 -1.715711 H 6.479352 -0.499481 1.804345 H -4.67615 1.786941 -1.647318
C -7.670331 0.75633 1.128031 C 6.971348 2.261989 -0.84032 C -7.315815 1.386829 1.134411
H -6.578759 -1.088114 1.087229 H 5.552898 1.171239 -2.020588 H -6.666991 -0.65397 1.243523
C -7.81189 2.021867 0.576057 C 7.671273 2.317553 0.35704 C -7.146767 2.615168 0.512485
H -7.076647 3.412975 -0.883103 H 8.039997 1.360602 2.242012 H -6.061879 3.714599 -0.977946
H -8.329341 0.434881 1.924937 H 7.109683 3.034782 -1.586214 H -8.058147 1.270352 1.914198
H -8.581394 2.690307 0.941944 H 8.356659 3.13417 0.547296 H -7.75726 3.460383 0.805292
E(RmPW1PW91) = –1406.67614091 a.u. E(RmPW1PW91) = –1406.67599662 a.u. E(RmPW1PW91) = –1406.67404005 a.u.
A.2. 13C NMR ANALYSIS OF 3,6-DIHYDRO-2H-PYRANS 365
cisOCO2BnOTBS_allylic_TZVP_confD.log
Created by GaussView 5.0.9
02/02/13 08:32:06
transOCO2BnOTBS_bisAx_TZVP_confA.log
Created by GaussView 5.0.9
02/02/13 08:40:38
transOCO2BnOTBS_bisAx_TZVP_confB.log
Created by GaussView 5.0.9
02/02/13 08:45:44
C -0.017384 -2.099946 -0.511823 C 0.185351 -1.615449 -0.821714 C 0.334522 -1.890076 -1.172412
C -1.339716 -2.030167 -0.557511 C 1.233552 -1.015804 -1.365919 C 1.40142 -1.256687 -1.634556
C -2.138903 -1.233916 0.433637 C 1.916068 0.160935 -0.733048 C 1.950575 -0.018122 -0.988832
O -1.328165 -0.28402 1.098211 O 1.183557 0.694204 0.338477 O 1.074611 0.519847 -0.034276
C -0.167576 -0.871602 1.637355 C 0.661761 -0.287634 1.211929 C 0.522815 -0.45098 0.833111
C 0.75807 -1.406036 0.564139 C -0.32538 -1.200826 0.521832 C -0.332764 -1.458714 0.09132
O 1.495745 -0.283073 0.027386 O -1.585778 -0.497229 0.415876 O -1.62612 -0.926944 -0.273211
O -3.158186 -0.57913 -0.218947 O 3.207771 -0.226405 -0.361196 O 3.208509 -0.319274 -0.457161
Si -4.192268 0.57876 0.469983 Si 4.411168 0.825659 0.204795 Si 4.310709 0.81569 0.15217
C -5.734084 0.526527 -0.65529 C 6.040872 -0.087367 -0.187573 C 6.00843 -0.025972 -0.075141
C -4.585021 0.078539 2.243372 C 4.273116 2.474418 -0.696838 C 4.160244 2.418045 -0.827655
C -3.361155 2.262427 0.446215 C 4.189496 1.103021 2.052065 C 3.930073 1.152325 1.962951
C -5.323817 0.821279 -2.101087 C 6.041071 -1.451917 0.508202 C 6.012075 -1.370218 0.659675
C -6.741472 1.581737 -0.189784 C 7.231191 0.737036 0.310779 C 7.114712 0.866989 0.493765
C -6.380764 -0.859267 -0.589217 C 6.162022 -0.294896 -1.699356 C 6.265937 -0.269453 -1.564344
C 2.636059 -0.576397 -0.588646 C -2.659176 -1.258567 0.229493 C -2.554573 -0.958333 0.6797
O 3.162644 0.558143 -1.038521 O -3.724626 -0.465817 0.163128 O -3.677337 -0.45039 0.181753
O 3.105116 -1.678506 -0.718317 O -2.670348 -2.459782 0.143625 O -2.408607 -1.378364 1.798857
C 4.448626 0.452416 -1.6839 C -4.977426 -1.149375 -0.042693 C -4.787191 -0.414606 1.102417
H 0.547221 -2.662197 -1.245365 H -0.316079 -2.44054 -1.311952 H -0.075899 -2.751069 -1.686547
H -1.912622 -2.550782 -1.315244 H 1.647672 -1.350446 -2.309448 H 1.923852 -1.602584 -2.518105
H -2.552946 -1.916228 1.201371 H 1.961519 0.983548 -1.455461 H 2.037775 0.772637 -1.742168
H 0.337423 -0.104033 2.220783 H 1.469382 -0.902287 1.62312 H 1.317353 -0.996061 1.35396
H -0.433826 -1.701306 2.307415 H 0.176471 0.248394 2.025319 H -0.066015 0.085943 1.573521
H 1.480865 -2.094076 1.008145 H -0.49132 -2.087218 1.138317 H -0.497241 -2.314933 0.748965
H -5.307795 0.767633 2.684879 H 4.341162 2.362771 -1.78021 H 4.313322 2.267534 -1.897655
H -3.680205 0.115195 2.852529 H 3.325427 2.963136 -0.462316 H 3.174671 2.865021 -0.68325
H -5.000471 -0.928334 2.306744 H 5.072934 3.146717 -0.379734 H 4.900883 3.143017 -0.483798
H -3.104765 2.565991 -0.569744 H 3.234474 1.597432 2.236668 H 2.936355 1.593829 2.054132
H -4.00254 3.0306 0.882898 H 4.981078 1.737167 2.456245 H 4.649142 1.850251 2.39642
H -2.436985 2.214284 1.022664 H 4.195948 0.161647 2.603616 H 3.948559 0.236277 2.55523
H -6.201197 0.783072 -2.756257 H 5.993854 -1.355342 1.595276 H 5.87284 -1.248856 1.736364
H -4.598768 0.094058 -2.470025 H 6.962079 -1.99554 0.270034 H 6.972477 -1.876426 0.511795
H -4.883743 1.815407 -2.204692 H 5.198483 -2.066847 0.187422 H 5.225873 -2.031111 0.29084
H -7.62925 1.563536 -0.831165 H 7.200183 0.890647 1.391938 H 6.983779 1.052271 1.562399
H -7.079562 1.405329 0.834388 H 8.169106 0.218672 0.084219 H 8.090174 0.385531 0.365644
H -6.327529 2.591453 -0.238117 H 7.281322 1.71862 -0.166807 H 7.163904 1.834612 -0.011656
H -5.685769 -1.641154 -0.901249 H 6.196869 0.653488 -2.240332 H 6.308444 0.664281 -2.129616
H -6.731515 -1.100345 0.416975 H 7.084629 -0.837061 -1.933516 H 7.226244 -0.778125 -1.702589
H -7.249892 -0.902696 -1.254919 H 5.3262 -0.877177 -2.091458 H 5.491267 -0.898285 -2.007133
H 4.457441 1.283443 -2.386296 H -4.917276 -1.713459 -0.974352 H -4.988891 -1.429045 1.44756
H 4.494508 -0.487756 -2.230987 H -5.131577 -1.85721 0.772041 H -4.505238 0.187819 1.966607
C 5.58053 0.565351 -0.706476 C -6.065241 -0.124192 -0.089428 C -5.966141 0.166411 0.389306
C 6.204458 -0.573971 -0.206589 C -6.331174 0.568355 -1.266902 C -6.855657 -0.658737 -0.29114
C 6.017741 1.817945 -0.283712 C -6.820017 0.157144 1.044043 C -6.184719 1.540273 0.389549
C 7.245575 -0.461583 0.703409 C -7.32964 1.528481 -1.309244 C -7.942694 -0.121233 -0.963344
H 5.859389 -1.549688 -0.525526 H -5.748092 0.354787 -2.155275 H -6.694087 -1.73057 -0.294407
C 7.055935 1.931845 0.627426 C -7.82232 1.115253 1.004789 C -7.27039 2.081561 -0.281668
H 5.53802 2.709812 -0.670632 H -6.620392 -0.378479 1.965073 H -5.497385 2.190255 0.918697
C 7.672646 0.790476 1.121562 C -8.077773 1.802984 -0.172413 C -8.151398 1.250604 -0.959289
H 7.725267 -1.354061 1.085868 H -7.527755 2.06128 -2.230976 H -8.629384 -0.77336 -1.488593
H 7.388458 2.911279 0.948357 H -8.404672 1.32422 1.893557 H -7.431118 3.152427 -0.273775
H 8.486826 0.877657 1.830462 H -8.860703 2.550478 -0.205455 H -9.001684 1.67161 -1.481406
E(RmPW1PW91) = –1406.67448119 a.u. E(RmPW1PW91) = –1406.67671726 a.u. E(RmPW1PW91) = –1406.67674020 a.u.
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C 0.871515 -0.943528 -0.904868 C 0.830639 1.022065 -0.65639 C 0.440375 -1.682898 -1.565306
C -0.399432 -1.206572 -1.16805 C -0.327116 0.764059 -1.246212 C -0.74987 -1.966823 -1.060409
C -1.446676 -1.285405 -0.095084 C -1.247002 -0.331126 -0.793106 C -1.321235 -1.239587 0.121363
O -0.890138 -1.221412 1.198817 O -0.632707 -1.195723 0.127242 O -0.359057 -0.451806 0.77317
C 0.126119 -0.249234 1.333632 C 0.094082 -0.521062 1.132986 C 0.4247 0.323452 -0.109446
C 1.324074 -0.660067 0.495544 C 1.254378 0.27165 0.568946 C 1.253918 -0.543078 -1.042646
O 2.236201 0.441262 0.536004 O 2.323781 -0.648956 0.285624 O 2.407666 -1.108427 -0.399383
O -2.380615 -0.276036 -0.323837 O -2.411047 0.253149 -0.289332 O -2.423717 -0.498452 -0.307952
Si -3.880257 -0.13104 0.457629 Si -3.831181 -0.583552 0.116045 Si -3.558373 0.254048 0.706654
C -4.936063 0.88589 -0.76299 C -5.207839 0.722294 -0.082599 C -5.117596 0.397316 -0.381207
C -3.650639 0.75635 2.099511 C -4.041909 -2.045529 -1.052714 C -3.836717 -0.821336 2.228144
C -4.583082 -1.85238 0.761578 C -3.700712 -1.207461 1.885569 C -2.904684 1.934276 1.238726
C -5.060335 0.133139 -2.09032 C -4.923298 1.910524 0.841417 C -4.790303 1.2028 -1.64272
C -6.331941 1.114821 -0.17568 C -6.562445 0.108383 0.282926 C -6.232473 1.10335 0.396541
C -4.263169 2.238811 -1.015047 C -5.245654 1.21216 -1.532472 C -5.590347 -1.000753 -0.789644
H 1.612276 -0.905561 -1.694905 H 1.487942 1.792734 -1.040001 H 0.855498 -2.253161 -2.387723
H -0.74425 -1.371709 -2.181261 H -0.662424 1.340188 -2.100144 H -1.365977 -2.753651 -1.478276
H -1.93175 -2.267451 -0.122319 H -1.483332 -0.978981 -1.644398 H -1.622881 -1.967967 0.882155
H 0.382387 -0.20324 2.390327 H -0.558068 0.165563 1.68271 H -0.211814 0.974603 -0.718735
H -0.219164 0.736266 1.007079 H 0.460285 -1.284021 1.817298 H 1.062275 0.947546 0.513892
H 1.80304 -1.536383 0.944415 H 1.595173 0.965966 1.34344 H 1.592371 0.066339 -1.886492
H -4.606457 0.908243 2.604887 H -4.058932 -1.741211 -2.10052 H -4.129737 -1.839878 1.967865
H -3.180163 1.731384 1.964453 H -3.231367 -2.764561 -0.918522 H -2.934432 -0.871763 2.840753
H -3.01289 0.161106 2.754987 H -4.977831 -2.567048 -0.842269 H -4.627329 -0.396256 2.849963
H -3.963704 -2.406462 1.469689 H -2.89982 -1.94508 1.958958 H -1.985459 1.805867 1.812581
H -5.584114 -1.78289 1.192005 H -4.627986 -1.684374 2.20912 H -3.624809 2.458393 1.870046
H -4.655463 -2.435859 -0.157672 H -3.478263 -0.395723 2.579747 H -2.681673 2.570441 0.380912
H -4.082867 -0.047357 -2.541213 H -4.918513 1.618279 1.894045 H -4.489324 2.226555 -1.408857
H -5.65165 0.719868 -2.801685 H -5.699203 2.674275 0.719998 H -5.673471 1.263544 -2.288028
H -5.561103 -0.830406 -1.97026 H -3.961341 2.37419 0.616085 H -3.987862 0.738241 -2.218282
H -6.86349 0.176627 0.001091 H -6.589211 -0.24128 1.317563 H -5.949328 2.1159 0.693455
H -6.296446 1.66395 0.768115 H -7.355498 0.855839 0.173731 H -7.129156 1.188112 -0.226641
H -6.939359 1.704315 -0.870638 H -6.821153 -0.733509 -0.363819 H -6.517505 0.555193 1.297869
H -4.847849 2.820077 -1.736411 H -5.483677 0.406326 -2.230581 H -5.871368 -1.607199 0.074481
H -4.189287 2.835044 -0.10264 H -6.015768 1.98211 -1.650198 H -6.472308 -0.925506 -1.43493
H -3.257405 2.118419 -1.421287 H -4.291471 1.649006 -1.832438 H -4.819342 -1.538655 -1.344267
C 3.522902 0.244943 0.223121 C 3.576342 -0.197129 0.178165 C 3.505673 -0.361898 -0.240193
C 4.329623 1.419534 0.319313 C 3.97954 1.09623 0.323441 C 4.585698 -1.050455 0.39284
C 4.081827 -0.93776 -0.155168 C 4.538474 -1.215272 -0.103492 C 3.661267 0.935887 -0.625892
C 5.641792 1.329182 0.034861 C 5.360873 1.455664 0.2042 C 5.745244 -0.397889 0.591616
H 3.884114 2.355729 0.617418 H 3.307984 1.915189 0.524194 H 4.460041 -2.077003 0.699843
C 5.480753 -1.027138 -0.453949 C 5.833932 -0.870571 -0.218277 C 4.900474 1.623744 -0.413705
H 3.527055 -1.855865 -0.261299 H 4.217636 -2.238599 -0.220929 H 2.888124 1.5224 -1.094851
O 6.093297 -2.000218 -0.793511 C 6.953699 -1.800352 -0.509272 C 6.958863 -0.966064 1.229626
O 6.208636 0.171429 -0.334962 H 6.590664 -2.819642 -0.621298 H 7.803361 -0.91925 0.539661
C 6.616265 2.447461 0.085872 H 7.463259 -1.499169 -1.426415 H 7.227031 -0.383584 2.112997
H 7.078064 2.588301 -0.893089 H 7.688481 -1.768438 0.297261 H 6.793211 -2.000787 1.521498
H 6.128382 3.372028 0.386642 O 5.842186 2.549066 0.312404 O 5.914587 0.878018 0.213023
H 7.415444 2.217886 0.79303 O 6.245669 0.398032 -0.074181 O 5.164419 2.756241 -0.70763
E(RmPW1PW91) = –1329.23013808 a.u. E(RmPW1PW91) = –1329.23000503 a.u. E(RmPW1PW91) = –1329.23008409 a.u.
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B.1 Furopyrone X-Ray Crystal Structure
Table B.1 Crystal Data and Structure Refinement for MJBA
Identification code MJBA
Empirical formula C11H10O4
Formula weight 206.19
Temperature / K 296.0
Crystal system monoclinic
Space group P21/c
a / Å, b / Å, c / Å 7.7627(3), 11.0574(4), 11.2765(4)
α/ ◦C, β/ ◦C, γ/ ◦C 90.00, 103.614(2), 90.00
Volume / Å3 940.73(6)
Z 4
ρcalc / mg mm-3 1.456
µ / mm?1 0.112
F(000) 432
Crystal size / mm3 0.54 x 0.44 x 0.35
Theta range for data collection 2.62 to 68.96 ◦C
Index ranges -11 ≤ h ≤ 12, -16 ≤ k ≤ 17, -17 ≤ l ≤ 16
Reflections collected 24388
Independent reflections 3438[R(int) = 0.0302]
Data/restraints/parameters 3438/0/176
Goodness-of-fit on F2 1.152
Final R indexes [I>2θ (I)] R1 = 0.0505, wR2 = 0.1202
Final R indexes [all data] R1 = 0.0568, wR2 = 0.1233
Largest diff. peak/hole / e Å-3 0.483/-0.216
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Table B.2 Fractional Atomic Coordinates (x 104) and Equivalent Isotropic Displacement
Parameters (Å2 x 103) for MJBA.
Ueq is defined as 1/3 of of the trace of the orthogonalised UIJ tensor.
Atom x y z U(eq)
O1 1639.0(11) 2951.8(7) 399.7(7) 20.97(17)
C2 2953.8(14) 4656.8(9) 1541.5(9) 17.26(18)
O 2899.7(13) 7999.5(7) 2121.0(8) 27.09(19)
O4 3322.7(11) 4714.5(7) 3603.7(7) 21.14(17)
O5 2370.8(15) 4514.7(8) -619.5(8) 32.7(2)
C6 2021.9(15) 2900(1) 2549.1(10) 20.2(2)
C7 2747.9(13) 4079.6(9) 2567.3(9) 17.18(18)
C8 4341.5(14) 5758.7(9) 3270.8(10) 19.6(2)
C9 1514.7(14) 2371.1(9) 1444.7(10) 18.81(19)
C10 3735.4(14) 5886.0(9) 1875.2(9) 17.89(19)
C11 2351.9(15) 4116.9(10) 382.4(10) 20.9(2)
C12 2324.7(16) 6863.6(10) 1539.2(10) 22.0(2)
C13 4080.4(16) 6872.5(10) 3941.1(10) 23.4(2)
C14 768.3(16) 1132.6(10) 1188.0(12) 24.3(2)
C15 3498.5(16) 7892.6(10) 3353.8(11) 25.0(2)
Table B.3 Hydrogen Atom Coordinates (Å x 104) and Isotropic Displacement Parameters
(Å2 x 103) for MJBA.
Atom x y z U(eq)
H15 3470.0(2) 8665(15) 3758(15) 27(4)
H8 5560.0(2) 5490(14) 3486(13) 22(4)
H6 1900.0(2) 2508(15) 3251(15) 27(4)
H10 4750.0(2) 6065(15) 1543(15) 29(4)
H12B 2000.0(2) 7018(14) 660(15) 28(4)
H14C 950.0(2) 658(17) 1902(17) 39(5)
H14A 1320.0(2) 734(16) 650(16) 35(4)
H12A 1249(19) 6626(14) 1818(14) 20(3)
H14B -460.0(2) 1191(15) 812(16) 32(4)
H13 4480.0(2) 6882(15) 4793(17) 32(4)
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Table B.4 Anisotropic Displacement Parameters (Å2 x 103) for MJBA.
The Anisotropic displacement factor exponent takes the form:
-2pi2[h2a*2U11+...+2hka x b x U12]
Atom U11 U22 U33 U23 U13 U12
O1 28.2(4) 17.4(3) 17.0(3) -1.8(3) 4.5(3) -3.9(3)
C2 21.5(4) 14.6(4) 16.3(4) -0.2(3) 5.6(3) -0.7(3)
O 38.8(5) 15.8(4) 27.7(4) -0.3(3) 9.7(4) 1.3(3)
O4 28.9(4) 18.6(4) 15.1(3) -0.8(3) 3.6(3) -3.4(3)
O5 57.8(6) 24.9(4) 16.9(4) -0.7(3) 11.5(4) -8.8(4)
C6 25.3(5) 17.3(4) 18.5(4) 2.2(3) 6.2(4) -1.3(4)
C7 19.9(4) 16.2(4) 15.2(4) 0.0(3) 3.7(3) 0.6(3)
C8 19.4(4) 17.7(4) 20.9(5) -1.8(3) 2.9(4) -1.8(3)
C9 19.3(4) 16.0(4) 21.3(5) 1.2(3) 4.9(4) -0.8(3)
C10 20.9(4) 15.5(4) 18.5(4) -1.2(3) 7.1(4) -1.7(3)
C11 28.2(5) 17.0(4) 18.3(4) -1.3(3) 6.8(4) -2.4(4)
C12 26.8(5) 17.2(4) 21.5(5) 0.7(3) 4.9(4) 0.9(4)
C13 27.3(5) 21.7(5) 21.0(5) -5.5(4) 5.1(4) -3.8(4)
C14 24.6(5) 17.2(5) 30.5(5) -2.2(4) 5.3(4) -3.7(4)
C15 30.3(5) 18.9(5) 28.0(5) -5.8(4) 11.4(4) -3.1(4)
Table B.5 Bond Lengths for MJBA.
Atom Atom Length/Å Atom Atom Length/Å
O1 C9 1.3652(12) O5 C11 1.2158(13)
O1 C11 1.4040(13) C6 C7 1.4191(14)
C2 C7 1.3631(13) C6 C9 1.3480(15)
C2 C10 1.4999(14) C8 C10 1.5393(15)
C2 C11 1.4126(14) C8 C13 1.4838(15)
O C12 1.4385(14) C9 C14 1.4886(15)
O C15 1.3632(15) C10 C12 1.5218(15)
O4 C7 1.3462(12) C13 C15 1.3319(17)
O4 C8 1.4963(13)
Table B.6 Bond Angles for MJBA.
Atom Atom Atom Angle/ ◦ Atom Atom Atom Angle/ ◦
O1 C9 C14 111.60(9) C7 C2 C10 109.43(9)
O1 C11 C2 114.87(9) C7 C2 C11 120.53(9)
C2 C7 C6 122.93(9) C7 O4 C8 105.75(8)
C2 C10 C8 100.48(8) C9 O1 C11 123.48(8)
C2 C10 C12 110.87(9) C9 C6 C7 116.15(9)
O C12 C10 112.26(9) C11 C2 C10 129.89(9)
O4 C7 C2 114.29(9) C12 C10 C8 110.39(8)
O4 C7 C6 122.77(9) C13 C8 O4 111.65(9)
O4 C8 C10 105.94(8) C13 C8 C10 113.54(9)
O5 C11 O1 115.84(9) C13 C15 O 125.09(10)
O5 C11 C2 129.29(10) C15 O C12 112.59(9)
C6 C9 O1 121.92(9) C15 C13 C8 121.37(10)
C6 C9 C14 126.47(10)
